Article 1:
nonexudative armd nonexudative armd practice essentials background pathophysiology nonexudative armd clinical presentation history physical causes nonexudative armd differential diagnoses nonexudative armd workup laboratory studies imaging studies tests nonexudative armd treatment management medical care surgical care consultations nonexudative armd medication nonexudative armd followup outpatient care inpatient outpatient medications complications nonexudative armd practice essentials background pathophysiology nonexudative armd clinical presentation history physical causes nonexudative armd differential diagnoses nonexudative armd workup laboratory studies imaging studies tests nonexudative armd treatment management medical care surgical care consultations nonexudative armd medication nonexudative armd followup outpatient care inpatient outpatient medications complications overview practice essentials background pathophysiology frequency mortalitymorbidity presentation history physical causes differential diagnoses workup laboratory studies imaging studies tests procedures histologic findings treatment medical care surgical care consultations diet activity medication followup outpatient care inpatient outpatient medications complications prognosis patient education nonexudative armd overview nonexudative armd clinical presentation nonexudative armd differential diagnoses nonexudative armd workup nonexudative armd treatment nonexudative armd medication nonexudative armd followup 1223154overview apr 24 2014 201508121509 0 ophthalmology 2002 diseases conditions condition 1 2 content 1223154 502 5005291 36 ssg jun 04 2015 condition diseases conditions ophthalmology ophthalmology ophthalmologyretina retina nonexudative armd nonexudative agerelated macular degeneration nonexudative amd agerelated macular degeneration amd dry macular degeneration macular degeneration senile macular degeneration geographic atrophy drusen drusenoid changes pigment epithelial degeneration photodynamic therapy pdt transpupillary thermotherapy ttt iris medical laser rheopheresis complications agerelated macular degeneration prevention trial capt drusen ablation laser drusen cnft intraocular implant chf complement factor h gene agerelated macular degeneration armd common cause irreversible vision loss developed world armd associated presence drusen without visual loss early disease often progresses retinal atrophy central retinal degeneration associated loss central vision 0 nonexudative armd overview practice essentials nonexudative dry agerelated macular degeneration armd see image comprises 90 patients diagnosed armd armd common cause irreversible vision loss developed world condition associated presence drusen without visual loss early disease often progresses retinal atrophy central retinal degeneration associated loss central vision generally nonexudative armd much slower decades progressive visual loss relative exudative wet armd months moderate nonexudative agerelated macular degeneration shown presence drusen moderate nonexudative agerelated macular degeneration shown presence drusen yellow deposits macular region signs symptoms signs symptoms armd include following difficulty night vision changing light conditions specifically changes amsler grid selfevaluation trouble reading visual fluctuation ie days vision poor days vision appears improved difficulty reading making faces metamorphopsia distortion visual images major patient complaint may present atrophy slowly progresses see clinical presentation diagnosis funduscopic examination patients suspected armd includes following findings amrd significant presence drusen usually confluent significant pigment changes pigment accumulation posterior pole retinal pigment epithelium rpe often appears atrophic easier visualization underlying choroid plexus advanced stages nonexudative armd coalescence focal islands atrophy formation large zones atrophy severely affected vision choroidal neovascularization rpe elevation exudate subretinal fluid procedures fluorescein angiography value patients amrd note recent onset worsening vision associated metamorphopsia amsler grid evaluation cornerstone evaluation nonexudative amrd slitlamp biomicroscopy biopsy histologic examination imaging studies fundus photography best modality follow nonexudative armd optical coherence tomography optional may used follow disease progression examine retinal thickness multifocal electroretinography optional may used follow disease progression evaluate functional response retinal rods cones see workup management prevention best treatment nonexudative armd satisfactory method exists treat condition accumulated evidence suggests armd genetic disease management nonexudative armd may include following intravitreal injection ranibizumab bevacizumab pegaptanib sodium photodynamic therapy verteporfin thermal laser photocoagulation surgery nonpharmacotherapy antioxidant vitamin mineral supplements vitamin vitamin e zinc lutein screening impaired visual acuity wraparound shades eg orangetinted blue blocker lenses effective solution delayed dark adaptation protect eyes direct sunlight avoidancecessation tobacco use frequent followup risk assessment conversion exudative armd see treatment medication background agerelated macular degeneration armd common cause irreversible vision loss developed world armd associated presence drusen without visual loss early disease often progresses retinal atrophy central retinal degeneration associated loss central vision intermediate form associated loss retinal pigment epithelium rpe overlying retinal layers atrophy loss contrast sensitivity loss reading speed difficulty adaptation changing light conditions advanced nonexudative form armd characterized presence atrophy associated severe central visualfield loss forms dry armd peripheral visual acuity preserved exudative armd greater 90 patients diagnosed armd nonexudative dry armd nonexudative armd generally associated much slower decades progressive visual loss compared exudative wet armd generally associated rapid months visual loss however patients advanced cases dry armd profound visual loss exudative armd armd describes collection inherited diseases multifactorial share common features including age predilection positive family history presence yellowgray material bruch membrane ie drusen rpe changes eg atrophy clumping rpe detachments posterior pole periphery visual disturbances eg abnormal reading stereo andor color vision disturbances darklight adaptation disturbances rpe degeneration accompanied variable loss overlying photoreceptors underlying choroidal perfusion appropriate age clinical findings accompanied loss visual acuity visual field visual functions condition often classified armd times step prior onset visual loss classified armd patient characteristic drusen relevant family history armd usually manifests age 50 years disease often bilateral patients report significant history disease family members lived later years life many patients develop rapid form visual loss secondary development neovascularization choroid develops either rpe form armd referred wet prevalent form known dry dry form armd progresses larger areas rpe atrophy condition referred geographic atrophy ga ga usually bilateral necessarily symmetrical develop neovascularization result rapid loss vision antioxidant multivitamin therapy consisting vitamin 25000 iu vitamin c 500 mg zinc 80 mg copper 2 mg vitamin e 400 mg shown large clinical trail agerelated eye diseases study areds helpful decreasing risk visual loss nonexudative armd decrease visual loss appeared due reduced risk conversion wet armd areds notably show benefit use vitamins early armd subjects without armd baseline womens antioxidant folic acid cardiovascular study looked cohort women without evidence armd randomized doubleblind placebocontrolled trial included 5442 female healthcare professionals noted combination folic acid 25 mgd pyridoxine hydrochloride 50 mgd cyanocobalamin 1 mgd reduced relative risk developing visually significant armd approximately 40 study also demonstrated reduced risk developing nonvisually significant armd similar amount phase study demonstrated visual benefit decreased progression armd subjects advanced dry armd provided intravitreal implant additional therapies tried include rheopheresis apheresis laser drusen therapies demonstrated small benefit short term 13 prove significant benefit time fact complications agerelated macular degeneration prevention trial capt demonstrated laser drusen ultimately beneficial may potentially harmful pathophysiology clinical pathophysiology clinical definition early agerelated macular degeneration armd varies source consulted clinically useful guideline drusen posterior pole greater 5 number least 63 µm size time drusen enlarge result shallow elevation rpe overlies bruch membrane deposits may merge time associated pigmentation change visible ophthalmoscopy evaluation areds results provided clinically useful method determining risk advanced armd use simple criteria 1 presence large drusen greater 125 µm size 2 presence pigment abnormalities thus one eye large drusen pigment abnormalities score 2 1 criterion eyes risk factor score 4 using simplified criteria areds found 5 years eyes risk factor score 0 04 move advanced armd 1 risk factor 31 move advanced armd however eyes 2 3 4 risk factors rate advanced armd conversion either large geographic atrophy neovascularization increased 12 26 47 respectively matrix simple powerful tool determine persons develop advanced armd useful recollect criteria performing clinical examination example presence large druse 125 µm size would easily remembered looking drusen whose shortest diameter approximately 125 µm large diameter retinal vein optic disc margin drusen within 2 disc diameters center used analysis pigment abnormalities included areas hyperpigmentation hypopigmentation well noncentral areas geographic atrophy visual acuity loss visualfield loss occurs rpe atrophies results secondary loss overlying photoreceptor cells supplies variety fundus changes described defines dry armd damaged rpe results development choroidal neovascularization late leakage fluoresce angiography decrease vision metamorphopsia exudative wet armd said occur molecular pathophysiology dry armd inherited autosomal dominant disease appears affected nutrition environmental factors nonexudative armd characterized degeneration retina choroid posterior pole due either atrophy rpe detachment atrophy generally preceded coincident cases presence yellow extracellular deposits adjacent basal surface rpe called drusen drusen composed vitronectin multifunctional plasma extracellular matrix protein lipids immune inflammatory related proteins amyloid associated proteins well poorly characterized substances drusen thought result accumulated waste material subretinal tissues data suggest accumulation due presence inflammation subretinal space extracellular material bruch membrane composed various substances including vitronectin proteinaceous material complement system alternative system ie independent antibodies defense infection complement factor h cfh robust antiinflammatory agent protects host cells complementmediated damage binding activated complement component c3b 2005 four separate groups reported common variation cfh 2006 two genes identified increased risk similarly cfh polymorphism significantly associated armd t→c substitution results tyrosinetohistidine substitution cfh protein thus appears affected individuals rpe cells may undergo damage via complement system inability inhibit complement cascade effectively additional indirect evidence support chain events noted publication indicates choroidal levels creactive protein elevated homozygote cfh polymorphic individuals studies dileneated molecular pathway leading geographic atrophy visual loss pathway indicates rpe death leads secondary photoreceptor loss consequent visual loss time ambati et al found rpe cells patients dry armd low levels rnacleaving enzyme dicer1 low levels enzyme lead decreased breakdown rnaalu molecules overabundance cytoplasmic rnaalu molecules noncoding sequences rna activates inflammatory proteins nlrp3 inflammosome activates cascade molecular responses lead rpe cell death frequency united states agerelated macular degeneration armd leading cause blindness united states people older 50 years actual frequency disease depends specific racial group studies armd prevalent whites likely severe course patients lightcolored eyes liberal definition armd includes patients significant drusen posterior pole without visual loss estimates prevalence greater 20 population older 60 years rigorous populationbased survey definition requires presence either late atrophy andor choroidal neovascularization results incidence 0 age 50 years younger 2 70 years 6 80 years african americans dry armd noted approximately half incidence rate stated international incidence agerelated macular degeneration armd japanese asian populations lower white population united states reports suggest incidence increasing inuit people greenland significantly higher incidence well distinctive phenotype black africans people darkerpigmented skin general lower incidence symptomatic macular degeneration similarly evident lesions resulting armd asian populations different white populations agreement accepted theory regarding armd multigenic inherited condition background specific gene affected would affect phenotype mortalitymorbidity agerelated macular degeneration armd results significant visual morbidity presence neovascularization results blurry central visual field even dry armd relatively good vision patients often report trouble adjusting varying light conditions often patients note difficulty initially placed dark environment relatively lighted one eg entering restaurant bright sunlight armd patients especially exudative variant higher incidence cerebrovascular accidents cardiac disease geographic atrophy may also associated cognitive impairment assessed minimental status exams similar tests one case control study demonstrated 3x increased odds mild cognitive impairment geographic atrophy subjects compared normal controls even controlled age visual acuity education level race incidence agerelated macular degeneration armd higher whites compared african americans studies report rate approximately half african west indians barbados compared whites baltimore maryland incidence asians 2 rates although appears incidence increasing population sex known difference exists males females incidence agerelated macular degeneration armd age implied name incidence agerelated macular degeneration armd related age patient incidence increases decade life significant rise patients aged 70 years older clinical presentation history patients agerelated macular degeneration armd usually report family history decreased vision late life often report difficulty night vision changing light conditions specifically patients report changes amsler grid selfevaluation trouble reading commonly armd patients report visual fluctuation ie days vision poor days appears improved patients report difficulty reading making faces metamorphopsia major complaint may present atrophy slowly progresses physical funduscopic examination agerelated macular degeneration armd significant drusen early stages disease drusen usually confluent significant pigment changes accumulation pigment posterior pole rpe often appears atrophic easier visualization underlying choroidal plexus advanced stages dry armd focal islands atrophy coalesce form large zones atrophy severely affected vision signs choroidal neovascularization include rpe elevation exudate subretinal fluid presence symptoms may indicate neovascularization occurring fluorescein angiography may indicated evaluate retina periphery patients armd often areas drusen well rpe mottling atrophy causes oxidative stress believed play major role pathogenesis agerelated macular degeneration armd combined exposures retina light oxygen additionally armd widely accepted genetically inherited disorder late onset groundbreaking studies genetics armd changed way specialists perceive disease specifically majority risk developing armd determined variations 3 specific genes follows cfh bf c2 loc maller others showed polymorphisms 3 genes independently raise risk armd smoking higher body mass index 2 common environmental factors contribute independently increase risk developing armd smoking clearly identified increasing risk armd 2 times large studies shown hypertension heart disease increase odds developing armd serum lipids extensively studied regard relationship armd national eye institute–sponsored areds one report suggests dietary total omega3 longchain polyunsaturated fatty acid lcpufa intake inversely associated development neovascular armd although nonexudative armd study looking whether regular consumption omega3 fatty acids fish may affect onset armd women found incidence disease significantly decreased among women ate 1 servings fish per week studying twins armd seddon others arrived interesting conclusions studies generally performed individuals united states european descent thus results may apply individuals races differential diagnoses angioid streaks best disease chloroquine hydroxychloroquine toxicity workup laboratory studies see list fluorescein angiography value agerelated macular degeneration armd patient notes recent onset worsening vision associated metamorphopsia metamorphopsia may indicate onset choroidal neovascularization clinical evidence neovascularization includes retinal pigment epithelium rpe elevation subretinal hemorrhage andor presence exudate fluorescein angiography shown images performed injecting 3 ml 25 sodium fluorescein peripheral vein followed rapid sequence angiography images fluorescein vegetablebased dye activated light particular wavelength causes emission higher wavelength using appropriate blocking transmission filters photographer able capture image dye blood vessels later dye leaks images retina choroid complications fluorescein angiography may occur dye relatively safe occasionally 5 patients may nausea vomiting shortly dye injection infrequently patients may develop allergic reaction dye hives angioedema venous dilation rarely death 1250000 crossreactivity occurs dye iodine dye cleared renal excretion safe patients dialysis note images angiography fluorescein dye passed peripheral vein transmits angiography fluorescein dye passed peripheral vein transmits vascular system dye fluoresces vasculature seen vascular prominences seen macula areas dye pooling staining abnormal vessels optic nerve however show dye leakage staining drusen drusen absorb dye late frames angiogram show staining drusen drusen absorb dye late frames angiogram show hyperfluorescence staining distinguished leakage occurs dye spreads outside boundary lesion atrophic retinal pigment epithelium rpe demonstrates staining underlying choroidal atrophic retinal pigment epithelium rpe demonstrates staining underlying choroidal vasculature normally intact rpe masks presence choroidal fluorescence however rpe atrophies underlying dye appears area hyperfluorescence early stages angiography late stages drusen lose fluorescence concert small time lag rest retinal layers atrophic areas easily distinguished hyperfluorescence retinal pigment atrophic areas easily distinguished hyperfluorescence retinal pigment epithelium rpe mid phase angiogram hypofluorescence dye due masking caused increased pigmentation seen areas frank dye leakage exudative agerelated macular degeneration armd apparent hot cross bun pattern dry armdrelated pigment changes evident near fovea fluorescein angiogram 4 minutes injection dye 67yearold woman showing pigment fluorescein angiogram 4 minutes injection dye 67yearold woman showing pigment epithelial detachments later frame angiogram demonstrating absence dye leakage outside lesion later frame angiogram demonstrating absence dye leakage outside lesion staining areas atrophy window defects macular region imaging studies see list dry agerelated macular degeneration armd followed best accurate fundus photography images shown normalappearing macula left eye note even pigmentation retinal pigment normalappearing macula left eye note even pigmentation retinal pigment epithelium absence yellow excrescences drusen fovea optic nerve unrelated changes moderate nonexudative agerelated macular degeneration shown presence drusen moderate nonexudative agerelated macular degeneration shown presence drusen yellow deposits macular region advanced case nonexudative agerelated macular degeneration armd image shows advanced case nonexudative agerelated macular degeneration armd image shows drusen larger confluent soft soft drusen defined drusen indistinct borders drusen likely convert wet armd areas atrophy noted retinal pigment epithelium rpe lost pigmentation retinal cells overlying atrophic rpe generally nonfunctional result scotoma advanced case dry agerelated macular degeneration several areas atrophy advanced case dry agerelated macular degeneration several areas atrophy present areas significant pigment mottling macula large drusen inferior fixation poorly distinguished fundus photo showing drusen 67yearold woman dry agerelated macular degeneration fundus photo showing drusen 67yearold woman dry agerelated macular degeneration performing tests eg fluorescein angiography routine basis necessary physician sometimes quandary patient describes loss vision new onset metamorphopsia patient sometimes notes changes geographic atrophy ga progresses unfortunately almost impossible discern symptoms symptoms occur neovascularization occurred therefore patient new onset metamorphopsia sudden decrease vision may require fluorescein angiogram distinguish exudative armd versus indeterminable progression ga tests see list reports agerelated macular degeneration armd examined thickness retina optical coherence tomography oct study shown decreased reflectance level rodcone layer indicating atrophy present layer note images highdefinition optical coherence tomography scan 67yearold woman showing retinal pigment highdefinition optical coherence tomography scan 67yearold woman showing retinal pigment epithelium mottling pigment epithelial detachments temporal fixation consistent dry macular degeneration high definition optical coherence tomography right eye demonstrating retinal pigment epithelium high definition optical coherence tomography right eye demonstrating retinal pigment epithelium atrophy changes deeper layers retina absence intraretinal cysts subretinal fluid subretinal pigment epithelium fluid indicates absence wet agerelated macular degeneration multifocal electroretinography merg may performed retina evaluate functional response rods cones 2 tests required evaluation armd performed various authors follow progression disease procedures see list amsler grid evaluation slitlamp biomicroscopy fluorescein angiography agerelated macular degeneration armd cornerstone evaluation dry armd consists visual acuity measurement evaluation amsler grid biggest treatable risk visual loss dry armd development neovascularization studies shown amsler grid evaluations performed properly quite sensitive detecting change specificity test somewhat limited patients dry armd often note amsler grid changes temporary good observers detect progression dry armd grid new metamorphopsia good indication performing fluorescein angiography test sensitive specific way evaluate choroidal neovascularization histologic findings earliest morphologic features dry agerelated macular degeneration armd consist accumulation 2 kinds lesions ie basal laminar deposits basal linear deposits beneath rpe layer accumulation deposits often uneven associated rpe hyperplasia migration condition clinically evident pigment clumping deposits slowly increase seen soft drusen andor localized rpe detachments drusen enlarge cause development new blood vessels wet armd andor slow demise overlying photoreceptor cells photoreceptor cell loss accompanied thinning atrophy rpe cells well underlying choroidal circulation end stage changes presence thin choroidal layer absence small choroidal vessels underlying area atrophic rpe rodcone layer overlying zone atrophied middle retinal layers show signs degeneration end stage gradually enlarges seen clinically ga treatment management medical care see list role vitamins antioxidants risk smoking hypertension evidence shows patients early moderate dry agerelated macular degeneration armd consume adequate quantities antioxidants including vitamin vitamin e zinc lutein prevention best treatment case satisfactory method exists treat dry armd accumulated evidence suggests armd genetic disease therefore children patients lost vision armd best candidates primary prevention trial first agerelated eye diseases study areds concluded results illuminating study patients mild moderate forms dry armd given antioxidant supplementation 15 mg betacarotene 500 mg vitamin c 400 iu vitamin e 80 mg zinc plus 2 mg copper patients small definite decrease progression advanced armd interestingly data showed benefit preventing conversion dry armd neovascular armd study millen et al examined relationship serum 25hydroxyvitamin 25ohd levels prevalence armd rotterdam study 1990–1993 investigated whether regular dietary intake antioxidants associated lower risk developing armd 4000 persons aged 55 years older netherlands study high dietary intake betacarotene vitamins c e zinc also associated substantially reduced risk armd elderly persons evidence indicates multivitamins antioxidants lutein may benefit clear evidence shows smoking accelerates disease process recommended patients family history armd specifically patients whose firstdegree relative lost vision due armd take multivitamin lutein day advised patients stop smoking consider supplemental oral antioxidants unable stop smoking controversy exists exact vitamin combination may beneficial zinc vitamin e commonly touted providing best benefits one study reports beneficial effects zinc another study shows worse outcome large doses zinc therefore would prudent take multivitamin containing moderate dose vitamins refine specific benefits antioxidants randomized controlled clinical trial agerelated eye disease study 2 areds2 observational epidemiologic studies indicate direct association homocysteine concentration blood risk armd objective women’s antioxidant folic acid cardiovascular study examine incidence armd trial combined folic acid pyridoxine hydrochloride cyanocobalamin specific data available combined benefits aredssupplemented diet use vitamins therefore awaiting results areds2 study would benefit purpose cardiovascular health association prevalence progression agerelated macular degeneration charm study determine cardiovascular health determined novel noninvasive techniques associated prevalent armd armd progression epidemiologic studies using computer database previously indicated use statins protective development armd however 2007 study using rigorous systems graded macular photographs confirmed use statins correlated armd incidence progression early symptoms prolonged darkness delayed dark adaptation upon entering restaurant bright sunlight one earliest symptoms patients noting phenomenon prior presence significant atrophy one effective suggestion patients symptom use wraparound shades lowvision specialists suggest use orangetinted blueblocker lenses patients dry armd often visual function much poorer suggested snellen acuity presence large areas atrophy usually perifoveal zone results large scotomas near center visual field scotomas prevent patients performing simple tasks eg recognizing faces reading lowvision specialists often prescribe magnifiers line marker patients lose place reading family members patients armd would seem logical vitamins used treat patients armd would benefit prior development armd family members areds supplements show significant benefit treatment 7year followup disease mild additionally many risks associated longterm zinc vitamin vitamin e supplementation instead family members patients armd following smoke avoid secondhand smoke protect eyes direct sunlight using either dark glasses widebrimmed hat eat wellbalanced diet high natural antioxidants eat fresh baked fish 12 servings daily eat green leafy vegetables eg spinach kale daily consider supplement consisting folic acid 25 mgd pyridoxine 50 mgd cyanocobalamin 1 mgd family members specifically requested take areds supplement vitamins risk associated longterm supplementation vitamins may overcome benefits taking example subjects 1 risk factor areds race progression disease 5 years minimally different placebotreated subjects also held true 10 years subjects risk factors 24 progressively increased levels benefit supplementation clinical guideline summaries american academy ophthalmology retinavitreous panel agerelated macular degeneration us preventive services task force screening impaired visual acuity older adults us preventive services task force recommendation statement national institute health clinical excellence nice ranibizumab pegaptanib treatment agerelated macular degeneration surgical care accepted surgical alternative dry agerelated macular degeneration armd available possible drusen present dry armd ameliorated performance light grid laser therapy recently patients underwent retinal translocation surgery retina rotated many patients developed accelerated dry macular degeneration retinal pigment epithelium rpe atrophy site new macula interestingly area atrophy developed new site resembled almost identically area atrophy preexistent prior translocation provides clinical evidence rpe layer source disease pathophysiology retinal atrophy results response diseased rpe phase ii study using encapsulated genetically modified cells secrete ciliary neurotrophic factor indicated retinal thickening occurred dosedependent statistically significant manner treated subjects also higher percentage preserved vision additional studies required prior approval us food drug administration fda isolated reports embryonic adultderived stem cells placed subretinal space noted small reports whose primary purpose determine feasibility endeavor near future rpe cell repair via external transplantation stem cells may provide reasonable method treatment patients severe disease consultations serial general ophthalmologic examination nonemergent basis indicated patients dry agerelated macular degeneration armd patients acute loss vision retina consultation fluorescein angiography indicated timely manner rule possibility conversion wet armd patients significant armd changes without vision loss may wish children evaluated ophthalmologist children reach age 50 years diet evidence suggests diet plays important role prevention dry agerelated macular degeneration armd activity limitations noted agerelated macular degeneration armd state specific visualacuity criteria driving private license commercial driving licenses typically require least 2040 vision worse eye typical requirements side vision medication medication summary currently approved drug treatment dry agerelated macular degeneration armd available see surgical care possible beneficial effects laser therapy followup outpatient care see list patients dry agerelated macular degeneration armd observed frequently followup care determined extent disease ophthalmologists assessment risk conversion wet armd daily amsler grid evaluation necessary immediate reports ophthalmologist changes noted inpatient outpatient medications see list approved medications treatment dry agerelated macular degeneration armd available complications see list major complication dry agerelated macular degeneration armd conversion wet exudativeneovascular armd prognosis see list prognosis disease significantly better prognosis wet agerelated macular degeneration armd patients likely steadily slowly deteriorating visual acuity also common visual dysfunction eg loss ability quickly adapt changing lighting conditions loss contrast sensitivity variability vision daytoday common patient education see list patients geographic atrophy ga may variety visual dysfunction location atrophy often suggests type visual dysfunction experienced patient many patients agerelated macular degeneration armd report difficulty adjusting changing light conditions specifically take significantly longer time adjust indoor lighting outside bright sunlight wraparound outdoor sunglasses orange tint work patients patients primarily central atrophy often note trouble reading performing fine motor tasks magnification increased contrast via monitor increased illumination best solutions visual dysfunction contrast patients ga spares foveal center affects entire perifoveal region patients often see 2020 unable navigate due small area good visual acuity patients scan screen able see 20400 character patients excess magnification would detrimental would effectively decrease limited visual field increased contrast minification way increased illumination reverse telescopes respectively may beneficial patients referral comprehensive vision rehabilitation indicated early disease process american academy ophthalmology aao recommends referral vision rehabilitation acuity less 2040 loss contrast sensitivity scotoma field loss noted aim early referral prevent many negative consequences vision loss example acuity reduced 2050 worse patients twice risk falling 3 times risk depression 4 greater times risk hip fracture rehabilitation aims maximize patients’ use partial vision provide practical adaptation reduce disability comprehensive rehabilitation addresses “whole person” outlined aao’s booklet vision rehabilitation adults patient education resources see eye vision center macular degeneration start media normalappearing macula left eye note even pigmentation retinal pigment normalappearing macula left eye note even pigmentation retinal pigment epithelium absence yellow excrescences drusen fovea optic nerve unrelated changes angiography fluorescein dye passed peripheral vein transmits angiography fluorescein dye passed peripheral vein transmits vascular system dye fluoresces vasculature seen vascular prominences seen macula areas dye pooling staining abnormal vessels optic nerve however show dye leakage moderate nonexudative agerelated macular degeneration shown presence drusen moderate nonexudative agerelated macular degeneration shown presence drusen yellow deposits macular region staining drusen drusen absorb dye late frames angiogram show staining drusen drusen absorb dye late frames angiogram show hyperfluorescence staining distinguished leakage occurs dye spreads outside boundary lesion advanced case nonexudative agerelated macular degeneration armd image shows advanced case nonexudative agerelated macular degeneration armd image shows drusen larger confluent soft soft drusen defined drusen indistinct borders drusen likely convert wet armd areas atrophy noted retinal pigment epithelium rpe lost pigmentation retinal cells overlying atrophic rpe generally nonfunctional result scotoma atrophic retinal pigment epithelium rpe demonstrates staining underlying choroidal atrophic retinal pigment epithelium rpe demonstrates staining underlying choroidal vasculature normally intact rpe masks presence choroidal fluorescence however rpe atrophies underlying dye appears area hyperfluorescence early stages angiography late stages drusen lose fluorescence concert small time lag rest retinal layers advanced case dry agerelated macular degeneration several areas atrophy advanced case dry agerelated macular degeneration several areas atrophy present areas significant pigment mottling macula large drusen inferior fixation poorly distinguished atrophic areas easily distinguished hyperfluorescence retinal pigment atrophic areas easily distinguished hyperfluorescence retinal pigment epithelium rpe mid phase angiogram hypofluorescence dye due masking caused increased pigmentation seen areas frank dye leakage exudative agerelated macular degeneration armd apparent hot cross bun pattern dry armdrelated pigment changes evident near fovea highdefinition optical coherence tomography scan 67yearold woman showing retinal pigment highdefinition optical coherence tomography scan 67yearold woman showing retinal pigment epithelium mottling pigment epithelial detachments temporal fixation consistent dry macular degeneration fundus photo showing drusen 67yearold woman dry agerelated macular degeneration fundus photo showing drusen 67yearold woman dry agerelated macular degeneration fluorescein angiogram 4 minutes injection dye 67yearold woman showing pigment fluorescein angiogram 4 minutes injection dye 67yearold woman showing pigment epithelial detachments later frame angiogram demonstrating absence dye leakage outside lesion later frame angiogram demonstrating absence dye leakage outside lesion staining areas atrophy window defects macular region high definition optical coherence tomography right eye demonstrating retinal pigment epithelium high definition optical coherence tomography right eye demonstrating retinal pigment epithelium atrophy changes deeper layers retina absence intraretinal cysts subretinal fluid subretinal pigment epithelium fluid indicates absence wet agerelated macular degeneration author raj k maturi md private practice vitreoretinal diseases surgery uveitis volunteer clinical associate professor department ophthalmology indiana university school medicine raj k maturi md member following medical societies american academy ophthalmology american society retina specialists society heed fellows indiana academy ophthalmology disclosure received grantresearch funds allergan consulting received consulting fee drcrnational eye institute nih consulting received grantresearch funds lux inc consulting received grantresearch funds drcrjaeb none received consulting fee alimera consulting received consulting fee alcon consulting received consulting fee glaxosmithkline consulting received consulting fee quark pharmaceuticals consulting received consul pharmacy editor simon k law md pharmd clinical professor health sciences department ophthalmology jules stein eye institute university california los angeles david geffen school medicine simon k law md pharmd member following medical societies american academy ophthalmology association research vision ophthalmology american glaucoma society disclosure nothing disclose managing editor steve charles md director charles retina institute clinical professor department ophthalmology university tennessee college medicine steve charles md member following medical societies american academy ophthalmology american society retina specialists macula society retina society club jules gonin disclosure received royalty consulting fees alcon laboratories chief editor hampton roy sr md associate clinical professor department ophthalmology university arkansas medical sciences hampton roy sr md member following medical societies american academy ophthalmology american college surgeons panamerican association ophthalmology disclosure nothing disclose additional contributors brian phillpotts md md brian phillpotts md md member following medical societies american academy ophthalmology american diabetes association american medical association national medical association disclosure nothing disclose american academy ophthalmology aao retinavitreous panel agerelated macular degeneration aao san francisco calif 2008 available httpguidelinegovcontentaspxid14275 blodi ba nutritional supplements prevention agerelated macular degeneration insight medline dashti n mcgwin g owsley c curcio ca plasma apolipoproteins risk age related maculopathy br j ophthalmol medline evans jr lawrenson jg antioxidant vitamin mineral supplements preventing agerelated macular degeneration cochrane database syst rev medline christen wg glynn rj chew ey albert cm manson je folic acaid pyridoxine cyanocobalamin combination treatment agerelated macular degeneration women womens antioxidant folic acid cardiovasacular study arch intern med guideline ferris fl davis md clemons te et al simplified severity scale agerelated macular degeneration areds report 18 arch ophthalmol medline full text johnson pt betts ke radeke mj hageman gs anderson dh johnson lv individuals homozygous agerelated macular degeneration riskconferring variant complement factor h elevated levels crp choroid proc natl acad sci u medline tarallo v hirano gelfand bd dridi kerur n kim et al dicer1 loss alu rna induce agerelated macular degeneration via nlrp3 inflammasome myd88 cell medline full text kaneko h dridi tarallo v gelfand bd fowler bj cho wg et al dicer1 deficit induces alu rna toxicity agerelated macular degeneration nature medline full text clemons te rankin mw mcbee wl cognitive impairment agerelated eye disease study areds report 16 arch ophthalmol medline full text baker ml wang jj rogers klein r kuller lh larsen ek et al early agerelated macular degeneration cognitive function dementia cardiovascular health study arch ophthalmol medline full text maller j george purcell et al common variation three genes including noncoding variant cfh strongly influences risk agerelated macular degeneration nat genet medline sangiovanni jp chew ey clemons te et al relationship dietary lipid intake agerelated macular degeneration casecontrol study areds report 20 arch ophthalmol medline christen wg schaumberg da glynn rj buring je dietary omega3 fatty acid fish intake incident agerelated macular degeneration women arch ophthalmol medline full text seddon jm george rosner b cigarette smoking fish consumption omega3 fatty acid intake associations agerelated macular degeneration us twin study agerelated macular degeneration arch ophthalmol medline hawkins bs bird klein r west sk epidemiology agerelated macular degeneration mol vis medline full text millen ae voland r sondel sa parekh n horst rl wallace rb et al vitamin status early agerelated macular degeneration postmenopausal women arch ophthalmol medline full text mccarty ca dowrick cameron j et al novel measure cardiovascular health association prevalence progression agerelated macular degeneration charm study bmc ophthalmology klein r knudtson md klein statin use fiveyear incidence progression agerelated macular degeneration j ophthalmol medline eter n krohne tu holz fg new pharmacologic approaches therapy agerelated macular degeneration biodrugs medline bartlett h eperjesi f agerelated macular degeneration nutritional supplementation review randomised controlled trials ophthalmic physiol opt medline jackson ml vision rehabilitation services medscape ophthalmology full text bird ac bressler nm bressler sb et al international classification grading system agerelated maculopathy agerelated macular degeneration international arm epidemiological study group surv ophthalmol medline christen wg glynn rj chew ey albert cm manson je folic acid pyridoxine cyanocobalamin combination treatment agerelated macular degeneration women womens antioxidant folic acid cardiovascular study arch intern med medline full text christen wg glynn rj chew ey albert cm manson je folic acid pyridoxine cyanocobalamin combination treatment agerelated macular degeneration women womens antioxidant folic acid cardiovascular study arch intern med medline full text christen wg glynn rj chew ey albert cm manson je folic acid pyridoxine cyanocobalamin combination treatment agerelated macular degeneration women womens antioxidant folic acid cardiovascular study arch intern med medline full text christen wg glynn rj chew ey albert cm manson je folic acid pyridoxine cyanocobalamin combination treatment agerelated macular degeneration women womens antioxidant folic acid cardiovascular study arch intern med medline full text coleman h chew e nutritional supplementation agerelated macular degeneration curr opin ophthalmol medline comer gm ciulla ta criswell mh tolentino current future treatment options nonexudative exudative agerelated macular degeneration drugs aging medline evans jr antioxidant vitamin mineral supplements slowing progression agerelated macular degeneration cochrane database syst rev medline garibaldi dc zhang k molecular genetics macular degeneration int ophthalmol clin medline helwick c mahalo finds new biomarker dry macular degeneration medscape medical news november 21 2013 available httpwwwmedscapecomviewarticle81482 luibl v isas jm kayed r glabe cg langen r chen j drusen deposits associated aging agerelated macular degeneration contain nonfibrillar amyloid oligomers j clin invest medline lutty g grunwald j majji ab uyama yoneya changes choriocapillaris retinal pigment epithelium agerelated macular degeneration mol vis medline full text mcbee wl lindblad ferris fl 3rd receive oral supplement treatment agerelated macular degeneration curr opin ophthalmol medline mitchell p smith w attebo k wang jj prevalence agerelated maculopathy australia blue mountains eye study ophthalmology medline regillo cd lampalizumab antifactor patients geographic atrophy mahalo phase ii results presented american academy ophthalmology aao 2013 annual meeting november 16 2013 new orleans la schmidterfurth u nutrition retina dev ophthalmol medline sunness js natural history geographic atrophy advanced atrophic form agerelated macular degeneration mol vis medline full text winkler bs boulton gottsch jd sternberg p oxidative damage agerelated macular degeneration mol vis medline full text woo sj park kh ahn j choe jy jeong h han jw et al cognitive impairment agerelated macular degeneration geographic atrophy ophthalmology medline

Article 2:
atrial septal defect atrial septal defect problem epidemiology etiology atrial septal defect workup laboratory studies imaging studies tests atrial septal defect treatment management medical therapy surgical therapy postoperative details atrial septal defect problem epidemiology etiology atrial septal defect workup laboratory studies imaging studies tests atrial septal defect treatment management medical therapy surgical therapy postoperative details overview problem epidemiology etiology pathophysiology presentation indications contraindications workup laboratory studies imaging studies tests diagnostic procedures treatment medical therapy surgical therapy postoperative details followup complications outcome prognosis future controversies atrial septal defect overview atrial septal defect workup atrial septal defect treatment 162914overview dec 19 2014 201508042027 0 cardiology 2002 diseases conditions condition 1 2 content 162914 502 5000584 2 ssg jun 04 2015 condition diseases conditions cardiology cardiology cardiologycongenital congenital heart disease adult atrial septal defect atrial septum defect asd atrial septal defect repair atrial septal defect closure atrial septal defect surgery atrial septal defect symptoms atrial septal defect asd one commonly recognized congenital cardiac anomalies presenting adulthood atrial septal defect characterized defect interatrial septum allowing pulmonary venous return left atrium pass directly right atrium 0 asd atrial septal defect overview problem atrial septal defect asd one commonly recognized congenital cardiac anomalies presenting adulthood atrial septal defect characterized defect interatrial septum allowing pulmonary venous return left atrium pass directly right atrium depending size defect size shunt associated anomalies result spectrum disease significant cardiac sequelae rightsided volume overload pulmonary arterial hypertension even atrial arrhythmias routine use echocardiography incidence atrial septal defect increased compared earlier incidence studies using catheterization surgery autopsy diagnosis epidemiology frequency 3 major types atrial septal defect asd account 10 congenital heart disease much 2040 congenital heart disease presenting adulthood common types asd include following ostium secundum common type asd accounting 75 asd cases representing approximately 7 congenital cardiac defects 3040 congenital heart disease patients older 40 years ostium primum second common type asd accounts 1520 asds primum asd form atrioventricular septal defect commonly associated mitral valve abnormalities sinus venosus least common three sinus venosus sv asd seen 510 asds defect located along superior aspect atrial septum anomalous connection rightsided pulmonary veins common expected alternate imaging generally required sex age etiology atrial septal defect asd congenital cardiac disorder caused spontaneous malformation interatrial septum ostium secundum asd type asd results incomplete adhesion flap valve associated foramen ovale septum secundum birth patent foramen ovale usually results abnormal resorption septum primum formation foramen secundum resorption abnormal locations causes fenestrated netlike septum primum excessive resorption septum primum results short septum primum close foramen ovale abnormally large foramen ovale occur result defective development septum secundum normal septum primum close type abnormal foramen ovale birth combination excessive resorption septum primum large foramen ovale produces large ostium secundum asd ostium primum asd defects caused incomplete fusion septum primum endocardial cushion defect lies immediately adjacent atrioventricular av valves either may deformed incompetent cases anterior septal leaflet mitral valve displaced commonly cleft tricuspid valve usually involved sinus venosus asd abnormal fusion embryologic sinus venosus atrium causes defects cases defect lies superior atrial septum near entry superior vena cava often associated anomalous drainage right superior pulmonary vein relatively uncommon inferior type associated partial anomalous drainage right inferior pulmonary vein anomalous drainage right atrium superior vena cava inferior vena cava coronary sinus asd coronary sinus defect characterized unroofed coronary sinus persistent left superior vena cava drains left atrium dilated coronary sinus often suggests defect result desaturation due righttoleft shunt left atrium diagnosis made injecting contrast agent left upper extremity coronary sinus opacification precedes right atrial opacification genetics atrial septal defect asd may occur familial basis holtoram syndrome characterized autosomal dominant pattern inheritance deformities upper limbs often absent hypoplastic radii attributed single gene defect tbx5 ellis van creveld syndrome autosomal recessive disorder associated skeletal dysplasia characterized short limbs short ribs postaxial polydactyly dysplastic nails teeth common atrium occurring 60 affected individuals mutations cardiac transcription factor nkx25 attributed syndrome familial asd associated progressive atrioventricular block pathophysiology magnitude lefttoright shunt across asd depends defect size relative compliance ventricles relative resistance pulmonary systemic circulation small asd left atrial pressure may exceed right atrial pressure several millimeters mercury whereas large asd mean atrial pressures nearly identical shunting across interatrial septum usually lefttoright occurs predominantly late ventricular systole early diastole likely augmentation occurs atrial contraction note however transient small righttoleft shunt occur especially respiratory periods decreasing intrathoracic pressure even absence pulmonary arterial hypertension chronic lefttoright shunt results increased pulmonary blood flow diastolic overload right ventricle resistance pulmonary vascular bed commonly normal children asd volume load usually well tolerated even though pulmonary blood flow may 2 times systemic blood flow altered ventricular compliance age result increased lefttoright shunt contributing symptoms chronic significant lefttoright shunt alter pulmonary vascular resistance leading pulmonary arterial hypertension even reversal shunt eisenmenger syndrome increase plasma volume pregnancy shunt volume increase leading symptoms pulmonary artery pressure usually remains normal presentation history see list atrial septal defect asd malformation go undiagnosed decades due subtle physical examination findings lack symptoms even isolated defects moderatetolarge size may cause symptoms childhood however may symptoms easy fatigability recurrent respiratory infections exertional dyspnea childhood diagnosis often considered heart murmur detected routine physical examination abnormal finding observed chest radiographs electrocardiogram ecg undetected childhood symptoms develop gradually decades largely result changing compliance age pulmonary arterial hypertension atrial arrhythmias sometimes associated mitral valve disease primum asd virtually patients asd survive beyond sixth decade symptomatic clinical deterioration older patients occurs means several mechanisms first agerelated decrease left ventricular compliance augments lefttoright shunt second atrial arrhythmias especially atrial fibrillation also atrial flutter paroxysmal atrial tachycardia increase frequency fourth decade precipitate right ventricular failure third symptomatic adults older 40 years mildtomoderate pulmonary arterial hypertension presence persistent large lefttoright shunt therefore aging right ventricle burdened pressure volume overload another mechanism symptoms particularly associated primum asd related clinically significant mitral regurgitation incidence extent degree dysfunction increases age mitral valve insufficiency leads increase left atrial pressure higher degree lefttoright shunt overall common presenting symptoms include dyspnea easy fatigability palpitations sustained atrial arrhythmia syncope stroke andor heart failure adults one common symptoms development palpitations related atrial arrhythmias physical see list findings physical examination depend degree lefttoright shunt hemodynamic consequences turn depends size defect diastolic properties ventricles relative resistance pulmonary systemic circulations patient hyperdynamic right ventricular impulse due increased diastolic filling large stroke volume palpable pulsation pulmonary artery ejection click detected dilated pulmonary artery 1 2 blood flow across asd cause murmur site shunt substantial pressure gradient exists atria however asd moderatetolarge lefttoright shunts result increased right ventricular stroke volume across pulmonary outflow tract creating crescendodecrescendo systolic ejection murmur murmur heard second intercostal space upper left sternal border patients large lefttoright shunts often rumbling middiastolic murmur lower left sternal border increased flow across tricuspid valve auscultatory findings asd may resemble mild valvular infundibular pulmonic stenosis idiopathic dilatation pulmonary artery disorders manifest systolic ejection murmur differ asd movement 2 patients ostium primum defect associated cleft mitral valve apical systolic regurgitant murmur mitral regurgitation may present patients develop pulmonary arterial hypertension right ventricular hypertrophy right ventricular 4 2 asd acyanotic lesion thus patient normally saturated rare case severe pulmonary arterial hypertension atrial shunt reversal eisenmenger syndrome may occur leading cyanosis clubbing indications decision repair kind atrial septal defect asd based clinical echocardiographic information including size location asd magnitude hemodynamic impact lefttoright shunt presence degree pulmonary arterial hypertension general elective closure advised asds evidence right ventricular overload clinically significant shunt pulmonary flow qp–to–systemic flow qs ratio 15 lack symptoms contraindication repair childhood spontaneous closure secundum asd may occur however adulthood spontaneous closure unlikely patients may monitored relatively conservatively period intervention advised considerations even contraindications consider intervention include small size defect shunt severe pulmonary arterial hypertension diagnosis pregnancy intervention deferred severe left right ventricular dysfunction guidelines management adults congenital heart disease recently updated children adults surgical mortality rates uncomplicated secundum asd approximately 13 lifetime risk associated asd outlined including paradoxical embolization ongoing evaluation review indication risks closure even patients small shunts however closure remains controversial patients small defects generally good prognosis risk cardiopulmonary bypass may warranted widespread use catheter closure secundum asd lower mortality without cardiopulmonary bypass raised question regarding need close even small defects longterm prevention death complications best achieved asd closed age 25 years systolic pressure main pulmonary artery less 40 mm hg even elderly patients large shunts surgical closure performed low risk good results reducing symptoms either method closure whether transcatheter surgical results excellent hemodynamic outcomes significant differences regard survival functional capacity atrial arrhythmias embolic neurologic events however atrial arrhythmia neurologic events remain longterm risks particularly patients preexisting events contraindications closure atrial septal defect asd recommended patients clinically insignificant shunt qpqs ratio 07 severe pulmonary arterial hypertension irreversible pulmonary vascular occlusive disease reversed shunt atrest arterial oxygen saturations less 90 addition high surgical mortality morbidity risk closure defect latter situation may worsen prognosis whether patient whose condition diagnosed well sixth decade life would benefit surgical closure remains controversial workup laboratory studies see list specific laboratory blood tests indicated workup atrial septal defects asds routine laboratory studies performed patients undergoing intervention asd complete blood count type screen metabolic profile chemistry coagulation studies prothrombin time pt activated partial thromboplastin time aptt imaging studies see list chest radiography presence clinically significant lefttoright shunt chest radiographs often show cardiomegaly dilatation right atrium right ventricular chamber pulmonary artery prominent pulmonary vascular markings increased lung fields left atrial enlargement rare clinically significant mitral regurgitation occasion proximal dilatation superior vena cava seen sinus venosus defect transthoracic echocardiography uncertain diagnosis clarified transthoracic 2dimensional echocardiography provides direct noninvasive visualization types asds including evaluation right atrium right ventricle pulmonary arteries well associated abnormalities view beneficial often subcostal view one exception diagnosis sinus venosus defect transesophageal echocardiography tee may needed image defect still may able visualize pulmonary venous return tees echocardiogram shown parasternal short axis rv dilation rv pressure overload evidenced flattening parasternal short axis rv dilation rv pressure overload evidenced flattening interventricular septum systole transesophageal echocardiogram moderatelarge asd lefttoright shunt across transesophageal echocardiogram moderatelarge asd lefttoright shunt across interatrial septum apical 4chamber view apical 4chamber view patient asd particularly sinus venosus defect anomalies systemic venous connection sought clearly identified 2dimensional imaging right atrial right ventricular enlargement without identification cause prompt consideration tee doppler echocardiography may helpful demonstrating flow across atrial septum typically shows biphasic systolic diastolic pattern small righttoleft shunt beginning systole transthoracic echocardiography may suboptimal patients poor echocardiographic windows patients tee provide excellent definition atrial septum tee also useful guiding device placement catheter asd occlusion procedures providing immediate intraoperative assurance defect closure accomplished continuouswave doppler echocardiography valuable estimating right ventricular pulmonary arterial associated right ventricular outflow tract obstruction systolic pressure tricuspid regurgitant jet present technique also useful evaluating patients obstruction pulmonary venous return contrast echocardiography provide additional confirmation righttoleft shunt detected visualizing microcavitation bubbles left atrium left ventricle lefttoright shunt detected negative contrast washout effect right atrium mri mri successfully used identify size position asd however utility limited small defects major advantage mri ability quantify right ventricular size volume function along ability identify systemic pulmonary venous return tests see list electrocardiography characteristic findings patients secundum asd normal sinus rhythm rightaxis deviation rsr pattern v 1 leftaxis deviation rsr pattern v 1 leftaxis deviation negative p wave lead iii suggest sinus venosus defect increasing pulmonary hypertension cause loss rsr pattern v 1 prolonged pr interval seen familial asd ostium primum secondary left atrial enlargement increased distance internodal conduction produced defect displacement av node posteroinferior direction patients enlarged right atrium also reported diagnostic procedures see list noninvasive techniques demonstrate presence uncomplicated asd child routine cardiac catheterization diagnosis unnecessary however cardiac catheterization may useful clinical data inconsistent clinically significant pulmonary arterial hypertension suspected concurrent coronary artery disease must assessed patients older 40 years catheterization also viable alternative intervention secundum asd diagnosis asd may confirmed directly passing catheter defect serial oxygen saturation measurements used estimate magnitude shunt young patients right heart pressures often normal despite large shunt high oxygen saturation present superior vena cava catheter enters pulmonary vein directly right atrium sinus venosus type likely partial anomalous pulmonary venous return usually associated sinus venosus defect may also accompany ostium secundum type treatment management medical therapy atrial septal defect asd disorder addressed surgically interventional catheterization specific definitive medical therapy available however patients significant volume overload atrial arrhythmias may require specific drug therapy surgical therapy criterion standard criterion standard treatment atrial septal defect asd direct closure defect using open approach extracorporeal support john gibbon performed first successful asd closure applying method 1953 surgical techniques equipment since improved point mortality rate repair approaches zero usual procedure median sternotomy incision made sternum split midline direct arterial double venous superior vena cava inferior vena cava cannulation performed applying cardiopulmonary bypass aorta clamped heart arrested cardioplegia solution caval snares tightened right atrium opened secundum defects closed using direct continuous suture 30 40 polypropylene prolene caution must taken large defects directly closed closure distort atrium large defects rise superiorly distort aortic anulus closed directly asds best closed using autologous pericardium synthetic patches made polyester polymer dacron polytetrafluoroethylene ptfe care must taken completely remove air debris left atrium ventricle cardiopulmonary bypass discontinued temporary pacing wires left place right ventricle chest closed drains ostium primum defect surgical closure complicated patch must attached septum juncture mitral tricuspid valves mitral valve repair including closure cleft mitral leaflet possibly annuloplasty may necessary correct prevent mitral insufficiency rare cases mitral valve replacement may required sinus venosus defect partial anomalous pulmonary venous return typical one pulmonary veins primarily drains right atrium asd must patched way ensure anomalous pulmonary venous drainage diverted left atrium patching may simple complex depending anomalous drainage enters many innovative techniques developed redirect pulmonary venous flow surgeon familiar several approaches pulmonary venous return must compromised redirection invariably causes localized pulmonary venous hypertension minimally invasive approaches recent years minimally invasive approaches repair asd garnered significant interest cases size incision simply decreased different approaches cardiopulmonary bypass examples include partial full submammary skin incision hemisternotomy limited thoracotomy goal improve better cosmetic results approaches associated decreased morbidity mortality percutaneous transcatheter closure recent times secundum asd closed using variety catheterimplanted occlusion devices rather direct surgical closure cardiopulmonary bypass devices placed femoral venous approach deployed like umbrella seal septal defect devices work best centrally located secundum defects although surgical closure associated low morbidity mortality excellent longterm results sternotomy cardiopulmonary bypass required drs king mills performed first transcatheter closure secundum asd mid1970s william rashkind pioneered development percutaneous asd closure technique late 1970s jim lock developed clamshell method 1989 around time sideris started clinical trials buttoned device although many devices studied last years 4 major devices become available cardioseal nmt medical inc boston mass amplatzer septal occluder aso aga medical corporation golden valley minn helex septal occluder gore medical wl gore associates inc flagstaff ariz sideris patch custom medical devices amarillo tex aso currently widely used device easy implant allows closure large orifices excellent success rates cases first used humans 1995 selection particular device difficult randomized trials conducted furthermore devices currently amenable percutaneous closure ostium primum sinus venosus defects method static diameter defect first assessed using tee diameter measured sizing balloon using “stopflow” technique select proper diameter device using technique sizing balloon inflated flow visible defect using tee margins orifice must wide enough ≤5 mm accommodate edges closing device tee mainstream technique device sizing positioning deployment cause discomfort addition airway protection general anesthesia required intracardiac echocardiography used purpose transcatheter closure asds established practice cardiac centers proven safe experienced hands costeffective favorably compares surgical closure successful implantation rates 96 transcatheter closure associated fewer complications shortened hospitalization reduced need blood products age asd closure followed symptomatic improvement regression positive airway pressure pap right ventricle size however best outcome achieved patients less functional impairment less elevated pap furthermore transcatheter closure appears additional benefits regarding hemodynamic improvement compared surgery one study transcatheter closure aso improved left atrial volume index left ventricular myocardial performance index right ventricular myocardial performance index another group compared atrial function 45 patients mean age 9 years surgery percutaneous closure using strainrate imaging postoperative details postoperative management atrial septal defect asd repair usually standard patients expected awake often extubated shortly operation drainage tubes removed chest first morning surgery except rhythm problems occur pacing wires removed shortly thereafter patients eat ambulate without difficulty first second postoperative day discharged third fourth postoperative day transcatheter occlusion patients generally discharged next day six months treatment aspirin without clopidogrel recommended prevent thrombus formation followup surgical followup care maintained patients wounds completely healed normal activities resumed period rarely exceeds 12 months complications must clearly resolved patient discharged surgical care obtain least 1 followup echocardiogram confirm complete closure asd cardiologist congenital experience continue patient care monitor recurrence shunt ensure patient returned normal activities cardiac function patients yearly appointment immediate postoperative period adequate large part follow evaluate arrhythmia complications patient education resources see heart center palpitations complications surgery may associated longterm risk atrial fibrillation flutter risk infective endocarditis congestive heart failure arrhythmias pulmonary hypertension cyanosis paradoxical embolization stroke infective endocarditis following complications specifically associated use transcatheter occlusion devices device embolization malpositioning incidence significantly varies among devices related operator experience appropriate case selection experienced clinicians incidence less 1 device embolization malpositioning happens result inadequate sizing defect incorrect device placement postimplantation arrhythmias incidence 14 varies first thirddegree av block atrial fibrillation arrhythmias usually shortlived require medical treatment patients develop complete heart block typically hemodynamically stable require pacing incidence arrhythmia appears related size device thrombus formation study 1000 patients performed investigate incidence thrombus performing tee 4 weeks 6 months procedure cardiac perforation incidence 0104 various devices oversizing device deficient anterosuperior rims risk factors perforation techniquerelated perforation procedure amenable intervention devicerelated perforations occur technically adequate procedure approximately 70 patients hospital discharge retrospective review 24 patients revealed presented chest pain shortness breath hemodynamic collapse sudden death 76 female patients 70 perforations late pericardial effusion present predischarge echocardiography patient hospitalized 2448 hours observation followup echocardiography device erosion erosion septal occluder devices occurs 01015 implants increased levels cardiac troponin transcatheter closure induces minor myocardial lesions extent depends size aso patients age factor residual shunts many 20 patients may residual shunt persisting 24 hours procedure 90 residua small followup incidence approaches 0 3 years series complications include pericardial effusion transient ischemic attack sudden death outcome prognosis natural history although life expectancy normal patients atrial septal defect asd patients generally survive adulthood without surgical percutaneous intervention many patients live advanced age however natural survival beyond age 4050 years less 50 attrition rate 40 years age 6 per year advanced pulmonary hypertension seldom occurs third decade late complications stroke atrial fibrillation postsurgical prognosis mortality rate surgical repair less 1 patients younger 45 years without heart failure systolic pulmonary artery pressures less 60 mm hg morbidity rate low surgical mortality rate increases increasing age pulmonary artery pressures surgical repair considered patients uncomplicated asds clinically significant lefttoright shunt repair ideally completed 24 years age early surgical repair considered infants young children clinically significant symptoms congestive heart failure chf surgery age 25 years results 30year survival rate comparable age sexmatched control subjects however age 2540 years surgical survival reduced though significantly pulmonary artery pressures normal pulmonary artery systolic pressure higher 40 mm hg late survival 50 less control rates though life expectancy surgically treated older patients better medically treated patients even select patients older 60 years serious comorbidities asds closed early possible indication present surgery improves symptoms–at least short term–regardless pulmonary artery pressure functional class long lefttoright shunt remains large although surgical closure asds adulthood associated significant mortality benefit benefit limited preventing atrial arrhythmias patients age time closure important predictor development atrial arrhythmia surgery sinus venosus asd also associated low morbidity mortality postoperative subjective clinical improvement occurs irrespective patients age surgery however contrast ostium secundum asd surgery sinus venosus defect relatively complex poses risks stenosis superior vena cava pulmonary veins residual shunting dysfunction sinoatrial node childhood right ventricular dimensions decrease often strikingly surgery however adults undergo surgery dimensions remain abnormal approximately 80 patients right ventricular failure tricuspid regurgitation present surgery late postoperative right atrial ventricular enlargement typical right ventricular systolic function seldom normalizes patients situation improve usually remain symptomatic preoperative pulmonary vascular resistance influences longterm outcome patients undergo surgical closure childhood lateonset supraventricular arrhythmias believed related patchy fibrosis right atrium secondary dilatation perhaps dysfunction sinus node adults chronic preoperative atrial fibrillation usually persists surgical repair cardioversion followed antiarrhythmics treatment may effective surgery performed patients older 40 years 50 preoperative normal sinus rhythm late postoperative atrial fibrillation intracardiac electrophysiologic studies shown high incidence intrinsic dysfunction sinoatrial av nodes persists surgical repair nodal abnormalities common sinus venosus type secundum type late events including atrial fibrillation stroke heart failure common patients undergoing repair adulthood observation emphasizes benefit early repair secundum asds symptomatic patients unfavorable prognosis late repairs presumably related longstanding deleterious effect volume overload chambers right side pulmonary hypertension right atrial enlargement increased vulnerability atrial arrhythmias stroke 22 late deaths attributed cerebrovascular events older age repair preoperative new york heart association class iii iv heart failure independent predictors late mortality also predictive atrial fibrillation sinus node dysfunction bradycardiadependent atrial arrhythmias scardependent multiple reentries atrial enlargement atrial fibrosis due increased pulmonary venous pressure exercise implicated potential mechanisms cohort 300 minimally symptomatic patients intervention either surgical transcatheter closure longterm followup median 10 years shows maintained functional class continued arrhythmia risk associated age procedure preexisting arrhythmia controlling variables trend toward arrhythmia surgical cohort however embolic events common transcatheter cohort prognosis transcatheter closure see treatment common comorbidities common comorbidities include following pulmonary hypertension pulmonary hypertension mean pulmonary artery pressure 20 mm hg systolic pulmonary artery pressure 50 mm hg occurs 1520 patients asd condition unusual young patients observed 50 patients older 40 years eisenmenger syndrome—a late rare complication isolated secundum asd occurs 515 patients—extreme pulmonary obstruction may result reversal shunt blood righttoleft flow desaturated blood entering systemic circulation results systemic hypoxemia cyanosis rightsided heart failure heart failure due cardiac volume overload experienced right side heart lefttoright shunting patients ages substantial relief complication generally observed defect closed atrial fibrillation atrial flutter conditions uncommon young patients though reported many 5060 patients older 40 years therefore arrhythmias occur frequently age may become major cause morbidity mortality use anticoagulants indicated patients atrial fibrillation high risk stroke although atrial fibrillation may present patients surgery surgery may also cause stroke regardless surgical status 510 patients thromboembolic events including stroke transient ischemic attacks even small defects paradoxical emboli may occur therefore presence asd considered patient cerebral systemic embolus leftsided source demonstrable future controversies increased experience years transcatheter closure suitable secundum atrial septal defects asds become preferable surgical repair limitations currently include size location defect perhaps innovative approach surgical closure many years recently accomplished form robotically assisted closure asd current technology allows excellent visualization magnification internal anatomy ability perform surgery remote distance patient reality however even amazing technology todays devices seem crude compared future computer robots improved access cardiopulmonary bypass technology likely make robotically assisted heart surgery routine procedure near future start media parasternal short axis rv dilation rv pressure overload evidenced flattening parasternal short axis rv dilation rv pressure overload evidenced flattening interventricular septum systole transesophageal echocardiogram moderatelarge asd lefttoright shunt across transesophageal echocardiogram moderatelarge asd lefttoright shunt across interatrial septum apical 4chamber view apical 4chamber view author david h adler md facc assistant professor medicine eastern virginia medical school cardiologist cardiovascular associates ltd david h adler md facc member following medical societies american college cardiology american heart association disclosure received honoraria abiomed speaking teaching coauthors alexander r ellis md msc faap facc assistant professor internal medicine pediatrics eastern virginia medical school codirector pediatric echocardiography laboratory division pediatric cardiology director adult congenital heart disease program children’s hospital king’s daughters director resident medical student education division cardiology children’s hospital king’s daughters eastern virginia medical school alexander r ellis md msc faap facc member following medical societies american academy pediatrics american college cardiology disclosure nothing disclose pharmacy editor francisco talavera pharmd phd adjunct assistant professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure received salary medscape employment medscape managing editor steven j compton md facc facp fhrs director cardiac electrophysiology alaska heart institute providence alaska regional hospitals steven j compton md facc facp fhrs member following medical societies american college physicians american heart association american medical association heart rhythm society alaska state medical association american college cardiology disclosure nothing disclose chief editor park w willis iv md sarah graham distinguished professor medicine pediatrics university north carolina chapel hill school medicine park w willis iv md member following medical societies american society echocardiography disclosure nothing disclose additional contributors park w willis iv md sarah graham distinguished professor medicine pediatrics university north carolina chapel hill school medicine park w willis iv md member following medical societies american society echocardiography disclosure nothing disclose acknowledgements marc g cribbs md marc g cribbs md member following medical societies american heart association american medical association christian medical dental society disclosure nothing disclose larry w markham md larry w markham md member following medical societies american academy pediatrics disclosure nothing disclose bekir hasan melek md bekir hasan melek member following medical societies american association advancement science american college cardiology american college physicians american heart association american medical association american society echocardiography louisiana state medical society disclosure nothing disclose jeffrey c milliken md jeffrey c milliken md member following medical societies alpha omega alpha american association thoracic surgery american college cardiology american college chest physicians american college surgeons american heart association american society artificial internal organs california medical association international society heart lung transplantation phi beta kappa society thoracic surgeons southwest oncology group western surgical association disclosure nothing disclose peter b smulowitz disclosure nothing disclose james v talano md mba mm facc faha james v talano md mba mm facc faha member following medical societies american college cardiology american college chest physicians american college physician executives american college physicians american heart association american society echocardiography american society nuclear cardiology heart failure society america society geriatric cardiology disclosure nothing disclose constantinescu magda sl niculescu r mincu ri zaharia toma cl et al new echocardiographic tehniques pulmonary arterial hypertension vs right heart catheterization pilot study maedica buchar medline full text li qy newburyecob ra terrett ja wilson di curtis ar yi ch holtoram syndrome caused mutations tbx5 member brachyury gene family nat genet medline ruizperez vl ide se strom tm lorenz b wilson woods k mutations new gene ellisvan creveld syndrome weyers acrodental dysostosis nat genet medline benson dw silberbach gm kavanaughmchugh cottrill c zhang riggs mutations cardiac transcription factor nkx25 affect diverse cardiac developmental pathways j clin invest medline full text guideline warnes ca williams rg bashore tm child js connolly hm dearani ja et al accaha 2008 guidelines management adults congenital heart disease executive summary report american college cardiologyamerican heart association task force practice guidelines writing committee develop guidelines management adults congenital heart disease circulation medline kutty hazeem aa brown k danford cj worley se delaney jw et al longterm 5 20year outcomes transcatheter surgical treatment hemodynamically significant isolated secundum atrial septal defect j cardiol medline kaya yurtdas ceylan bulut mo söylemez n güvenç ts et al percutaneous closure secundum atrial septal defects pediatric adult patients short midterm followup results turk kardiyol dern ars medline humenberger rosenhek r gabriel h et al benefit atrial septal defect closure adults impact age eur heart j medline salehian horlick e schwerzmann haberer k mclaughlin p siu sc improvements cardiac form function transcatheter closure secundum atrial septal defects j coll cardiol medline di salvo g drago pacileo g rea carrozza santoro g et al atrial function surgical percutaneous closure atrial septal defect strain rate imaging study j soc echocardiogr medline krumsdorf u ostermayer billinger k trepels zadan e horvath k incidence clinical course thrombus formation atrial septal defect patient foramen ovale closure devices 1000 consecutive patients j coll cardiol medline brandt rr neumann neuzner j rau faude hamm cw transcatheter closure atrial septal defect patent foramen ovale adult patients using amplatzer occlusion device evidence thrombus deposition antiplatelet agents j soc echocardiogr medline divekar gaamangwe shaikh n raabe ducas j cardiac perforation device closure atrial septal defects amplatzer septal occluder j coll cardiol medline amin z hijazi zm bass jl cheatham jp hellenbrand kleinman cs erosion amplatzer septal occluder device closure secundum atrial septal defects review registry complications recommendations minimize future risk catheter cardiovasc interv medline tarnok bocsi j osmancik p hausler hj schneider p dahnert cardiac troponin release transcatheter atrial septal defect closure depends occluder size patients age heart medline egred andron albouaini k alahmar grainger r morrison wl percutaneous closure patent foramen ovale atrial septal defect procedure outcome mediumterm followup j interv cardiol medline fischer g stieh j uebing hoffmann u morf g kramer hh experience transcatheter closure secundum atrial septal defects using amplatzer septal occluder single centre study 236 consecutive patients heart medline anzai h child j natterson b krivokapich j fishbein mc chan vk incidence thrombus formation cardioseal amplatzer interatrial closure devices j cardiol medline argenziano oz mc derose jr jj et al totally endoscopic atrial septal defect repair robotic assistance heart surgery forum full text bartel konorza arjumand j et al intracardiac echocardiography superior conventional monitoring guiding device closure interatrial communications circulation medline bartel konorza neudorf u ebralize eggebrecht h gutersohn intracardiac echocardiography ideal guiding tool device closure interatrial communications eur j echocardiogr medline bedford de anatomical types atrial septal defect incidence clinical diagnosis j cardiol medline benson dw sharkey fatkin lang p basson ct mcdonough b reduced penetrance variable expressivity genetic heterogeneity familial atrial septal defects circulation medline besterman e atrial septal defect pulmonary hypertension br heart j medline bialkowski j karwot b szkutnik banaszak p kusa j skalski j closure atrial septal defects children surgery versus amplatzer device implantation tex heart inst j medline full text braunwald e atrial septal defect braunwald e ed heart disease text cardiovascular medicine carlsson e anatomic diagnosis atrial septal defects j roentgenol radium ther nucl med medline cherian g uthaman cb durairaj et al pulmonary hypertension isolated secundum atrial septal defect high frequency young patients heart j medline chessa carminati butera g et al early late complications associated transcatheter occlusion secundum atrial septal defect j coll cardiol medline goldman l braunwald e primary cardiology holmvang g palacios vlahakes gj et al imaging sizing atrial septal defects magnetic resonance circulation medline humenberger rosenhek r gabriel h rader f heger klaar u et al benefit atrial septal defect closure adults impact age eur heart j medline isselbacher kj braunwald e wilson jd atrial septal defect isselbacher kj ed harrisons principles internal medicine jost ch connolly hm danielson gk et al sinus venosus atrial septal defect longterm postoperative outcome 115patients circulation kirklin jw barrattboyes bg cardiac surgery konstantinides geibel olschewski et al comparison surgical medical therapy atrial septal defect adults n engl j med medline kronzon tunick pa freedberg rs et al transesophageal echocardiography superior transthoracic echocardiography diagnosis sinus venosus atrial septal defect j coll cardiol medline latson la percatheter asd closure pediatr cardiol medline marelli aj moodie ds topol ej adult congenital heart disease textbook cardiovascular medicine masura j gavora p podnar longterm outcome transcatheter secundumtype atrial septal defect closure using amplatzer septal occluders j coll cardiol moore kl persaud tvn born essentials embryology birth defects murphy jg gersh bj mair dd et al longterm outcome patients undergoing surgical repair tetralogy fallot n engl j med medline olaughlin mp catheter closure secundum atrial septal defects tex heart inst j medline full text piéchaud jf closing transcatheter closure intracardiac defects vessel embolisations heart medline rao ps catheter closure atrial septal defects j invasive cardiol medline ruge h wildhirt sm libera p vogt holper k lange r images cardiovascular medicine left atrial thrombus atrial septal defect closure device source cerebral emboli 3 years implantation circulation medline sealy wc farmer jc young jr wg et al atrial dysrhythmia atrial secundum defects j thorac cardiovasc surg medline seward jb khandheria bk edwards wd et al biplanar transesophageal echocardiography anatomic correlations image orientation clinical applications mayo clin proc medline staniloae cs elkhally z ibrahim r et al percutaneous closure secundum atrial septal defect adults single center experience amplatzer septal occluder j invasive cardiol medline stark j secundum atrial septal defect surgery congenital heart defects tardif jc schwartz sl vannan et al clinical usefulness multiplane transesophageal echocardiography comparison biplanar imaging heart j medline thuny f di salvo g belliard avierinos jf pergola v rosenberg v et al risk embolism death infective endocarditis prognostic value echocardiography prospective multicenter study circulation medline tonni g ferrari b defelice c centini g neonatal porencephaly low birth weight infants ultrasound timing asphyxial injury neurodevelopmental outcome two years age j matern fetal neonatal med medline vick gw 3rd murphy dj jr ludomirsky et al pulmonary venous systemic ventricular inflow obstruction patients congenital heart disease detection combined twodimensional doppler echocardiography j coll cardiol medline warnes ca adult congenital heart disease born bad j coll cardiol medline webb g gatzoulis atrial septal defects adult recent progress overview circulation medline weyman ae wann ls caldwell rl et al negative contrast echocardiography new method detecting leftto right shunts circulation medline zanchetta onorato e rigatelli g pedon l zennaro carrozza intracardiac echocardiographyguided transcatheter closure secundum atrial septal defect new efficient device selection method j coll cardiol medline

Article 3:
complications myocardial infarction complications myocardial infarction overview arrhythmic complications mi arrhythmic complications supraventricular tachyarrhythmias complications myocardial infarction overview arrhythmic complications mi arrhythmic complications supraventricular tachyarrhythmias overview overview arrhythmic complications mi arrhythmic complications supraventricular tachyarrhythmias arrhythmic complications accelerated junctional rhythm arrhythmic complications bradyarrhythmias arrhythmic complications av intraventricular blocks arrhythmic complications ventricular arrhythmias arrhythmic complications reperfusion arrhythmias mechanical complications mi left ventricular aneurysm miscellaneous complications complications myocardial infarction overview 164924overview dec 18 2014 201508041821 1 cardiology 2002 diseases conditions condition 1 2 content 164924 502 315 2 r96 jun 04 2015 condition diseases conditions cardiology cardiology cardiologycad coronary artery disease myocardial infarction mi arrhythmic complications mi mechanical complications mi postmi complications postinfarct complications acute myocardial infarction ami acute myocardial infarction radiology myocardial infarction emergency heart attack stelevation myocardial infarction stemi non–stelevation myocardial infarction nstemi cardiogenic shock cardiogenic shock emergency cardiac arrhythmias dysrhythmia periinfarction arrhythmia reperfusion arrhythmia ventricular fibrillation ventricular fibrillation emergency ventricular arrhythmia supraventricular tachyarrhythmia supraventricular tachycardia ventricular tachycardia junctional rhythm accelerated junctional rhythm bradyarrhythmias sinus bradycardia junctional bradycardia atrioventricular block av blockcoronary artery disease cad coronary artery atherosclerosis atherosclerosis myocardial ischemia sudden cardiac death congestive heart failure chf congestive heart failure pulmonary edema left ventricular mural thrombus early pericarditis acute pericarditis postmi syndrome dressler syndrome dresslers syndrome right ventricular infarctionmyocardial rupture rupture ventricular free wall ventricular free wall rupture ventricular septal rupture papillary muscle rupture mitral regurgitation left ventricular aneurysm ventricular aneurysms myocardial infarction mi due coronary artery disease leading cause death united states 1 million people acute myocardial infarctions amis year advent coronary care units early reperfusion therapy lytic percutaneous coronary intervention substantially decreased inhospital 0 complications myocardial infarction overview myocardial infarction mi due coronary artery disease leading cause death united states 1 million people acute myocardial infarctions amis year advent coronary care units early reperfusion therapy lytic percutaneous coronary intervention substantially decreased inhospital mortality rates improved outcome survivors acute phase mi complications mi include arrhythmic mechanical inflammatory early pericarditis postmi syndrome sequelae well left ventricular mural thrombus lvmt addition broad categories right ventricular rv infarction cardiogenic shock possible complications acute mi see image modified 2dimensional top echocardiogram color flow doppler image bottom apical 4 modified 2dimensional top echocardiogram color flow doppler image bottom apical 4chamber views show breach interventricular septum free communication ventricles large apical septum ventricular septal defect patient recently anterior myocardial infarction discussions myocardial infarction see myocardial infarction right ventricular infarction imaging acute myocardial infarcts use cardiac markers emergency department arrhythmic complications mi 90 patients acute myocardial infarction ami develop form cardiac arrhythmia immediately event 25 patients rhythm abnormalities manifest within first 24 hours group patients risk serious arrhythmias ventricular fibrillation greatest first hour declines thereafter incidence arrhythmia higher stelevation myocardial infarction stemi lower non–stelevation myocardial infarction nstemi clinician must aware arrhythmias addition reperfusion strategies must treat require intervention avoid exacerbation ischemia subsequent hemodynamic compromise periinfarct arrhythmias benign selflimited however result hypotension increase myocardial oxygen requirements andor predispose patient develop additional malignant ventricular arrhythmias aggressively monitored treated pathophysiology arrhythmic complications ami characterized generalized autonomic dysfunction results enhanced automaticity myocardium conduction system electrolyte imbalances eg hypokalemia hypomagnesemia hypoxia contribute development cardiac arrhythmia damaged myocardium acts substrate reentrant circuits due changes tissue refractoriness enhanced efferent sympathetic activity increased concentrations circulating catecholamines local release catecholamines nerve endings heart muscle proposed play roles development periinfarction arrhythmias furthermore transmural infarction interrupt afferent efferent limbs sympathetic nervous system innervates myocardium distal area infarction net result autonomic imbalance promotion arrhythmias classification periinfarction arrhythmias periinfarction arrhythmias broadly classified following categories supraventricular tachyarrhythmias including sinus tachycardia premature atrial contractions paroxysmal supraventricular tachycardia atrial flutter atrial fibrillation accelerated junctional rhythms bradyarrhythmias including sinus bradycardia junctional bradycardia atrioventricular av blocks firstdegree av block seconddegree av block thirddegree av block intraventricular blocks including left anterior fascicular block right bundle branch block left bundle branch block ventricular arrhythmias including premature ventricular contractions accelerated idioventricular rhythm ventricular tachycardia ventricular fibrillation reperfusion arrhythmias arrhythmic complications supraventricular tachyarrhythmias sinus tachycardia associated enhanced sympathetic activity result transient hypertension causes persistent sinus tachycardia include following pain anxiety heart failure hypovolemia hypoxia anemia pericarditis pulmonary embolism setting ami sinus tachycardia must identified appropriate treatment strategies must devised treatment strategies include adequate pain medication diuresis manage heart failure oxygenation volume repletion hypovolemia administration antiinflammatory agents treat pericarditis use betablockers andor nitroglycerin relieve ischemia premature atrial contractions premature atrial contractions often occur development paroxysmal supraventricular tachycardia atrial flutter atrial fibrillation usual cause extra impulses atrial distention due increased left ventricular lv diastolic pressure inflammation associated pericarditis specific therapy indicated however attention given identifying underlying disease process particularly occult heart failure paroxysmal supraventricular tachycardia incidence paroxysmal supraventricular tachycardia setting ami less 10 absence definitive data patient ami consensus adenosine synchronized electrical cardioversion atrial flutter atrial flutter occurs less 5 patients ami atrial flutter usually transient results sympathetic overstimulation atria treatment strategies persistent atrial flutter similar atrial fibrillation except ventricularrate control drugs less easily accomplished atrial flutter atrial fibrillation therefore synchronized electrical cardioversion beginning 50 j biphasic equivalent may needed relatively promptly decrease coronary blood flow andor hemodynamic compromise patients whose atrial flutter refractory medical therapy overdrive atrial pacing may considered atrial fibrillation rate atrial fibrillation 1015 among patients amis onset atrial fibrillation first hours ami usually caused lv failure ischemic injury atria rv infarction pericarditis conditions leading elevated left atrial pressure also lead atrial fibrillation association ami presence atrial fibrillation ami associated increased risk mortality stroke particularly patients anteriorwall mis immediate electrical cardioversion indicated patient unstable condition one new worsening ischemic pain andor hypotension synchronized electrical cardioversion treat atrial fibrillation begins 200 j biphasic equivalent conscious sedation preferred general anesthesia patients stable condition controlling ventricular response immediate objective atrial fibrillation respond cardioversion iv amiodarone digoxin patients develop hypotension betablocker used example metoprolol diltiazem atrial fibrillation atrial flutter confer increased risk thromboembolism see deep venous thrombosis pulmonary embolism arrhythmic complications accelerated junctional rhythm accelerated junctional rhythm results increased automaticity junctional tissue leads heart rate 70130 bpm type dysrhythmia common patients develop inferior myocardial infarctions treatment directed correcting underlying ischemia arrhythmic complications bradyarrhythmias sinus bradycardia sinus bradycardia common arrhythmia patients inferior posterior acute myocardial infarctions amis highest incidence 40 observed first 12 hours ami likely mechanism leading bradycardia hypotension stimulation cardiac vagal afferent receptors result efferent cholinergic stimulation heart early phases ami resultant sinus bradycardia may actually protective reducing myocardial oxygen demand clinically significant bradycardia decreases cardiac output hypotension may result ventricular arrhythmias therefore treated aggressively isolated sinus bradycardia associated increase acute mortality risk therapy typically unnecessary patient adverse signs symptoms emergency therapy indicated eg patient sinus rate 40 bpm hypotension atropine sulfate 051 mg may given every 35 minutes maximum 003004 mgkg inability reverse hypotension atropine patients develop sinus bradycardia inferior mi suggests volume depletion andor rv infarction atropine ineffective patient symptomatic hypotensive transcutaneous transvenous pacing indicated see main article external pacemakers interventions fail additional pharmacologic intervention may useful examples dopamine epinephrine dobutamine junctional bradycardia junctional bradycardia protective av junctional escape rhythm rate 3560 bpm patients inferior mi arrhythmia usually associated hemodynamic compromise treatment typically required arrhythmic complications av intraventricular blocks firstdegree av block firstdegree av block characterized prolongation pr interval longer 020 seconds type block occurs approximately 15 patients acute myocardial infarction ami commonly inferior infarction almost patients develop firstdegree av block conduction disturbances bundle patients progression complete heart block ventricular asystole rare specific therapy indicated unless associated hemodynamic compromise present calcium channel blockers betablockers may cause exacerbate firstdegree av block stopped hemodynamic impairment higherdegree block occurs firstdegree av block associated sinus bradycardia hypotension atropine administered continued cardiac monitoring advisable view possible progression higher degrees block seconddegree av block mobitz type wenckebach av block occurs approximately 10 patients ami accounts 90 patients ami seconddegree av block seconddegree av block associated narrow qrs complex commonly associated inferior mi affect patients overall prognosis mobitz type block necessarily require treatment heart rate inadequate perfusion immediate treatment atropine 051 mg administered intravenously indicated transcutaneous temporary transvenous pacing rarely required mobitz type ii av block accounts 10 seconddegree av blocks overall rate 1 setting ami mobitz type ii block characterized wide qrs complex almost always associated anterior infarction type block often progresses suddenly complete heart block mobitz type ii av blocks associated poor prognosis mortality rate associated progression complete heart block approximately 80 therefore type seconddegree av block immediately treated transcutaneous pacing atropine atropine helps 50 cases occasionally worsens block increased heart rate temporary transvenous pacemaker possibly permanent demand pacemaker must ultimately placed thirddegree av block thirddegree av block ie complete heart block occurs 515 patients ami may occur anterior inferior infarctions patients inferior infarctions type block usually develops gradually progressing firstdegree type seconddegree block patients level block supranodal intranodal escape rhythm usually stable narrow qrs rates exceeding 40 bpm 30 patients block bundle results escape rhythm rate slower 40 bpm wide qrs complex complete heart block patients inferior mi usually responds atropine patients resolves within days without need temporary permanent pacemaker mortality rate patients inferior mi develop complete heart block approximately 15 unless coexisting rv infarction present case mortality rate higher immediate treatment atropine indicated patients thirddegree av blocks therapy mobitz type ii block treatment may help may sometimes worsen block temporary transcutaneous transvenous pacing indicated symptomatic patients whose condition unresponsive atropine permanent pacing considered patients persistent symptomatic bradycardia remains unresolved lysis percutaneous coronary intervention patients anterior mi intraventricular block mobitz type ii av block usually precedes thirddegree av block thirddegree block occurs suddenly associated high mortality rate cardiac arrhythmias risk stratification myocardial infarction carisma trial monitored patients acute myocardial infarction reduced left ventricular ejection fraction found highdegree atrioventricular block powerful predictor cardiac death immediate treatment atropine andor transcutaneous pacing indicated followed temporary transvenous pacing patients anterior mi develop thirddegree av block survive hospitalization often receive permanent pacemaker intraventricular blocks conduction bundle transmitted 3 fascicles anterior division left bundle posterior division left bundle right bundle abnormality electrical conduction 1 fascicles noted 15 patients ami isolated left anterior fascicular block lafb occurs 35 patients ami progression complete av block uncommon isolated left posterior fascicular block occurs 12 patients ami blood supply posterior fascicle larger anterior fascicle therefore block associated relatively large infarct high mortality rate right bundle branch receives dominant blood supply left anterior descending lad artery therefore new rbbb seen approximately 2 patients ami suggests large infarct territory however progression complete heart block uncommon patients develop anterior mi new rbbb substantial risk death mostly cardiogenic shock presumably due large size myocardial infarct combination rbbb lafb known bifascicular block commonly occurs occlusion proximal lad coronary artery risk developing complete av block heightened complete block still uncommon mortality mostly related amount muscle loss bifascicular block presence firstdegree av block called trifascicular block 40 patients trifascicular block progresses complete heart block arrhythmic complications ventricular arrhythmias premature ventricular contractions past frequent premature ventricular contractions pvcs considered represent warning arrhythmias indicators impending malignant ventricular arrhythmias however presumed warning arrhythmias frequently observed patients acute myocardial infarction ami never develop ventricular fibrillation converse primary ventricular fibrillation often occurs without antecedent premature ventricular ectopy reasons prophylactic suppression pvcs antiarrhythmic drugs lidocaine longer recommended prophylaxis associated increased risk fatal bradycardia asystole suppression escape pacemakers given evidence clinicians pursue conservative course pvcs observed patient ami routinely administer prophylactic antiarrhythmics instead attention directed toward correcting electrolytic metabolic abnormalities plus identifying treating recurrent ischemia accelerated idioventricular rhythm accelerated idioventricular rhythm seen many 20 patients ami pattern defined ventricular rhythm characterized wide qrs complex regular escape rate faster atrial rate less 100 bpm av dissociation frequent slow nonconducted p waves seen unrelated fast wide qrs rhythm episodes short terminate spontaneously occur equal frequency anterior inferior infarctions mechanism might involve 1 sinoatrial node av node may sustain structural damage depress nodal automaticity andor 2 abnormal ectopic focus ventricle takes dominant pacemaker presence accelerated idioventricular rhythm affect patients prognosis definitive evidence shown untreated occurrence increases incidence ventricular fibrillation death rhythm occurs somewhat frequently patients develop early reperfusion others however neither sensitive specific marker reperfusion temporary pacing indicated unless rhythm sustained results hypotension ischemic symptoms accelerated idioventricular rhythm represents appropriate escape rhythm suppression escape rhythm antiarrhythmic drug result clinically significant bradycardia asystole therefore accelerated idioventricular rhythm left untreated nonsustained ventricular tachycardia nonsustained ventricular tachycardia defined 3 consecutive ventricular ectopic beats rate greater 100 bpm lasting less 30 seconds patients experience multiple runs nonsustained ventricular tachycardia risk sudden hemodynamic collapse may substantial nonetheless nonsustained ventricular tachycardia immediate periinfarction period appear associated increased mortality risk evidence suggests antiarrhythmic treatment offers morbidity mortality benefit however nonsustained ventricular tachycardia occurring 48 hours infarction patients lv systolic dysfunction lv ejection fraction 040 poses increased risk sudden cardiac death electrophysiologic testing appropriate therapy indicated patients multiple episodes nonsustained ventricular tachycardia require intensified monitoring attention electrolyte imbalances serum potassium levels maintained 45 meql serum magnesium levels kept 20 meql ongoing ischemia aggressively sought corrected found sustained ventricular tachycardia sustained ventricular tachycardia defined 3 consecutive ventricular ectopic beats rate greater 100 bpm lasting longer 30 seconds causing hemodynamic compromise requires intervention monomorphic ventricular tachycardia likely caused myocardial scar whereas polymorphic ventricular tachycardia may responsive measures directed ischemia sustained polymorphic ventricular tachycardia ami associated hospital mortality rate 20 emergency treatment sustained ventricular tachycardia mandatory hemodynamic effects frequently deteriorates ventricular fibrillation rapid polymorphic ventricular tachycardia rate 150 bpm associated hemodynamic instability treated immediate directcurrent unsynchronized cardioversion 200 j biphasic energy equivalent monomorphic ventricular tachycardia treated synchronized discharge 100 j biphasic energy equivalent sustained ventricular tachycardia well tolerated antiarrhythmic therapy amiodarone drug choice procainamide may attempted electrical cardioversion precipitating causes electrolyte abnormalities acidbase disturbances hypoxia medication sought corrected persistent recurrent ventricular tachycardia overdrive pacing may effective electrically converting patients rhythm sinus rhythm ventricular fibrillation incidence primary ventricular fibrillation greatest first hour onset infarct 45 declines rapidly thereafter approximately 60 episodes occur within 4 hours 80 occur within 12 hours secondary late ventricular fibrillation occurring 48 hours mi usually associated pump failure cardiogenic shock factors associated increased risk secondary ventricular fibrillation large infarct intraventricular conduction delay anteroseptal ami secondary ventricular fibrillation conjunction cardiogenic shock associated inhospital mortality rate 4060 treatment ventricular fibrillation unsynchronized electrical countershock least 200300 j biphasic energy equivalent administered rapidly possible minute onset uncorrected ventricular fibrillation associated 10 decrease likelihood survival restoration synchronous cardiac electrical activity without return effective contraction ie electromechanical dissociation pulseless electrical activity antiarrhythmics intravenous amiodarone lidocaine facilitate successful electrical defibrillation help prevent recurrent refractory episodes ventricular fibrillation successfully converted antiarrhythmic therapy generally continued constant intravenous infusion 1224 hours prophylactic lidocaine reduces incidence ventricular fibrillation used seems associated excessive mortality risk owing bradycardic asystolic events arrhythmic complications reperfusion arrhythmias past sudden onset rhythm disturbances thrombolytic therapy patients ami believed marker successful coronary reperfusion however high incidence identical rhythm disturbances observed patients ami coronary reperfusion unsuccessful therefore socalled reperfusion arrhythmias neither sensitive specific reperfusion treated discussed accelerated idioventricular rhythm arrhythmic complications ventricular arrhythmias section mechanical complications mi 3 major mechanical complications ami ventricular free wall rupture vfwr ventricular septal rupture mitral regurgitation myocardial rupture overview ventricular free wall rupture vfwr serious complication ami vfwr usually associated large transmural infarctions antecedent infarct expansion common cause death second lv failure accounts 1530 deaths associated ami incontrovertibly catastrophic mechanical complications vfwr leads acute hemopericardium death cardiac tamponade overall incidence vfwr ranges 0862 incidence complication declined years better 24 hour systolic blood pressure control increased use reperfusion therapy beta blockers ace inhibitors decreased use heparin data national registry myocardial infarction nrmi showed elevated incidence inhospital mortality among patients received thrombolytic therapy 121 among patients 61 risk factors vfwr include advanced age greater 70 years female sex previous mis q waves ecg hypertension initial phase stemi corticosteroid nsaid use fibrinolytic therapy 14 hours stemi onset patients history angina pectoris clinical presentation vfwr vfwrs dramatic present acutely occasionally subacutely pseudoaneurysms often involve anterior lateral wall lv vfwrs occur within first week ami becker et al classified following 3 types vfwrs type abrupt slitlike tear frequently associated anterior infarcts occurs early within 24 h type ii erosion infarcted myocardium border infarcted viable myocardium type iii early aneurysm formation correlated older severely expanded infarcts type iii usually occurs later type type ii ruptures thrombolytic therapy accelerates occurrence cardiac rupture becker type type ii vfwrs severely expanded infarctions type iii thrombolytic therapy decreases incidence cardiac rupture pseudoaneurysm formed adjacent pericardium hematoma seals myocardial rupture perforation wall pseudoaneurysm often visualized aneurysmal outpouching communicates lv cavity means narrow neck wall composed pericardium organized thrombus andor hematoma devoid myocardial elements whereas true aneurysm elements original myocardial wall relatively wide base pseudoaneurysm may vary size high risk rupturing clinical presentations vfwr vary depending acuity location size rupture patients acute vfwr present severe chest pain abrupt electromechanical dissociation asystole hemodynamic collapse possibly death one third patients course subacute present symptoms syncope hypotension shock arrhythmia prolonged recurrent chest pain diagnosis vfwr early diagnosis vfwrs intervention critical patient survival high index suspicion required patients ami present severe chest pain shock arrhythmias abrupt development electromechanical dissociation ecg signs impending vfwr limited specificity include sinus tachycardia intraventricular conduction defect persistent recurrent stsegment elevation echocardiography diagnostic tool choice key diagnostic finding moderatetolarge pericardial effusion clinical echocardiographic signs impending pericardial tamponade patients cardiac tamponade electromechanical dissociation moderatetosevere pericardial effusion increases mortality risk patients without initial cardiac tamponade lower rate mortality still followed late rupture may still occur mri provides superior image quality permits identification site anatomy ventricular pseudoaneurysm ie ruptured lv restrained pericardium enclosed clot however mri limited use acute setting time involved nonportability imaging units treatment vfwr important prevention strategy early reperfusion therapy percutaneous coronary intervention pci preferred modality fibrinolytic therapy associated overall decreased risk vfwr however use 14 hours stemi onset increase risk early rupture standard treatment vfwr emergency surgical repair hemodynamic stability achieved patients may first need intravenous fluids inotropic agents emergency pericardiocentesis pifarré associates recommended deployment intraaortic balloon pump decrease systolic afterload improve diastolic myocardial perfusion several surgical techniques applied including infarctectomy adhering biologic glue patches made polyethylene terephthalate polyester fiber dacron dupont wilmington de polytetrafluoroethylene fluoropolymer resin teflon dupont use pledgeted sutures without infarctectomy mortality rate significantly high largely depends patients preoperative hemodynamic status early diagnosis rapid institution measures described achieve hemodynamic stability prompt surgical repair improve survival rates followup acorn randomized trial demonstrated longterm improvement left ventricular structure function mitral valve surgery long 5 years data provide evidence supporting mitral valve repair combination acorn corcap device patients nonischemic heart failure severe left ventricular dysfunction medically optimized yet remain symptomatic significant mitral regurgitation overview ventricular septal rupture vsr infrequent lifethreatening complication ami despite optimal medical surgical treatment patients vsr high inhospital mortality rate prethrombolytic era vsrs occurred 13 individuals mis incidence declined thrombolytic therapy 02034 improvements reperfusion myocardial salvage bimodal distribution vsr characterized high incidence first 24 hours another peak days 35 rarely 2 weeks ami patients receiving thrombolytics median time onset symptoms ami septal rupture 1 day global utilization streptokinase tpa tissue plasminogen activator occluded coronary arteries gustoi trial risk factors septal rupture include advanced age 65 female sex singlevessel disease extensive mi poor septal collateral circulation patients ami without reperfusion coagulation necrosis develops within 35 days infarction neutrophils migrate necrotic zone undergo apoptosis release lytic enzymes hasten disintegration necrotic myocardium patients infarcts large intramural hematomas dissect tissue result early septal rupture size septal rupture ranges millimeters several centimeters vsr categorized simple complex depending length course location simple septal rupture perforation level sides septum direct throughandthrough communication present across septum complex septal rupture characterized extensive hemorrhage irregular serpiginous tracts necrotic tissue septal ruptures common patients large anterior mis due occlusion lad artery causing extensive septal infarcts infarcts associated stsegment elevations q waves inferior leads ii iii avf ecg changes therefore commonly seen septal ruptures septal ruptures patients inferior mi occur relatively infrequently ruptures involve basal inferoposterior septum often complex clinical presentation vsr symptoms vsr complicating ami include chest pain shortness breath hypotension biventricular failure shock within hours days patients often present new loud harsh holosystolic murmur murmur loudest along lower left sternal border associated palpable parasternal systolic thrill rv lv s3 gallops common patients cardiogenic shock complicating septal rupture murmur thrill may difficult identify contrast patients acute mr often soft systolic murmur apex without thrill diagnosis vsr echocardiography color flow doppler imaging diagnostic tool choice identifying vsr see image sensitivity specificity reported high 100 addition used following define site size septal rupture assess lv rv function estimate rv systolic pressure quantify lefttoright shunt cardiac catheterization usually required confirm diagnosis quantitate degree lefttoright shunt differentiate vsr conditions eg mitral regurgitation plus visualize coronary arteries modified 2dimensional top echocardiogram color flow doppler image bottom apical 4 modified 2dimensional top echocardiogram color flow doppler image bottom apical 4chamber views show breach interventricular septum free communication ventricles large apical septum ventricular septal defect patient recently anterior myocardial infarction patients vsr rightheart catheterization shows stepup oxygen saturation right atrium rv contrast stepup oxygen saturation occurs among patients mr presence large v waves pulmonary capillary wedge tracing supports diagnosis severe acute mr left ventriculography also used identify site ventricular rupture see cardiac catheterization left heart treatment vsr key management vsr prompt diagnosis aggressive approach hemodynamic stabilization angiography surgery optimal approach includes hemodynamic stabilization administration oxygen mechanical support use intraaortic balloon pump well administration vasodilators reduce afterload thus lv pressure lefttoright shunt diuretics inotropic agents cardiac catheterization needed define coronary anatomy followed urgent surgical repair medical therapy intended temporary stabilization surgery patients conditions deteriorate rapidly die absence surgical intervention gustoi trial 30day mortality rate lower patients vsr underwent surgical repair patients treated medically 47 vs 94 1year mortality rate 53 vs 97 current guidelines american college cardiologyamerican heart association treatment patients septal rupture complicating ami highlight urgent surgical intervention regardless clinical status prompt establishment hypothermic cardiopulmonary bypass approach septal rupture infarct area excision necrotic friable margins septum ventricular walls avoid postoperative hemorrhage residual septal defect reconstruction septum ventricular walls using prosthetic material preservation geometric configuration ventricles heart function percutaneous closure septal rupture relatively new approach one used select patients alternative surgical repair acute stabilization critically ill patients however percutaneous closure currently unavailable many institutions longterm outcome data available several studies failed show relationship perioperative mortality concomitant coronary revascularization coronary artery bypass grafting patients cardiogenic shock due septal rupture poorest outcome shock trial inhospital mortality rate higher patients cardiogenic shock due septal rupture 873 patients cardiogenic shock causes 592 pure lv failure 551 acute mr patients survive surgical repair rate recurrent residual septal defect reported 28 associated mortality rate high repeat surgical intervention indicated patients clinical heart failure pulmonarysystemic fraction greater 2 overview acute mitral regurgitation mr common complication ami results local global lv remodeling independent predictor heart failure death mr typically occurs 710 days ami though onset may vary according mechanism mr papillary muscle rupture resulting mr occurs within 114 days median 1 mildtomoderate mr often clinically silent detected doppler echocardiography performed early phase ami cases mr rarely causes hemodynamic compromise speckle tracking 3dimensional echocardiography proved important imaging tools assessing reverse lv remodeling degenerative mitral valve regurgitation surgery subtle regional preoperative changes diastolic function septal lateral wall could preoperatively identified aiding optimizing referral timing recognizing potential culprits indicators disease recurrence mitral repair severe acute mr results rupture papillary muscles chordae tendineae results abrupt hemodynamic deterioration cardiogenic shock rapid diagnosis hemodynamic stabilization prompt surgical intervention needed acute severe mr associated high mortality rate reported incidence mr may vary several factors including diagnostic methods used presence absence heart failure degree mr reported type therapy rendered time infarct onset testing gustoi trial incidence mr patients receiving thrombolytic therapy 173 risk factors mr advanced age female sex large infarct previous ami recurrent ischemia multivessel coronary artery disease heart failure several mechanisms cause mr ami rupture papillary muscle commonly reported mechanism rupture occurs 1 patients ami frequently involves posteromedial papillary muscle rather anterolateral papillary muscle former single blood supply versus dual supply latter papillary muscle rupture may lead flailing prolapse leaflets resulting severe mr papillary muscle dysfunction due scarring recurrent ischemia may also lead mr subacute chronic phases mi condition resolve spontaneously large posterior infarctions produce acute mr due asymmetric annular dilation altered function geometry papillary muscle clinical presentation mr patients functional mild moderate mr often asymptomatic severity symptoms varies depending ventricular function clinical features acute severe mr include shortness breath fatigue new apical holosystolic murmur flash pulmonary edema shock new systolic murmur may earlytomid systolic holosystolic may soft even absent abrupt rise left atrial pressure lessens pressure gradient left atrium lv compared chronic mr murmur best heard apex rather lower left sternal border uncommonly associated thrill s3 s4 gallops expected diagnosis mr clinician cannot rely new holosystolic murmur diagnose mr assess severity variable hemodynamic status patient ami presents new apical systolic murmur acute pulmonary edema cardiogenic shock high index clinical suspicion severe mr key diagnosis chest radiography may show evidence pulmonary edema acute setting without clinically significant cardiac enlargement echocardiography color flow doppler imaging standard diagnostic tool detecting mr transthoracic echocardiography preferred initial screening tool transesophageal echocardiography invaluable defining severity exact mechanism acute mr especially suspicion papillary muscle rupture high cardiac catheterization performed patients determine extent severity coronary artery disease treatment mr determination hemodynamic stability elucidation exact mechanism acute mr expedient therapy necessary favorable outcome medical management includes afterload reduction use diuretics sodium nitroprusside nitrates patients hypotensive patients hemodynamic compromise intraaortic balloon counterpulsation deployed rapidly intervention usually substantially reduces afterload regurgitant volume improving cardiac output preparation surgical repair without surgical repair medical therapy alone patients papillary muscle rupture results inadequate hemodynamic improvement poor shortterm prognosis emergency surgical intervention treatment choice papillary muscle rupture surgical approaches may include mitral valve repair replacement absence papillary muscle necrosis mitral valve repair improves survival rate mitral valve replacement difference subvalvular apparatus usually preserved mitral valve repair also eliminates complications related malfunction prosthesis patients extensive necrosis papillary muscle andor ventricular free wall mitral valve replacement preferred modality coronary artery bypass grafting cabg performed time surgery shown one study improve short longterm survival situation emergency surgery safely avoided case intermittent mr due recurrent ischemia patients successful myocardial revascularization may effective procedure accomplished means either angioplasty coronary artery bypass grafting left ventricular aneurysm overview lva left ventricular aneurysm lva defined localized area myocardium abnormal outward bulging deformation systole diastole rate lvas ami approximately 315 risk factors lva ami include female sex total occlusion lad artery singlevessel disease absence previous angina 80 lvas affect anterolateral wall usually associated total occlusion lad posterior inferior walls less commonly affected lvas generally range 18 cm histologically lvas composed fibrous scar notably thinned scar clearly delineated adjacent ventricular muscle microscopic examination history mi third fourth heart sounds common findings patients history physical examination diagnosis lva chest radiograph may reveal enlarged cardiac silhouette electrocardiography characterized st elevation persists several weeks ami appears leads showing acute infarct echocardiography 93 sensitive 94 specific detection lva see image cardiac catheterization remains standard establishing diagnosis parasternal longaxis view left ventricle demonstrates large inferobasal aneurysm note parasternal longaxis view left ventricle demonstrates large inferobasal aneurysm note wide neck base aneurysm treatment lva patients small clinically insignificant aneurysms treated conservatively close followup medical therapy generally consists use angiotensinconverting enzyme ace inhibitors reduce afterload infarct extension lv remodeling anticoagulation required patients severe lv dysfunction andor thrombus lv aneurysm surgical resection lva indicated severe heart failure ventricular tachyarrhythmias refractory medical treatment recurrent thromboembolism present miscellaneous complications left ventricular mural thrombus lvmt wellknown complication ami frequently develops anterior infarcts lv wall incidence lvmt complication ami ranges 2040 may reach 60 patients large anteriorwall amis treated anticoagulant therapy lvmt associated high risk systemic embolization anticoagulant therapy may substantially decrease rate embolic events 33 compared anticoagulation factors contributing lvmt formation include lv regionalwall akinesia dyskinesia blood stasis injury inflammation endocardial tissue provides thrombogenic surface hypercoagulable state common clinical presentation patients lvmt complicating mi stroke episodes occur within first 10 days ami physical findings depend site embolism transthoracic echocardiography remains imaging modality choice 92 sensitive 88 specific detecting lvmt see image management lvmt includes heparin warfarin apical 2chamber view depicts large left ventricular apical thrombus mobile extensions apical 2chamber view depicts large left ventricular apical thrombus mobile extensions pericarditis incidence early pericarditis mi approximately 10 complication usually develops within 2496 pericarditis caused inflammation pericardial tissue overlying infarcted myocardium clinical presentation may include severe chest pain usually pleuritic pericardial friction rub key ecg change diffuse stsegment elevation nearly leads echocardiography may reveal small pericardial effusion mainstay therapy usually includes aspirin nonsteroidal antiinflammatory drugs nsaids colchicine may beneficial patients recurrent pericarditis postmi syndrome dressler syndrome era reperfusion incidence postmi syndrome ranged 15 ami rate dramatically declined advent thrombolysis coronary angioplasty although exact mechanism yet elucidated postmi syndrome considered autoimmune process clinical features include fever chest pain signs symptoms pericarditis occurring 23 weeks ami management involves hospitalization observation evidence cardiac tamponade treatment comprises rest use nsaids andor steroids patients recurrent postmi syndrome disabling symptoms offhour mi admissions despite perception patients acute mi admitted hours higher rates death compared admitted regular hours multivariate analyses outcomes data mayo clinic weekends nights holidays admissions patients acute mi underwent percutaneous coronary interventions found significant association inpatient mortality 30day mortality 30day readmissions differences findings without stelevation mi stemi nonstemi start media modified 2dimensional top echocardiogram color flow doppler image bottom apical 4 modified 2dimensional top echocardiogram color flow doppler image bottom apical 4chamber views show breach interventricular septum free communication ventricles large apical septum ventricular septal defect patient recently anterior myocardial infarction apical 2chamber view depicts large left ventricular apical thrombus mobile extensions apical 2chamber view depicts large left ventricular apical thrombus mobile extensions parasternal longaxis view left ventricle demonstrates large inferobasal aneurysm note parasternal longaxis view left ventricle demonstrates large inferobasal aneurysm note wide neck base aneurysm author ashok k kondur md clinical assistant professor department internal medicine detroit medical center wayne state university ashok k kondur md member following medical societies american college physicians michigan state medical society disclosure nothing disclose coauthors luis c afonso md assistant professor department internal medicinecardiology program director cardiology fellowship program wayne state university director echocardiography laboratory harper university hospital luis c afonso md member following medical societies american college cardiology american college physicians american medical association american society echocardiography disclosure nothing disclose pawan hari md mph resident physician department internal medicine wayne state university school medicine disclosure nothing disclose pharmacy editor francisco talavera pharmd phd adjunct assistant professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure received salary medscape employment medscape managing editor brian olshansky md professor emeritus medicine department internal medicine university iowa college medicine brian olshansky md member following medical societies american college cardiology heart rhythm society cardiac electrophysiology society american heart association disclosure received honoraria guidantboston scientific speaking teaching received honoraria medtronic speaking teaching received consulting fee guidantboston scientific consulting received consulting fee biocontrol consulting received consulting fee boehringer ingelheim consulting received consulting fee amarin review panel membership received consulting fee sanofi aventis review panel membership chief editor eric h yang md associate professor medicine director cardiac catherization laboratory interventional cardiology mayo clinic arizona eric h yang md member following medical societies alpha omega alpha disclosure nothing disclose acknowledgements authors editors medscape reference gratefully acknowledge contributions previous authors sumanth r daram md sridevi r pitta md development writing source article rosamond w flegal k friday g et al heart disease stroke statistics2007 update report american heart association statistics committee stroke statistics subcommittee erratum appears circulation 2007 feb 61155e172 circulation medline full text dayan v soca g parma g mila r early coronary artery bypass surgery improve survival nonst acute myocardial infarction interact cardiovasc thorac surg medline kontoyannis da anastasiounana mi kontoyannis sa zaga ak nanas jn intravenous amiodarone decreases duration atrial fibrillation associated acute myocardial infarction cardiovasc drugs ther medline bloch thomsen pe jons c raatikainen mj moerch joergensen r hartikainen j virtanen v et al longterm recording cardiac arrhythmias implantable cardiac monitor patients reduced ejection fraction acute myocardial infarction cardiac arrhythmias risk stratification acute myocardial infarction carisma study circulation medline macmahon collins r peto r koster rw yusuf effects prophylactic lidocaine suspected acute myocardial infarction overview results randomized controlled trials jama medline hjalmarson herlitz j holmberg rydén l swedberg k vedin et al göteborg metoprolol trial effects mortality morbidity acute myocardial infarction circulation medline figueras j alcalde barrabés ja serra v alguersuari j cortadellas j changes hospital mortality rates 425 patients acute stelevation myocardial infarction cardiac rupture 30year period circulation medline becker rc gore jm lambrew c weaver wd rubison rm french wj composite view cardiac rupture united states national registry myocardial infarction j coll cardiol medline kleiman ns terrin mueller h chaitman b roberts r knatterud gl mechanisms early death despite thrombolytic therapy experience thrombolysis myocardial infarction phase ii timi ii study j coll cardiol medline honan mb harrell fe jr reimer ka califf rm mark db pryor db cardiac rupture mortality timing thrombolytic therapy metaanalysis j coll cardiol medline becker rc hochman js cannon cp spencer fa ball sp rizzo mj et al fatal cardiac rupture among patients treated thrombolytic agents adjunctive thrombin antagonists observations thrombolysis thrombin inhibition myocardial infarction 9 study j coll cardiol medline becker ae van mantgem jp cardiac tamponade study 50 hearts eur j cardiol medline figueras j barrabés ja serra v cortadellas j lidón rm carrizo et al hospital outcome moderate severe pericardial effusion complicating stelevation acute myocardial infarction circulation medline nakamura f minamino higashino ito h fujii k fujita cardiac free wall rupture acute myocardial infarction ameliorative effect coronary reperfusion clin cardiol medline pollak h nobis h mlczoch j frequency left ventricular free wall rupture complicating acute myocardial infarction since advent thrombolysis j cardiol medline pifarré r sullivan hj grieco j montoya bakhos scanlon pj management left ventricular rupture complicating myocardial infarction j thorac cardiovasc surg medline acker jessup bolling sf et al mitral valve repair heart failure fiveyear followup mitral valve replacement stratum acorn randomized trial j thorac cardiovasc surg medline crenshaw bs granger cb birnbaum pieper ks morris dc kleiman ns risk factors angiographic patterns outcomes patients ventricular septal defect complicating acute myocardial infarction gustoi global utilization streptokinase tpa occluded coronary arteries trial investigators circulation medline menon v webb jg hillis ld et al outcome profile ventricular septal rupture cardiogenic shock myocardial infarction report shock trial registry emergently revascularize occluded coronaries cardiogenic shock j coll cardiol medline birnbaum wagner gs gates kb thompson td barbash gi siegel rj et al clinical electrocardiographic variables associated increased risk ventricular septal defect acute anterior myocardial infarction j cardiol medline skehan jd carey c norrell ms de belder balcon r mills pg patterns coronary artery disease postinfarction ventricular septal rupture br heart j medline hayashi hirano takai h kimura taniguchi kurooka usefulness stsegment elevation inferior leads predicting ventricular septal rupture patients anterior wall acute myocardial infarction j cardiol medline lemery r smith hc giuliani er gersh bj prognosis rupture ventricular septum acute myocardial infarction role early surgical intervention j cardiol medline guideline ogara pt kushner fg ascheim dd et al 2013 accfaha guideline management stelevation myocardial infarction report american college cardiology foundationamerican heart association task force practice guidelines j coll cardiol medline demondion p fournel l golmard jl niculescu pavie leprince p predictors 30day mortality outcome cases myocardial infarction cardiogenic shock treated extracorporeal life support eur j cardiothorac surg medline pandis grapsa j athanasiou punjabi p nihoyannopoulos p left ventricular remodeling mitral valve surgery prospective study realtime 3dimensional echocardiography speckle tracking j thorac cardiovasc surg medline picard mh davidoff r sleeper la mendes la thompson cr dzavik v et al echocardiographic predictors survival response early revascularization cardiogenic shock circulation medline kinn jw oneill ww benzuly kh jones de grines cl primary angioplasty reduces risk myocardial rupture compared thrombolysis acute myocardial infarction cathet cardiovasc diagn medline kishon oh jk schaff hv mullany cj tajik aj gersh bj mitral valve operation postinfarction rupture papillary muscle immediate results longterm followup 22 patients mayo clin proc medline sorita lennon rj haydour q et al offhour admission outcomes patients acute myocardial infarction undergoing percutaneous coronary interventions heart j medline

Article 4:
heatstroke heatstroke background pathophysiology epidemiology heatstroke clinical presentation history physical causes heatstroke differential diagnoses heatstroke workup laboratory studies imaging studies tests heatstroke treatment management medical care surgical care consultations heatstroke medication benzodiazepines alkalinizing agents diuretics osmotic adrenergic agonist agents heatstroke followup outpatient care inpatient care deterrenceprevention heatstroke background pathophysiology epidemiology heatstroke clinical presentation history physical causes heatstroke differential diagnoses heatstroke workup laboratory studies imaging studies tests heatstroke treatment management medical care surgical care consultations heatstroke medication benzodiazepines alkalinizing agents diuretics osmotic adrenergic agonist agents heatstroke followup outpatient care inpatient care deterrenceprevention overview background pathophysiology epidemiology racial sexual disparities incidence agerelated disparities incidence presentation history physical causes differential diagnoses workup laboratory studies imaging studies tests procedures treatment medical care surgical care consultations diet activity medication followup outpatient care inpatient care deterrenceprevention complications prognosis patient education heatstroke overview heatstroke clinical presentation heatstroke differential diagnoses heatstroke workup heatstroke treatment heatstroke medication heatstroke followup 166320overview may 01 2015 201508042027 0 emergency medicine 2002 diseases conditions condition 1 2 content 166320 502 34 ssg jun 04 2015 condition diseases conditions emergencymedicine emergency medicine emergencymedicineenvironmental environmental heatstroke heatstroke symptoms heatstroke signs heatstroke causes heatstroke treatment heat stroke hyperthermia heatrelated diseases heat illness heat rash heat edema heat cramps heat illness may viewed continuum illnesses relating bodys inability cope heat includes minor illnesses heat edema heat rash ie prickly heat heat cramps tetany well heat syncope heat exhaustion 0 heatstroke overview background heat illness may viewed continuum illnesses relating bodys inability cope heat includes minor illnesses heat edema heat rash ie prickly heat heat cramps tetany well heat syncope heat exhaustion heatstroke severe form heatrelated illnesses defined body temperature higher 411°c 106°f associated neurologic dysfunction two forms heatstroke exist exertional heatstroke ehs generally occurs young individuals engage strenuous physical activity prolonged period time hot environment classic nonexertional heatstroke nehs commonly affects sedentary elderly individuals persons chronically ill young persons classic nehs occurs environmental heat waves common areas typically experience periods prolonged hot weather types heatstroke associated high morbidity mortality especially cooling therapy delayed influence global warming predicted incidence heatstroke cases fatalities also become prevalent behavioral responses important management temperature elevations may provide clues preventing development heatstroke see heat illness cool hyperthermic patients pathophysiology despite wide variations ambient temperatures humans mammals maintain constant body temperature balancing heat gain heat loss heat gain overwhelms bodys mechanisms heat loss body temperature rises potentially leading heatstroke excessive heat denatures proteins destabilizes phospholipids lipoproteins liquefies membrane lipids leading cardiovascular collapse multiorgan failure ultimately death exact temperature cardiovascular collapse occurs varies among individuals coexisting disease drugs factors may contribute delay organ dysfunction full recovery observed patients temperatures high 46°c death occurred patients much lower temperatures temperatures exceeding 106°f 411°c generally catastrophic require immediate aggressive therapy heat may acquired number different mechanisms rest basal metabolic processes produce approximately 100 kcal heat per hour 1 kcalkgh reactions raise body temperature 11°ch heatdissipating mechanisms nonfunctional strenuous physical activity increase heat production 10fold levels exceeding 1000 kcalh similarly fever shivering tremors convulsions thyrotoxicosis sepsis body also acquire heat environment mechanisms involved heat dissipation including conduction convection radiation mechanisms occur level skin require properly functioning skin surface sweat glands autonomic nervous system also may manipulated behavioral responses conduction refers transfer heat 2 surfaces differing temperatures direct contact convection refers transfer heat bodys surface gas fluid differing temperature radiation refers transfer heat form electromagnetic waves body surroundings efficacy radiation means heat transfer depends position sun season clouds factors example summer lying sun result heat gain 150 kcalh normal physiologic conditions heat gain counteracted commensurate heat loss orchestrated hypothalamus functions thermostat guiding body mechanisms heat production heat dissipation thereby maintaining body temperature constant physiologic range simplified model thermosensors located skin muscles spinal cord send information regarding core body temperature anterior hypothalamus information processed appropriate physiologic behavioral responses generated physiologic responses heat include increase cardiac output blood flow skin much 8 lmin major heatdissipating organ dilatation peripheral venous system stimulation eccrine sweat glands produce sweat major heatdissipating organ skin transfer heat environment conduction convection radiation evaporation radiation important mechanism heat transfer rest temperate climates accounting 65 heat dissipation modulated clothing high ambient temperatures conduction becomes least important 4 mechanisms evaporation refers conversion liquid gaseous phase becomes effective mechanism heat loss efficacy evaporation mechanism heat loss depends condition skin sweat glands function lung ambient temperature humidity air movement whether person acclimated high temperatures example evaporation occur ambient humidity exceeds 75 less effective individuals acclimated nonacclimated individuals produce 1 l sweat per hour dispels 580 kcal heat per hour whereas acclimated individuals produce 23 l sweat per hour dissipate much 1740 kcal heat per hour evaporation acclimatization hot environments usually occurs 710 days enables individuals reduce threshold sweating begins increase sweat production increase capacity sweat glands reabsorb sweat sodium thereby increasing efficiency heat dissipation heat gain exceeds heat loss body temperature rises classic heatstroke occurs individuals lack capacity modulate environment eg infants elderly individuals individuals chronically ill furthermore elderly persons patients diminished cardiovascular reserves unable generate cope physiologic responses heat stress therefore risk heatstroke patients skin diseases taking medications interfere sweating also increased risk heatstroke unable dissipate heat adequately additionally redistribution blood flow periphery coupled loss fluids electrolytes sweat place tremendous burden heart ultimately may fail maintain adequate cardiac output leading additional morbidity mortality factors interfere heat dissipation include inadequate intravascular volume cardiovascular dysfunction abnormal skin additionally high ambient temperatures high ambient humidity many drugs interfere heat dissipation resulting major heat illness similarly hypothalamic dysfunction may alter temperature regulation may result unchecked rise temperature heat illness cellular level heat directly influences body interfering cellular processes along denaturing proteins cellular membranes turn array inflammatory cytokines interleukins heat shock proteins hsps produced particular hsp70 allows cell endure stress environment stress continues cell succumb stress apoptosis die microvascular level heat stroke resembles sepsis involves inflammation translocation lipopolysaccharides gut activates coagulation cascade certain preexisting factors age genetic makeup nonacclimatized individual may allow progression heat stress heatstroke systemic inflammatory response syndrome sirs multiorgan dysfunction syndrome mods ultimately death progression heatstroke may occur thermoregulatory failure amplified acutephase response alterations expression hsps index used including american college sports medicine wet bulb globe temperature wbgt environmental heat stress index used evaluate risk heat heatrelated illness individual calculated using 3 parameters temperature humidity radiant heat low risk wbgt 65ºf moderate risk 6573ºf high risk 7382ºf high risk 82ºf epidemiology frequency united states united states heat waves claim lives year weatherrelated exposures combined hurricanes tornadoes floods earthquakes heatstroke deaths excessive heat exposure common summers prolonged heat waves example heat wave 1980 record year heat 1700 deaths attributed heat compared 148 deaths attributed heat previous year persons older 65 years accounted least 44 cases numbers published nchs believed grossly underestimate true incidence heatrelated deaths death rates causes eg cardiovascular disease respiratory disease also increase summer especially heat waves international heatstroke uncommon subtropical climates condition recognized increasingly countries experience heat waves rarely eg japan commonly affects people undertake pilgrimage mecca especially pilgrims come cold environment 1998 one worst heat waves strike india 50 years resulted 2600 deaths 10 weeks unofficial reports described number deaths almost double figure mortalitymorbidity morbidity mortality heatstroke related duration temperature elevation therapy delayed mortality rate may high 80 however early diagnosis immediate cooling mortality rate reduced 10 mortality highest among elderly population patients preexisting disease confined bed socially isolated racial sexual disparities incidence risk factors environmental conditions heatstroke affects races equally however differences social advantages annual death rate due environmental conditions 3 times higher blacks whites risk factors environmental conditions heatstroke affects genders equally however gender differences workforce annual death rate due environmental conditions 2 times higher men women agerelated disparities incidence infants children elderly persons higher incidence heatstroke young healthy adults infants children risk heat illness due inefficient sweating higher metabolic rate inability care control environment elderly persons also increased risk heatrelated illnesses limited cardiovascular reserves preexisting illness use many medications may affect volume status sweating ability addition elderly people unable care increased risk heatstroke presumably inability control environment exertional heat stroke ehs leading cause injury death high school athletes approximately twothirds cases occur august involve football players often obese overweight clinical presentation history heatstroke defined typically hyperthermia exceeding 41°c anhidrosis associated altered sensorium however patient allowed cool prior measurement temperature may occur transportation cool ambulance evaluation emergency department measured temperature may much lower 41°c making temperature criterion relative similarly patients may retain ability sweat removing anhidrosis criterion diagnosis heatstroke therefore strict adherence definition advised may result dangerous delays diagnosis therapy clinically 2 forms heatstroke differentiated classic nonexertional heatstroke nehs exertional heatstroke ehs classic heatstroke occurs environmental heat waves common young elderly suspected children elderly persons chronically ill individuals present altered sensorium classic heatstroke occurs failure bodys heat dissipating mechanisms hand ehs affects young healthy individuals engage strenuous physical activity ehs suspected individuals exhibit bizarre irrational behavior experience syncope ehs results increased heat production overwhelms bodys ability dissipate heat exertional heatstroke ehs characterized hyperthermia diaphoresis altered sensorium may manifest suddenly extreme physical exertion hot environment number symptoms eg abdominal muscular cramping nausea vomiting diarrhea headache dizziness dyspnea weakness commonly precede heatstroke may remain unrecognized syncope loss consciousness also observed commonly development ehs ehs commonly observed young healthy individuals eg athletes firefighters military personnel engaging strenuous physical activity overwhelm thermoregulatory system become hyperthermic ability sweat remains intact patients ehs able cool cessation physical activity may present medical attention temperatures well 41°c despite education preventive measures ehs still leading cause disability death high school athletes particularly football players risk factors increase likelihood heatrelated illnesses include preceding viral infection dehydration fatigue obesity lack sleep poor physical fitness lack acclimatization although lack acclimatization risk factor heatstroke ehs also occur acclimatized individuals subjected moderately intense exercise ehs also may occur increased motor activity due drug use cocaine amphetamines complication status epilepticus nonexertional heatstroke nehs characterized hyperthermia anhidrosis altered sensorium develop suddenly period prolonged elevations ambient temperatures ie heat waves core body temperatures greater 41°c diagnostic although heatstroke may occur lower core body temperatures numerous central nervous system cns symptoms ranging minor irritability delusions irrational behavior hallucinations coma described possible cns symptoms include seizures cranial nerve abnormalities cerebellar dysfunction opisthotonos anhidrosis due cessation sweating late occurrence heatstroke may present patients examined patients nehs initially may exhibit hyperdynamic circulatory state severe cases hypodynamic states may noted classic heatstroke commonly occurs episodes prolonged elevations ambient temperatures affects people unable control environment water intake eg infants elderly persons individuals chronically ill people reduced cardiovascular reserve eg elderly persons patients chronic cardiovascular illnesses people impaired sweating eg skin disease ingestion anticholinergic psychiatric drugs addition infants immature thermoregulatory system elderly persons impaired perception changes body ambient temperatures decreased capacity sweat physical vital signs temperature typically patients temperature exceeds 41°c however presence sweating evaporating mechanisms initiation cooling methods body temperatures lower 41°c common pulse tachycardia rates exceeding 130 beats per minute common blood pressure patients commonly normotensive wide pulse pressure however hypotension common may result number factors including vasodilation cutaneous vessels pooling blood venous system dehydration hypotension also may due myocardial damage may signal cardiovascular collapse blood pressure usually correct normalization body temperature central nervous system symptoms cns dysfunction present universally persons heatstroke symptoms may range irritability coma patients may present delirium confusion delusions convulsions hallucinations ataxia tremors dysarthria cerebellar findings well cranial nerve abnormalities tonic dystonic contractions muscles patients also may exhibit decerebrate posturing decorticate posturing may limp coma also may caused electrolyte abnormalities hypoglycemia hepatic encephalopathy uremic encephalopathy acute structural abnormalities intracerebral hemorrhage due trauma coagulation disorders cerebral edema herniation also may occur course heatstroke eyes examination eyes may reveal nystagmus oculogyric episodes due cerebellar injury pupils may fixed dilated pinpoint normal cardiovascular heat stress places tremendous burden heart patients preexisting myocardial dysfunction tolerate heat stress prolonged periods patients commonly exhibit hyperdynamic state tachycardia low systemic vascular resistance high cardiac index however hypodynamic state high systemic vascular resistance low cardiac index may occur patients preexisting cardiovascular disease low intravascular volume hypodynamic state also may signal cardiovascular collapse central venous pressure generally within reference range elevated unless patient severely volume depleted highoutput cardiac failure lowoutput cardiac failure may occur pulmonary patients heatstroke commonly exhibit tachypnea hyperventilation caused direct cns stimulation acidosis hypoxia hypoxia cyanosis may due number processes including atelectasis pulmonary infarction aspiration pneumonia pulmonary edema gastrointestinal gastrointestinal hemorrhage occurs frequently patients heatstroke hepatic patients commonly exhibit evidence hepatic injury including jaundice elevated liver enzymes rarely fulminant hepatic failure occurs accompanied encephalopathy hypoglycemia disseminated intravascular coagulation dic bleeding musculoskeletal muscle tenderness cramping common rhabdomyolysis common complication ehs patients muscles may rigid limp renal acute kidney injury common complication heatstroke may due hypovolemia low cardiac output myoglobinuria rhabdomyolysis patients may exhibit oliguria change color urine causes etiology heatstroke may involve following increased heat production decreased heat loss reduced ability acclimatize reduced behavioral responsiveness increased heat production increased metabolism result following infections sepsis encephalitis stimulant drugs thyroid storm drug withdrawal increased muscular activity may involve following exercise convulsions tetanus strychnine poisoning sympathomimetics drug withdrawal thyroid storm moderate physical exercise convulsions shivering double heat production result temperature elevations generally selflimited resolve discontinuation activity strenuous exercise status epilepticus increase heat production 10fold uninterrupted overwhelm bodys heatdissipating mechanisms leading dangerous rises body temperature stimulant drugs including cocaine amphetamines generate excessive amounts heat increasing metabolism motor activity stimulatory effects dopamine serotonin norepinephrine development heatstroke individuals intoxicated stimulants multifactorial may involve complex interaction dopamine serotonin hypothalamus brainstem neuroleptic agents also may elevate body temperature increasing muscle activity occasionally agents may cause neuroleptic malignant syndrome certain drugs inhaled volatile anesthetics succinylcholine may result malignant hyperthermia contrast heatstroke malignant hyperthermia decreased heat loss reduced sweating result following dermatologic diseases drugs burns reduced central nervous system cns responses may result following advanced age young age toddlers infants alcohol barbiturates sedatives reduced cardiovascular reserve may result following advanced age betablockers calcium channel blockers diuretics cardiovascular drugs interfere cardiovascular responses heat therefore interfere heat loss drugs result decreased heat loss include following anticholinergics neuroleptics antihistamines exogenous factors decrease heat loss include following high ambient temperatures high ambient humidity reduced ability acclimatize persons extremes age ie toddlers young children elderly may less able generate adequate physiologic responses heat stress diuretic use hypokalemia also impair accommodation heat stress reduced behavioral responsiveness infants patients bedridden patients chronically ill risk heatstroke unable control environment water intake compound matters comorbidities polypharmacy elderly compromise recovery differential diagnoses diagnostic considerations problems considered include following sepsis diabetic ketoacidosis closed head trauma malignant hyperthermia encephalitis cerebral malaria cerebral hemorrhage amphetamine cocaine toxicity strychnine poisoning cocaine toxicity delirium delirium tremens dts hepatic encephalopathy hyperthyroidism meningitis neuroleptic malignant syndrome salicylate toxicity tetanus uremic encephalopathy workup laboratory studies arterial blood gas testing arterial blood gas lactic acidosis lactic acidosis glucose hypoglycemia may occur patients ehs patients fulminant hepatic failure electrolytes sodium hypernatremia hyponatremia potassium hypokalemia hyperkalemia hypophosphatemia hyperphosphatemia hypocalcemia hypomagnesemia hepatic function tests hepatic injury consistent finding patients heatstroke aminotransferase aspartate aminotransferase ast alanine aminotransferase alt llevels commonly rise tens thousands early phases heatstroke peak 48 hours may take long 2 weeks peak jaundice may striking may noted 3672 hours onset liver failure muscle function tests creatinine kinase ck lactate dehydrogenase ldh aldolase myoglobin commonly released muscles muscle necrosis occurs ck levels exceeding 100000 iuml common patients ehs elevations myoglobin may noted despite muscle necrosis myoglobin metabolized rapidly liver excreted rapidly kidneys complete blood cell count elevated white blood cell counts commonly observed patients heatstroke levels high 40000μ l reported platelet levels may low renal function tests elevations serum uric acid levels blood urea nitrogen serum creatinine common patients whose course complicated renal failure urinalysis remember urinary benzidine dipsticks differentiate blood hemoglobin myoglobin urine dipstick analyses positive blood must followed microscopic urinalysis determine presence absence red blood cells proteinuria also common cerebrospinal fluid analysis cerebrospinal fluid csf cell counts may show nonspecific pleocytosis csf protein levels may elevated high 150 mgdl myoglobin causes reddish brown discoloration urine affect color plasma contrast hemoglobin causes discoloration plasma urine imaging studies computerized tomography scans may helpful ruling cns injury patients altered mental status chest radiographs may show atelectasis pneumonia pulmonary infarction pulmonary edema tests electrocardiography sinus tachycardia 130140 beats per minute nonspecific ischemic stt wave abnormalities common addition number conduction abnormalities eg right bundle branch block prolonged qt interval may noted procedures procedures may include following endotracheal intubation pulmonary artery catheter insertion central venous line insertion nasogastric tube insertion lumbar puncture compartment pressure measurements fasciotomy thoracostomy peritoneal lavage hemodialysis treatment management medical care heatstroke medical emergency continues one leading causes preventable death sports heatstroke suspected cooling must begin immediately must continued patients resuscitation american college sports medicine recommends cooling initiated scene transporting patient emergency department evaluation treatment controversy still exists therapeutic modality effective treatment heatstroke however basic premise rapidly lowering core temperature 39°c avoid overshooting rebound hyperthermia remains primary goal according one study oral temperature assessments consistently reflected inaccurate core body temperatures delayed diagnosis ultimate treatment patients heatstroke rectal temperatures still preferred method accurately obtaining core body temperatures studies shown promptly reducing exposure time excessive heat dramatically improve longterm outcomes decrease irreversible injury treatment initiated within socalled golden hour aggressive enough rapidly reduce core body temperature complications including multisystem organ failure may averted patient may much better prognosis review 19 clinical trials observational studies involving 556 patients conduction method cooling found efficacious young active adults ehs unfortunately review identify preferred treatment found nehs temperature endpoint prevent overcooling removal restrictive clothing spraying water body covering patient ice water–soaked sheets placing ice packs axillae groin may reduce patients temperature significantly patients unable protect airway intubated patients awake responsive receive supplemental oxygen intravenous lines may placed anticipation fluid resuscitation infusion dextrose thiamine indicated hypoglycemia common occurrence patients ehs may manifestation liver failure therefore infusion dextrose 50 water solution d50w considered patients heatstroke intensive care personnel must pay meticulous attention airway reduce temperature limit production heat optimize circulation monitor treat complications interventions enable monitoring include following insert thermistor probe temperaturesensing foley catheter monitor temperature continuously insert nasogastric tube monitor gastrointestinal bleeding fluid losses place foley catheter monitor urine output andor monitor body temperature goal treatment reduce temperature least 02°cmin approximately 39°c active external cooling generally halted 39°c prevent overshooting result iatrogenic hypothermia flexible indwelling thermistor rectally esophageal probe placed monitor core body temperature treatment alternatively modern method use temperaturesensing foley catheter thermal instability may persist days onset heatstroke temperature must monitored continuously stable methods cooling optimal method rapidly cooling patients matter debate time 2013 guideline wilderness medical society recommends icewater immersion superior method rapidly lowering core body temperature critical levels normally found heatstroke patients icewater immersion equivalent method advantage rapidly reducing core body temperature high thermal conductivity ice water reduce core body temperature less 39°c approximately 2040 minutes disadvantages icewater immersion include fact may extremely uncomfortable patients awake addition theory cause subcutaneous vasoconstriction preventing transfer heat via conduction ice water also increases shivering turn increases internal heat production criticisms include difficulty monitoring resuscitating patients using method evaporative heat loss although perhaps less effective immersion techniques poses fewer practical difficulties evaporative body heat loss may accomplished removing patients clothes intermittently spraying patients body warm water powerful fan blows across body allowing heat evaporate number cooling techniques suggested none proven superior equal coldwater immersion evaporative techniques include peritoneal thoracic rectal gastric lavage ice water cold intravenous fluids cold humidified oxygen cooling blankets wet towels cardiopulmonary bypass suggested use severe cases however requires highly trained personnel sophisticated equipment pharmacologic measures antipyretics eg acetaminophen aspirin nonsteroidal antiinflammatory drugs role treatment heatstroke antipyretics interrupt change hypothalamic set point caused pyrogens expected work healthy hypothalamus overloaded case heatstroke situation antipyretics actually may harmful patients develop hepatic hematologic renal complications may aggravate bleeding tendencies dantrolene studied possible pharmacologic option treatment hyperthermia heatstroke date however proved efficacious clinical trials immediate administration benzodiazepines indicated patients agitation shivering stop excessive production heat addition benzodiazepines sedatives choice patients sympathomimeticinduced delirium well alcohol sedative drug withdrawals neuroleptics eg chlorpromazine mainstays therapy past best avoided deleterious adverse effects including lowering seizure threshold interference thermoregulation anticholinergic properties hypotension hepatotoxicity adverse effects benzodiazepines necessary barbiturates recommended agents treatment patients convulsions barbiturates may used despite theoretical impedance sweat production phenytoin effective controlling convulsions situation patients whose convulsions refractory benzodiazepines barbiturates paralyzed provided mechanical ventilation electroencephalographic monitoring recommended patients anticonvulsant medications adjusted accordingly fluid resuscitation recommendations administration intravenous fluids circulatory support differ among patient populations depend presence hypovolemia preexisting medical conditions preexisting cardiovascular disease patients heatstroke invariably volume depleted cooling alone may improve hypotension cardiac function allowing blood redistribute centrally aggressive fluid resuscitation generally recommended may lead pulmonary edema cor pulmonale also common finding patients heatstroke pulse rate blood pressure urine output provide adequate hemodynamic information fluid administration guided invasive hemodynamic parameters central venous pressure cvp pulmonary capillary wedge pressure systemic vascular resistance index svri cardiac index ci measurements patients exhibit hyperdynamic state ie high ci low svri generally respond cooling require large amounts intravenous crystalloid infusions hypotensive patients exhibit hypodynamic response ie high cvp low ci traditionally treated lowdose isoproterenol however arrhythmogenicity raised questions continued use dobutamine less arrhythmogenic isoproterenol cardioselective may inotrope choice patients alphaadrenergic drugs generally contraindicated cause vasoconstriction may interfere heat loss rhabdomyolysis occurrence rhabdomyolysis acute kidney injury treatment rhabdomyolysis involves infusion large amounts intravenous fluids fluid requirements may high 10 l alkalinization urine infusion mannitol fluid administration best guided invasive hemodynamic parameters urine output maintained 3 mlkgh minimize risk renal failure alkalinization urine ph 7580 prevents precipitation myoglobin renal tubules may control acidosis hyperkalemia acute massive muscle necrosis mannitol may improve renal blood flow glomerular filtration rate increase urine output prevent fluid accumulation interstitial compartment osmotic action mannitol also free radical scavenger therefore may reduce damage caused free radicals renal failure occurs dialysis effective therapeutic modality rhabdomyolysis metabolic support muscle necrosis may occur rapidly hyperkalemia hypocalcemia hyperphosphatemia become significant enough cause cardiac arrhythmias require immediate therapy presence renal failure hemodialysis may necessary hypertonic dextrose sodium bicarbonate may used shift potassium intracellular environment definitive measures eg intestinal potassium binding dialysis prepared use insulin may necessary patients diabetic may deleterious patients ehs patients liver failure commonly develop hypoglycemia calcium used judiciously may precipitate cause additional muscle damage use calcium reserved patients ventricular ectopy impending convulsions electrocardiographic evidence hyperkalemia various electrolyte abnormalities reported patients heatstroke must monitored closely treated carefully abnormalities may related solutealtering conditions vomiting diarrhea use diuretics example hypokalemia common early phases heatstroke may develop response respiratory alkalosis diarrhea sweating similarly hyponatremia may due sodium losses andor rehydration saltpoor solutions eg water hypernatremia may due dehydration hepatic injury heatstroke commonly leads severe reversible hepatic damage hepatic injury represented elevations transaminase levels bilirubin phase hypoglycemia abnormal coagulation cerebral edema death occur although rarely prolonged coagulation times also may signal development disseminated intravascular coagulation treatment hepatic failure includes following infusion dextrose solutions correct hypoglycemia early recognition treatment dic replacement clotting factors fresh frozen plasma platelets blood meticulous respiratory support pulmonary injury pulmonary edema common complication heatstroke may due number factors including fluid overload aggressive rehydration renal failure congestive heart failure ards latter may develop multiple insults including heatinduced pulmonary damage aspiration pneumonia complication liver failure ards treated aggressively early mechanical ventilation positive endexpiratory pressure peep renal injury aki may occur direct thermal injury kidney myoglobinuria hypotension andor shock acute tubular necrosis aki initially treated intravenous fluids diuretics correction associated acidbase electrolyte abnormalities setting rhabdomyolysis mannitol may diuretic choice interfere acidbase status urine may antioxidant activity furosemide may cause tubular acidosis therefore may promote myoglobin deposition within renal tubules renal failure set hemodialysis effective therapy surgical care compartment syndrome consultations consider consultation nephrologist soon renal failure occurs consultation surgeon indicated compartment syndrome suspected consider consultation liver transplant service patients persistent fulminant liver failure diet activity patients may resume oral feeding mental status swallowing gastrointestinal tract function normal initial phase therapy neuromuscular blockade muscular paralysis considered patients cooling adequately depolarizing agents eg succinylcholine inhaled anesthetics avoided risk malignant hyperthermia patients may resume activity temperature stabilized medication medication summary patients heatstroke benzodiazepines play major role providing sedation controlling convulsions controlling shivering barbiturates eg phenobarbital may used control convulsions benzodiazepines effective hypotension treated first cooling intravenous crystalloid fluids dobutamine considered patients hypodynamic treatment rhabdomyolysis involves infusing large amounts intravenous fluids much 10 l may required alkalinization urine mannitol infusion benzodiazepines class summary benzodiazepines safe effective controlling agitation convulsions shivering lorazepam ativan predictability ease use make lorazepam drug choice cases may used intravenously well absorbed intramuscular injection onset action within minutes effects peak 1520 minutes duration action 68 hours midazolam versed midazolam rapidly acting benzodiazepine short duration action ideal sedation short procedures may effective convulsions alkalinizing agents class summary alkalinizing agents indicated severe acidosis rhabdomyolysis sodium bicarbonate neut sodium bicarbonate useful alkalization urine prevent acute myoglobinuric renal failure may administered bolus injection infusion ideal solution sodium bicarbonate added hypotonic diuretics osmotic class summary osmotic effects retain water urine formation dilute electrolytes urine making resorption less efficient mannitol osmitrol mannitol drug choice forced diuresis patients rhabdomyolysis number beneficial effects kidneys including antioxidant effect adrenergic agonist agents class summary adrenergic agonist agents produce vasodilation increase inotropic state dobutamine dobutrex dobutamine synthetic compound structurally similar catecholamines drug choice circulatory support heatstroke followup outpatient care longterm outpatient therapy may required chronic renal failure develops irreversible damage cns lungs heart liver occurs inpatient care acute phase stabilized inpatient care may necessary address complications heatstroke deterrenceprevention heatstroke preventable illness education single important tool prevention recognition host risk factors modification behavior eg limiting alcohol drug intake avoiding use medications drugs interfere heat dissipation physical activity also prevent heatstroke complications heatstroke multisystem insult potentially affect almost every organ system central nervous system cns especially sensitive damaging effects hyperthermia widespread cell death occurs evident region cerebellum purkinje cells heatstroke–related longterm cns sequelae include cerebellar deficits dementia hemiplegia quadriparesis personality changes one study rhabdomyolysis observed almost patients ehs many 86 patients nehs compartment syndrome observed commonly patients severe rhabdomyolysis patients immobilized acute kidney injury may occur many 2530 patients heatstroke especially ehs acute liver failure due centrilobular hepatic necrosis cholestasis generally occurs first 48 hours peak long 2 weeks onset heatstroke rare instances liver failure may complicated fulminant course requiring liver transplantation patients survive generally complete return hepatic function dic rare complication caries poor prognosis occurs electron microscopy studies shown direct thermal injury vascular endothelium primary trigger platelet aggregation possibly dic ards may due direct thermal injury lung may complicate liver failure infection aspiration associated liver failure patients prognosis much worse prognosis indicators poor prognosis acute episodes include following initial temperature measurement higher 41°c 106°f temperature higher 42°c 108°f temperature persisting 39°c 102°f despite aggressive cooling measures coma duration longer 2 hours severe pulmonary edema delayed prolonged hypotension lactic acidosis patients classic heatstroke acute kidney injury hyperkalemia aminotransferase levels greater 1000 iul first 24 hours patient education education single important tool prevention heatstroke media public education public health programs athlete safety programs play pivotal role increasing publics awareness dangers heat heat waves advising public methods remaining cool similarly drinking fluids schedule based thirst frequent cooling breaks frequent visits airconditioned places important even short stays airconditioned environment may drastically reduce incidence heatstroke recognition host risk factors modification behavior eg limiting alcohol drug intake use medications drugs interfere heat dissipation physical activity also prevent heatstroke patient education information see first aid injuries center healthy living center heat exhaustion heat stroke heat cramps author robert helman md director premier care great neck urgent care center disclosure nothing disclose coauthors rania habal md assistant professor department emergency medicine new york medical college rania habal md member following medical societies american academy emergency medicine disclosure nothing disclose pharmacy editor francisco talavera pharmd phd adjunct assistant professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure received salary medscape employment medscape chief editor joe alcock md ms associate professor department emergency medicine university new mexico health sciences center joe alcock md ms member following medical societies american academy emergency medicine disclosure nothing disclose additional contributors laurie robin grier md medical director micu professor medicine emergency medicine anesthesiology obstetricsgynecology fellowship director critical care medicine section pulmonary critical care medicine louisiana state university health science center shreveport laurie robin grier md member following medical societies american college chest physicians american college physicians american society parenteral enteral nutrition society critical care medicine disclosure nothing disclose centers disease control prevention climate effects health updated december 22 2014 available httpwwwcdcgovclimateandhealtheffectsdefaulthtm centers disease control prevention extreme heat prevention guide promote personal health safety reviewed may 31 2012 available httpemergencycdcgovdisastersextremeheatheatguideasp heat illness among high school athletes united states 20052009 mmwr morb mortal wkly rep medline full text national center catastrophic injury research catastrophic sport injury 29th annual report university north carolina available httpwwwuncedudeptsnccsi2011allsportpdf guideline american college sports medicine joint statement national athletic trainers association interassociation task force exertional heat illnesses consensus statement 2003 available httpwwwnataorgsitesdefaultfilesinterassociationtaskforceexertionalheatillnesspdf mazerolle sm pinkus de casa dj et al evidencebased medicine recognition treatment exertional heat stroke part ii perspective clinical athletic trainer j athl train medline full text mazerolle sm ganio ms casa dj vingren j klau j oral temperature accurate measurement deep body temperature systematic review j athl train medline full text heled ravacha shani epstein moran ds golden hour heatstroke treatment mil med medline bouchama dehbi chavescarballo e cooling hemodynamic management heatstroke practical recommendations critical care 2007 full text guideline lipman gs eifling kp ellis gaudio fg otten em grissom ck wilderness medical society practice guidelines prevention treatment heatrelated illness wilderness environ med medline

Article 5:
tilttable testing tilttable testing background indications contraindications tilttable testing periprocedural care patient education consent equipment patient preparation tilttable testing technique approach considerations tilttable testing test results tilttable testing medication vasodilators beta1beta2 adrenergic agonists isotonic crystalloids tilttable testing background indications contraindications tilttable testing periprocedural care patient education consent equipment patient preparation tilttable testing technique approach considerations tilttable testing test results tilttable testing medication vasodilators beta1beta2 adrenergic agonists isotonic crystalloids overview background indications contraindications technical considerations outcomes periprocedural care patient education consent equipment patient preparation monitoring followup technique approach considerations tilttable testing test results definitions key terms web links medication tilttable testing overview tilttable testing periprocedural care tilttable testing technique tilttable testing medication 1839773overview nov 20 2014 201506060031 0 clinical procedures 2002 procedures procedure 1 2 content 1839773 503 2 ssg jun 04 2015 procedure procedures clinicalprocedures clinical procedures clinicalproceduresphysical examination protocols tilttable testing tilt table testing tilt table tilttable test syncope autonomic nervous system dysfunction neurological disorders tilt testing tilttable test simple noninvasive informative test first described 1986 diagnostic tool patients syncope unknown origin usually performed hospital electrophysiology departments endpoint reproducing syncope subsequent appropriate therapy 0 tilttable testing overview background tilttable test simple noninvasive informative test first described 1986 diagnostic tool patients syncope unknown origin causes syncope divided 6 major categories listed echocardiography 6 major categories syncopal etiologies neurological disorders vertebrobasilar transient ischemic attacks subclavian steal syndrome normal pressure hydrocephalus seizure disorders metabolic disorders hypoxia hyperventilation hypoglycemia mechanical heart disease aortic stenosis mitral stenosis global ischemia aortic dissection pulmonic dissection obstructive cardiomyopathy left atrial myxoma prosthetic valve dysfunction pulmonary embolus pulmonary hypertension cardiac arrhythmiasbrady arrhythmiastachyarrhythmias bradycardiapauses sinus node dysfunction av conduction disease psychiatric disorders panic attacks hysteria autonomic nervous system dysfunction primary secondary dysautonomias postural orthostatic tachycardia syndrome pots postural orthostatic hypotension vasodepressor vasovagal syncope indications consider tilttable testing patients signs symptoms suggestive orthostatic hypotension vasodepressor vasovagal syncope postural orthostatic tachycardia causes syncope eliminated general consider tilttable testing patients following issues hypotension unexplained tachycardia standing pallor upright orthostatic palpitations dizziness unexplained lightheadedness history frequent unexplained falls history episodes fainting loss consciousness acc expert consensus document tilttable testing including indications first published 1996 table 1 european society cardiology 2009 indications tilttable testing recommendations class level tilt table indicated case unexplained single syncopal episode highrisk settings eg occurrence potential risk physical injury occupational implicationsor recurrent episodes absence organic heart disease cardiac causes syncope excluded b tilt testing indicated clinical value demonstrate susceptibility reflex syncope patient c tilt testing considered discriminate reflex orthostatic hypotensive syncope iia c tilt testing may considered differentiating syncope jerking movement epilepsy iib c tilt testing may indicated evaluating patients recurrent unexplained falls iib c tilt testing may indicated evaluating patients frequent syncope psychiatric disease iib c tilt testing recommended assessment treatment iii b isoproterenol tilt testing contraindicated patients ischemic heart disease iii c contraindications contraindications tilttable testing include following coma feeble patient unable stand lower extremity fractures severe anemia recent stroke within seven days recent myocardial infarction severe proximal cerebral coronary arterial disease critical mitral aortic stenosis left ventricular outflow tract obstruction hypotensive shock tachyarrhythmias severe metabolic acidosis electrolyte imbalance endstage renal failure severe heart failure technical considerations complication prevention avoid invasive intraarterial blood pressure monitoring tilttable testing catheterization may provoke vasovagal reaction use manual sphygmomanometer digital plethysmography outcomes generally tilttable testing safe complications may occur related decreased perfusion heart including following electrocardiographic changes transient myocardial ischemia without angina vasospasm isoproterenol administration occasionally cardiac arrhythmias result termination test advanced atrioventricular block second third degree severe bradycardia pauses atrial fibrillation tachyarrhythmias complications may also occur related decreased perfusion brain including following seizures prolonged hypotension transient phenomenon indicative seizure disorder rarely transient ischemic attacks strokes occur transient mental confusion occur patients may also experience nonspecific symptoms nausea anxiety periprocedural care patient education consent discuss test findings patient companion increase proper understanding results patient instructions avoid dehydration day study patients npo midnight receiving diuretic therapy infuse 250 ml 09 saline prior tilt testing administer iv saline cautiously patients heart failure renal failure hold medications night procedure morning increase sensitivity study however diuretic antihypertensive medications suspected etiology syncopal episodes allow patient take medications usual morning procedure equipment equipmentpersonnel follows tilt table blood pressure monitor heart rate monitor ecg rhythm monitor oxygen saturation monitor crash cart defibrillator available infusion pumps quiet air conditioned room soft background music optional direct physician supervision nurse trained technician assistance patient preparation anesthesia anesthesia used procedure patient must remain alert awake detect moment unconsciousness positioning see technique section monitoring followup discharge patient home blood pressure heart rate back baseline patient symptomatic advise patient drive 2 hours procedure technique approach considerations tilttable test involves placing patient flat table foot support tilting table upward period time observe changes blood pressure heart rate patient initially positioned supine horizontal table tilted degrees completely vertical upright position study blood pressure heart rate oxygen saturation cardiac rhythms recorded monitored end point fainting indicates positive tilttest result tilttable testing following steps describe positioning technique tilttable testing dress patient hospital gown without restrictive binding around abdomen legs insert intravenous catheter start maintenance iv fluid drip 09 nacl place patient supine tilt table secure patient protective straps avoid falls apply blood pressure heart rate oxygen saturation rhythm monitors record baseline measurements patient rest supine 10 minutes provide room quiet dim comfortable temperature raise tilt table 80° record blood pressure heart rate oxygen saturations every minute tilt table upright 2045 minutes depending protocol record rhythm changes ecg strip decide pharmacologic provocation nitroglycerine 5 minutes tilt isoproterenol 20 minutes tilt needed provoke response record symptoms signs observed terminate tilt systolic blood pressure falls 70 mmhg even symptoms present terminate tilt patient faints return patient supine position place patient reverse trendelenburg position blood pressure normalize administer 250ml bolus 09 nacl hypotension record blood pressure heart rate back baseline disconnect patient allow patient sit chair 5 minutes test results provocative pharmaceuticals isoproterenol nitroglycerine used differentiate expected pharmacological effects drug abnormal response avoidance pharmacologic testing desired patient ischemic heart disease proceed upright tilt 45 minutes fainting response occur test negative positive tilttable test result may described mixed cardio inhibitory vasodepressor see overview classification positive responses tilt testing one particular problem tilttable testing plethora protocols differing sensitivity make reproduction results unreliable reliability accuracy tilttable studies improved combined hemodynamic volume measurements table 1 classification positive responses tilt testing type 1 mixed heart rate falls time syncope ventricular rate fall less 40 beatsmin 1 1 type 2 cardioinhibitory cardioinhibition without asystole heart rate falls ventricular rate less 40 beatsmin 1 b cardioinhibition asystole asystole occurs 3 blood pressure falls occur heart rate fall type 3 vasodepressor heart rate fall 10 peak time syncope exception 1 chronotropic incompetence heart rate rise tilt testing ie less 10 pretilt rate exception 2 excessive heart rate rise excessive heart rate onset position throughout duration syncope ie greater 130 beatsmin 1 definitions key terms dysautonomias primary deficiency mechanisms increase α β adrenergic tone result baroreceptor stimulation compensate decrease venous blood return heart hut abbreviation headup tilt test neurally mediated hypotension reduction systolic blood pressure 25 mmhg baseline supine values sustained least 1 minute associated increase heart rate accompanied symptoms presyncope neurocardiogenic syncope acute hypotension without bradycardia orthostatic postural hypotension greater 2030 mmhg drop systolic blood pressure plus greater 10 mmhg drop diastolic blood pressure orthostatic hypotension common cause temporary loss consciousness feelings lightheadedness results changing body position supine sitting position vertical upright position normally blood tends pool lower extremities due gravity whenever person stands potentially reducing amount blood available return heart brain sympathetic nervous system regulates blood vessel tone modulating nerve traffic lower extremity blood vessels arterial venous circulations compensate pooling constricting thus redirecting blood flow leg veins back toward heart however poor sympathetic tone lower extremity blood vessels cause mechanisms arterial venous constriction fail resulting disproportionate pooling blood legs instead returning blood circulation resulting less oxygen supplied brain heart result person feels lightheaded may even faint postural orthostatic tachycardia syndrome pots occurrence orthostatic symptoms association either 30 beats minute increase heart rate baseline within 10 minutes tilted upright sustained 1 minute heart rate higher 120 beats minute period presyncope presence premonitory symptoms signs imminent syncope severe weakness lightheadedness nausea diaphoresis syncope pancerebral hypoperfusion accompanied lack postural tone unconsciousness without focal neurological deficit vasodepressor syncope abrupt drop blood pressure symptoms vasovagal syncope abrupt drop blood pressure heart rate symptoms hallmark vasovagal syncope occurrence one several symptoms either immediately brief loss consciousness symptoms varied may include nausea flushing headache vertigo palpitations asthenia web links see list brignole update treatment vasovagal syncope hjc httpwwwhellenicjcardiolcomarchivefulltext2004320043132pdf national dysautonomia research foundation medication medication summary goals pharmacotherapy reduce morbidity prevent complications vasodilators class summary vasodilators decrease preload andor afterload nitroglycerin sublingual nitrostat agent causes relaxation vascular smooth muscle stimulating intracellular cyclic gmp result decrease blood pressure dosage forms include sl td iv preparations distinction shortacting preparations treatment acute attacks longacting preparations prevention recurrent episodes important administration 300400 µg sublingual nitroglycerine order increase average heart rate approximately 2025 baseline trigger abnormal responses susceptible patients tilt stabilization phase 5 minutes beta1beta2 adrenergic agonists class summary given systemically isoproterenol stimulates beta receptors heart produces positive inotropic chronotropic effects results increased cardiac output isoproterenol isuprel isoproterenol sympathomimetic effects specifically beta1 beta2adrenergic receptor agonist activity intravenous medication used incremental doses usually 3 µgmin order increase average heart rate approximately 2025 baseline trigger abnormal responses susceptible patients tilt stabilization phase 20 minutes isotonic crystalloids class summary isotonic sodium chloride normal saline ns standard crystalloid intravenous iv fluid used initial volume resuscitation expands intravascular interstitial fluid spaces typically 30 administered isotonic fluid stays intravascular therefore large quantities may required maintain adequate circulating volume normal saline ns 09 nacl ns restores interstitial intravascular volume administer 250ml bolus 09 nacl hypotension start media patient undergoing upright tilttable testing patient undergoing upright tilttable testing tilttable test tilttable test author james v talano md mba mm facc faha director cardiovascular medicine swicft institute james v talano md mba member following medical societies american college cardiology heart failure society america society geriatric cardiology american society nuclear cardiology american college chest physicians american association physician leadership american college physicians american heart association american society echocardiography disclosure nothing disclose coauthors janet k sparker ms pac assistant professor southwest florida physician assistant program nova southeastern university physician assistant certified private cardiology practice james v talano md southwest institute cardiovascular fitness testing disclosure nothing disclose chief editor karlheinz peter md phd professor medicine monash university head centre thrombosis myocardial infarction head division atherothrombosis vascular biology associate director baker heart research institute interventional cardiologist alfred hospital australia karlheinz peter md phd member following medical societies american heart association german cardiac society cardiac society australia new zealand disclosure nothing disclose acknowledgements acknowledgments authors gratefully acknowledge contributions dr fredrick jaeger director cardiac arrhythmia monitoring lab medical director syncope center cleveland clinic development writing article moya tilt testing neurally mediated syncope many protocols one condition specific protocols different situations eur heart j medline fogoros r 2nd ed electrophysiologic testing moya sutton r et al guidelines diagnosis management syncope version 2009 task force diagnosis management syncope european society cardiology esc eur heart j medline benditt dg ferguson dw grubb bp kapoor wn kugler j lerman bb tilt table testing assessing syncope american college cardiology j coll cardiol medline goldman l braunwald e primary cardiology leman rb clarke e gillette p significant complications occur ischemic heart disease tilt table testing pacing clin electrophysiol medline parry sw reeve p lawson j shaw fe davison j norton newcastle protocols 2008 update headup tilt table testing management vasovagal syncope related disorders heart medline strickberger sa benson dw biaggioni callans dj cohen mi ellenbogen ka ahaaccf scientific statement evaluation syncope american heart association councils clinical cardiology cardiovascular nursing cardiovascular disease young stroke quality care outcomes research interdisciplinary working group american college cardiology foundation collaboration heart rhythm society j coll cardiol medline barónesquivias g martínezrubio tilt table test state art indian pacing electrophysiol j medline full text fouadtarazi f calcatti j christian r armstrong r depaul blood volume measurement tool diagnosing syncope j med sci medline full text guida p iacoviello forleo c ferrara sorrentino balducci c prevalence timing haemodynamic correlates prodromes patients vasovagal syncope induced headup tilt test europace medline brignole update treatment vasovagal syncope hjc full text

Article 6:
brain anatomy brain anatomy overview gross anatomy cerebrum gross anatomy cortex brain anatomy overview gross anatomy cerebrum gross anatomy cortex overview overview gross anatomy cerebrum gross anatomy cortex gross anatomy brainstem cranial nerves gross anatomy cerebellum gross anatomy meninges gross anatomy ventricles cerebrospinal fluid gross anatomy blood vessels microscopic anatomy functional neuroanatomy brain anatomy overview 1898830overview feb 24 2015 201506052213 1 anatomy 2002 anatomy anatomy 1 2 content 1898830 504 25 ssg jun 04 2015 anatomy anatomy anatomy anatomy anatomyanatomy anatomy brain anatomy brain images cerebral anatomy central nervous system anatomy brain anatomy central nervous system consists brain spinal cord peripheral nervous system consists extensions neural structures beyond central nervous system includes somatic autonomic divisions 0 brain anatomy overview central nervous system consists brain spinal cord peripheral nervous system consists extensions neural structures beyond central nervous system includes somatic autonomic divisions brain composed 3 main structural divisions cerebrum brainstem cerebellum see images base brain brainstem extends upper cervical spinal cord diencephalon cerebrum brainstem divided medulla pons midbrain posterior brainstem lies cerebellum brain coronal view brain coronal view brain inferior view brain inferior view brain lateral view brain lateral view brain midsagittal view brain midsagittal view gross anatomy cerebrum cerebrum largest component brain divided right left hemispheres corpus callosum collection white matter fibers joins hemispheres cerebral hemispheres divided 4 lobes frontal lobe parietal lobe temporal lobe occipital lobe medial temporal lobe structures considered part socalled limbic lobe briefly frontal lobe distinguished parietal lobe posteriorly central sulcus see image frontal lobe parietal lobes divided inferiorly temporal lobe lateral sulcus parietal lobe distinguished occipital lobe parietooccipital sulcus medial surface lateral medial surfaces cerebrum showing major sulci gyri lateral medial surfaces cerebrum showing major sulci gyri cerebrum divided telencephalon diencephalon telencephalon consists cortex subcortical fibers basal nuclei diencephalon mainly consists thalamus hypothalamus telencephalon cerebrum disproportionately welldeveloped humans compared mammals cortex subcortical fibers outermost layer cerebrum cortex slightly gray appearancehence term gray matter cortex folded structure fold termed gyrus groove folds termed sulcus cortical anatomy discussed greater detail cortex axons long fibers emanate connect neurons axons insulated myelin increases speed conduction myelin gives white appearance fibers brainhence term white matter limbic system limbic system grouping cortical subcortical structures involved memory formation emotional responses limbic system allows complex interactions cortex thalamus hypothalamus brainstem limbic system defined strict anatomic boundaries incorporates several important structures limbic structures conventionally include amygdala hippocampus fornix mammillary bodies cingulate gyrus parahippocampal gyrus functional connections within limbic system best summarized papez circuit hippocampus signals relayed via fornix mammillary bodies via mammillothalamic tract anterior nucleus thalamus thalamocingulate radiation projects cingulate gyrus back hippocampus complete circuit hippocampus serves primary output structure limbic system unlike 6layered neocortex hippocampus 3 layers termed archicortex hippocampus felt structure crucial formation memorymore specifically type memory called declarative explicit memory declarative memory essentially ability recall life events past meal eaten breakfast car parked time however certain declarative memories distant past independently recalled without hippocampal structures hippocampus likely allows longterm memory encoding cortex allows shortterm memory retrieval laboratory studies animals humans hippocampus shown also cellular memory termed longterm potentiation amygdala collection nuclei lies within uncus receives multiple modes sensory information inputs outputs amygdala travel stria terminalis ventral amygdalofugal pathway output structures include hypothalamus well thalamus hippocampus brainstem cortex amygdala appears involved mediating emotional aspects memory especially subjective aspects fear responses basal nuclei ganglia basal nuclei formerly referred basal ganglia comprise caudate nucleus putamen globus pallidus subthalamic nucleus substantia nigra pairs structures bear different names putamen globus pallidus combined form lentiform nuclei putamen caudate nucleus combined form striatum striatum derives name striped appearance given gray matter connections bridging across internal capsule basal nuclei closely integrated motor cortex premotor cortex motor nuclei thalamus plays crucial role modulation movements primary input basal nuclei primary motor cortex premotor cortex brodmann areas 4 6 consists primarily pyramidal cells cortical layer v excitatory projections lead primarily striatum striatum also receives input dopaminergic cells substantia nigra turn striatum sends inhibitory projections globus pallidus externa interna globus pallidus externa sends inhibitory projections subthalamic nucleus sends excitatory projections globus pallidus interna globus pallidus interna turn projects ventral anterior ventral lateral nuclei thalamus certain movement disorders traced pathologies basal nuclei notable parkinson disease huntington disease thalamus positioned brainstem telencephalon diencephalon composed thalamus epithalamus subthalamus hypothalamus thalamus serves relay station ascending input cortex receives information cardinal senses except smell hypothesized thalamus serves gating function filtering information thalamus consists multiple nuclei briefly described see image major nuclei thalamus major nuclei thalamus left right sides thalamus divided third ventricle side divided internal medullary lamina series anterior nuclei ventrolateral nuclei medial nuclei smaller nuclei found within regions numbering perhaps excess 100 anterior thalamic nuclei functionally associated limbic system share reciprocal connections cingulate gyrus mammillary bodies medial nuclei project frontal association cortex premotor cortex reciprocal connectivity ventrolateral nuclei divided ventral anterior va ventral lateral vl ventral posterolateral vpl ventral posteromedial vpm nuclei va vl nuclei share input globus pallidus projections motor cortex vpl vpm serve sensory relays body face respectively lateral nuclei divided lateral dorsal lateral posterior nuclei projections cingulate gyrus parietal cortex respectively thalamic structures included anatomic divisions include medial lateral geniculate bodies process auditory visual information respectively pulvinar connects reciprocally parietal occipital association cortex intralaminar nuclei within internal medullary lamina obtain input brainstem cerebellum thalamic nuclei project basal nuclei structures thalamic nuclei amongst intralaminar nuclei centromedian nucleus part reticular activating system plays role maintaining cortical arousal epithalamus epithalamus made habenula habenular commissure posterior commissure pineal gland subthalamus located midbrain thalamus subthalamus contains subthalamic nucleus red nucleus substantia nigra subthalamic structures closely integrated basal nuclei play role modulation movement hypothalamus thy hypothalamic nuclei lie walls third ventricle anteriorly hypothalamus involved mediating endocrine autonomic visceral homeostatic functions roughly divided anterior posterior middle groups nuclei anterior nuclei include preoptic supraoptic paraventricular nuclei posterior nuclei include supramammillary nucleus mammillary nucleus intercalate nucleus posterior nucleus middle nuclei include infundibular tuberal dorsomedial ventromedial lateral nuclei parasympathetic control attributed anterior medial nuclear groups whereas sympathetic control attributed posterior lateral nuclear groups satiety localized stimulation medial nuclei hunger localized stimulation lateral nuclei functions hypothalamus include regulation body temperature heart rate blood pressure water balance hypothalamus close connections cingulate gyrus frontal lobe hippocampus thalamus brainstem spinal cord basal nuclei pituitary gland gross anatomy cortex neocortex phylogenetically developed structure human brain compared brains species complex pattern folding allows increased cortical surface occupy smaller cranial volume pattern folding forms sulcal gyral patterns remains highly preserved across individuals enables nomenclature cortical anatomy left right cerebral hemispheres separated longitudinal cerebral fissure principal connection 2 hemispheres corpus callosum cortical hemisphere divided 4 lobes frontal temporal parietal occipital frontal lobe distinguished temporal lobe lateral sulcus sylvian fissure frontal lobe distinguished parietal lobe central sulcus rolandic fissure parietooccipital sulcus visible medial aspect hemisphere divides parietal occipital lobes within lateral sulcus another cortical surface referred insula frontal lobe divided superior middle inferior frontal gyri divided superior inferior frontal sulci respectively inferior frontal gyrus forms frontal operculum overlies lateral sulcus frontal operculum divided 3 triangular gyri pars orbitalis pars triangularis pars opercularis order anterior posterior precentral gyrus gyrus immediately anterior central sulcus similarly temporal lobe divided superior middle inferior temporal gyri separated superior inferior temporal sulci inferior surface temporal lobe lateral midbrain parahippocampal gyrus identified collateral sulcus lying lateral parahippocampal gyrus inferior temporal gyrus lies occipitotemporal gyrus also known fusiform gyrus within parietal lobe superior temporal sulcus capped angular gyrus lateral sulcus capped supramarginal gyrus angular gyrus lateral occipital gyrus caps inferior temporal sulcus gross anatomy brainstem cranial nerves evolutionarily brainstem ancient part brain structurally divided medulla oblongata pons midbrain three structures briefly described crosssectional anatomy brainstem rather complex given multiple traversing pathways cranial nerve nuclei see image three views brainstem three views brainstem medulla oblongata medulla oblongata simply medulla continuous superior cervical spinal cord several external anatomic features medulla visible grossly ventrally pyramids pyramidal decussation visualized pons descending corticospinal tracts lateral pyramids rootlets hypoglossal nerve seen exit brainstem lateral rootlets hypoglossal nerve inferior olive dorsolateral inferior olive rootlets 9th 10th cranial nerves glossopharyngeal vagus exit dorsally 2 pairs protrusions visible gracile tubercles medially cuneate tubercles lateral represent nuclei sensory information dorsal columns relayed onto thalamic projection neurons superior protrusions floor fourth ventricle bears several characteristic impressions vagal trigone dorsal nucleus vagus nerve cranial nerve x lies inferiorly hypoglossal trigone pons superior medulla lies pons ventral surface characteristic band horizontal fibers fibers pontocerebellar fibers turn projections corticopontine fibers cross enter contralateral middle cerebellar peduncle thus enter cerebellum either side midline bulges produced descending corticospinal tracts pontomedullary junction 6th cranial nerve abducens seen exiting brainstem laterally anterior middle cerebellar peduncle fifth cranial nerve trigeminal seen exiting brainstem middle cerebellar peduncle seventh eighth cranial nerves facial vestibulocochlear seen exiting dorsally pons forms floor fourth ventricle midbrain midbrain also termed mesencephalon superiormost aspect brainstem ventrally midbrain appears 2 bundles diverge rostrally cerebral peduncles cerebral peduncles third cranial nerve oculomotor seen exiting fourth cranial nerve trochlear exits dorsally unique regard courses anteriorly cerebral peduncles posterior aspect midbrain 2 pairs characteristic protrusions superior inferior colliculi superior colliculi involved mediating vestibuloocular reflex whereas inferior colliculi involved sound localization cranial nerves 12 pairs cranial nerves function mainly convey motor signals sensory information head neck lower cranial nerves somewhat complex visceral functions strictly limited head neck cranial nerves follows olfactory nerve ii optic nerve relays visual information retina right left optic nerves join optic chiasm give rise optic tracts convey visual information thalamus brainstem ultimately visual cortex optic gliomas iii oculomotor nerve principally involved control eye movements iv trochlear nerve innervates superior oblique muscle purely motor nerve v trigeminal nerve 1 2 3 trigeminal neuralgia vi abducens nerve innervates lateral rectus nerve allowing lateral eye movements vii facial nerve bells palsy viii vestibulocochlear nerve purely sensory nerve conveys auditory information cochlea brainstem via cochlear branch vestibular ix glossopharyngeal nerve involved taste salivation well sensation oropharynx afferent limb gag reflex mediated glossopharyngeal nerve x vagus nerve xi accessory nerve contributions spinal component innervates neck muscles involved head turning xii hypoglossal nerve motor nerve innervates muscles tongue gross anatomy cerebellum cerebellum occupies posterior fossa dorsal pons medulla involved primarily modulating motor control enable precisely coordinated body movements similar cerebrum gyri sulci cerebellum finer folia fissures increase surface area cerebellum consists 2 hemispheres connected midline structure called vermis contrast neocortex cerebrum cerebellar cortex 3 layers molecular purkinje granular 4 deep cerebellar nuclei fastigial globose emboliform dentate nuclei sequence medial lateral afferent efferent pathways cerebellum exist within 3 cerebellar peduncles top anterior views cerebellum top anterior views cerebellum children cerebellum common location tumors juvenile pilocytic astrocytomas medulloblastomas hemangioblastomas chiari gross anatomy meninges meninges consist 3 tissue layers cover brain spinal cord pia arachnoid dura mater see image pia along arachnoid referred leptomeninges whereas dura referred pachymeninx crosssectional view meninges dural venous sinus crosssectional view meninges dural venous sinus innermost 3 layers pia mater tightly covers brain conforming grooves folds layer rich blood vessels outside pia mater tightly contours brain arachnoid mater arachnoid mater thin weblike layer pia mater arachnoid mater space called subarachnoid space contains cerebrospinal fluid csf space major arteries supplying blood brain lie blood vessel ruptures space cause subarachnoid hemorrhage meningiomas outermost meningeal layer dura mater lines interior skull dura mater composed 2 individual layers meningeal dura periosteal dura part layers fused venous sinuses found areas separation tentorium cerebelli dura mater fold separates cerebellum cerebrum falx cerebri fold separates left right cerebral hemispheres arachnoid mater dura mater subdural space bleeding occurs space underneath dura mater called subdural hematoma epidural hematoma gross anatomy ventricles cerebrospinal fluid brain bathed cerebrospinal fluid csf continuously produced absorbed ventricles csfcontaining cavities within brain structures produce csf contained within ventricles called choroid plexuses csf produced rate 450 mlday although given time 150 ml found within csf spaces thus volume csf adults turned 3 times per day brain 4 ventricles see image within cerebral hemispheres lateral ventricles connected third ventricle pathway called interventricular foramen monro third ventricle lies midline separating deeper brain structures left right thalami third ventricle communicates fourth ventricle cerebral aqueduct sylvius long narrow tube ventricular system circulates cerebrospinal fluid brain ventricular system circulates cerebrospinal fluid brain fourth ventricle csf flows subarachnoid space around brain spinal cord subarachnoid space csf absorbed venous system arachnoid granulations villi structures projecting superior sagittal sinus release csf back venous system hydrocephalus gross anatomy blood vessels arteries supply blood brain via 2 main pairs vessels internal carotid artery vertebral artery side internal carotid artery side terminates anterior cerebral artery middle cerebral artery posterior communicating artery vertebral arteries side join form basilar artery basilar artery gives rise posterior cerebral arteries superior cerebellar arteries basilar artery posterior cerebral arteries posterior communicating arteries anterior cerebral arteries along anterior communication artery form important collateral circulation base brain termed cerebral arterial circle willis cerebral aneurysms venous return heart occurs combination deep cerebral veins superficial cortical veins veins contribute larger venous sinuses lie within dura ultimately drain internal jugular veins brachiocephalic veins superior vena cava microscopic anatomy cellular structure brain composed primarily neurons support cells broadly termed glial cells 3 principal types glial cells astrocytes oligodendrocytes microglia glial cells give rise glial tumors astrocytomas oligodendrogliomas glioblastomas examined histologically neurons cortical gray matter demonstrate laminar pattern neocortex contains 6 distinct layers contrast evolutionarily older paleocortex archicortex typically contain 3 layers specific cytoarchitectural patterns cortex uniform throughout cerebral cortex variation mapped german physician korbinian brodmann presented 1909 socalled brodmann areas represent cytoarchitectural differences across different brain regions numbering scheme developed brodmann still used refer distinct areas cortex layers neocortex see list molecular layer outermost layer cortex lies adjacent pial surface ii external granular layer dense layer primarily inhibitory granule cells layer serves mainly establish intracortical connections iii external pyramidal layer contains smaller neurons deeper counterpart layer provides projections association fibers commissural fibers iv internal granular layer principal input layer cortex input derived largely thalamus v internal pyramidal layer typically largest layer within cortex containing large pyramidal cells one principal output layers cortex projecting subcortical spinal pathways motor cortex cells layer termed betz cells vi fusiform layer contains cells form association projection fibers white matter white matter tracts connect nearby distal brain structures distinguished according types connections mediate projection fibers connect structures longest distances corticospinal projections motor cortex anterior horn cells spinal cord association fibers connect structures within hemisphere arcuate fasciculus connects temporoparietal receptive speech areas frontal speech areas commissural fibers connect homologous structures left right hemispheres notable example corpus callosum diffusion tensor imaging glial cells glial cells provide supportive regulatory functions neurons fact glial cells outnumber neurons three principal types glial cells exist microglia astrocytes oligodendrocytes microglia function brain similar immune system astrocytes play role creating bloodbrain barrier allows certain substances selectively pass capillary system also responsible reactive scar formation brain oligodendrocytes form myelin serves electrically insulate axons nerve cells allowing increased rates conduction abnormal proliferation oligodendrocytes astrocytes lead primary brain tumors called oligodendrogliomas astrocytomas glioblastoma multiforme functional neuroanatomy current understanding functional localization cortex see image derived several sources include insights patients lesions involving specific areas cortex awake mapping cortex brain surgery functional imaging studies functional magnetic resonance imaging mri positron emission tomography pet healthy volunteers functional localization within cerebral cortex functional localization within cerebral cortex earliest contributions modern language mapping traced work neurologist paul broca studied language deficits patients stroke brocas area termed region frontal operculum also overlaps brodmann area 44 45 three overlapping names describe region responsible speech production selective damage region leads difficulty speaking typically preserved comprehension contrast wernickes area refers posterior aspect superior temporal gyrus overlaps brodmann area 22 region generally responsible speech comprehension selective injury lead impaired understanding preserved speech production additionally language function hemispherically dominant means brocas wernickes aphasia primary motor sensory cortex mapped extensively intraoperative stimulation awake patients early work performed neurosurgeon wilder penfield montreal led conceptualization homunculus somatotopic representation body primary motor primary sensory cortex see image homunculus somatotopic representation human body primary motor sensory cortex homunculus somatotopic representation human body primary motor sensory cortex body parts disproportionately represented motor sensory fibers devoted regions face fingers primary motor cortex corresponds precentral gyrus brodmann area 4 intraoperative stimulation motor cortex awake patients leads contralateral muscle contraction single muscle discrete group muscles premotor cortex corresponds brodmann area 6 also occupied movement typically complex movements elicited stimulation primary sensory cortex corresponds postcentral gyrus brodmann areas 13 homunculus obtained awake mapping corresponds motor cortex stimulation awake patients surgery typically leads subjective sensation tingling corresponding body part opposite side body caudally superior parietal lobule brodmann areas 5 7 represents secondary sensory cortex felt subserve multimodal sensory information primary visual cortex corresponds brodmann area 17 occupies occipital pole also termed striate cortex visual cortex retinotopically organized surrounding primary visual cortex visual association cortex brodmann areas 18 19 primary auditory cortex lies superior bank superior temporal gyrus corresponds brodmann area 41 like primary motor primary sensory visual cortices primary auditory cortex tonotopically organized auditory association cortex brodmann area 42 surrounds primary auditory cortex start media brain coronal view brain coronal view brain inferior view brain inferior view brain lateral view brain lateral view brain midsagittal view brain midsagittal view three views brainstem three views brainstem top anterior views cerebellum top anterior views cerebellum major nuclei thalamus major nuclei thalamus lateral medial surfaces cerebrum showing major sulci gyri lateral medial surfaces cerebrum showing major sulci gyri homunculus somatotopic representation human body primary motor sensory cortex homunculus somatotopic representation human body primary motor sensory cortex body parts disproportionately represented motor sensory fibers devoted regions face fingers inferior surface cerebrum showing major sulci gyri inferior surface cerebrum showing major sulci gyri functional localization within cerebral cortex functional localization within cerebral cortex crosssectional view meninges dural venous sinus crosssectional view meninges dural venous sinus ventricular system circulates cerebrospinal fluid brain ventricular system circulates cerebrospinal fluid brain author anand rughani md neurosurgeon epilepsy functional neurosurgery maine medical center anand rughani md member following medical societies american association neurological surgeons american medical association congress neurological surgeons disclosure nothing disclose coauthors paul l penar md facs professor department surgery division neurosurgery director functional neurosurgery radiosurgery programs university vermont college medicine paul l penar md facs member following medical societies alpha omega alpha american association neurological surgeons world society stereotactic functional neurosurgery congress neurological surgeons disclosure nothing disclose chief editor thomas r gest phd professor anatomy department medical education texas tech university health sciences center paul l foster school medicine disclosure received royalty lippincott williams wilkins baehr frotscher duus topical diagnosis neurology nolte j human brain dearmond sj fusco mm dewey mm structure human brain loukas pennell c groat c tubbs cohengadol aa korbinian brodmann 18681918 contributions mapping cerebral cortex neurosurgery crossman ar neary neuroanatomy carpenter mb core text neuroanatomy waxman sg clinical neuroanatomy

Article 7:
auditory system anatomy auditory system anatomy overview cochlear nerve central auditory pathways neurophysiologic considerations auditory system anatomy overview cochlear nerve central auditory pathways neurophysiologic considerations overview overview cochlear nerve central auditory pathways neurophysiologic considerations clinical applications auditory system anatomy overview 1948643overview aug 17 2015 201508171139 1 anatomy 2002 anatomy anatomy 1 2 content 1948643 504 25 ssg aug 17 2015 anatomy anatomy anatomy anatomy anatomyanatomy anatomy anatomy auditory system auditory system anatomy auditory system acoustic pathway spiral organ corti auditory pathway eighth cranial nerve cranial nerve viii vestibulocochlear nerve 8th cranial nerve clinical anatomy article discusses anatomy auditory pathway see following images well physiologic considerations clinical applicationsfile12616file12617file12626the eighth cranial nerve cn viii vestibulocochlear nerve composed 2 different sets fibers 1 cochlear nerve 2 vestibular nerve 0 auditory system anatomy overview article discusses anatomy auditory pathway see following images well physiologic considerations clinical applications illustration auditory reflex pathway illustration auditory reflex pathway illustration conscious auditory pathway illustration conscious auditory pathway anatomy auditory system courtesy hamid r djalilian md eighth cranial nerve cn viii vestibulocochlear nerve composed 2 different sets fibers 1 cochlear nerve 2 vestibular nerve 2 nerves anatomically physiologically different peripheral segments cochlear vestibular nerves join lateral part internal auditory canal iac form vestibulocochlear nerve also joined facial nerve iac cochlear nerve central auditory pathways embryology embryologically vestibulocochlear acousticovestibular ganglion initially develops fused viith nerve facial ganglion separation 3 components occurs gradually vestibular cochlear acoustic ganglia neuroblasts derived almost exclusively otocyst epithelium contrast cranial sensory ganglia ganglionic neural crest placodes make extensive contributions neuroblast populations however supporting schwann satellite cells cranial ganglia entirely neural crest origin apparently arising ganglion facial nerve see image illustration showing almost neurons vestibular acoustic ganglia derived illustration showing almost neurons vestibular acoustic ganglia derived otocyst placodal neurons contrast supporting schwann cells derived neural crest cells possibly viith nerve ganglion vestibulocochlear ganglion initially attached ascending afferent projective pathways auditory nerve ascending pathway transmits impulses spiral organ corti cerebral cortex see following image illustration afferent auditory reflex pathway illustration afferent auditory reflex pathway firstorder neurons auditory system fibers cochlear nerve originate aggregation nerve cell bodies spiral ganglion located modiolus cochlea neurons spiral ganglion first 4 order neurons cochlea cerebrum bipolar cells 2 sets processes fibers extend opposite ends cell bodies longer central fibers also called primary auditory fibers form cochlear nerve shorter peripheral fibers extend bases inner outer hair cells extend radially spiral ganglion habenula perforata series tiny holes beneath inner hair cells point become demyelinated enter spiral organ corti 30000 fibers exist greater number them—about 95—innervate inner hair cells remainder cross tunnel corti innervate outer hair cells longer central processes bipolar cochlear neurons unite form cochlear nerve trunk primary auditory fibers exit modiolus internal meatus enter medulla oblongata mouth internal auditory canal iac called porus acusticus anatomic relationship viith viiith nerves iac cerebellopontine angle region important anatomic areas related skull base surgery neurootologists viith viiith nerves encased glial tissue throughout intracranial course nerves surrounded schwann cells beginning iac close porus acusticus obersteinerredlich zone glialschwann junction scarpa vestibular ganglion lies approximately middle iac division cranial nerve cn viii cochlear vestibular branches may occur medial segment iac subarachnoid space posterior half iac occupied superior inferior branches vestibular nerve cochlear nerve located anteroinferiorly canal viith nerve located anterosuperior portion iac vertical crest bill bar separates facial superior vestibular nerves upper part iac transverse crest separates upper portion iac lower part containing lower vestibular cochlear divisions cerebellopontine angle potential space posterior cranial fossa boundaries follows anteriorly posterior fossa temporal bone posteriorly anterior surface cerebellum medially inferior olive superiorly inferior border pons cerebellar peduncle inferiorly cerebellar tonsil trigeminal nerve entering medulla cochlear nerve fibers proceed cochlear nucleus cochlear nucleus consists 5 distinct cell types distinct morphologic physiologic features response stimulus onset stimulus offset frequency modulation cochlear nucleus divided dorsal ventral parts cochlear fibers divide 2 main bundles one group passes lateral dorsal restiform body group remains slightly ventral medial restiform body terminates ventral cochlear nucleus fibers coming basal coils cochlea found terminate dorsal part dorsal cochlear nucleus fibers apical parts cochlea end ventral part dorsal cochlear nucleus ventral nucleus however fibers pass higher order neurons along pathway synapse second third fourthorder neurons auditory system cell bodies second order neurons lie dorsal ventral cochlear nuclei fibers ventral cochlear nucleus pass across midline cells superior olivary complex whereas others make connection olivary cells side superior olivary complex considered first center ascending auditory system inputs ears converge together fibers form trapezoid body third order neurons located fibers dorsal cochlear nucleus cross midline end cells nuclei lateral lemniscus joined fibers ventral cochlear nuclei sides olivary complex auditory nuclei superior olivary complex excitatory inhibitory inputs ear lemniscus major tract fibers end inferior colliculus auditory center midbrain inferior colliculus complex nucleus least 18 major cell types least 5 areas specialization involved areas auditory behavior including differential sensitivity frequency intensity loudness binaural hearing although fibers may bypass colliculus end together fibers colliculus next higher level medial geniculate body thalamus fourth order neurons located medial geniculate body orderly projection fibers portion cortex temporal lobe auditory input primary auditory cortex first region cerebral cortex receive auditory input humans primates primary acoustic area cerebral cortex superior transverse temporal gyri heschl ridge temporal lobe lower lip deep cleft temporal parietal lobes known lateral sulcus sylvian fissure half fibers auditory pathways cross midline whereas others ascend side brain ear represented right left cortex reason even auditory cortical area one side injured trauma stroke binaural hearing may minimally affected perception sound associated right posterior superior temporal gyrus stg superior temporal gyrus contains several important structures brain including brodmann 41 42 marking location primary auditory cortex cortical region responsible sensation basic characteristics sound pitch rhythm auditory association area located within temporal lobe brain area called wernicke area area 22 area near lateral cerebral sulcus important region processing acoustic signals distinguished speech music noise common thalamocortical connections nuclei within medial geniculate body send fibers auditory cortex also receive fibers area cortex impaired hearing due bilateral cortical injury involving auditory areas reported extremely rare however bilateral lesions temporal lube shown produce wideranging effects cortical deafness several behaviors affected including speech discrimination localization sound detection faint shortduration signals following image depict conscious reflex afferent auditory pathways illustration conscious auditory pathway illustration conscious auditory pathway illustration auditory reflex pathway illustration auditory reflex pathway descending pathways auditory nerve besides conscious reflex afferent auditory pathways descending efferent pathways also exist efferent projections brain cochlea also play role perception sound general descending pathways inhibiting effect upon ascending fibers tend provide selfregulation auditory system relay auditory station considered dually innervated thus providing way incoming impulses internally influenced modified negated parallel pathway ascending cochlear nuclei cortex pathway descending cortex cochlear nuclei pathways fibers remain side whereas others cross midline opposite side brain evidence spur line ascending dorsal cochlear nucleus cerebellum another descending inferior colliculus cerebellum also exist significance cerebral connections clear may antedate evolutionary development cerebral cortex superior olivary complex region medulla oblongata fiber tract called olivocochlear bundle also originates see image constitutes efferent system feedback loop nerve impulses thought inhibitory reach hair cells illustration descending pathways auditory nerve crosses represent small illustration descending pathways auditory nerve crosses represent small olivocochlear bundle ocb neurons triangles represent large ocb neurons dmp dmpo dorsal medial preolivary nucleus ihc inner hair cell lso lateral superior olivary nucleus mntb medial nucleus trapezoid body mso medial superior olivary nucleus ohc outer hair cell vntb ventral nucleus trapezoid body microscopic anatomy see inner ear spiral organ corti spiral organ corti scanning electron micrograph upper surface organ corti removal scanning electron micrograph upper surface organ corti removal tectorial membrane 3 rows outer hair cells characteristic varranged stereocilia single row inner hair cells slightly curved row stereocilia also shown cochleas afferent innervation pattern illustration shown vestibular cochleas afferent innervation pattern illustration shown vestibular reissners membrane looking spiral organ corti principal fiber bundles 1 2 2a 3a internal spiral fibers 4 external spiral fibers 5 6 radial fibers innervating inner hair cells neurophysiologic considerations complex chain nerve cells auditory system helps process relay auditory information encoded form nerve impulses directly highest cerebral levels cortex brain extent different properties auditory stimulus conveyed along distinct parallel pathways method transmission employed sensory systems provides way central nervous system cns analyze different properties single auditory stimulus information processed low levels information higher levels lower levels pathway information pitch loudness localization sounds processed appropriate responses contraction intraaural muscles turning eyes head movements body whole initiated patterns spatial representations spiral organ corti lower levels auditory pathway seem accord place theory cochlear analysis sound physiologic evidence tuning auditory system also obtained recording electrical potentials individual neurons various levels neurons auditory pathway show best frequency frequency individual neuron responds minimal intensity see image crosssection cochlear nucleus showing track made electrode penetration crosssection cochlear nucleus showing track made electrode penetration characteristic frequencies neurones within anteroventral avcn dorsal nucleus dn posteroventral nucleus pvcn spacial separation frequencies tonotropic organization maintained throughout central auditory pathway finding entirely compatible experimental evidence frequency tuning hair cells increase intensity sound neuron able respond wider band frequencies thus reflecting broad tuning basilar membrane increased intensity stimulation causes rapid rate responding pitch sound tends coded terms neurons responding loudness determined rate response total number neurons activated sound localization discrimination localization sounds stationary source horizontal plane known depend recognition minute differences intensity time arrival sound 2 ears sound arrives left ear microseconds sooner right sounds decibels louder ear recognized coming left reallife situation head may also turned pinpoint sound facing thus canceling differences lowfrequency tones difference phase 2 ears criterion localization higher frequencies difference loudness caused sound shadow head becomes allimportant comparisons discriminations appear carried brainstem midbrain levels central auditory pathway spectral shapes sounds shown important determining elevation source horizontal plane localization sound emanates moving source complicated task nervous system apparently involves cerebral cortex shortterm memory injury auditory area cortex one side brain interferes localization moving sound source opposite side body experimental studies indicated cortex even necessary frequency recognition carried lower levels essential recognition temporal patterns sound therefore cortex appears reserved analysis complex auditory stimuli speech music temporal sequence sounds equally important presumably also cortical level meaning sounds interpreted behavior adjusted accordance significance functions formerly attributed auditory association area immediately surrounding primary area probably thought involving much cerebral cortex thanks multiple parallel interconnections various areas cochlear nucleus receives impulses ear side comparison responses 2 ears first becomes possible superior olivary complex receives fibers cochlear nuclei neurons accessory nucleus olivary complex respond impulses ears others respond impulses one side response modified simultaneous arrival impulses side auditory system appears capable making minute fine discriminations time intensity necessary localization sound virtue bilateral neural interconnections brain 2 ears together much effective 1 ear alone picking particular sound presence background noise also permit attention directed single source sound one aspect cocktail party effect whereby listener normal hearing attend different conversations turn concentrate one speaker despite surrounding babble observation significantly activated areas monaural binaural stimulation suggests differences auditory perception binaural stimulation due involvement significantly different centers likely type information reaches centers processing furthermore degree stimulation may less intense binaural monaural stimulation supports concept richer binaural auditory stimulation compared monaural stimulation mean summation stimuli integration better processing information whether muscles within ear play part filtering unwanted sounds selective listening established lessfavorable aspect cocktail party effect background noises mask dialogue make following conversation difficult persons sensorineural impairment efferent projections brain cochlea also play role perception sound efferent synapses occur outer hair cells afferent dendrites inner hair cells clinical applications clinical applications related auditory pathway addressed section auditory brainstem response obvious application study auditory central nervous system cns involves interpretation auditory evoked potentials aeps auditory brainstem response abr first reported 1967 component potentials abr series 7 waves occurring within 1015 milliseconds onset acoustic stimulus waves test function auditory nerve auditory pathways brainstem wave generated follows normal subjects waves ii viiith nerve wave iii cochlear nucleus wave iv superior olivelateral lemniscus wave v lateral lemniscusinferior colliculus following 3 main uses abr threshold testing infants young children malingerers diagnosis acoustic neuromas diagnosis brainstem lesions neuropathies 2 uses abr gaining popularity 1 screening babies intensive care unit icu risk hearing loss 2 intraoperative monitoring surgery viiith nerve vascular decompression vestibular nerve section otoacoustic emissions techniques measuring efferent effects using otoacoustic emissions oaes well developed promise clinical applications ranging predicting patients susceptible acoustic trauma characterizing relationships efferent activation learning disabilities efferent auditory pathways efferent auditory pathways modulate outer hair cells cochlea protect noise improve detection sound sources noisy environments prospective clinical quantitative crosssectional contemporary study fronza et al concluded young normalhearing adults experience efferent auditory pathways dysfunctions tinnitus developmental learning impairments neuroscience research auditory processing pathways behavioral electrophysiologic correlates provided important clinical applications deviations disruptions auditory pathways children adolescents result welldocumented range developmental learning impairments frequently referred neuropsychologic evaluation auditory deprivation enhancement training recently researchers used behavioral measures identification discrimination speech nonspeech stimuli assess effects auditory deprivation enhancement training recent advances measure electrical activity auditory system response sound made possible study changes auditory input hearing loss auditory input modification training affect function central auditory system evidence changes auditory cortex mature animals humans acquired sensorineural hearing loss well changes associated auditory training persons normal hearing reported results study measures psychoacoustic speechrecognition performance persons hearing loss without hearing aids cochlear implants cochlear implants severe profound sensorineural loss ears functioning auditory nerve lived least short time period without hearing approximately 70 decibel hearing loss average good speech language communication skills case infants young children family willing work toward speech language skills therapy benefitting enough kinds hearing aids medical reason avoid surgery living desiring live hearing world realistic expectations results support family friends appropriate services set postcochlear implant aural rehabilitation speech language pathologist deaf educator auditory verbal therapist cochlear nerve deficiency cnd increasingly diagnosed children sensorineural hearing loss snhl clemmens et al 2013 used magnetic resonance imaging mri study prevalence cnd correlations audiologic phenotype children unilateral snhl yan et al 2013 also found hypoplastic cochlear nerve canal might indicative cnd narrow internal auditory canal ryugo found auditory brain highly malleable experience auditory brainstem implant abi implant like cochlear implant except bypasses cochlea altogether attaches electrode directly brainstem abis provide sound information direct stimulation cochlear nucleus patients dysfunctional absent cranial nerve viii recipients abis reported able hear sounds help lip read able discriminate speech sounds alone candidates implant carefully chosen surgery much invasive surgery required cochlear implants usually undertaken situations patient become completely deaf however contrast patients cochlear implants use abis less successful cannot fully explained different location stimulation rather nonspecific neuronal stimulation many candidates abi trials patients neurofibromatosis ii nf2 second tumor removed directly comparing cochlear implants abis somewhat difficult types implants constantly updated general however shown abi particularly recent multichannel abi provides levels sound detection discrimination similar provided original singlechannel cochlear implant mandala et al found definition potential threshold number auditory extraauditory waves generated significantly improved using electrical compound action potentials auditory brainstem implantation start media illustration auditory reflex pathway illustration auditory reflex pathway illustration conscious auditory pathway illustration conscious auditory pathway illustration showing almost neurons vestibular acoustic ganglia derived illustration showing almost neurons vestibular acoustic ganglia derived otocyst placodal neurons contrast supporting schwann cells derived neural crest cells possibly viith nerve ganglion vestibulocochlear ganglion initially attached illustration afferent auditory reflex pathway illustration afferent auditory reflex pathway illustration descending pathways auditory nerve crosses represent small illustration descending pathways auditory nerve crosses represent small olivocochlear bundle ocb neurons triangles represent large ocb neurons dmp dmpo dorsal medial preolivary nucleus ihc inner hair cell lso lateral superior olivary nucleus mntb medial nucleus trapezoid body mso medial superior olivary nucleus ohc outer hair cell vntb ventral nucleus trapezoid body spiral organ corti spiral organ corti scanning electron micrograph upper surface organ corti removal scanning electron micrograph upper surface organ corti removal tectorial membrane 3 rows outer hair cells characteristic varranged stereocilia single row inner hair cells slightly curved row stereocilia also shown cochleas afferent innervation pattern illustration shown vestibular cochleas afferent innervation pattern illustration shown vestibular reissners membrane looking spiral organ corti principal fiber bundles 1 2 2a 3a internal spiral fibers 4 external spiral fibers 5 6 radial fibers innervating inner hair cells crosssection cochlear nucleus showing track made electrode penetration crosssection cochlear nucleus showing track made electrode penetration characteristic frequencies neurones within anteroventral avcn dorsal nucleus dn posteroventral nucleus pvcn spacial separation frequencies tonotropic organization maintained throughout central auditory pathway normal brainstem responses broadband click latency increases click intensity decreases normal brainstem responses broadband click latency increases click intensity decreases anatomy auditory system courtesy hamid r djalilian md author ted l tewfik md professor otolaryngologyhead neck surgery professor pediatric surgery mcgill university faculty medicine senior staff montreal childrens hospital montreal general hospital royal victoria hospital ted l tewfik md member following medical societies american society pediatric otolaryngology canadian society otolaryngologyhead neck surgery disclosure nothing disclose chief editor thomas r gest phd professor anatomy department medical education texas tech university health sciences center paul l foster school medicine disclosure received royalty lippincott williams wilkins acknowledgements medscape reference thanks hamid r djalilian md associate professor otolaryngology director neurotology skull base surgery university california irvine medical center assistance video contribution article benoudiba f toulgoat f sarrazin jl vestibulocochlear nerve viii diagn interv imaging medline nakamichi r yamazaki ikeda isoda h kawai h sone et al establishing normal diameter range cochlear facial nerves 3dciss 3t magn reson med sci medline kandel er schwartz jh jessell tm principles neuroscience johnston mc developmental biology ear tewfik tl der kaloustian vm eds congenital anomalies ear nose throat josey af glasscock 3rd musiek fe correlation abr medical imaging patients cerebellopontine angle tumors j otol medline ferguson smith pa lutman mason sm coles rr gibbin kp efficiency tests used screen cerebellopontine angle tumours prospective study br j audiol medline lonsburymartin bl martin gk coats ac chapter 47 physiology auditory vestibular systems ballenger jj ed diseases nose throat ear head neck sooy cd boles r neuroanatomy otolaryngologisthead neck surgeon paparella mm shunrick da gluckman jl meyerhoff wl eds otolaryngology colletti v shannon rv carner veronese colletti l complications auditory brainstem implant surgery adults children otol neurotol medline kemp dt otoacoustic emissions origin cochlear function use br med bull medline mills jh khariwala ss weber pc chapter 129 anatomy physiology hearing bailey bj johnson jt newlands sd eds head neck surgery otolarygology guinan jj jr cochlear efferent innervation function curr opin otolaryngol head neck surg medline bailey auditory pathways processes implications neuropsychological assessment diagnosis children adolescents child neuropsychol medline fronza ab barreto dc tochetto tm da cruz ib da silveira af association auditory pathway efferent functions genotoxicity young adults portugese braz j otorhinolaryngol medline neuman ac central auditory system plasticity aural rehabilitation adults j rehabil res dev medline goycoolea mena neubauer difference activation inhibition cortical auditory centers depending ear stimulated acta otolaryngol medline offeciers e morera c müller j huarte shallop j cavallé l international consensus bilateral cochlear implants bimodal stimulation acta otolaryngol medline godar sp litovsky ry experience bilateral cochlear implants improves sound localization acuity children otol neurotol medline litovsky ry johnstone pm godar sp benefits bilateral cochlear implants andor hearing aids children int j audiol medline full text strydom hanekom jj performance different synthesis signals acoustic models cochlear implants j acoust soc medline jamróz b lachowska niemczyk k morawski k bartoszewicz r pierchala k possibility hearing preservation treatment patient suffered neurofibromatosis type 2 case report otolaryngol pol medline gudwani munjal sk panda nk verma rk correlation tinnitus loudness onset duration audiological profile indicating variation prognosis isrn otolaryngol medline full text clemmens cs guidi j caroff cohn sj brant ja laury et al unilateral cochlear nerve deficiency children otolaryngol head neck surg medline yan f li j xian j wang z mo l cochlear nerve canal internal auditory canal children normal cochlea cochlear nerve deficiency acta radiol medline ryugo auditory neuroplasticity hearing loss cochlear implants cell tissue res medline mandalà colletti l colletti g colletti v improved outcomes auditory brainstem implantation use nearfield electrical compound action potentials otolaryngol head neck surg medline brackmann de crawford jv douglas green j chapter 149 cerebellopontine angle tumors bailey bj johnson jt newlands sd eds head neck surgery otolarygology

Article 8:
bariatric surgery bariatric surgery background history procedure problem bariatric surgery workup laboratory studies imaging studies diagnostic procedures bariatric surgery treatment management medical therapy surgical therapy preoperative details bariatric surgery background history procedure problem bariatric surgery workup laboratory studies imaging studies diagnostic procedures bariatric surgery treatment management medical therapy surgical therapy preoperative details overview background history procedure problem epidemiology etiology pathophysiology presentation indications contraindications workup laboratory studies imaging studies diagnostic procedures treatment medical therapy surgical therapy preoperative details intraoperative details postoperative details followup complications outcome prognosis future controversies bariatric surgery overview bariatric surgery workup bariatric surgery treatment 197081overview feb 10 2015 201508042357 0 clinical procedures 2002 procedures procedure 1 2 content 197081 503 3032278 20 diet1 jun 04 2015 procedure procedures clinicalprocedures clinical procedures clinicalproceduresgastro gastrointestinal bariatric surgery gastric bypass stomach obesity gastric bariatric weight loss surgery weight surgery stomach surgery gastric banding gastrectomy rouxeny gastric sleeve gastric bypass surgery body mass index bmi laparoscopic gastric bypass duodenal switch gastric bypass complications adjustable gastric banding rouxeny gastric bypass sleeve gastrectomy biliopancreatic diversion duodenal switch obesity major health problem worldwide reached epidemic proportion western society evidence continues accumulate obesity major risk factor many diseases associated significant morbidity mortality 0 bariatric surgery overview background obesity major health problem worldwide reached epidemic proportion western society evidence continues accumulate obesity major risk factor many diseases associated significant morbidity mortality bariatric surgery currently modality provides significant sustained weight loss morbidly obese patients resultant improvement obesityrelated comorbidities prospective controlled swedish study involving 4047 obese patients half undergone bariatric procedures followed 147 years found compared usual care bariatric surgery associated significantly reduced number cardiovascular deaths lower incidence cardiovascular events obese adults essential update 2015 espghan guidelines bariatric surgery children january 2015 european society pediatric gastroenterology hepatology nutrition espghan published position statement bariatric surgery severely obese children adolescents provided following guidelines consider bariatric surgery carefully selected patients body mass index bmi higher 40 kgm 2 2 additional factors consider deciding whether child adolescent undergo bariatric surgery include physical psychological maturity personal desire undergo procedure previous attempts weight loss ability adhere followup care rouxeny gastric bypass laparoscopic adjustable gastric banding sleeve gastrectomy widely used procedures pediatric obesity use associated subsequent nutritional deficiencies temporary intragastric devices could represent better option initial treatment pediatric populations current evidence suggests bariatric surgery decrease grade steatosis hepatic inflammation fibrosis nafld uncomplicated nafld indication bariatric surgery rouxeny gastric bypass considered safe effective option extremely obese adolescents long appropriate longterm followup provided laparoscopic adjustable gastric banding approved fda use adolescents therefore considered investigational sleeve gastrectomy types weight loss surgery grown increasingly common adults must still considered investigational history procedure 1954 kremen linner introduced jejunoileal bypass first effective surgery obesity united states procedure proximal jejunum connected directly distal ileum bypassing 90 small intestine intestinal stream ingested nutrients blind loop procedure induced state malabsorption modifications original procedures development new techniques led 3 basic concepts bariatric surgery 1 gastric restriction adjustable gastric banding sleeve gastrectomy 2 gastric restriction mild malabsorption rouxeny gastric bypass 3 combination mild gastric restriction malabsorption duodenal switch see images adjustable gastric banding adjustable gastric banding sleeve gastrectomy sleeve gastrectomy laparoscopic rouxeny gastric bypass laparoscopic rouxeny gastric bypass long rouxeny gastric bypass long rouxeny gastric bypass biliopancreatic diversion duodenal switch biliopancreatic diversion duodenal switch problem widely accepted measure obesity body mass index bmi number calculated dividing patients mass kilograms height meters squared normal bmi considered range 185249 kgm 2 2 2 considering factors eg total muscle mass waist circumference besides bmi may important example extremely muscular individual may elevated bmi without considered overweight waist circumference shown excellent indicator abdominal fat mass circumference greater 88 cm 35 women greater 102 cm 40 men strongly correlates increased risk obesityrelated disease epidemiology frequency number overweight individuals world estimated 17 billion united states problem epidemic proportions two thirds population united states overweight half people group classified obese etiology obesity complex multifactorial chronic disease influenced interaction several factors genetic endocrine metabolic environmental social cultural behavioral psychological components basic mechanism occurs energy intake exceeds energy output pathophysiology obesity occurs result imbalance energy expenditure caloric intake imbalance thought genetic environmental influence discovery immunological abnormalities obesity related leptinproopiomelanocortin system elevated tumor necrosis factoralpha brought new perspective understanding obesity leptin hormone made primarily adipocytes leptin greek word leptos presentation morbid obesity harbinger many diseases affect essentially every organ system cardiovascular eg hypertension atherosclerotic heart peripheral vascular disease myocardial infarction cerebral vascular accidents peripheral venous insufficiency thrombophlebitis pulmonary embolism respiratory eg asthma obstructive sleep apnea obesityhypoventilation syndrome metabolic eg type 2 diabetes impaired glucose tolerance hyperlipidemia musculoskeletal eg back strain disc disease weightbearing osteoarthritis hips knees ankles feet gastrointestinal eg cholelithiasis gastroesophageal reflux disease urologic eg stress incontinence endocrine reproductive eg polycystic ovary syndrome increased risk pregnancy fetal abnormalities male hypogonadism cancer endometrium breast ovary prostate pancreas dermatologic eg intertriginous dermatitis neurologic eg pseudotumor cerebri psychologic eg depression eating disorders body image disturbance indications surgery obesity considered treatment last resort dieting exercise psychotherapy drug treatments failed developed 1991 national institutes health nih consensus development conference panel generally accepted criteria surgical treatment include bmi greater 40 kgm 2 2 contraindications contraindications bariatric surgery include illnesses greatly reduce life expectancy unlikely improved weight reduction including advanced cancer endstage renal hepatic cardiopulmonary disease patients unable understand nature bariatric surgery behavioral changes required afterward including untreated schizophrenia active substance abuse noncompliance previous medical care also considered contraindications bariatric surgery workup laboratory studies preoperative laboratory evaluation include complete blood count cbc complete chemistry panel liver function tests thyroid function tests lipid profile coagulation tests serum iron total iron binding capacity tibc vitamin b12 folic acid blood typing urinalysis imaging studies see list chest radiography ultrasonography gallbladder diagnostic procedures upper endoscopy performed rule intrinsic upper gastrointestinal disease gastric bypass surgery ability nonsurgically visualize distal stomach duodenum could challenge treatment management medical therapy preoperative trial weight loss beneficial ensure patient compliance postoperative diet protocol also preoperative liquid diet shrink liver thus facilitating surgical procedure surgical therapy types bariatric surgery include following restrictive procedures eg adjustable gastric banding sleeve gastrectomy restrictive procedures malabsorption eg rouxeny gastric bypass malabsorptive procedures restriction eg biliopancreatic diversion duodenal switch bariatric surgery performed open technique laparoscopic technique laparoscopic approach currently become popular approach gastric bypass gastric bypass currently popular procedure performed united states see image procedure earned reputation gold standard procedures compared procedure restrictive malabsorptive component laparoscopic rouxeny gastric bypass laparoscopic rouxeny gastric bypass gastric bypass provides substantial amount dietary restriction restriction created small stomach pouch gives patient feeling satiety eating small meal restrictive element operation consists creation small gastric pouch approximately 20 ml volume probably small outlet distention food causes sensation satiety addition gastric bypass provides smalltomoderate degree intentional malabsorption due separation food passes alimentary limb biliopancreatic secretions pass biliopancreatic limb degree malabsorption adjusted modifying length alimentary biliopancreatic limbs malabsorptive element result bypassing distal stomach entire duodenum varying length jejunum extent bypass intestine determines degree macronutrient malabsorption standard roux limb 75 cm extensive malabsorptive variations consist gastric bypasses 150cm roux limb longlimb longlimb distal gastric bypass addition restricting food intake causing degree malabsorption also causes dumping syndrome weight loss standard 75cm roux gastric bypass usually exceeds 100 lb 6570 excess body weight 35 bmi longerlimb bypasses used obtain comparable weight reductions patients super obese bmi 50 kgm 2 reversal bariatric procedures pure reversal without conversion another bariatric procedure almost certainly followed return morbid obesity gastric bypass reversed though rarely required revision standard roux gastric bypass failed weight loss revised longlimb rouxeny procedure dilated gastric pouch revised see image long rouxeny gastric bypass long rouxeny gastric bypass gastric bypass surgery patients may experience dumping syndrome upon ingestion sweets caused rapid passage gastric pouch contents directly small bowel unimpeded pyloric valve presence concentrated simple sugars roux limb presents substantial osmotic load may result cramping abdominal discomfort additionally ensuing rapid release insulin pancreas may cause symptomatic hypoglycemia unpleasant reaction sugar considered desired effect gastric bypass surgery referred patients postoperative police officer weight loss gastric bypass shown greater obtained dietary medical behavioral combined approaches weight loss longterm followup study performed maclean et al defined postoperative success reduction weight bmi less 35 kgm 2 2 2 since initial description 1994 wittgrove others laparoscopic gastric bypass approach shown combine efficacy open approach decreased pain lower wound morbidity shorter convalescence minimally invasive procedure prospective randomized trial completed compared results laparoscopic gastric bypass results open gastric bypass patients undergone laparoscopic gastric bypass found substantially less impairment pulmonary function surgery decreased postoperative pain authors experience convalescence laparoscopic gastric bypass substantially reduced relative open procedures patients returning work 2 weeks less laparoscopic adjustable gastric banding laparoscopic adjustable gastric banding common bariatric procedure performed europe australia south america see image june 2001 us food drug administration fda approved use united states lapband inamed device approved use united states adjustable gastric banding adjustable gastric banding device consists adjustable inflatable band placed around proximal part stomach creates small gastric pouch approximately 15 ml volume small stoma band restriction adjustable adding removing saline inflatable band reservoir system saline attached band accessible port attached catheter band port placed subcutaneously anterior abdominal wall band secured around stomach adjustment band access port essential part laparoscopic adjustable gastric banding therapy appropriate adjustments performed 6 times annually critical successful outcomes patients must chew food thoroughly allow food pass band adjusting inflation cuff changes size opening food passes change size gastric pouch deflation cuff useful outlet obstructed weight loss laparoscopic adjustable gastric banding 5060 excess body weight approximately 2 years laparoscopic adjustable gastric banding completely reversed removal band tubing port combining laparoscopic adjustable gastric banding gastric plication may improve weightloss outcomes least short term biliopancreatic diversion duodenal switch biliopancreatic diversion duodenal switch see image includes following lateral 75 gastrectomy resulting tubular stomach duodenum divided past pyloric valve ileum divided distal end anastomosed proximal duodenum common channel created distally yanastomosis optional appendectomy cholecystectomy biliopancreatic diversion duodenal switch biliopancreatic diversion duodenal switch malabsorption achieved separating food biliopancreatic digestive fluids weight loss results fat malabsorption protein absorption also reduced best weight loss least regain less disruption eating patterns early weight loss restriction malabsorption later mostly malabsorption 7585 excess body weight loss 18 months pyloric preservation protects marginal ulceration dumping syndrome procedure technically challenging difficult reverse insurance companies may cover procedure still considered investigational laparoscopic sleeve gastrectomy laparoscopic sleeve gastrectomy lsg type unbanded gastroplasty employs subtotal gastric resection create long lesser curvature–based gastric conduit see image sleeve gastrectomy sleeve gastrectomy procedure stomach reduced 1520 original size surgical removal large portion stomach following greater curve mechanism weight loss resultant comorbidity improvement follows sleeve gastrectomy may related gastric restriction neurohumoral changes observed following procedure due gastric resection sleeve gastrectomy used first 2stage procedure highrisk patients compared bariatric procedures sleeve gastrectomy physiologic treatment involve malabsorption abnormal tracts blind tracts placement foreign body procedure widely performed laparoscopically hutter et conducted first large prospective multiinstitutional study comparing 1yr outcomes lsg procedures results show lsg morbidity effectiveness laparoscopic adjustable gastric banding standard roux bypass bariatric procedures involve stomach transaction main drawback sleeve gastrectomy severity postoperative complications use stapleline reinforcement shown associated improved perioperative outcomes considered effective method preventing leaks larger prospective comparative study involving 187 patients undergoing laparoscopic sleeve gastrectomy procedure found reinforcement staple line bovine pericardium strips associated significant reduction bleeding staple line intraabdominal collections whereas leak rate significantly reduced unclear though controlling high bmi previous bariatric surgery diabetes taken account randomized study involved 120 patients undergone laparoscopic sleeve gastrectomy using either polyglycolide acid trimethylene carbonate gelatin ﬁbrinmatrix slr wasfound faster compared oversewing whereas significant differences postoperative complications observed three methods incision reduction strategies growing trend bariatric surgery toward reduction abdominal incisions change offering muchimproved cosmetic outcomes potentially shorter patient hospital stays see image progression surgical techniques open surgery first image singleincision progression surgical techniques open surgery first image singleincision transumbilical laparoscopic surgery third illustration minimally invasive surgery also provides result decreased abdominal trauma reductions pain scarring tissue injury saber colleagues developed singleincision transumbilical laparoscopic approach sleeve gastrectomies procedure performed mainly umbilicus sleeve extracted umbilicus without extending incision addition saber colleagues developed singleincision transumbilical laparoscopic technique placement adjustable gastric band addition offering aforementioned benefits approach technique facilitates later outpatient adjustment band preoperative details diversity clinical occult obesityrelated comorbidities necessitates multidisciplinary team approach preoperative evaluation patient morbidly obese evaluation enhance postoperative outcome preoperative cardiac pulmonary psychiatric endocrine evaluations may necessary evaluations help exclude patients may benefit surgery time optimize considered potential good candidates surgery preoperative nutritional consultation helps obtaining detailed diet history explaining preoperative postoperative diet protocol intraoperative details see surgical therapy postoperative details surgery patients must remain highprotein lowfat diet must supplement diet multivitamins iron calcium usually twicedaily basis ursodiol may given minimize risk developing gallstones period acute weight loss patients must modify eating habits avoiding chewy meats foods may inhibit normal emptying stomach pouch nutritional metabolic blood tests must performed frequent basis authors practice tests performed 6 months surgery 12 months surgery annually thereafter post – bariatric surgery body contouring massive weight loss associated negative consequences body flabby skin abdominal skin overhang pendulous breasts excess skin contract back preweight gain tightness redundant rolls tissue may also associated intertrigo significant hygiene problems surgical correction body deformities significantly enhance physical physiological changes usual time lapse gastric bypass plastic surgery procedures 1218 months treatment alternatives body contouring procedures include lipoplasty conventional surgery combination 2 procedures conventional contouring procedures include abdominoplasty buttock lift lower body lift thigh lift upper arm lift facelift breast reduction mastopexy andor augmentation multiple procedures usually required staged approach body contouring surgery following bariatric surgery seems improve safety outcomes complications body contouring procedures include hematomas seromas well fat necrosis skin slough infection deep vein thrombosis addition patient involved team assesses nutritional psychological issues needed followup patient education resources see healthy living center obesity surgery treatment obesity complications early complications rouxeny gastric bypass follows anastomotic leak 13 pulmonary embolism deep vein thrombosis 1 wound infection common open approach gastrointestinal hemorrhage bleeding 052 respiratory insufficiency pneumonia acute distention distal stomach late complications less frequent less dramatic gastric banding rouxeny procedure follows stomal stenosis common 20 bowel obstruction small bowel obstruction 1 internal hernia cholelithiasis micronutrient deficiencies marginal ulcer staple line disruption ventral hernia formation prevalent open approach although statistical increase number patients needing cholecystectomy obesity surgery number small enough prevent suggesting prophylactic procedure time bariatric surgery risk factors associated increased risk postoperative morbidity include recent myocardial infarctionangina stroke bleeding disorder hypertension higher bmi lifelong oral intramuscular vitamin b12 supplementation iron vitamin b folate calcium supplementation recommended avoid specific nutrient deficiency conditions anemia early complications adjustable gastric band procedure follows injury stomach esophagus bleeding food intolerance common immediate postoperative complication wound infection pneumonia late complications follows food intolerance noncompliance band 13 band slippage stomach prolapse 228 pouch dilatation band erosion stomach port complications reoperation rate 241 esophageal dilatation failure lose weight port infection band infection leakage balloon tubing mortality rate 05 0 series biliopancreatic diversion duodenal switch procedure less well known complications potentially problematic surgeon unfamiliar procedure fat malabsorption results diarrhea foulsmelling gas approximately 30 patients potential nutritional deficiencies mandate frequent followup visits close monitoring supplementation multivitamins minerals malabsorption fat soluble vitamins vitamins e k vitamin deficiency causes night blindness vitamin deficiency causes osteoporosis iron deficiency similar incidence rouxeny gastric bypass procedure proteinenergy malnutrition may require second operation lengthen common channel outcome prognosis care postoperative bariatric surgery patient recommended lifetime patient least 3 followup visits bariatric surgery team within first year laparoscopic adjustable gastric banding requires frequent visits band adjustment postoperative dietary changes including vitamin mineral possibly liquid protein supplementation exercise lifestyle changes reinforced counseling support groups patients family physician favorable outcomes bariatric surgery lead socioeconomic advancement may require patient guidance postoperative care may also include planning reconstructive operations weight stabilization certain patients swedish obese subjects sos study ongoing prospective study 2010 obese participants underwent bariatric surgery 2037 obese patients received usual care primary health care system compared control group obese adults underwent surgery experienced reduced number cardiovascular deaths lower incidence heart attack stroke low back pain common complaint among obese patients retrospective study morbidly obese patients underwent bariatric surgery found patients experienced significant decrease low back radicular pain surgery led improvements quality life patients also experienced marked increase l45 intervertebral disc height australian study keating et al compared results weightloss treatments patients diagnosed type 2 diabetes mellitus class iii obesity estimating lifetime costs qualityadjusted lifeyears qalys individuals undergone surgically induced weight loss patients utilized conventional weight loss treatment investigators found mean length time diabetes remission lifetime 114 years patients undergone surgical treatment 21 years patients utilized conventional therapy remainder lifetime patients surgical therapy group lived 157 discounted qalys compared 145 discounted qalys patients conventional therapy group surgical conventional therapy patients mean discounted lifetime costs respectively 98900 101400 australian dollars per patient 1 australian dollar 074 us dollars compared conventional therapy surgically induced weight loss associated mean health care saving 2400 australian dollars 12 additional qalys per patient another study keating coauthors looked withintrial cost efficacy 2 years surgical treatment relative conventional therapy achieving remission patients recently diagnosed type 2 diabetes mellitus class iii obesity incremental costeffectiveness analysis demonstrated mean 2year intervention costs per patient 13400 australian dollars surgical therapy 3400 australian dollars conventional therapy laparoscopic adjustable gastric band lagb surgery responsible 85 difference surgical patients outpatient medical consultation costs 3fold greater conventional patients medication costs 15 times higher patients underwent conventional therapy cost differences occurred primarily trials first 6 months relation conventional treatment incremental costeffectiveness ratio surgical therapy 16600 australian dollars per case diabetes remitted updated cochrane review 2014 included 22 trials 1798 participants concluded surgical treatment obesity yielded greater improvement weight loss weightassociated comorbidities nonsurgical interventions regardless type procedure review rouxeny gastric bypass rygb sleeve gastrectomy comparable outcomes better outcomes adjustable gastric banding general 22 studies taken account rates adverse events reoperation well reported future controversies past 10 years field bariatric surgery enriched data numerous clinical investigations experience direction future clinical investigations manifold includes following controlled prospective intervention studies establishment major prospective database study bariatric surgery outcomes establishment pediatric adolescent bariatric surgery registry performance randomized clinical trials compare safety efficacy different operative procedures controlled studies new operative modalities eg gastric pacing nonoperative modalities treatment study metaanalysis outcomes comorbid conditions morbid obesity study socioeconomic outcomes bariatric surgery study stratified risk assessment risktobenefit ratio treating morbid obesity bariatric surgery without bariatric surgery start media laparoscopic rouxeny gastric bypass laparoscopic rouxeny gastric bypass adjustable gastric banding adjustable gastric banding sleeve gastrectomy sleeve gastrectomy long rouxeny gastric bypass long rouxeny gastric bypass biliopancreatic diversion duodenal switch biliopancreatic diversion duodenal switch progression surgical techniques open surgery first image singleincision progression surgical techniques open surgery first image singleincision transumbilical laparoscopic surgery third illustration author alan saber md ms facs fasmbs director bariatric metabolic surgery university hospitals case medical center surgical director bariatric surgery metabolic nutrition center university hospitals digestive health institute associate professor surgery case western reserve university school medicine alan saber md ms facs member following medical societies american college surgeons american society metabolic bariatric surgery american society gastrointestinal endoscopy disclosure nothing disclose coauthors tarek h elghazaly md fellow minimally invasive bariatric surgery research michigan state university kalamazoo center medical studies disclosure nothing disclose pharmacy editor francisco talavera pharmd phd adjunct assistant professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure received salary medscape employment medscape chief editor john geibel md dsc msc vice chair professor department surgery section gastrointestinal medicine department cellular molecular physiology yale university school medicine director surgical research department surgery yalenew hospital american gastroenterological association fellow john geibel md dsc msc member following medical societies american gastroenterological association american physiological society american society nephrology association academic surgery international society nephrology new york academy sciences society surgery alimentary tract disclosure received royalty amgen consulting received ownership interest ardelyx consulting additional contributors brian j daley md mba facs fccp cnsc professor program director department surgery chief division trauma critical care university tennessee health science center college medicine brian j daley md mba facs fccp cnsc member following medical societies american association surgery trauma eastern association surgery trauma southern surgical association american college chest physicians american college surgeons american medical association association academic surgery association surgical education shock society society critical care medicine southeastern surgical congress tennessee medical association disclosure nothing disclose acknowledgements wish thank ollie j jackson iii md department general surgery michigan state university kalamazoo center medical studies previous contributions entry sjöström l peltonen jacobson p sjöström cd karason k wedel h et al bariatric surgery longterm cardiovascular events jama medline tucker new guidelines address bariatric surgery children medscape medical news full text nobili v vajro p dezsofi fischler b hadzic n jahnel j et al indications limitations bariatric intervention severely obese children adolescents without nonalcoholic steatohepatitis espghan hepatology committee position statement j pediatr gastroenterol nutr medline maclean ld rhode bm nohr cw late outcome isolated gastric bypass ann surg medline wittgrove ac clark gw tremblay lj laparoscopic gastric bypass rouxeny preliminary report five cases obes surg medline higa kd ho boone kb laparoscopic rouxeny gastric bypass technique 3year followup j laparoendosc adv surg tech medline lee wj lee kt ser kh chen jc tsou jj lee yc laparoscopic adjustable gastric banding lagb gastric plication shortterm results comparison lagb alone sleeve gastrectomy surg obes relat dis medline regan jp inabnet wb gagner et al early experience twostage laparoscopic rouxeny gastric bypass alternative supersuper obese patient obes surg medline himpens j dapri g cadière gb prospective randomized study laparoscopic gastric banding laparoscopic isolated sleeve gastrectomy results 1 3 years obes surg medline lee cm cirangle pt jossart gh vertical gastrectomy morbid obesity 216 patients report twoyear results surg endosc medline cottam qureshi fg mattar sg sharma holover bonanomi g laparoscopic sleeve gastrectomy initial weightloss procedure highrisk patients morbid obesity surg endosc medline hamoui n anthone gj kaufman hs crookes pf sleeve gastrectomy highrisk patient obes surg medline silecchia g boru c pecchia rizzello casella g leonetti f effectiveness laparoscopic sleeve gastrectomy first stage biliopancreatic diversion duodenal switch comorbidities superobese highrisk patients obes surg medline himpens j dapri g cadière gb prospective randomized study laparoscopic gastric banding laparoscopic isolated sleeve gastrectomy results 1 3 years obes surg medline baltasar serra c pérez n bou r bengochea ferri l laparoscopic sleeve gastrectomy multipurpose bariatric operation obes surg medline roa pe kaidarperson pinto cho szomstein rosenthal rj laparoscopic sleeve gastrectomy treatment morbid obesity technique shortterm outcome obes surg medline langer fb bohdjalian felberbauer fx fleischmann e reza hoda ludvik b gastric dilatation limit success sleeve gastrectomy sole operation morbid obesity obes surg medline melissas j koukouraki askoxylakis j stathaki daskalakis perisinakis k sleeve gastrectomy restrictive procedure obes surg medline almogy g crookes pf anthone gj longitudinal gastrectomy treatment highrisk superobese patient obes surg medline milone l strong v gagner laparoscopic sleeve gastrectomy superior endoscopic intragastric balloon first stage procedure superobese patients bmi 50 obes surg medline moy j pomp dakin g parikh gagner laparoscopic sleeve gastrectomy morbid obesity j surg medline saber aa elgamal mh itawi ea rao aj single incision laparoscopic sleeve gastrectomy sils novel technique obes surg medline gagner gumbs aa milone l yung e goldenberg l pomp laparoscopic sleeve gastrectomy supersuperobese body mass index 60 kgm2 surg today medline american society metabolic bariatric surgery statements guidelines action items available httpwwwasmbsorgnewsite07resourcesasmbsitemshtm hutter mm schirmer bd jones db ko cy cohen merkow rp et al first report american college surgeons bariatric surgery center network laparoscopic sleeve gastrectomy morbidity effectiveness positioned band bypass ann surg medline daskalakis berdan theodoridou weigand g weiner ra impact surgeon experience buttress material postoperative complications laparoscopic sleeve gastrectomy surg endosc medline stamou km menenakos e dardamanis arabatzi c alevizos l albanopoulos k et al prospective comparative study efficacy stapleline reinforcement laparoscopic sleeve gastrectomy surg endosc medline gentileschi p camperchioli dugo benavoli gaspari al stapleline reinforcement laparoscopic sleeve gastrectomy using three different techniques randomized trial surg endosc medline de zwaan georgiadou e stroh ce teufel köhler h tengler et al body image quality life patients without body contouring surgery following bariatric surgery comparison pre postsurgery groups front psychol medline plecka östlund wenger u mattsson f ebrahim f botha lagergren j populationbased study need cholecystectomy obesity surgery br j surg medline gupta pk franck c miller wj gupta h forse ra development validation bariatric surgery morbidity risk calculator using prospective multicenter nsqip dataset j coll surg medline sjöström l peltonen jacobson p sjöström cd karason k wedel h et al bariatric surgery longterm cardiovascular events jama medline romeo maglio c burza pirazzi c sjöholm k jacobson p et al cardiovascular events bariatric surgery obese subjects type 2 diabetes diabetes care medline lidar z behrbalk e regev gj salame k keynan schweiger c et al intervertebral disc height changes weight reduction morbid obese patients effect life quality radicular low back pain spine phila pa 1976 medline keating cl dixon jb moodie ml et al costeffectiveness surgically induced weight loss management type 2 diabetes modeled lifetime analysis diabetes care medline keating cl dixon jb moodie ml et al costefficacy surgically induced weight loss management type 2 diabetes randomized controlled trial diabetes care medline colquitt jl pickett k loveman e frampton gk surgery weight loss adults cochrane database syst rev medline balsiger bm murr mm poggio jl sarr mg bariatric surgery surgery weight control patients morbid obesity med clin north medline belachew legrand vincent v lismonde le docte n deschamps v laparoscopic adjustable gastric banding world j surg medline brolin kenler ha gorman jh cody rp longlimb gastric bypass superobese prospective randomized study ann surg medline considine rv sinha mk heiman ml kriauciunas stephens tw nyce mr et al serum immunoreactiveleptin concentrations normalweight obese humans n engl j med medline mantzoros cs role leptin human obesity disease review current evidence ann intern med medline nguyen nt goldman c rosenquist cj arango cole cj lee sj et al laparoscopic versus open gastric bypass randomized study outcomes quality life costs ann surg medline podnos yd jimenez jc wilson se stevens cm nguyen nt complications laparoscopic gastric bypass review 3464 cases arch surg medline saber aa gastric pacing new modality treatment morbid obesity j invest surg medline saber aa boros mj mancl et al effect laparoscopic rouxeny gastric bypass fibromyalgia obes surg medline saber aa elghazaly th early experience single incision transumbilical laparoscopic adjustable gastric banding using sils port int j surg medline saber aa elghazaly th early experience singleaccess transumbilical adjustable laparoscopic gastric banding obes surg medline saber aa elghazaly th elian singleincision transumbilical laparoscopic sleeve gastrectomy j laparoendosc adv surg tech medline saber aa elgamal mh mcleod mk bariatric surgery past present future obes surg medline saber aa jackson omental wrap simple technique reinforcement gastrojejunostomy rouxeny gastric bypass obes surg medline saber aa scharf kr turk az elgamal mh martinez rl early experience intraluminal reinforcement stapled gastrojejunostomy laparoscopic rouxeny gastric bypass obes surg medline schauer pr ikramuddin gourash w ramanathan r luketich j outcomes laparoscopic rouxeny gastric bypass morbid obesity ann surg medline song itawi ea saber aa natural orifice translumenal endoscopic surgery notes j invest surg medline

Article 9:
pediatric appendicitis organismspecific therapy pediatric appendicitis organismspecific therapy organismspecific therapy pediatric appendicitis organismspecific therapy organismspecific therapy overview organismspecific therapy pediatric appendicitis organismspecific therapy overview 1976427overview jul 26 2013 201508041755 1 pediatrics general medicine 2002 diseases conditions condition 1 2 content 1976427 502 6004986 9 age12 jun 04 2015 condition diseases conditions pediatricsgeneral pediatrics general medicine pediatricsgeneralgastroenterology gastroenterology organismspecific therapeutic regimens appendicitis children outlined including anaerobic organisms including bacteroides fragilis clostridium species spp prevotella spp aerobic gramnegative bacilli including escherichia coli klebsiella spp proteus mirabilis pseudomonas aeruginosa streptococci 1 pediatric appendicitis organismspecific therapy organismspecific therapy organismspecific therapeutic regimens appendicitis children outlined including anaerobic organisms including bacteroides fragilis clostridium prevotella escherichia coli klebsiella proteus mirabilis pseudomonas aeruginosa anaerobic organisms including bacteroides fragilis clostridium spp prevotella spp see list clindamycin metronidazole ampicillinsulbactam ticarcillinclavulanate aerobic gramnegative bacilli including escherichia coli klebsiella spp proteus mirabilis see list aztreonam ampicillin cefoxitin cefotetan cefotaxime ceftriaxone pseudomonas aeruginosa see list aztreonam 90120 mgkgday iv divided q68h piperacillintazobactam imipenemcilastin 60100 mgkgday iv divided q6h meropenem streptococci enterococci see list ampicillinsulbactam 200 mgkgday based ampicillin component ivim divided q6h ticarcillinclavulanate 200300 mgkgday based ticarcillin component iv divided q46h piperacillintazobactam 200300 mgkgday based piperacillin component iv divided q68h imipenemcilastin 60100 mgkgday iv divided q6h meropenem 60 mgkgday iv divided q8h mixtures aerobes anaerobes see list cefoxitin 80160 mgkgday iv divided q46h cefotetan 4080 mgkgday iv divided q12h ticarcillinclavulanate 200300 mgkgday based ticarcillin component iv divided q46h piperacillintazobactam 200300 mgkgday based piperacillin component iv divided q68h ampicillinsulbactam 200 mgkgday based ampicillin component ivim divided q6h imipenemcilastin 60100 mgkgday iv divided q6h meropenem 60 mgkgday iv divided q8h author kara e hennelly md instructor department pediatric emergency medicine childrens hospital boston kara e hennelly md member following medical societies american academy pediatrics disclosure nothing disclose pharmacy editor francisco talavera pharmd phd adjunct assistant professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure received salary medscape employment medscape chief editor thomas e herchline md professor medicine wright state university boonshoft school medicine medical director public health dayton montgomery county ohio thomas e herchline md member following medical societies alpha omega alpha infectious diseases society ohio infectious diseases society america disclosure nothing disclose bundy dg byerley js liles ea perrin em katznelson j rice child appendicitis jama hernanzschulman ct us diagnosis appendicitis argument ct radiology katz ms freitas ms tucker jr glick p appendicitis medscape reference updated january 9 2009 available httpemedicinemedscapeconarticle926795overview kharbanda ab taylor ga fishman sj bachur rg clinical decision rule identify children low risk appendicitis pediatrics solomkin js mazuski je bradley js et al diagnosis management complicated intraabdominal infection adults children guidelines surgical infection society infectious diseases society america clin infect dis tsao k st peter sd valusek pa et al management pediatric acute appendicitis computed tomographic era j surg res

Article 10:
ankle block ankle block overview anatomy medications ankle block overview anatomy medications overview overview anatomy medications supplies superficial peroneal nerve deep peroneal nerve saphenous nerve posterior tibial nerve sural nerve pearls contraindications ankle block overview 1999563overview aug 06 2015 201508061730 1 clinical procedures 2002 procedures procedure 1 2 content 1999563 503 5000003 46 ssg aug 06 2015 procedure procedures clinicalprocedures clinical procedures clinicalproceduresanesthetic anesthetic techniques ankle block ankle block procedure regional anesthesia ankle anesthesia ankle anesthesia regional anesthesia increasing utility treatment injuries foreign body removal even operative setting providing regional block affected anatomy properly cleaned explored treated without causing unnecessary pain patient 0 ankle block overview regional anesthesia increasing utility treatment injuries foreign body removal even operative setting providing regional block affected anatomy properly cleaned explored treated without causing unnecessary pain patient many settings regional anesthetic also preferred prevents distortion anatomy commonly seen local anesthesia regional anesthesia ankle presents challenge provider complicated nerve supply foot varied locations nerves around ankle however adequately anesthetizing foot patients offered relief often painful injuries complex anatomy foot examined repaired see ankle joint anatomy providing local anesthesia foot particularly sole presents many difficulties first thick sensitive skin must penetrated needle often must larger gauge might used elsewhere pass skin — painful second underlying soft tissue sole tightly bound fascia separate easily injecting even small amounts anesthesia locally sole result compression blood vessels vascular damage tissue already injured regional anesthesia difficulties avoided blocking pain sensation carried foot point nerves pass safe readily accessible region anatomy image depicting crosssection ankle seen crosssection ankle crosssection ankle anatomy five main nerves originate major nerve roots lower extremity innervating foot see image dorsal aspect foot innervated 3 nerves run anterior side lower leg ankle — superficial peroneal deep peroneal saphenous nerves volar aspect foot innervated posterior tibial sural nerves posterolateral aspect ankle complete regional anesthesia foot requires blocking 5 nerves crosssection ankle crosssection ankle medications commonly used shortacting subcutaneous anesthetic agent lidocaine given 1 2 mixtures epinephrine 11000 may added 1 2 solutions epinephrine typically added local anesthetic cause vasoconstriction prolonging activity anesthetic limiting bleeding time injection onset anesthesia lidocaine approximately 6090 seconds effects lidocaine typically last 2030 minutes 2 hours mixed epinephrine maximum dose lidocaine adults 300 mg 34 mgkg children mixed epinephrine maximum dose 500 mg 7 mgkg bupivacaine 025 05 marcaine sensorcaine common longacting anesthetic agent time onset longacting agents approximately 1020 minutes anesthetic effects last 46 hours alone 8 hours mixed epinephrine maximum dose bupivacaine 175 mg 2 mgkg adult increased 225 mg 3 mgkg mixed epinephrine 5050 2575 mixtures lidocaine bupivacaine may provide optimal anesthetic certain ankle anesthesia providing nearly immediate relief pain shortacting component providing 8 hours anesthesia longacting medication regional anesthesia administered distance away wound site also epinephrine used great caution distal extremities anesthetic medications mixed vasoconstrictors epinephrine recommended ankle anesthesia table 1 maximum dosing common shortacting longacting local anesthetic agents medication adult pediatrics lidocaine 300 mg 34 mgkg lidocaine epinephrine 500 mg 7 mgkg bupivacaine 175 mg 2 mgkg bupivacaine epinephrine 225 mg 3 mgkg supplies injections performed sterile conditions area injection cleaned iodine chlorhexidine size syringe varies depending amount anesthetic given keep mind maximum doses injections given smallest needle possible effort cause least pain 25gauge needle small enough provide little trauma skin excellent choice administration anesthesia superficial peroneal nerve superficial peroneal nerve provides sensation dorsum foot dorsal aspect toes web spaces exception lateral portion great toe medial side second toe corresponding web space nerve passes subcutaneously anterolateral side ankle block nerve palpate extensor hallucis longus tendon lateral malleolus insert needle lateral malleolus tunnel needle subcutaneously toward extensor hallucis longus tendon complete anesthesia superficial peroneal nerve achieved placing 57 ml anesthesia bandlike pattern 2 points see image administration anesthetic care must taken draw back syringe injecting medication prevent intravascular administration superficial peroneal nerve block superficial peroneal nerve block deep peroneal nerve deep peroneal nerve provides sensation lateral portion great toe medial side second digit well web space 2 distribution commonly referred “flipflop” nerve innervates area surrounding thong sandal nerve runs deeper ankle superficial peroneal nerve hidden behind extensor hallucis longus tendon provide anesthesia “flipflop” region first palpate anterior tibial tendon extensor hallucis longus tendon patient dorsiflect foot great toe insert needle 2 tendons approximately 1 cm superior medial malleolus draw back prevent intravascular administration medication deposit 1 ml anesthetic beyond extensor hallucis longus tendon angle needle toward lateral malleolus insert tip needle rests anterior tibia 12 cm remove needle 12 mm tip resting bone draw back deposit 5 ml anesthetic deep peroneal nerve see image deep peroneal nerve block deep peroneal nerve block saphenous nerve saphenous nerve provides sensation skin medial aspect foot along arch runs alongside saphenous vein medial malleolus anterior tibial tendon anesthetize arch patient’s foot palpate anterior tibial tendon medial malleolus place 35 ml anesthetic subcutaneous wheal 2 landmarks see image saphenous nerve block saphenous nerve block posterior tibial nerve posterior tibial nerve largest ankle branches medial lateral plantar nerves foot supplying sensation entire volar surface well providing motor innervation intrinsic muscles foot runs deep posterior tibial artery anesthetize sole patient’s foot palpate posterior tibial artery medial malleolus achilles tendon insert needle 1 cm superior medial malleolus posterior artery needle angled toward lateral malleolus see image pass needle rests posterior aspect tibia withdraw 12 mm aspirate syringe prevent intravascular administration place 57 ml anesthetic alternative passing needle posterior tibia insert needle 12 cm wiggle tip needle paresthesia elicited movement needle tip indicate contact posterior tibial nerve posterior tibial nerve block posterior tibial nerve block sural nerve sural nerve supplies sensation lateral medial aspects foot passes lateral malleolus achilles tendon anesthesia provided sural nerve first palpating achilles tendon lateral malleolus insert needle 1 cm superior lateral malleolus deposit 5 ml bandshaped pattern 2 landmarks see image sural nerve block sural nerve block pearls anesthesia posterior tibia nerve may cause loss sympathetic tone vascular supply foot resulting vasodilation effect vasodilation increased warmth foot may also result increase blood loss injury volar aspect foot advise patients pay special attention care anesthetized foot affected limb numb avoid reinjecting nerves anesthesia medication administered contraindications contraindications local regional anesthesia ankle exist injection local anesthetic never performed infected tissue start media crosssection ankle crosssection ankle superficial peroneal nerve block superficial peroneal nerve block deep peroneal nerve block deep peroneal nerve block sural nerve block sural nerve block saphenous nerve block saphenous nerve block posterior tibial nerve block posterior tibial nerve block author jeff cloyd md emergency physician department emergency medicine university tennessee medical center disclosure nothing disclose coauthors adam j rosh md assistant professor program director emergency medicine residency department emergency medicine detroit receiving hospital wayne state university school medicine adam j rosh md member following medical societies american academy emergency medicine american college emergency physicians society academic emergency medicine disclosure nothing disclose pharmacy editor mary l windle pharmd adjunct associate professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure nothing disclose chief editor meda raghavendra raghu md associate professor interventional pain management department anesthesiology chicago stritch school medicine loyola university medical center meda raghavendra raghu md member following medical societies american society anesthesiologists american society regional anesthesia pain medicine american association physicians indian origin disclosure nothing disclose spektor kelly j regional anesthesia thorax extremities roberts hedges clinical procedures emergency medicine ankle block regional anesthesia nysora new york school regional anesthesia available httpwwwnysoracomperipheralnerveblocksclassicblocktecniques3035ankleblockhtml hadzic vloka jd kuroda mm koorn r birnbach dj practice peripheral nerve blocks united states national survey p2e comments reg anesth pain med medline mcgee local topical anesthesia roberts hedges clinical procedures emergency medicine reilley te gerhardt anesthesia foot ankle surgery clin podiatr med surg medline reilley te terebuh vd gerhardt regional anesthesia techniques lower extremity foot ankle clin medline

Article 11:
kaposi sarcoma treatment protocols kaposi sarcoma treatment protocols treatment protocols kaposi sarcoma treatment protocols treatment protocols overview treatment protocols kaposi sarcoma treatment protocols overview 2006845overview oct 15 2014 201508041730 1 oncology 2002 diseases conditions condition 1 2 content 2006845 502 3029380 7 ssg jun 04 2015 condition diseases conditions oncology oncology oncologybonesofttissue bone soft tissue cancers natural history kaposi sarcoma ks variable assessment therapy may difficult treatment usually based extent disease patient’s immune status 0 kaposi sarcoma treatment protocols treatment protocols natural history kaposi sarcoma ks variable assessment therapy may difficult treatment usually based extent disease patient’s immune status optimal therapy ks acquired immune deficiency syndrome ksaids yet determined challenge treat ksaids effectively without immunocompromising patient further—or better reconstitution immune system management childhood hivassociated ks resourcepoor settings challenging general treatment approach see list observation preferred beginning treatment patients limited asymptomatic lesions localized nodular disease may respond well surgical excision radiotherapy intralesional outpatient lowdose vinblastine chemotherapy choice topical therapy depends site extent disease individual patient status kaposi sarcomaassociated paradoxical immune reconstitution inflammatory syndrome ksiris antiretroviral artnaïve hivinfected patients major contributor ksassociated mortality africa increased awareness entity important children ks hiv infection subsaharan africa art together chemotherapy regimen appears better use either art chemotherapy alone radiotherapy see list radiotherapy often produces good therapeutic results classic nodular ks tends palliative patients ksaids localized nodular ks conventional radiotherapy highly effective electron beam radiation therapy ebrt limited penetration beyond dermis may good modality superficial lesions deeper unresponsive ks may treated standard non–electron beam radiation therapy approaches initial response radiotherapy usually complete demonstrates marked regression nodules extensive involvement less responsive tends radiotherapy may effective new lesions chronic ones may provide local ks control patients ksaids radioisotope scanning using technetium99m may detect occult ks infiltration subcutaneous muscular tissues draining lymph nodes allows improved efficiency largefield radiotherapy argon laser photocoagulation therapy also may beneficial classic ks lesions lowvoltage 100 kv photon radiation 810 gy single dose 1520 gy 1wk ebrt 4 gy weekly 68wk consecutively chemotherapy see list systemic vinblastine treatment classic ks may also accomplished topical imiquimod ksaids highly active antiretroviral therapy haart without local ks therapy employed interferon alfa cd4 cell count 200µl early disease course interferon alfa2b interferon alfa2b 510 million units sc im 3 times weekly total weekly dose 1530 million units interferon alfa2b 1 million units sc daily twice weekly total weekly dose 27 million units cd4 cell count 200µl advanced ksaids pegylated liposomal doxorubicin pld 20 mgm 2 nonresponders given cytotoxic agents paclitaxel paclitaxel pld compared randomized trial showed comparable response rates median progressionfree survival pfs 2y survival rates 2 agents somewhat grade 35 toxicity paclitaxel efficacy taxanes paclitaxel docetaxel pld used secondline therapy treatment patients advanced classic ks iatrogenic ks cessation immunosuppressive therapy may effective treatment patients immunosuppressive therapy—specifically corticosteroids cytotoxic drugs—may experience partial complete regression therapy discontinued possible immunosuppressive medication doses reduced discontinued specific therapy iatrogenic ks initiated open label randomized trial malawi included 92 children 46 naïve art 11 hiv negative found oral etoposide safe effective treatment containing ks improving quality life compared either intravenous vincristine vincristine bleomycin followup prevention see list reducing human herpesvirus8 hhv8 kaposi sarcoma–associated herpesvirus kshv infection rate diminish incidence ks screening transplant recipients hhv8 infection may beneficial use sirolimus comparison immunosuppressants—namely calcineurin inhibitors—sirolimus advantage associated decreased risk malignancies including ks may also lead regression ks antiviral therapy foscarnet use haart appears reduce risk developing new ks significantly treatment initiated followup care important check recurrence visceral spread followup care recommendations may include imaging procedures laboratory tests eg complete blood count cbc urinalysis liver function studies monitoring symptoms potentially related return cancer screening types cancers particularly lymphomas important followup survival data see list clinical ks type localized nodular disease locally aggressive disease generalized ks may best predictor prognosis cutaneous skin testing anergy employed decades good correlate clinical disease type prognosis addition degree immunosuppression also correlates clinical type prognosis localized nodular ks favorable prognosis deaths attributable ks prognosis also excellent iatrogenic ks transplant recipients shows regression suitable therapeutic modification thus classic ks long regarded disorder immunocompetent people die locally aggressive ks favorable prognosis african 3y survival rate two thirds calculated decades ago remains accurate generalized ks type common ksaids 3y survival rate closer 0 without therapy people dying either disseminated ks intervening opportunistic infection within 3y diagnosis regardless therapeutic intervention one african country median survival ks 35 mo hivassociated advanced ks median survival 31 mo range 1848 mo patients treated protease inhibitor–based haart compared 7 mo range 128 mo receiving haart importantly 81 haart group alive 18 mo start chemotherapy compared 12 nonhaart group another analysis documented ks develop patients haart exhibits less aggressive clinical pattern patients already receiving haart naive treatment natural history outcome unaltered 3y survival rate 64 kshaart comparable 78 without haart median survivals hivinfected homosexual men good poorrisk categories 27 mo 15 mo respectively tumor extent 40 mo 13 mo degree immunosuppression 22 mo 16 mo hivassociated systemic disorders multivariate analysis indicating severity immunosuppression gave predictive information one study ksaids patients overall 5year survival 92 earlystage ks 83 advancedstage ks 140 patients advancedstage ks treated combination antiretroviral therapy liposomal anthracycline chemotherapy 5year overall survival 85 author robert schwartz md mph professor head dermatology professor pathology pediatrics medicine preventive medicine community health rutgers new jersey medical school visiting professor rutgers university school public affairs administration robert schwartz md mph member following medical societies alpha omega alpha new york academy medicine american academy dermatology american college physicians sigma xi disclosure nothing disclose pharmacy editor jasmeet anand pharmd rph adjunct instructor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure nothing disclose managing editor christopher braden hematologistoncologist chancellor center oncology deaconess hospital disclosure nothing disclose chief editor jules e harris md facp frcpc clinical professor medicine section hematologyoncology university arizona college medicine arizona cancer center jules e harris md facp frcpc member following medical societies american association advancement science american society hematology central society clinical translational research american society clinical oncology disclosure nothing disclose schwartz ra micali g nasca mr scuderi l kaposi sarcoma continuing conundrum j acad dermatol medline krown se metroka c wernz jc kaposis sarcoma acquired immune deficiency syndrome proposal uniform evaluation response staging criteria aids clinical trials group oncology committee j clin oncol medline mitsuyasu rt clinical variants staging kaposis sarcoma semin oncol medline schwartz ra volpe ja lambert mw lambert wc aposi’s sarcoma semin dermatol omahony gandjbakche hassan vogel yarchoan r imaging techniques kaposis sarcoma j hiv ther medline full text theron andronikou du plessis j goussard p george r mapukata et al pulmonary kaposi sarcoma six children pediatr radiol medline klein e schwartz ra laor milgrom h burgess gh holtermann oa treatment kaposis sarcoma vinblastine cancer medline goiriz r ríosbuceta l de arriba ag aragüés garcíadiez treatment classic kaposis sarcoma topical imiquimod dermatol surg medline molyneux e davidson orem j hesseling p balagaddekambugu j githanga j et al management children kaposi sarcoma resource limited settings pediatr blood cancer medline letang e lewis jj bower mosam borok campbell tb et al immune reconstitution inflammatory syndrome associated kaposi sarcoma higher incidence mortality africa uk aids medline anglemyer agrawal ak rutherford gw treatment kaposi sarcoma children hiv1 infection cochrane database syst rev medline hamilton cr cummings bj harwood ar radiotherapy kaposi’s sarcoma int j radiat oncol biol phys nisce lz safai b poussinrosillo h weekly total subtotal skin electron beam therapy kaposi’s sarcoma cancer solan aj greenwald es silvay longterm complete remissions kaposi’s sarcoma vinblastine therapy cancer célestin schartz ne chevret paz c et al imiquimod 5 cream treatment hivnegative kaposi’s sarcoma skin lesions phase ii openlabel trial 17 patients j acad dermatol hengge ur ruzicka stuschke roggendorf schwartz ra seeber update kaposi’s sarcoma hhv8 associated diseases part 1 epidemiology environmental predispositions clinical manifestations therapy lancet infect dis krown se management kaposi sarcoma role interferon thalidomide curr opin oncol vonroenn jh clinical presentations standard therapy aidsassociated kaposis sarcoma hematol oncol clin north northfelt dw dezube bj thommes ja et al pegylatedliposomal doxorubicin versus doxorubicin bleomycin vincristine treatment aidsrelated kaposi’s sarcoma results randomized phase iii clinical trial j clin oncol cianfrocca lee von roenn j tulpule dezube bj aboulafia dm et al randomized trial paclitaxel versus pegylated liposomal doxorubicin advanced human immunodeficiency virusassociated kaposi sarcoma evidence symptom palliation chemotherapy cancer medline di lorenzo g di trolio r montesarchio v palmieri g nappa p delfino et al pegylated liposomal doxorubicin secondline therapy treatment patients advanced classic kaposi sarcoma retrospective study cancer medline fardet l stoebner pe bachelez h descamps v kerob meunier l et al treatment taxanes refractory lifethreatening kaposi sarcoma associated human immunodeficiency virus infection cancer medline chagaluka g stanley c banda k depani nijrammadzi j katangwe et al kaposis sarcoma children open randomised trial vincristine oral etoposide combination vincristine bleomycin eur j cancer medline paghdal kv schwartz ra sirolimus rapamycin soil easter island bright future j acad dermatol medline boratynska watorek e smolska patrzalek klinger anticancer effect sirolimus renal allograft recipients de novo malignancies transplant proc medline leder ha galor peters gb kedhar sr dunn jp thorne je resolution conjunctival kaposi sarcoma institution highly active antiretroviral therapy alone br j ophthalmol medline morgan malamba ss orem j mayanja b okongo whitworth ja survival aids defining condition rural uganda sex transm infect templeton ac bhana prognosis kaposi’s sarcoma j natl cancer inst leitch h trudeau routy jp effect protease inhibitorbased highly active antiretroviral therapy survival hivassociated advanced kaposi’s sarcoma patients treated chemotherapy hiv clin trials nasti g talamini r antinori et al aidsrelated kaposi’s sarcoma evaluation potential new prognostic factors assessment aids clinical trial group staging system haart era—the italian cooperative group aids tumors italian cohort patients naive antiretrovirals j clin oncol nasti g martellotta f berretta et al impact highly active antiretroviral therapy presenting features outcome patients acquired immunodeficiency syndromerelated kaposi sarcoma cancer lodi guiguet costagliola et al kaposi sarcoma incidence survival among hivinfected homosexual men hiv seroconversion j natl cancer inst bower dalla pria coyle c andrews e tittle v dhoot et al prospective stagestratified approach aidsrelated kaposis sarcoma j clin oncol medline

Article 12:
prostate cancer treatment protocols prostate cancer treatment protocols treatment protocols prostate cancer treatment protocols treatment protocols overview treatment protocols prostate cancer treatment protocols overview 2007095overview oct 07 2014 201508041730 1 oncology 2002 diseases conditions condition 1 2 content 2007095 502 3003438 7 ssg jun 04 2015 condition diseases conditions oncology oncology oncologygenitourinary genitourinary cancers treatment protocols prostate cancer provided including general treatment recommendations localized prostate cancer recurrent disease advanced metastatic disease see prostate cancer diagnosis staging critical images slideshow help determine best diagnostic approach potenti 0 prostate cancer treatment protocols treatment protocols treatment protocols prostate cancer provided including general treatment recommendations localized prostate cancer recurrent disease advanced metastatic disease see prostate cancer diagnosis staging also see advanced prostate cancer signs metastatic disease general treatment recommendations prostate cancer selecting initial treatment requires assessing risk disease spreading progressing based evaluating patients life expectancy comorbidities biopsy grade gleason score clinical stage prostatespecific antigen psa level treatment recommendations clinically localized prostate cancer low risk recurrence patients clinical stage t1c gleason score ≤6 psa 10 ngml fewer three positive prostate cores ≤50 cancer core psa density 015 ngmlg life expectancy 20 treated active surveillance also referred observation surveillance includes periodic psa prostate exam prostate biopsy optimal protocol surveillance still unknown treatment recommendations patients life expectancy ≥20 see initial therapy low risk recurrence low risk recurrence treatment patients clinical stage t1t2a gleason score 26 psa 10 ngml life expectancy 10 includes active surveillance treatment patients life expectancy ≥10y includes active surveillance radical prostatectomy rp without pelvic lymph node dissection plnd predicted probability lymph node metastases ≥2 rp standard therapy localized prostate cancer involving removal prostate seminal vesicles without pelvic lymph nodes may done using either open laparoscopic roboticassisted technique radiation therapy standard therapy patients localized disease 3dimensional 3d techniques 3d conformal radiation treatment 3dcrt offer benefits reduced toxicity use higher doses secondgeneration techniques including intensitymodulated radiation therapy imrt also required especially doses ≥78 gy administered radiation therapy doses 75679 gy conventional 3641 gy fractions prostate patients lowrisk cancer candidates pelvic lymph node irradiation androgen deprivation therapy adt intermediate risk recurrence treatment options patients clinical stage t2bt2c gleason score 7 psa 1020 ngml life expectancy 10 include active surveillance radiation therapy doses 7880 gy 3dcrtimrt daily igrt without shortterm neoadjuvantconcomitantadjuvant adt 46 mo without brachytherapy recommended dose rate 145 gy iodine125 125 gy palladium103 treatment recommendations patients life expectancy ≥10 include rp plnd predicted probability lymph node metastasis ≥2 radiation therapy doses 7880 gy 3dcrtimrt daily igrt without shortterm neoadjuvantconcomitantadjuvant adt 46 mo without brachytherapy recommended dose rate 145 gy iodine125 125 gy palladium103 intermediaterisk cancers consider combining brachytherapy recommended dose rate 145 gy iodine125 125 gy palladium103 external beam radiation therapy ebrt4050 gy without 46 mo neoadjuvantconcomitantadjuvant adt administering adt radiation prolongs survival high risk recurrence clinical stage t3a gleason score 810 psa 20 ngml treatment options include radiation therapy doses 7880 gy 3dcrtimrt plus longterm neoadjuvantconcomitantadjuvant adt 23 radiation therapy doses 7880 gy 3dcrtimrt daily igrt plus brachytherapy recommended dose rate 145 gy iodine125 125 gy palladium103 without shortterm neoadjuvantconcomitantadjuvant adt 46 mo rp plus plnd selected patients fixation highrisk cancers may treated combination ebrt 4050 gy brachytherapy without 46 mo neoadjuvantconcomitantadjuvant adt alternative treatment recommendations localized prostate cancer treatments used initial management localized prostate cancer include following cryotherapy highintensity focused ultrasound particle beam therapy cryotherapy cryotherapy also known cryosurgery cryoablation involves using transrectal ultrasonographic guidance percutaneous cryoprobes placed used freeze prostate tissue treatment optimal may used select patients localized prostate cancer focal therapy lowrisk patients experimental also considered salvage therapy failed radiation therapy complications include tissue sloughing perineal ecchymosis stricture contracture incontinence impotence fistula formation urinary gastrointestinal tracts highintensity focused ultrasound acoustic ablative technique uses ultrasound destroy prostate tissue yet fda approved united states pending multicenter trials particle beam therapy similar radiation therapy uses protons energy however longterm followup data technique lacking biochemical failure see list approximately 50 patients treated intent cure biochemical recurrence commonly manifests rising psa level biopsy prostatic bed usually recommended unless patient candidate salvage therapy post–radical prostatectomy recurrence see list defined detectable psa increases two subsequent measurements psa fails fall undetectable levels best psa threshold unknown probably 02 04 ngml treatment options include salvage radiation therapy androgen deprivation surveillance adjuvant radiation therapy may beneficial salvage radiation therapy men poor pathologic features post–radiation therapy recurrence see list defined rise psa 2 ngml nadir psa bounce radiation treatment options include salvage prostatectomy adt surveillance highintensity focused ultrasound hifu trials cryotherapy repeat irradiation treatment recommendations locally advanced prostate cancer high risk clinical stage t3bt4 treatment options include radiation therapy doses 7880 gy 3dcrtimrt plus longterm neoadjuvantconcomitantadjuvant androgen deprivation therapy adt 23 radiation therapy doses 7880 gy 3dcrtimrt daily igrt plus brachytherapy without shortterm neoadjuvantconcomitantadt 46 mo rp plus plnd selected patients fixation adt selected patients metastatic disease n1 treatment includes adt n m1 treatment includes adt patients m1 androgen deprivation therapy adt recommendations advanced metastatic disease see list adt preferred initial treatment symptomatic metastatic prostate cancer androgenic effects promote growth malignant transformation prostatic tissue adts include luteinizing hormone lh receptor agonists eg histrelin leuprolide gonadotropinreleasing hormone gnrh receptor agonists eg goserelin histrelin leuprolide triptorelin antagonists eg degarelix complete androgen blockade cab cab includes medical surgical castration oral antiandrogen eg bicalutamide flutamide nilutamide patients show adequate suppression serum testosterone 50 ngdl may considered cab monotherapy nonsteroidal antiandrogens less effective agents associated fewer hot flashes fatigue impair libido hormone therapy fails therapy continued next hormone manipulation gonadotropinreleasing hormone agonists therapy gnrh analogs may induce medical castration suppressing luteinizing hormone lh production agonists potentially cause transient surge lh therapy initiated lh levels fall flare phenomenon gnrh agonists offered 1 mo 3 mo onceyearly depots premedication antiandrogen necessary prevent flare phenomenon leuprolide histrelin goserelin triptorelin gonadotropinreleasing hormone antagonists pure gnrh antagonists suppress testosterone avoid flare phenomenon associated gnrh agonists degarelix nonsteroidal antiandrogens antiandrogens bind androgen receptors competitively inhibit interaction testosterone dihydrotestosterone agents decrease lh levels androgen production antiandrogens usually used combination gnrh agonist prevent disease flare caused transient increase testosterone levels flutamide bicalutamide nilutamide enzalutamide 160 mg po daily hormonerefractory prostate cancer taxanes alone combination agents demonstrated efficacy treatment hormonerefractory prostate cancer recommended dose paclitaxel 2 paclitaxel 150 mgm 2 management castrationrecurrent prostate cancer see list patients metastatic disease become resistant adt median time symptomatic progression rise psa level 4 ngml approximately 68 mo median time death 1218 mo symptomatic patients median survival 1 radiation may used palliation patients painful bone metastases impending spinal cord compression surgical intervention may necessary weightbearing bones involved pathologic fracture therapeutic options limited focus improving quality life using single multimodal therapies docetaxel every 3 wk plus prednisone treatment choice men symptomatic castrationrecurrent prostate cancer docetaxel 2 plus prednisone symptomatic men candidates docetaxelbased regimens may candidates mitoxantrone 2 plus men less advanced disease good performance status life expectancy 6 mo visceral disease minimal symptoms resistant standard hormone treatment may candidates autologous immunotherapy sipuleucelt sipuleucelt acetaminophen abiraterone treatment recommendations latestage castrationresistant prostate cancer prior docetaxel chemotherapy abiraterone approved treatment patients metastatic castrationresistant prostate cancer either chemotherapynaive prior docetaxel therapy recommended dose 1000 mg po daily plus alternative regimens include cabazitaxel prednisone patients hormonerefractory metastatic prostate cancer previously treated docetaxelcontaining treatment regimen cabazitaxel 2 plus 2 enzalutamide treatment recommendations patients castrationrecurrent prostate cancer bone metastases see list bisphosphonates recommended men hormonerefractory prostate cancer bone metastases bisphosphonates shown reduce skeletonrelated events pathologic fracture zoledronic acid alendronate denosumab radiopharmaceutical radium223 dichloride xofigo approved may 2013 men castrationresistant prostate cancer symptomatic bone metastases known visceral metastatic disease 50 kbq 136 microcurie per kg iv infused 1 minute repeat q 4 wk six cycles total dosage calculation must based decay correction factor radium223 listed prescribing information author reza ghavamian md professor clinical urology albert einstein college medicine director urologic oncology director minimally invasive robotic urologic surgery montefiore medical center reza ghavamian md member following medical societies american urological association society urologic oncology disclosure nothing disclose pharmacy editor mary l windle pharmd adjunct associate professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure nothing disclose managing editor christopher braden hematologistoncologist chancellor center oncology deaconess hospital disclosure nothing disclose chief editor jules e harris md facp frcpc clinical professor medicine section hematologyoncology university arizona college medicine arizona cancer center jules e harris md facp frcpc member following medical societies american association advancement science american society hematology central society clinical translational research american society clinical oncology disclosure nothing disclose cagiannos karakiewicz p eastham ja et al preoperative nomogram identifying decreased risk positive pelvic lymph nodes patients prostate cancer j urol medline heidenreich ohlmann ch polyakov anatomical extent pelvic lymphadenectomy patients undergoing radical prostatectomy eur urol medline hu jc gu x lipsitz sr barry mj damico av weinberg ac et al comparative effectiveness minimally invasive vs open radical prostatectomy jama medline carter hb kettermann warlick c et al expectant management prostate cancer curative intent update johns hopkins experience j urol medline choo r klotz l danjoux c morton gc et al feasibility study watchful waiting localized low intermediate grade prostate carcinoma selective delayed intervention based prostate specific antigen histological andor clinical progression j urol medline obrien mf cronin fearn pa et al pretreatment prostatespecific antigen psa velocity doubling time associated outcome neither improves prediction outcome beyond pretreatment psa alone patients treated radical prostatectomy j clin oncol medline full text albertsen pc hanley ja fine j 20year outcomes following conservative management clinically localized prostate cancer jama medline albertsen pc hanley ja gleason df barry mj competing risk analysis men aged 55 74 years diagnosis managed conservatively clinically localized prostate cancer jama medline kuban da tucker sl dong l et al longterm results anderson randomized doseescalation trial prostate cancer int j radiat oncol biol phys medline stief p behrendt lavik g de beer combined gel probe isotope labeling technique measuring dissimilatory nitrate reduction ammonium sediments millimeterlevel resolution appl environ microbiol medline full text luyao gl albertsen pc moore df et al survival following primary androgen deprivation therapy among men localized prostate cancer jama medline full text bolla collette l blank l et al longterm results immediate androgen suppression external irradiation patients locally advanced prostate cancer eortc study phase iii randomised trial lancet medline merrick gs butler wm wallner ke galbreath rw adamovich e permanent interstitial brachytherapy younger patients clinically organconfined prostate cancer urology medline babaian rj donnelly b bahn et al best practice statement cryosurgery treatment localized prostate cancer j urol medline ismail ahmed kastner c davies j salvage cryotherapy recurrent prostate cancer radiation failure prospective case series first 100 patients bju int medline freedland sj moul jw prostate specific antigen recurrence definitive therapy j urol medline amling cl bergstralh ej blute ml slezak jm zincke h defining prostate specific antigen progression radical prostatectomy appropriate cut point j urol medline wiegel bottke steiner u et al phase iii postoperative adjuvant radiotherapy radical prostatectomy compared radical prostatectomy alone pt3 prostate cancer postoperative undetectable prostatespecific antigen aro 9602auo ap 0995 j clin oncol medline van der kwast th bolla van poppel h et al identification patients prostate cancer benefit immediate postoperative radiotherapy eortc 22911 j clin oncol medline roach 3rd hanks g thames h jr et al defining biochemical failure following radiotherapy without hormonal therapy men clinically localized prostate cancer recommendations rtogastro phoenix consensus conference int j radiat oncol biol phys medline loblaw da virgo ks nam r et al initial hormonal management androgensensitive metastatic recurrent progressive prostate cancer 2006 update american society clinical oncology practice guideline j clin oncol medline prostate cancer trialists collaborative group maximum androgen blockade advanced prostate cancer overview randomised trials prostate cancer trialists collaborative group lancet medline terk md stock rg stone nn identification patients increased risk prolonged urinary retention following radioactive seed implantation prostate j urol medline petrylak dp tangen cm hussain mh et al docetaxel estramustine compared mitoxantrone prednisone advanced refractory prostate cancer n engl j med medline tannock de wit r berry wr horti j pluzanska chi kn docetaxel plus prednisone mitoxantrone plus prednisone advanced prostate cancer n engl j med medline berthold dr pond gr soban f de wit r eisenberger tannock docetaxel plus prednisone mitoxantrone plus prednisone advanced prostate cancer updated survival tax 327 study j clin oncol medline kantoff pw higano cs shore nd et al sipuleucelt immunotherapy castrationresistant prostate cancer n engl j med medline small ej schellhammer pf higano cs et al placebocontrolled phase iii trial immunologic therapy sipuleucelt apc8015 patients metastatic asymptomatic hormone refractory prostate cancer j clin oncol medline attard g reid ah de bono js abiraterone acetate well tolerated without concomitant use corticosteroids j clin oncol medline salem garcia ja abiraterone acetate novel adrenal inhibitor metastatic castrationresistant prostate cancer curr oncol rep medline ryan cj smith mr de bono js molina logothetis c de souza pl et al interim analysis results couaa302 randomized phase iii study abiraterone acetate chemotherapynaïve patients metastatic castrationresistant prostate cancer presented american society clinical oncology asco 2012 annual meeting june 15 2012 chicago il full text us food drug administration fda fda expands zytiga’s use latestage prostate cancer – drug used treatment chemotherapy december 10 2012 available httpwwwfdagovnewseventsnewsroompressannouncementsucm331492htm haverkort van de kamer jb pieters br et al position verification prostate effect rectal wall dose int j radiat oncol biol phys medline saad f gleason dm murray r et al randomized placebocontrolled trial zoledronic acid patients hormonerefractory metastatic prostate carcinoma j natl cancer inst medline nccn clinical practice guidelines oncology prostate cancer version 12014 available httpwwwnccnorgprofessionalsphysicianglspdfprostatepdf parker c heinrich o’sullivan jm et al overall survival benefit safety profile radium223 chloride firstinclass alphapharmaceutical results phase iii randomized trial alsympca patients castrationresistant prostate cancer crpc bone metastases j clin oncol 2012 30 supp 5 abstract 8

Article 13:
breast cancer staging breast cancer staging tnm classification breast cancer breast cancer staging tnm classification breast cancer overview tnm classification breast cancer breast cancer staging overview 2007112overview sep 06 2013 201508041730 1 oncology 2002 diseases conditions condition 1 2 content 2007112 502 840 7 ssg jun 04 2015 condition diseases conditions oncology oncology oncologybreast breast cancer tnm classification staging breast cancer provided table 0 breast cancer staging tnm classification breast cancer tnm classification staging breast cancer provided table tnm classification breast cancer primary tumor tx primary tumor cannot assessed t0 evidence primary tumor tis carcinoma situ tis dcis ductal carcinoma situ tis lcis lobular carcinoma situ tis paget paget disease nipple associated invasive carcinoma andor carcinoma situ dcis andor lcis underlying breast parenchyma carcinomas breast parenchyma associated paget disease categorized based size characteristics parenchymal disease although presence paget disease still noted t1 tumor ≤ 20 mm greatest dimension t1mi tumor ≤ 1 mm greatest dimension t1a tumor 1 mm ≤ 5 mm greatest dimension t1b tumor 5 mm ≤ 10 mm greatest dimension t1c tumor 10 mm ≤ 20 mm greatest dimension t2 tumor 20 mm ≤ 50 mm greatest dimension t3 tumor 50 mm greatest dimension t4 tumor size direct extension chest wall andor skin ulceration skin nodules t4a extension chest wall including pectoralis muscle adherenceinvasion t4b ulceration andor ipsilateral satellite nodules andor edema including peau d’orange skin meet criteria inflammatory carcinoma t4c t4a t4b t4d inflammatory carcinoma regional lymph nodes n clinical nx regional lymph nodes cannot assessed eg previously removed n0 regional lymph node metastasis n1 metastasis movable ipsilateral level ii axillary lymph nodes n2 metastases ipsilateral level ii axillary lymph nodes clinically fixed matted clinically detected ipsilateral internal mammary nodes absence n2a metastases ipsilateral level ii axillary lymph nodes fixed one another matted structures n2b metastases clinically detected ipsilateral internal mammary nodes absence n3 metastases ipsilateral infraclavicular level iii axillary lymph nodes without level ii axillary node involvement clinically detected presence n3a metastasis ipsilateral infraclavicular lymph nodes n3b metastasis ipsilateral internal mammary lymph nodes axillary lymph nodes n3c metastasis ipsilateral supraclavicular lymph nodes clinically detected defined detected imaging studies excluding lymphoscintigraphy clinical examination characteristics highly suspicious malignancy presumed pathologic macrometastasis basis fineneedle aspiration fna biopsy cytologic examination pathologic pn pnx regional lymph nodes cannot assessed example previously removed removed pathologic study pn0 regional lymph node metastasis identified histologically note pn0i regional lymph node metastases histologically negative ihc pn0i malignant cells regional lymph nodes ≤ 02 mm detected hematoxylineosin stain ihc including itc pn0mol regional lymph node metastases histologically negative molecular findings reverse transcriptase polymerase chain reaction rtpcr pn0mol positive molecular findings rtpcr regional lymph node metastases detected histology ihc pn1 micrometastases metastases 13 axillary lymph nodes andor internal mammary nodes metastases detected sentinel lymph node biopsy clinically detected† pn1mi micrometastases 02 mm andor 200 cells none 20 mm pn1a metastases 13 axillary lymph nodes least 1 metastasis 20 mm pn1b metastases internal mammary nodes micrometastases macrometastases detected sentinel lymph node biopsy clinically detected† pn1c metastases 13 axillary lymph nodes internal mammary lymph nodes micrometastases macrometastases detected sentinel lymph node biopsy clinically detected† pn2 metastases 49 axillary lymph nodes clinically detected‡ internal mammary lymph nodes absence axillary lymph node metastases pn2a metastases 49 axillary lymph nodes least 1 tumor deposit 20 mm pn2b metastases clinically detected‡ internal mammary lymph nodes absence axillary lymph node metastases pn3 metastases ≥ 10 axillary lymph nodes infraclavicular level iii axillary lymph nodes clinically detected‡ ipsilateral internal mammary lymph nodes presence ≥ 1 positive level ii axillary lymph nodes 3 axillary lymph nodes internal mammary lymph nodes micrometastases macrometastases detected sentinel lymph node biopsy clinically detected† ipsilateral supraclavicular lymph nodes pn3a metastases ≥ 10 axillary lymph nodes least 1 tumor deposit 20 mm metastases infraclavicular level iii axillary lymph nodes pn3b metastases clinically detected‡ ipsilateral internal mammary lymph nodes presence ≥ 1 positive axillary lymph nodes 3 axillary lymph nodes internal mammary lymph nodes micrometastases macrometastases detected sentinel lymph node biopsy clinically detected† pn3c metastases ipsilateral supraclavicular lymph nodes classification based axillary lymph node dissection without sentinel lymph node biopsy classification based solely sentinel lymph node biopsy without subsequent axillary lymph node dissection designated sn sentinel node—for example pn0sn † clinically detected defined detected imaging studies excluding lymphoscintigraphy detected clinical examination ‡ clinically detected defined detected imaging studies excluding lymphoscintigraphy clinical examination characteristics highly suspicious malignancy presumed pathologic macrometastasis basis fna biopsy cytologic examination distant metastasis m0 clinical radiographic evidence distant metastasis cm0i clinical radiographic evidence distant metastases deposits molecularly microscopically detected tumor cells circulating blood bone marrow nonregional nodal tissue larger 02 mm patient without symptoms signs metastases m1 distant detectable metastases determined classic clinical radiographic means andor histologically proven 02 mm table histologic grade histologic grade g gx grade cannot assessed g1 low combined histologic grade favorable g2 intermediate combined histologic grade moderately favorable g3 high combined histologic grade unfavorable table anatomic stageprognostic groups stage n 0 tis n0 m0 ia t1 n0 m0 ib t0 n1mi m0 t1 n1mi m0 iia t0 n1 m0 t1 n1 m0 t2 n0 m0 iib t2 n1 m0 t3 n0 m0 iiia t0 n2 m0 t1 n2 m0 t2 n2 m0 t3 n1 m0 t3 n2 m0 iiib t4 n0 m0 t4 n1 m0 t4 n2 m0 iiic n3 m0 iv n m1 author joseph sparano md md joseph sparano md md member following medical societies american association cancer research american college physicians american society hematology disclosure nothing disclose pharmacy editor mary l windle pharmd adjunct associate professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure nothing disclose managing editor christopher braden hematologistoncologist chancellor center oncology deaconess hospital disclosure nothing disclose chief editor jules e harris md facp frcpc clinical professor medicine section hematologyoncology university arizona college medicine arizona cancer center jules e harris md facp frcpc member following medical societies american association advancement science american society hematology central society clinical translational research american society clinical oncology disclosure nothing disclose nccn clinical practice guidelines oncology breast cancer v 32013 national comprehensive cancer network available httpbitlyjousuf

Article 14:
malaria organismspecific therapy malaria organismspecific therapy specific organisms therapeutic regimens malaria organismspecific therapy specific organisms therapeutic regimens overview specific organisms therapeutic regimens malaria organismspecific therapy overview 2015022overview jan 08 2015 201506052101 1 infectious diseases 2002 diseases conditions condition 1 2 content 2015022 502 5005294 3 ssg jun 04 2015 condition diseases conditions infectiousdiseases infectious diseases infectiousdiseasesparasitic parasitic infections efforts made confirm diagnosis malaria identify species diagnosis generally via giemsastained thick thin peripheral blood smears 0 malaria organismspecific therapy specific organisms therapeutic regimens efforts made confirm diagnosis malaria identify species diagnosis generally via giemsastained thick thin peripheral blood smears multiple antibodybased rapid diagnostic tests rdts also available complications plasmodium falciparum choice therapeutic regimen dependent regional resistance patterns likely species involved clinical condition patients well complicating factors altered mental state pregnancy treatment must initiated species known treat p falciparum p falciparum primaquine given plasmodium vivax plasmodium ovale resistance patterns chloroquineresistant p falciparum eastern hemisphere subsaharan africa saudi arabia yemen iran pakistan afghanistan china nepal southeast asia western hemisphere panama haiti brazil peru bolivia colombia venezuela ecuador french guiana guyana suriname chloroquinesensitive p falciparum eastern hemisphere turkey iraq syria georgia azerbaijan tajikistan turkmenistan kyrgyzstan western hemisphere argentina paraguay mexico guatemala costa rica honduras nicaragua el salvador dominican republic mefloquineresistant p falciparum southeast asia regions vietnam laos thailand burma cambodia chloroquineresistant p vivax papua new guinea indonesia uncomplicated p falciparum infection see list artemetherlumefantrine atovaquoneproguanil quinine plus doxycycline mefloquine uncomplicated plasmodium malariae plasmodium knowlesi chloroquinesensitive p falciparum infection see list chloroquine phosphate hydroxychloroquine uncomplicated p vivax p ovale infection expected chloroquinesusceptible see list chloroquine phosphate 1000 mg 10 mgkg base po initial dose 300 mg 5 mgkg 6h 24h 48h plus primaquine hydroxychloroquine 800 mg po initial dose 400 mg po 6h 24h 48h plus uncomplicated p vivax infection expected chloroquineresistant see list quinine 650 mg po tid 3d 7d malaria acquired southern asia plus plus atovaquoneproguanil 1000400 mg po q24h 3d pediatric dosing uncomplicated p falciparum plus mefloquine 1250 po single dose may give 750 mg po initial dose 500 mg po 612h later plus amodiaquine 10 mgkg po q24h 3d available united states plus complicated malaria preferred treatment united states quinidine gluconate parasitemia 1 patient take oral medication switch quinine 650 mg po tid complete 3d course 7d course malaria acquired southern asia addition give doxycycline 100 mg iv po bid 7d pregnant women instead doxycycline give clindamycin investigational treatment united states available many countries artesunate plus atovaquoneproguanil 1000400 mg po q24h 3d pediatric dosing uncomplicated p falciparum chemoprophylaxis options atovaquoneproguanil atovaquoneproguanil 1 tabletday po used prophylaxis areas begin 12d travel malarial areas discontinue 7d departure malarial areas recommended prophylaxis creatinine clearance 30 mlmin atovaquoneproguanil taken food milky drink chloroquine phosphate chloroquine phosphate 300 mg base 500 mg salt po weekly used prophylaxis areas chloroquinesensitive malaria begin 12wk travel malarial areas discontinue 4wk departure malarial areas doxycycline doxycycline 100 mgday po used prophylaxis areas begin 12d travel malarial areas discontinue 4wk departure malarial areas contraindicated children 8y pregnant women significant risk photosensitivity mefloquine mefloquine 250 mg po weekly used prophylaxis areas mefloquinesensitive malaria begin 12wk travel malarial areas discontinue 4wk departure malarial areas contraindicated persons active recent history depression generalized anxiety disorder psychosis schizophrenia seizures prolongs qt interval recommended persons cardiac conduction abnormalities primaquine primaquine 30 mg baseday po used prophylaxis shortduration travel areas 90 p vivax begin 12d travel malarial areas discontinue 7d departure malarial areas contraindicated persons glucose6phosphate dehydrogenase g6pd deficiency persons take primaquine documented normal g6pd level starting also contraindicated pregnancy lactation unless infant breastfed documented normal g6pd level special considerations see list enroll patient severe malaria artesunate treatment protocol contact centers disease control prevention cdc malaria hotline 7704887788 business hours monfri 800 430 pm eastern time hours call 7704887100 ask speak cdc malaria branch clinician quinidine may cause qt prolongation hypoglycemia electrocardiography serum glucose monitoring required patients prescribed primaquine checked presence g6pd deficiency author joseph u becker md fellow global health international emergency medicine stanford university school medicine joseph u becker md member following medical societies american college emergency physicians phi beta kappa society academic emergency medicine emergency medicine residents039 association disclosure nothing disclose pharmacy editor jasmeet anand pharmd rph adjunct instructor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure nothing disclose chief editor thomas e herchline md professor medicine wright state university boonshoft school medicine medical director public health dayton montgomery county ohio thomas e herchline md member following medical societies alpha omega alpha infectious diseases society ohio infectious diseases society america disclosure nothing disclose centers disease control prevention pretravel consultation malaria available http1usagovlmzudn perezjorge e herchline malaria medscape reference available httpemedicinemedscapecomarticle221134overview world health organization guidelines treatment malaria full text sagara piarroux r djimde giorgi r kayentao k doumbo ok et al delayed anemia assessment patients treated oral artemisinin derivatives uncomplicated malaria pooled analysis clinical trials data mali malar j medline carvalho lj moreira ada danielribeiro ct martins yc vascular dysfunction target adjuvant therapy cerebral malaria mem inst oswaldo cruz medline full text paczkowski mm landman kl arguin pm update cases delayed hemolysis parenteral artesunate therapy malaria united states 2008 2013 mmwr morb mortal wkly rep medline fda drug safety communication fda approves label changes antimalarial drug mefloquine hydrochloride due risk serious psychiatric nerve side effects available httpwwwfdagovdrugsdrugsafetyucm362227htm

Article 15:
nonbacterial noninfectious cystitis nonbacterial noninfectious cystitis background anatomy pathophysiology nonbacterial noninfectious cystitis differential diagnoses nonbacterial noninfectious cystitis workup approach considerations nonbacterial noninfectious cystitis treatment management approach considerations treatment infectious nonbacterial cystitis treatment noninfectious nonbacterial cystitis nonbacterial noninfectious cystitis medication antibiotics antifungal systemic antivirals others antiparasitic agents antidotes nonbacterial noninfectious cystitis background anatomy pathophysiology nonbacterial noninfectious cystitis differential diagnoses nonbacterial noninfectious cystitis workup approach considerations nonbacterial noninfectious cystitis treatment management approach considerations treatment infectious nonbacterial cystitis treatment noninfectious nonbacterial cystitis nonbacterial noninfectious cystitis medication antibiotics antifungal systemic antivirals others antiparasitic agents antidotes overview background anatomy pathophysiology etiology epidemiology prognosis differential diagnoses workup approach considerations treatment approach considerations treatment infectious nonbacterial cystitis treatment noninfectious nonbacterial cystitis medication nonbacterial noninfectious cystitis overview nonbacterial noninfectious cystitis differential diagnoses nonbacterial noninfectious cystitis workup nonbacterial noninfectious cystitis treatment nonbacterial noninfectious cystitis medication 2056602overview apr 28 2015 201506181615 0 urology 2002 diseases conditions condition 1 2 content 2056602 502 720 15 ssg jun 18 2015 condition diseases conditions urology urology urologyinfections infections related inflammatory conditions nonbacterial noninfectious cystitis interstitial cystitis noninfectious cystitis urgencyfrequency syndrome chemical cystitis radiation cystitis autoimmune cystitis viral cystitis mycobacterial cystitis chlamydial cystitis fungal cystitis hypersensitivity cystitis nonbacterial infectious cystitis potassium leak test chronic pelvic pain syndrome painful bladder syndrome infectious cystitis tuberculous cystitis eosinophilic cystitis nonbacterial cystitis catchall term encompasses various medical disorders including infectious noninfectious cystitis well painful bladder syndromeinterstitial cystitis pbsic pbsic describes syndrome pain genitourinary symptoms eg frequency urgency pain dysuria nocturia etiology 0 nonbacterial noninfectious cystitis overview background nonbacterial cystitis noninfectious cystitis interstitial cystitis cystitis infectious nonbacterial cystitis includes following forms disease viral mycobacterial chlamydial fungal schistosomal candidal infection bladder shown image gross pathology bladder candidal infection hemorrhage gross pathology bladder candidal infection hemorrhage noninfectious nonbacterial cystitis radiation induced chemical autoimmune hypersensitivity general symptoms cystitis include urgency frequency dysuria occasionally hematuria dyspareunia abdominal cramps andor bladder pain spasms establishing excluding specific diagnosis often requires repeated cultures various urologic procedures including cystoscopy bladder biopsies various bladder tests immune system function examinations conditions carcinoma situ bladder calculi patient education information see womens health center bladder control problems blood urine cystoscopy pain intercourse anatomy images demonstrate anatomy female pelvis gross anatomy bladder muscles pelvic floor may involved nonbacterial cystitis gross anatomy female pelvis gross anatomy female pelvis gross anatomy bladder gross anatomy bladder female perineal anatomy urogenital diaphragm levator ani muscles removed female perineal anatomy urogenital diaphragm levator ani muscles removed revealing internal pudendal nerves vessels rectum posterior vaginal wall pathophysiology pathophysiology disorder depends etiology advances understanding pathophysiology complex pain syndromes demonstrated growth bridging neurons dorsal horns spinal cord type c pain fibers type pain fibers indicating perception pain started stimulus usually nonpainful another example neural crosstalk experiment rats demonstrated increased muscle spasm bladder colonic irritation colon bladder irritation may help explain concomitant occurrences irritable bowel syndrome pelvic pain syndrome interstitial cystitis infectious cystitis viruses cytopathologic viruses herpes simplex virus–1 hsv1 hsv2 live integrated host genome nervous system impairment immune surveillance caused comorbid diseases drugs chronic activation neuroendocrine pathways involved corticosteroid production allow virus activate travel peripheral nerves cause outbreak disease viruses normally cause cystitis immunocompetent adults given patient however whether infection due primary infection reactivation latent virus unclear chlamydia chlamydiae obligate intracellular parasites unique reproductive cycle involves 2 forms 1 extracellular form adapted survival environment allows infection transmitted one person another 2 intracellular form replicates produces extracellular forms chlamydia trachomatis urethritis cervicitis pelvic inflammatory disease proctitis epididymitis mycobacteria initial infection mycobacteria generally elicits mild inflammatory response symptoms weeks primary infection continued replication bacilli development cellmediated immunity leads macrophage infiltration ingestion pathogen mycobacteria persist within macrophages replication usually ceases spread disease contained individuals disturbances cellmediated immune responses therefore higher risk dissemination infection infections fungal infections occur immunocompetent hosts likely occur individuals abnormal immune systems species fungi associated urogenital fungal infections include blastomyces dermatitidis candida torulopsis glabrata schistosomiasis schistosoma noninfectious cystitis radiation cystitis presumably due ionizing radiation administered treatment pelvic urogenital cancers study perez et al eosinophilic cystitis associated various etiologic factors allergies bladder tumors parasitic infections stimulate antigen formation leading antigenantibody complexes stimulate inflammatory cascades turn leads eosinophil infiltration chemokine release causing fibrosis chemical cystitis due chemotherapy alkylating agents cyclophosphamide thought due metabolites excreted urine effects appear related dose duration therapy etiology infectious etiologies viruses normally cause cystitis immunocompetent adults improved molecular detection techniques allowed recognition viral infections following immunocompromised patients bk polyomavirus infections cytomegalovirus cmv infections associated hemorrhagic cystitis bone marrow transplantation adenovirus infections herpes chlamydial cystitis sexually transmitted types fungal cystitis occur mainly immunocompromised hosts corynebacterium urealyticum infiltration yeast bladder wall infiltration yeast bladder wall schistosomiasis schistosoma schistosomiasis ureter schistosomiasis ureter noninfectious etiologies cystitis may occur following radiation therapy pelvis cancer treatment average time beginning radiation therapy initial symptoms several months several years symptoms include anything mild bleeding severe recurrent bleeding pain requiring hospitalization treatment autoimmune diseases systemic lupus erythematosus sle sjögren syndrome also associated irritative bladder symptoms frequency pain eosinophilic cystitis rare pathologic condition characterized transmural inflammation bladder predominantly eosinophils fibrosis without muscle necrosis cystitis may also caused chemicals medications intravenous oral cyclophosphamide used treat malignancies vasculitides eg sle wegener granulomatosis reports documented cystitis arising recreational abuse ketamine anesthetic agent cases characterized marked frequency urgency dysuria display cystoscopic evidence inflammation throughout bladder epidemiology infectious cystitis frequency viral herpetic cystitis unclear culture results falsely negative example proposed hsv1 hsv2 may initially cause asymptomatic infections incidence herpetic cystitis may higher culturepositive results indicate hemorrhagic cystitis due adenoviral infections common immunocompromised hosts especially bone marrow transplant recipients acquired immunodeficiency syndrome aids hemorrhagic cystitis due infection adenoviruses bk polyomavirus reported 20 8 pediatric bone marrow transplant patients respectively frequency chlamydial genitourinary infections may also higher cultures indicate study 130 patients aged 1425 years urban outpatient clinic demonstrated 21 frequency c trachomatis chlamydia c trachomatis mycobacterial cystitis urogenital tuberculosis common underdeveloped countries continues major urologic problem places north africa mainly diagnosis delays tuberculosis vaccine bacillus calmetteguérin bcg may instilled bladder treat bladder tumors also reported cause cystitis fungal cystitis commonly due candida schistosomiasis frequently occurs developing world although estimated 400000 cases exist united states five different species schistosomes schistosoma haematobium noninfectious cystitis radiation cystitis reported occur 65 1784 patients treated combination external beam intracavitary radiotherapy stage ib carcinoma cervix perez et al reported moderatetosevere cystitis occurring 12 738 patients treated definitive irradiation therapy prostate cancer 10 years autoimmune disease related cystitis another entity may common previously realized review sweden demonstrated 17 patients diagnosed interstitial cystitis rheumatoid arthritis 47 hypersensitivity reactions allergies 23 either ulcerative colitis crohn disease rate 30 times prevalence rate general population sjögren syndrome sle associated urinary symptoms one study haarala et al 121 patients 121 age sexmatched controls 60 patients urinary symptoms compared 20 controls prognosis infectious etiologies infectious causes nonbacterial cystitis hsv1 hsv2 treated however treatment eliminate dormant virus integrated host genome disease recur chlamydial mycobacterial infections cured chlamydial disease cure protective disease reacquired addition mycobacterial infections generally cured regimens containing 3 4 drugs review mnif et al 60 cases urogenital tuberculosis found 2 cured medical therapy alone remaining patients 54 required one following surgical interventions nephrectomy 43 patients ureterovesical reimplantation 7 augmentation enterocystoplasty 11 ureteral diversions 5 two patients whose medical status nutritional status poor begin died despite aggressive therapy fungal infections usually curable depending underlying health status patient patients severe immunosuppression eg untreatable malignancies aids poorly controlled diabetes transplant recipients ones likely develop infections patients may require continued treatment ensure infection recur noninfectious etiologies radiation cystitis occur usually mild require specific therapy chemical cystitis due chemotherapy agents generally mild longterm consequences resolves medications stopped known cures exist autoimmune disease–associated cystitis symptoms often controlled antiinflammatory agents corticosteroids eosinophilic cystitis often recurs despite resection lesion antiinflammatory treatments longterm followup required differential diagnoses diagnostic considerations chronic pelvic pain syndrome common debilitating condition multifactorial etiology including social psychological biologic factors diagnosis exclusion etiologies pelvic pain eliminated differential chronic pelvic pain men chronic pelvic pain women workup approach considerations infectious etiologies viruses viral infections often difficult diagnose viral culture results falsely negative viruses detected polymerase chain reaction pcr assay detection antibodies virus also chlamydia chlamydia mycobacteria prior mycobacterial infection mycobacterium tuberculosis tuberculosis mycobacteria also detected examination tissue stained acidfast dye carbolfuchsin slender curved polychromatic beaded rods pairs small clumps growing bacteria highly selective media allows cultivation within 12 weeks although identification antibiotic sensitivity testing may take longer finally mycobacterial infection detected pcr assay study moussa et al sensitivity acidfast bacilli afb staining 52 versus 96 pcr assay compared cultures intravenous urography remains primary imaging modality mycobacterial cystitis although ultrasonography computed tomography ct scanning magnetic resonance imaging mri may also used however imaging findings may normal early disease information see medscape reference article imaging tuberculosis genitourinary tract infections fungal infection indicated findings hyphae andor spores microscopic evaluation wet smears histopathologic sections culture microbiologic diagnosis funguria based fungal concentration 10 3 candida blastomyces dermatitidis schistosomal infection detected searching terminally spined eggs urinary sediment histopathologic analysis also performed squash preparation glass slide urinary urethral andor vaginal prostatic cultures also performed special stains pcr assays viruses chlamydia fungi mycobacteria included selected patients noninfectious etiologies diagnosis cystitis due radiation therapy chemicals autoimmune disease established part obtaining relevant history patients radiation cystitis associated urinary tract infections uncommon cystoscopy may required exclude causes bleeding recurrent tumor new primary tumor benign prostatic hyperplasia cystoscopy biopsy criterion standard diagnosing eosinophilic cystitis diagnosis autoimmune diseases relies compatible history supported serologic tissue confirmation detection antinuclear antibodies ana often used screening test connective tissue disease positive test results subjected assays specific serologic tests likely positive patients systemic lupus erythematosus sle include low c3 anti–double stranded ds dna antismith sm antiribonucleoprotein antirnp antibodies patients sle bladder involvement abdominal ct scanning may demonstrate thickening bladder wall hydronephrosis ascites bowelwall thickening biopsy affected organs may show vasculitis tests likely positive results patients sj ö gren syndrome include schirmer tear test antirossa antilassb minor lacrimal gland biopsy urine cytology useful first step diagnosis genitourinary malignancies treatment management approach considerations treatment nonbacterial cystitis addresses specific cause noninfectious etiologies require separate consideration radiation cystitis chemical cystitis autoimmune cystitis interstitial cystitis treatment options painful bladder syndromeinterstitial cystitis see medscape reference article interstitial cystitis infectious cystitis cause may viral chlamydial mycobacterial schistosomal fungal infectious cases treated systemic cases local pharmacotherapy patient taking immunosuppressive medication treatment regimen may need adjusted types infectious recurrent nonbacterial cystitis treated transfer factor tf specific kind infection candida treatment infectious nonbacterial cystitis viral cystitis treatment immunocompetent adults cystitis herpes simplex virus–1 hsv1 hsv2 includes acyclovir 400mg 5 times daily 7 days valacyclovir 500mg twice daily 510 days acyclovir requires dose adjustment patients decreased glomerular filtration rate ganciclovir vidarabine used cases hemorrhagic cystitis cytomegalovirus cmv adenovirus patients undergone bone marrow transplantation cystitis due bk polyomavirus reportedly resolved without treatment 9 pediatric patients however adults undergone renal transplantation cidofovir decrease dose immunosuppressants usually recommended concern renal parenchymal damage virus mycophenolate mofetil associated adenoviral infections azathioprine chlamydial cystitis treatment regimens cystitis caused chlamydia doxycycline 100mg twice daily 7 days azithromycin 1g orally single dose erythromycin 500mg 4 times daily 7 days fluoroquinolone eg ofloxacin 300mg twice daily 7 days erythromycin azithromycin amoxicillin also used pregnant women mycobacterial cystitis mycobacterial treatment begins 3 4 agents generally including isoniazid inh rifampin rif depending probable sensitivities organism underlying state immune system standard regimen follows inh 300mgday rif 600 mg daily ethambutol emb 15mgkgday pyrazinamide 2gday drugs used include streptomycin 0751gday ethionamide eth 1gday one fluoroquinolones treatment regimens modified actual drug sensitivities determined drug toxicities sufficient require change regimen occur 5 patients surgery rarely needed treat tuberculosis genitourinary system fungal cystitis treatment recommended funguria symptomatic cases fungal colonization host factors increase risk fungemia immunosuppressed patients another option may intravenous amphotericin b depending degree dissemination infection azole antifungal agents often effective candida echinocandins eg caspofungin micafungin newer class agents active azole polyeneresistant fungi possible alternative one trial compared caspofungin amphotericin b invasive candidiasis demonstrated similar efficacy markedly fewer side effects caspofungin infectious disease specialists consider caspofungin firstline therapy invasive non albicans bladder outlet obstruction suspected setting severe funguria foley catheter suprapubic tube placed resolution infection benign prostatic hyperplasia managed surgically schistosomal cystitis patients schistosomiasis treated regardless disease severity surgery reserved cases respond medical therapy patients intractable gross hematuria schistosomiasis cause large granulomas bladder may warrant surgical extirpation obstructive uropathy due ureteral strictures common sequela management ureteral stricture based stricture length location deep nonhealing bladder ulcers may require partial cystectomy biopsyproven bladder cancer often requires radical cystectomy treatment noninfectious nonbacterial cystitis radiation cystitis minor bleeding episodes due radiation treatment stop without treatment severe bleeding may require hospitalization therapy clot evacuation continuous bladder irrigation standard treatment heavy bleeding small number patients severe bleeding require treatment methods tried include hyperbaric oxygen therapy chemical therapy urinary diversion study del pizzo et al longterm results hyperbaric oxygen 11 patients 3 complete resolution symptoms 3 persistent symptoms 5 initial improvement relapsed srisupundit colleagues reported good shortterm results followup 19mo 13 20 patients treated intravenous infusion chemically stabilized chlorite matrix tetrachlorodecaoxygen tcdo chemical cystitis chemical cystitis chemotherapy agents cyclophosphamide may resolve hydration discontinuation drug another alternative mesna semisynthetic sulfhydryl compound reacts chemically drug metabolites cause urotoxicity detoxifying manner similar physiologic cysteinecystine system ballen colleagues suggested extremely aggressive hydration intravenous fluids diuretics maintain urine output greater 150mlh may effective therapy mesna well much less expensive autoimmune cystitis treatment autoimmune diseases generally relies combination symptomatic relief antiinflammatory drugs immunosuppressive agents last several years monoclonal antibodies tumor necrosis factor tnf–alpha several interleukins markedly improved symptoms rheumatic diseases greater variety immunologic targets amenable treatment modification allowed rheumatologists tailor combinations drugs yield improved efficacy fewer symptoms present therapy eosinophilic cystitis curative treatments tried include antiinflammatory therapies nonsteroidal antiinflammatory drugs steroids transurethral resection bladder lesion medication medication summary goals pharmacotherapy eradicate infection reduce morbidity prevent complications depending cause agents used may include antimicrobials antifungals antivirals anthelmintics antidotes combination antibiotics isoniazid inh rifampin rif ethambutol pyrazinamide commonly used treat mycobacterial cystitis oral fluconazole bladder irrigations containing amphotericin b used fungal cystitis antiviral agents acyclovir valacyclovir administered treatment cystitis caused herpes simplex virus1 hsv1 hsv2 ganciclovir prodrug valganciclovir employed hemorrhagic cystitis caused cytomegalovirus cmv praziquantel kills parasites responsible schistosomiasis current recommended therapy 2 oral doses praziquantel 40mgkg 1 day regimen 83100 cure rate antibiotics class summary empiric antimicrobial therapy must comprehensive cover likely pathogens context clinical setting rifampin rifadin rifampin inhibits ribonucleic acid rna synthesis bacteria binding beta subunit dnadependent rna polymerase turn blocks rna transcription dosage adults 600mg orally daily 6 months rifampin induces microsomal enzymes may decrease effects drugs blood pressure may increase coadministration enalapril coadministration isoniazid pyrazinamide may result higher rate hepatotoxicity either agent alone discontinue 1 agents alterations liver function test results occur obtain complete blood counts cbcs baseline clinical chemistries prior throughout rifampin therapy liver disease weigh benefits rifampin use risk liver damage interruption therapy highdose intermittent therapy associated thrombocytopenia reversible therapy discontinued soon purpura occurs treatment continued resumed appearance purpura cerebral hemorrhage death may occur rifampin pregnancy category c drug isoniazid isoniazid isonicotinic acid hydrazide agent used part tripledrug regimen adult dosage 300 mg orally daily 6 months previous isoniazidassociated hepatic injury severe adverse reactions contraindications daily alcohol ingestion may predispose patients isoniazidrelated hepatitis aluminum salts may decrease isoniazid serum levels administer 12 hours taking aluminum salts isoniazid may increase anticoagulants effects coadministration may inhibit metabolic clearance benzodiazepines carbamazepine toxicity isoniazid hepatotoxicity may result concurrent use monitor carbamazepine concentrations liver function coadministration cycloserine may increase central nervous system cns side effects eg dizziness acute behavioral coordination changes may occur coadministration disulfiram coadministration rifampin halothane anesthesia may result hepatotoxicity hepatic encephalopathy isoniazid may inhibit hepatic microsomal enzymes increase toxicity hydantoin monitor patients active chronic liver disease severe renal dysfunction periodic ophthalmologic examinations isoniazid therapy recommended even visual symptoms occur isoniazid pregnancy category c drug pyrazinamide pyrazinamide used combination effective antituberculous agents mechanism action unknown well absorbed gastrointestinal gi tract hydrolyzed active metabolite liver note 70 excreted urine within 24 hours treat patients drugresistant disease individualized regimens adult dose 2g orally daily 2 months contraindications include severe hepatic damage acute gout coadministration rifampin may result higher rate hepatotoxicity either agent alone discontinue alterations liver function test results occur pyrazinamide inhibits renal excretion urates may result hyperuricemia usually asymptomatic perform baseline serum uric acid determinations discontinue drug upon signs hyperuricemia acute gouty arthritis perform baseline liver function tests closely monitor liver disease discontinue drug signs hepatocellular damage appear observe caution history diabetes mellitus pyrazinamide pregnancy category c drug ethambutol myambutol ethambutol diffuses actively growing mycobacterial cells tubercle bacilli impairs cell metabolism inhibiting synthesis 1 metabolites turn causes cell death crossresistance demonstrated mycobacterial resistance frequent previous therapy use patients combination previously unadministered secondline drugs adult dosage ethambutol 15mgkg orally daily 2 months aluminum salts may delay reduce absorption give several hours ethambutol dose reduce dose patients impaired renal function optic neuritis may develop reversible drug promptly discontinued ethambutol pregnancy category c drug doxycycline adoxa doryx periostat vibramycin monodox doxycycline broadspectrum synthetically derived bacteriostatic antibiotic tetracycline class almost completely absorbed concentrates bile excreted urine feces biologically active metabolite high concentrations inhibits protein synthesis thus bacterial growth binding 30s possibly 50s ribosomal subunits susceptible bacteria may block dissociation peptidyl transfer rna trna ribosomes causing rnadependent protein synthesis arrest adult dosage 100mg orally twice daily severe hepatic dysfunction contraindication bioavailability doxycycline decreases antacids containing aluminum calcium magnesium iron bismuth subsalicylate tetracyclines increase hypoprothrombinemic effects anticoagulants decrease efficacy oral contraceptives causing breakthrough bleeding increased risk pregnancy photosensitivity may occur prolonged exposure sunlight tanning equipment reduce dose patients renal impairment consider drug serum level determinations prolonged therapy tetracycline use tooth development last half pregnancy age 8 years permanently discolor teeth fanconilike syndrome may occur outdated tetracyclines doxycycline pregnancy category drug azithromycin zithromax zmax azithromycin used treat mild moderate microbial infections adults given single dose 1g orally azithromycin acts binding 50s ribosomal subunit susceptible microorganisms blocks dissociation peptidyl trna ribosomes causing rnadependent protein synthesis arrest nucleic acid synthesis affected concentrates phagocytes fibroblasts demonstrated vitro incubation techniques vivo studies suggest concentration phagocytes may contribute drug distribution inflamed tissues contraindications azithromycin use include hepatic impairment administer pimozide azithromycin may increase toxicity theophylline warfarin digoxin effects reduced coadministration aluminum andor magnesium antacids nephrotoxicity neurotoxicity may occur agent coadministered cyclosporine site reactions occur given iv route bacterial fungal overgrowth may result prolonged antibiotic use azithromycin may increase hepatic enzymes cholestatic jaundice use agent caution patients impaired hepatic function prolonged qt intervals azithromycin pregnancy category b drug ofloxacin ofloxacin penetrates prostate well effective neisseria gonorrhoeae chlamydia trachomatis antacids iron salts zinc salts may reduce serum levels patients take antacids 24 hours taking fluoroquinolones cimetidine may interfere metabolism fluoroquinolones ofloxacin may increase toxicity theophylline caffeine cyclosporine digoxin monitor digoxin levels may increase effects anticoagulants monitor prothrombin time prolonged therapy periodically evaluate organ system functions eg renal hepatic hematopoietic adjust dose patients impaired renal function superinfections may occur prolonged repeated antibiotic therapy ofloxacin pregnancy category c drug antifungal systemic class summary mechanism action antifungal agents may involve alteration rna dna metabolism intracellular accumulation peroxide toxic fungal cell amphotericin b deoxycholate amphotericin b produced strain streptomyces nodosus low concentrations main effect agent increased intracellular loss potassium resulting reversible fungistatic activity however higher concentrations pores 40105nm cytoplasmic membrane produced leading large losses ions molecules second effect amphotericin b ability cause autooxidation cytoplasmic membrane release lethal free radicals main fungicidal activity amphotericin b may reside ability cause autooxidation cell membranes adult dose 05mgkg intravenously daily 714 days 50mcgml given bladder irrigation continuously 5 days antineoplastic agents may enhance potential amphotericin b renal toxicity bronchospasm hypotension corticosteroids digitalis thiazides may potentiate hypokalemia risk renal toxicity increased cyclosporine monitor renal function serum electrolytes eg magnesium potassium liver function cbcs hemoglobin concentrations resume therapy lowest dose level eg 025mgkg therapy interrupted 7 days hypoxemia acute dyspnea interstitial infiltrates may occur neutropenic patients receiving leukocyte transfusions give amphotericin infusions different times leukocyte transfusions fever chills uncommon first doses drug rare acute reactions may include hypotension bronchospasm arrhythmias shock amphotericin b pregnancy category b drug fluconazole diflucan fluconazole synthetic oral antifungal broadspectrum bistriazole selectively inhibits fungal cytochrome p450 sterol c14 alphademethylation prevents conversion lanosterol ergosterol thereby disrupting cellular membranes drug little affinity mammalian cytochromes believed explain low toxicity fluconazole available tablet form oral administration powder oral suspension sterile solution intravenous use fewer adverse effects better tissue distribution older systemic imidazoles adult dosage 200mg orally intravenously daily 714 days probenecid zidovudine cimetidine coadministration prolongs halflife increases cns toxicity adjust dose renal insufficiency closely monitor rashes develop discontinue drug lesions progress fluconazole may cause clinical hepatitis cholestasis fulminant hepatic failure including death patients certain underlying medical conditions eg aids malignancy taking multiple concomitant medications recommended breastfeeding mothers convenience efficacy singledose regimen treatment vaginal yeast infections weighed difficulties resulting higher incidence adverse reactions reported oral fluconazole versus intravaginal agents fluconazole pregnancy category c drug antivirals others class summary nucleoside analogues initially phosphorylated viral thymidine kinase eventually form nucleoside triphosphate molecules inhibit hsv polymerase 3050 times potency human alphadna polymerase acyclovir zovirax acyclovir activated via phosphorylation virusspecific thymidine kinase guanylate kinase converts monophosphate form diphosphate triphosphate analogues inhibit viral dna replication acyclovir affinity viral thymidine kinase phosphorylated causes dnachain termination acted dna polymerase acyclovir inhibits activity hsv1 hsv2 patients experience less pain faster resolution cutaneous lesions agent started within 48 hours rash onset may prevent recurrent outbreaks early initiation therapy imperative adult dosage 400mg orally 5 times daily 7 days concomitant use probenecid zidovudine prolongs halflife increases cns toxicity acyclovir use agent caution patients renal failure using nephrotoxic drugs acyclovir pregnancy category b drug valacyclovir valtrex valacyclovir prodrug rapidly converted active drug acyclovir expensive acyclovir convenient dosing regimen adult dosage 500mg orally twice daily 510 days risk hyperkalemia increased patients taking angiotensinconverting enzyme ace inhibitors cyclosporine potassiumsparing diuretics use valacyclovir caution patients renal failure decrease dose patients also taking nephrotoxic drugs valacyclovir associated onset hemolytic uremic syndrome valacyclovir pregnancy category b drug valganciclovir valcyte valganciclovir lvalyl ester prodrug ganciclovir used cmv disease prophylaxis various solid organ transplants ganciclovir synthetic analogue 2deoxyguanosine inhibits replication human cmv vitro vivo viral activity halted due inhibition viral dna synthesis agent advantage twicedaily oral administration achieves serum levels comparable obtained intravenous ganciclovir adult dosage 450mg orally twice daily 21 days contraindications include severe renal dysfunction hemodialysis pregnancy breastfeeding absolute neutrophil count less 500 cellsµl platelet count less 25000µl hemoglobin level less 8gdl interactions valganciclovir similar reported ganciclovir coadministration cytotoxic drugs dapsone vinblastine doxorubicin pentamidine flucytosine vincristine amphotericin b trimethoprimsulfamethoxazole combinations nucleoside analogues may result additive toxicity rapidly dividing cell populations including bone marrow spermatogonia germinal layers skin gi mucosa coadminister agents benefits outweigh risks coadministration imipenemcilastatin may cause generalized seizures use benefits outweigh risks serum creatinine levels may increase following concurrent use ganciclovir either cyclosporine amphotericin b presence probenecid ganciclovir renal clearance reduced bioavailability may increase didanosine administered either 2 hours simultaneously ganciclovir bioavailability ganciclovir may decrease presence zidovudine bioavailability zidovudine increased presence ganciclovir strict adherence dosage guidelines valganciclovir essential avoid overdose valganciclovir tablets may substituted ganciclovir capsules onetoone basis adjust dose according creatinine clearance crcl patients impaired renal function valganciclovir may cause granulocytopenia anemia thrombocytopenia indicated cmv disease prevention liver transplantation incidence cmv disease liver transplant recipients higher valganciclovir ganciclovir valganciclovir pregnancy category c drug antiparasitic agents class summary biochemical pathways schistosomes sufficiently different human host allow selective interference chemotherapeutic agents relatively small doses praziquantel biltricide praziquantel increases cell membrane permeability susceptible worms resulting loss intracellular calcium massive contractions paralysis musculature addition produces vacuolization disintegration schistosome tegument followed attachment phagocytes parasite death tablets swallowed whole liquid meals keeping tablets mouth may reveal bitter taste produce nausea vomiting adult dosage 40mgkg orally twice daily 1 day ocular cysticercosis contraindication hydantoins may reduce serum praziquantel concentrations possibly leading treatment failures destruction parasites within eyes cause irreparable lesions ocular cysticercosis treated praziquantel patients use caution driving performing tasks requiring alertness day treatment following day minimal increases liver enzymes reported schistosomiasis fluke infection associated cerebral cysticercosis hospitalize patient duration treatment praziquantel pregnancy category b drug antidotes class summary agents counteract toxic effects drugs mesna mesnex kidney mesna disulfide reduced free mesna free mesna thiol groups react acrolein ifosfamide cyclophosphamide metabolite considered responsible urotoxicity inactivates acrolein prevents urothelial toxicity without affecting cytostatic activity adult dosage 240mg intravenously 0 4 8 hours ifosfamide cyclophosphamide dose mesna may increase warfarin effects mesna prevent hemorrhagic cystitis patients monitoring hematuria morning prior ifosfamide cyclophosphamide dose required prevent alleviate toxicities associated ifosfamide cyclophosphamide common adverse effects include hypotension headache gi toxicity limb pain mesna pregnancy category b drug start media gross pathology bladder candidal infection hemorrhage gross pathology bladder candidal infection hemorrhage gross anatomy female pelvis gross anatomy female pelvis gross anatomy bladder gross anatomy bladder female perineal anatomy urogenital diaphragm levator ani muscles removed female perineal anatomy urogenital diaphragm levator ani muscles removed revealing internal pudendal nerves vessels rectum posterior vaginal wall schistosomiasis ureter schistosomiasis ureter infiltration yeast bladder wall infiltration yeast bladder wall author lynda frassetto md clinical professor department internal medicine university california san francisco school medicine lynda frassetto md member following medical societies american college physicians american society nephrology disclosure nothing disclose coauthors benjamin newell breyer md ms assistant professor trauma reconstruction department urology university california san francisco school medicine benjamin newell breyer md ms member following medical societies alpha omega alpha american college surgeons american urological association endourological society disclosure nothing disclose chief editor edward david kim md facs professor surgery division urology university tennessee graduate school medicine consulting staff university tennessee medical center edward david kim md facs member following medical societies american college surgeons tennessee medical association sexual medicine society north america american society reproductive medicine american society andrology american urological association disclosure received honoraria lilly speaking teaching received honoraria astellas speaking teaching received honoraria actavis speaking teaching received honoraria auxilium speaking teaching acknowledgements erik goluboff md erik goluboff md member following medical societies alpha omega alpha american medical association american urological association medical society state new york new york academy medicine phi beta kappa society basic urologic research disclosure nothing disclose stephen w leslie md facs stephen w leslie md facs member following medical societies american college surgeons american urological association national kidney foundation ohio state medical association disclosure nothing disclose grannum r sant md grannum r sant md member following medical societies american urological association international association study pain massachusetts medical society society basic urologic research society university urologists disclosure nothing disclose francisco talavera pharmd phd disclosure medscape salary employment pezzone liang r fraser mo model neural crosstalk irritation pelvis implications overlap chronic pelvic pain disorders gastroenterology medline perez ca lee hk georgiou lockett technical factors affecting morbidity definitive irradiation localized carcinoma prostate int j radiat oncol biol phys medline teegavarapu ps sahai chandra dasgupta p khan ms eosinophilic cystitis management int j clin pract medline sharma bn li r bernhoff e et al fluoroquinolones inhibit human polyomavirus bk bkv replication primary human kidney cells antiviral res medline boeckh erard v zerr englund j emerging viral infections hematopoietic cell transplantation pediatr transplant medline fioriti degener mischitelli videtta arancio sica et al bkv infection hemorrhagic cystitis allogeneic bone marrow transplant int j immunopathol pharmacol medline carrigan dr adenovirus infections immunocompromised patients j med medline bavastrelli midulla rossi salzano calzolari e midulla c et al sexually active adolescents young adults highrisk group chlamydia trachomatis infection j travel med medline wald zeh j selke warren ryncarz aj ashley r et al reactivation genital herpes simplex virus type 2 infection asymptomatic seropositive persons n engl j med medline pierciaccante pompeo fabi f venditti successful treatment corynebacterium urealyticum encrusted cystitis case report literature review infez med medline martinsuarez dcruz mansoor fernandes ap khamashta hughes gr immunosuppressive treatment severe connective tissue diseases effects low dose intravenous cyclophosphamide ann rheum dis medline full text kawabe eguchi k tsuboi kita tsukada takashima h et al untoward effects low dose methotrexate therapy rheumatoid arthritis ryumachi medline chu ps wk wong sc chu rw cheng ch wong et al destruction lower urinary tract ketamine abuse new syndrome bju int medline kauffman ca diagnosis management fungal urinary tract infection infect dis clin north medline barsoum rs schistosomiasis kidney semin nephrol medline haarala alanen hietarinta kiilholma p lower urinary tract symptoms patients sjögrens syndrome systemic lupus erythematosus int urogynecol j pelvic floor dysfunct medline mnif loussaief h ben hassine l chebil ayed aspects evolving urogenital tuberculosis 60 cases ann urol paris medline beard cj lamb c buswell l schneider l propert kj gladstone et al radiationassociated morbidity patients undergoing smallfield external beam irradiation prostate cancer int j radiat oncol biol phys medline levenback c eifel pj burke tw morris gershenson dm hemorrhagic cystitis following radiotherapy stage ib cancer cervix gynecol oncol medline wagenlehner fm van till jw magri v perletti g houbiers jg weidner w et al national institutes health chronic prostatitis symptom index nihcpsi symptom evaluation multinational cohorts patients chronic prostatitischronic pelvic pain syndrome eur urol medline shurbaji ms dumler js gage wr pettis gl gupta pk kuhadja fp immunohistochemical detection chlamydial antigens association cystitis j clin pathol medline moussa om eraky elfar osman hg ghoneim rapid diagnosis genitourinary tuberculosis polymerase chain reaction nonradioactive dna hybridization j urol medline etienne caron f management fungal urinary tract infections presse med medline sandhu gs kline bc stockman l roberts gd molecular probes diagnosis fungal infections j clin microbiol medline full text min jk byun jy lee sh hong ys park sh cho cs et al urinary bladder involvement patients systemic lupus erythematosus review literature korean j intern med medline de vinci c pizza g cuzzocrea menniti aiello e maver p et al use transfer factor treatment recurrent nonbacterial female cystitis nbrc preliminary report biotherapy medline egli binggeli bodaghi dumoulin funk ga khanna n et al cytomegalovirus polyomavirus bk posttransplant nephrol dial transplant medline xu hg fang jp huang sl zhou dh chen c huang k et al risk factors treatment hemorrhagic cystitis children hematopoietic stem cell transplantation zhonghua er ke za zhi medline mott ke dixon h oseitutu e england ec davis effect praziquantel hematuria proteinuria urinary schistosomiasis j trop med hyg medline sommariva ml sandri sd ceriani v efficacy sodium hyaluronate management chemical radiation cystitis minerva urol nefrol medline damiano r cicione role sodium hyaluronate sodium chondroitin sulphate management bladder disease ther adv urol medline full text allen kilian c phelps j et al use hyperbaric oxygen treating delayed radiation injuries gynecologic malignancies review literature report radiation injury incidence support care cancer medline del pizzo jj chew bh jacobs sc sklar gn treatment radiation induced hemorrhagic cystitis hyperbaric oxygen longterm followup j urol medline chong kt hampson nb corman jm early hyperbaric oxygen therapy improves outcome radiationinduced hemorrhagic cystitis urology medline srisupundit kraiphibul p sangruchi linasmita v chingskol k veerasarn v efficacy chemicallystabilized chloritematrix tcdo management late postradiation cystitis j med assoc thai medline ballen kk becker p levebvre k emmons r lee k levy w et al safety cost hyperhydration prevention hemorrhagic cystitis bone marrow transplant recipients oncology medline

Article 16:
thyroidstimulating hormone thyroidstimulating hormone reference range interpretation collection panels thyroidstimulating hormone reference range interpretation collection panels overview reference range interpretation collection panels background thyroidstimulating hormone overview 2074091overview jul 16 2015 201508101231 1 laboratory medicine 2002 laboratory medicine lab 1 2 content 2074091 505 1089 43 ssg aug 10 2015 lab laboratory medicine laboratorymedicine laboratory medicine laboratorymedicinelabmed laboratory medicine thyroidstimulating hormone thyroidstimulating hormone levels tsh thyroidstimulating hormone test thyroidstimulating hormone testing thyroid thyroid testing lower limit reference range 030 0 thyroidstimulating hormone reference range agespecific pregnancyspecific reference intervals established significant sex race specific differences expected values using thirdgeneration immunochemiluminometric assay follows premature 2836 weeks first week life 07270 cord blood 37 wk 23132 children birth 4 days 139 220 weeks 1791 21 weeks 20 years0764 adults 2154 years 0442 5587 years 0589 pregnancy first trimester 0345 second trimester 0546 third trimester 0852 concentration tsh circulation expressed milliinternational units biological activity per liter serum miul way expressing concentration originates way tsh hormones initially evaluated tsh initially measured using bioassay colloidal tissue isolated guinea pig thyroid gland international unit defined minimum amount tsh would elicit biological response stimulation thyroid camp cyclase activity preparations currently tsh assays using purified calibrators second irp 80558 75 pg purified human pituitary extract equivalent 37 miu noted pituitary extracts also contain small amounts luteinizing hormone lh folliclestimulating hormone fsh 55 lh 277 fsh interpretation conditions associated increases tsh include following congenital hypothyroidism primary hypothyroidism tshsecreting pituitary tumors uncommon pituitary resistance thyroid hormone uncommon typical laboratory results progression hashimoto thyroiditis subclinical overt disease stage disease tsh ft4 t3 subclinical increased normal concentrations normal concentrations early increased decreased normal concentrations mature increased decreased decreased conditions associated decreases tsh include following hyperthyroidism pituitary secondary hypothyroidism rare nonthyroid illness typical laboratory results progression graves disease subclinical overt disease stage disease tsh ft4 t3 subclinical decreased normal concentrations normal concentrations early decreased normal concentrations increased mature decreased increased increased hypothyroidism signs symptoms hypothyroidism include following weight gain decreased appetite dry skin constipation cold intolerance puffy skin hair loss fatigue lethargy menstrual irregularity blurred vision hyperthyroidism signs symptoms hyperthyroidism include following nervousness anxiety increased perspiration heat intolerance weight loss despite increase appetite hyperactivity tremor palpitations oligomenorrhea tachycardia atrial arrhythmia systolic hypertension warm moist smooth skin lid lag stare muscle weakness considerations drugs increase tsh include following dopamine antagonists chlorpromazine haloperidol iodinecontaining drugs amiodarone amiodaroneinduced hypothyroidism drugs decrease tsh include following exogenous thyroxine glucocorticoids dopamine levodopa dopamine agonists apomorphine pyridoxine amiodarone early amiordarone therapy amiodaroneinduced thyrotoxicosis collection panels preferred specimen acceptable tubes serum red top tube sst plasma green top tube sodium heparin ammonium heparin lithium heparin pst whole blood newborn screening collected heel puncture 4872 hours birth specimen volume 05 ml plasma serum 025 ml minimum volume specimen stability centrifuge specimens remove serum plasma cells within 2 hours collection store room temperature 8 hours refrigerate 28 degrees celsius 3646 degrees fahrenheit 5 days assays completed within 48 hours separated sample stored beyond 48 hours samples frozen 20 degrees celsius colder frozen samples thawed analyte deterioration may occur samples repeatedly frozen thawed related tests thyroxine triiodothyronine t3 antithyroid autoantibodies thyroxine binding proteins thyroglobulin tg thyrotropinreleasing hormone trh measurement tsh two major ways tsh currently evaluated radioimmunoassay ria chemiluminescence immunoassays ria endogenous tsh present sample competing radiolabeled tsh limited amount tshspecific antibodies “competitive assay” measured signal inversely proportional amount tsh present sample chemiluminescence assay using two antibodies “sandwich immunoassay” “capture antibody” binding usually within alpha subunit tsh “detection antibody” always binding within tshspecific betasubunit measured signal directly proportional amount tsh present sample chemiluminescence assay significantly sensitive ria current generation immunometric assay fourth generation functional detection limit 00010002 miul immunoassays assays prone specific interferences especially heterophilic antibodies hook effect rarely seen macro tsh also considered face spurious results match clinical conditions interferences eliminated well background description thyroidstimulating hormone tsh produced adenohypophysis promotes development thyroid gland maintenance normal function tsh stimulates thyroid produce release thyroid hormones t4 t3 hypothalamuspituitarythyroid axis measurement tsh frequently included t4 t3 laboratory panel screen evaluate thyroid disease diagnosis thyroid disorders complex requiring combined results thyroid testing indicationsapplications indications tsh testing include following screening congenital hypothyroidism newborns screening subclinical hypothyroidism diagnosis monitoring thyroid disorders monitoring patients receiving thyroid hormone author alina g sofronescu phd assistant professor board certified clinical chemist technical director clinical chemistry laboratory department pathology microbiology university nebraska medical center alina g sofronescu phd member following medical societies american association clinical chemistry canadian society clinical chemists disclosure nothing disclose chief editor thomas wheeler md chairman department pathology immunology wl moody jr professor pathology professor urology baylor college medicine thomas wheeler md member following medical societies alpha omega alpha american association cancer research american medical association american society clinical pathology american society cytopathology american thyroid association american urological association college american pathologists united states canadian academy pathology international society urological pathology harris county medical society disclosure received ownership interest dna seqalliance board membership received stock pathxl medical advisory board mitchell ml hsu hw sahai changing perspectives screening congenital hypothyroidism congenital adrenal hyperplasia curr opin endocrinol diabetes obes medline leger j olivieri donaldson et al espepesslepjspeapegappesispae congenital hypothyroidism consensus conference group european society paediatric endocrinology consensus guidelines screening diagnosis management congenital hypothyroidism j clin endocrinol metab medline lee sl hyperthyroidism medscape drugs diseases full text orlander pr hypothyroidism medscape drugs diseases full text burris ca ashwood er burns de tietz textbook clinical chemistry molecular diagnostics mcpherson ra matthew r pincus mr henrys clinical diagnosis management laboratory methods wallach j interpretation diagnostic tests rugge jb bougatsos c chou r screening treatment thyroid dysfunction evidence review us preventive services task force ann intern med medline gaines das bristow af second international reference preparation thyroidstimulating hormone human immunoassay calibration bioassay immunoassay international collaborative study j endocrinol medline william clarke ed contemporary practice clinical chemistry

Article 17:
management dental patient neurological disease management dental patient neurological disease overview epilepsy stroke management dental patient neurological disease overview epilepsy stroke overview overview epilepsy stroke parkinson disease myasthenia gravis facial paralysis management dental patient neurological disease overview 2091727overview may 23 2013 201508031809 1 dentistry 2002 diseases conditions condition 1 2 content 2091727 502 3029823 49 ssg jun 04 2015 condition diseases conditions dentistry dentistry dentistrymisc miscellaneous topics dentistry dental treatment dental management neurologic disease dental treatment dental management parkinsons disease dental management parkinson disease dental management myasthenia gravis dental management epilepsy stroke dental management stroke patient convulsions seizures parkinson disease parkinsons disease myasthenia gravis epilepsy patients neurological disease require special management considerations include pretreatment treatment planning therapeutic techniques posttreatment requirements 0 management dental patient neurological disease overview patients neurological disease require special management considerations include pretreatment treatment planning therapeutic techniques posttreatment requirements neurologic conditions facing dentist include abnormalities associated cranial nerves facial sensory loss facial paralysis conditions epilepsy parkinson disease multiple sclerosis stroke myasthenia gravis article strategies managing patients conditions presented epilepsy epilepsy describes set conditions associated paroxysmal neurologic function observed seizures include convulsive neurosensory disturbances 10 population estimated epilepsy clinical signs associated tonicclonic convulsions quite distinctive disconcerting dental personnel confronted situation patient dental chair eliminate potential treatment issues guidelines presented prior dental treatment ensure patient compliant medication coverage questions regarding compliance contact patient’s physician ascertain patient toxicity medication taken mental function normal patients taking valproic acid depakene may increased bleeding procedures acknowledged problems order bleeding time assessment prior treatment consult physician values questionable dental treatment aware grand mal seizure could occur seizure occurs place chair back supine position turn patient side keep patient comfortable without restraint passed placement tongue blade recommended unless patient aware impending seizure assist placement injury lip tongue occurs seizure appropriate treatment suturing lacerations localization potential fractures removal fragments followup dental treatment required dental treatment necessitates replacement one missing teeth restoration missing teeth using fixed appliances preferable removaltype prosthetics addition clinician needs cognizant potential fracture anterior fullcoverage restorations complete porcelain crowns may preferable use threequarter gold crowns porcelain veneers concern exists regarding frequency seizures oral medicine aspects monitor gingival hyperplasia secondary use anticonvulsant medication eg phenytoin monitor oral hygiene provide educational information training facilitate patient’s ability manage oral health effectively evidence suggests meticulous oral hygiene may reduce prevent gingival hyperplasia subluxation temporomandibular joint occur seizure episodes specific treatment necessary unless results joint hypermobility subsequent frequent nonseizure subluxation stroke neurovascular accident stroke often fatal may precipitated multiple non–lifethreatening events identified reduce risk acute serious outcome patient dental treatment knowing clinical signs symptoms stroke important managing older patients longstanding cardiovascular disease prior dental treatment clinician aware patients longstanding hypertension cerebrovascular disease increased risk cerebrovascular accident stroke third common cause death united states signs stroke quite subtle major event may associated many transient ischemic attacks tias minor strokes last minutes tia dizziness diplopia hemiplegia altered speech may occur thorough history possible patient symptoms prior treatment may provide useful information regarding possibility impending major event treatment several tias occurring close together often precede major stroke important clinician aware patient experiencing minor event office may major event leaving office leading mortality warning signs severe stroke event include sudden temporary weakness numbness face body parts loss speech difficulty speaking understanding speech visual changes unexplained loss balance dizziness patients identified increased risk stroke pretreatment exhibit signs mild tia occurring treatment followup phone call recommended patient exhibiting signs symptoms tia stroke requires immediate medical referral obvious stroke occurred dental procedure patient’s airway must maintained emergency medical personnel arrive dental treatment patients stroke residual patients experienced physical deficits eg handeye coordination problems arm hand deficit masticatory muscle weakness personal oral hygiene efforts may compromised treatment planning include following comprehensive oral hygiene instruction may include instruction use electric toothbrush large handheld toothbrush water irrigation instrument coupled plaquerevealing tablets running washcloth vestibule help reduce accumulation food matter recommendation regarding anticaries preparations including rinses containing fluoride xylitol use xylitol lozenges eg xylimelts help reduce oral bacterial burden streptococcus mutans possible need antifungal prescription accumulation saliva patients facial palsy may problematic corners mouth predispose patient fungal infection awareness depending type stroke poststroke patient may prescribed anticoagulant medication parkinson disease parkinson disease resulting degeneration cells substantia nigra causes number motor symptoms complicate dental management include tremors involuntary movements facial limb rigidity bradykinesia particularly relates swallowing akathisia ie restlessness dental treatment disabilities must taken consideration following list specific recommendations managing dental patient parkinson disease predental treatment oral hygiene information offered parkinson disease patient stroke patient recommend use electric toothbrush large handheld toothbrush water irrigation instrument coupled plaquerevealing tablets running washcloth vestibule help reduce accumulation food matter patients parkinson disease may able effectively communicate needs family member caregiver present treatment plan presented patient cognitive decline particularly important ensure understanding full risks benefits proposed intervention eg multiple extractions periodontal treatment dental treatment recommendations severe tremors involuntary jaw limb movements present difficulty management patient particularly true patient medication dosage incorrect medication completely effective gain maximum benefit prescribed drugs patients instructed take prescribed medication scheduled dentistry appointments made within short time frame following use since facial musculature tonicity associated parkinson disease lead patient’s inability express emotion important treating clinician sympathetic attentive eye limb movements could suggest pain procedure bradykinesia causes swallowing difficulty also potential problem parkinson disease patients treatment adequate suction fluid imperative dental procedures including involving dental hygiene temperature regulation may compromised patient comorbid shydrager disease abnormality autonomic nervous system placement blanket patient may help maintain warmth dental reconstruction involves occlusal surfaces needs tailored fact bruxism may severe patients parkinson disease occlusion placed restorations kept flat possible avoid breakage restoration teeth care taken overstress patient parkinson disease short appointments helpful patient parkinson disease may difficulty placing oral sleepapnea appliance approach management sleep apnea discouraged apnea confounding problem medical consultation required use continuous positiveairway pressure cpap device considered parkinson patients develop temporomandibular joint problems particularly hypermobility mandible frequent subluxation difficult problem treat patient also comorbid severe bruxism cases patients benefit herbst appliances strong elastics worn night however problem patient placement face muscle rigidity bradykinesia also concern cases myasthenia gravis myasthenia gravis results generalized muscle weakness including muscles face tongue neck patients myasthenia gravis may hold jaws slack position mouth open problem becomes worse towards end day fatigue stress dental considerations dental treatment scheduled time patient fatigued preferably remission disease appointments need made 12 hours patient taken medication anticholinesterase eg pyridostigmine preferably morning consideration made reducing stress prior dental appointment anxious patients may benefit low dose anxiolytic benzodiazepine diazepam valium lorazepam ativan taken prior treatment procaine anesthetics used local anesthesia patient dental abscess antibiotics penicillin erythromycin safely used treat infection drugs avoided include tetracyclines clindamycin lincomycin sulphonamides aminoglycosides pain paracetamol coupled narcotic eg codeine may helpful aspirin associated cholinergic crisis patients taking anticholinesterases avoided since patients myasthenia gravis often impaired respiration special consideration needs taken maintaining oxygenation procedures involving conscious sedation fact best treat patients inpatient hospital setting drugs often used conscious sedation eg opioids barbiturates may potentiate aggravate breathing difficulty myasthenia gravis patients facial paralysis conditions causing loss function seventh cranial nerve include multiple sclerosis infection eg syphilis hiv disease lyme disease leprosy sarcoidosis cholesteatoma bell palsy several intracranial problems eg tumor trauma upper lower motor neuron abnormality differentiated resulting loss function many conditions affect oral health dental considerations loss taste occur associated abnormality chorda tympani cases involving bell palsy corneas protected dental treatment cases facial palsy may accumulation food debris potentially increasing dental plaque patients instructed techniques used eating aimed eliminating material leaking saliva corners mouth may predispose patient angular cheilitis antifungal cream appropriately placed may useful fungal infection emerges placement splint may helpful improving facial aesthetics approaches may include appliances anchored teeth suturing may also useful pain region eartemporomandibular joint may result inflammation geniculate ganglia facial nerve avoidance misdiagnosis temporomandibular joint pathology important facial dyskinesias lead tongue jaw movement confound dental treatment bruxism lead tooth wear fracture patients facial dyskinesias may benefit predental treatment prescription benzodiazepine sensory deficits associated conditions involving fifth cranial nerve may result conditions paget disease peripheral lesions involving bones canals brain stem lesions affect mastication cause mouthopening difficulty facial paralysis result alveolar nerve blocks cases permanent author jeff burgess dds msd retired clinical assistant professor department oral medicine university washington school dental medicine retired attending pain center university washington medical center retired private practice hawaii washington director oral care research associates disclosure nothing disclose chief editor arlen meyers md mba professor otolaryngology dentistry engineering university colorado school medicine arlen meyers md mba member following medical societies american academy facial plastic reconstructive surgery american academy otolaryngologyhead neck surgery american head neck society disclosure served director officer partner employee advisor consultant trustee medvoytestappropriatecerescanempiricanrxrevubrreceived none allergy solutions inc board membership received honoraria rxrevu chief medical editor received salary medvoy founder president received consulting fee corvectra senior medical advisor received ownership interest cerescan consulting received consulting fee essiahealth advisor received consulting fee carespan advisor received consulting fee covidien consulting scully c cawson ra eds neurologic disease facial pain medical problems dentistry reid ay metcalfe patten sb wiebe macrodimitris jetté n epilepsy associated unmet health care needs compared general population despite higher health resource utilizationa canadian populationbased study epilepsia medline kosyfaki p woerner w att w prosthodontic treatment partially edentulous patient complex medical history epilepsy deep vein thrombosis case report quintessence int medline capp pl de faria siqueira sr cillo mt prado eg de siqueira jt special care dentistry midazolam conscious sedation patients neurological diseases eur j paediatr dent medline ferreira mc guare ro prokopowitsch santos mt prevalence dental trauma individuals special needs dent traumatol medline alaali barnes gd froehlich jb kaatz management oral anticoagulation patients undergoing minor dental procedures j mich dent assoc medline asberg kh wertsén wårdh impaired oral health stroke growing problem increased cooperation care dental care possible factor progress lakartidningen medline mccreary c ní ríordáin r oral medicine elderly dent update medline mccreary c ni riordáin r systemic diseases elderly dent update medline chávez em ship ja sensory motor deficits elderly impact oral health j public health dent medline grover rhodus nl dental management parkinsons disease northwest dent medline debowes sl tolle sl bruhn parkinsons disease considerations dental hygienists int j dent hyg medline friedlander ah mahler norman km ettinger rl parkinson disease systemic orofacial manifestations medical dental management j dent assoc medline hockstein ng samadi ds gendron k handler sd sialorrhea management challenge fam physician medline brailsford sr fiske j gilbert clark beighton effects combination chlorhexidinethymol fluoridecontaining varnishes severity root caries lesions frail institutionalised elderly people j dent medline lotia randall c dawson lj longman lp dental management myasthenic patient dent update medline tolle l myasthenia gravis review dental hygienists j dent hyg medline yarom n barnea e nissan j gorsky dental management patients myasthenia gravis literature review oral surg oral med oral pathol oral radiol endod medline patil pm singh g patil sp dentistry myasthenia gravis patient review current state art oral surg oral med oral pathol oral radiol medline pregerson b myasthenia gravis elderly man slurred speech consultantlivecom available httpwwwconsultantlivecomnervoussystemdiseasescontentarticle101622111633 bagchi g nath dk restoration facial symmetry patient bell palsy using modified maxillary complete denture case report int j prosthodont medline pereira fp guskuma mh luvizuto er faco ef magrofilho hochulivieira e unilateral facial paralysis caused ramsay hunt syndrome j craniofac surg medline selvi f guven e mutlu clinical management microstomia due static treatment facial paralysis oral rehabilitation dental implants j craniofac surg medline chevalier v arbabchirani r tea sh roux facial palsy inferior alveolar nerve block case report review literature int j oral maxillofac surg medline sajjan mc krishna rg lipsupport prosthesisa unique approach management bilateral facial palsy quintessence int medline

Article 18:
creatinine clearance creatinine clearance reference range interpretation collection panels creatinine clearance reference range interpretation collection panels overview reference range interpretation collection panels background creatinine clearance overview 2117892overview may 07 2013 201506200510 1 laboratory medicine 2002 laboratory medicine lab 1 2 content 2117892 505 43 age12 jun 04 2015 lab laboratory medicine laboratorymedicine laboratory medicine laboratorymedicinelabmed laboratory medicine creatinine clearance creatinine creatinine lab test creatinine lab testing creatinine test glomerular filtration rate gfr heart failure renal failure hypoperfusion hypovolemic shock azotemia chronic kidney disease serum male serum reference ranges follows infant established age 12 years 01–0 0 creatinine clearance reference range serum male serum reference ranges follows infant established age 12 years 01–04 mgdl age 34 years 01–05 mgdl age 59 years 0206 mgdl age 1011 years 0307 mgdl age 1213 years 0408 mgdl age 1415 years 0509 mgdl age 16 years older 0813 mgdl female serum reference ranges follows infant established age 13 years 01–04 mgdl age 45 years 02–05 mgdl age 68 years 0306 mgdl age 915 years 0407 mgdl age 16 years older 0611 mgdl urine normal range 24hour urine creatinine level 5002000 mgday interpretation creatinine clearance widely used value estimate glomerular filtration rate gfr decrease creatinine clearance indicates decreased gfr impaired renal function increased creatinine clearance often called hyperfiltration usually seen pregnancy patients diabetes mellitus diabetic nephropathy occurred may also occur large dietary protein intake plasma volume expansion information see medscape reference topics chronic kidney disease acute renal failure heart failure hypovolemic shock azotemia collection panels serum urine needed serum collection must obtained within 24 hours urine collection serum specimen see list containertube red top serum gel specimen volume 1 ml minimum volume 05 ml collection instructions label specimen serum specimen stability refrigerated preferred frozen urine specimen container plastic urine container without 6n hcl specimen volume 10ml aliquot entire collection minimum volume 05ml aliquot special instructions record total 24hour urine volume request form collection instructions instruct patient void 8 discard specimen collect urine including final specimen voided end 24hour collection period ie 8 next morning secure container send laboratory note samples gross hemolysis gross lipemia rejected background glomerular filtration rate gfr commonly assessed via creatinine clearance test requires measurement serum creatinine urine creatinine 24hour urine volume creatinine product metabolism dietary meat creatine skeletal muscle exception extreme muscle exertion muscle breakdown rhabdomyolysis creatinine stable plasma concentration released circulation relatively constant rate creatinine freely filtered across glomerulus kidney reabsorb metabolize creatinine proximal tubules secrete approximately 15 urinary creatinine patients normal gfr patients declining renal function progressively higher percentage secreted net effect progressive overestimation gfr severe loss renal function ignoring proximal tubular secretion filtered creatinine gfr product serum creatinine concentration excreted equal product urine creatinine concentration ucr urine flow rate volume v expressed follows gfr x serum creatinine concentration ucr x v gfr ucr x vserum creatinine concentration formula provides creatinine clearance however formula tends overestimate real gfr approximately 15 percent maximize accuracy creatinine clearance usually determined 24hour urine collection shortertimed collections less accurate owing bladder retention variability creatinine excretion see formula creatinine clearance 70135 mlminsurface area surface area adults younger 50 years daily creatinine clearance 2025 mgkg ideal body weight males 1520 mgkg ideal body weight females adults older 50 years daily creatinine clearance decreases progressively owing reduction muscle mass gfr suddenly decreases 50 kidneys transiently filter excrete half much creatinine causing accumulation creatinine body fluids raising plasma concentrations plasma concentrations creatinine continue rise filtered load creatinine p cr cr gfr falls one fourth normal plasma creatinine increases 4 times normal decrease gfr one eighth normal would raise plasma creatinine 8 times normal thus steadystate conditions creatinine excretion rate equals rate creatinine production despite reductions gfr however normal rate creatinine excretion occurs expense elevated plasma creatinine concentration ideally inulin clearance accurate measure gfrcreatinine clearance freely filtered reabsorbed secreted kidneys however main limiting factor administer intravenously substances used radioactive iothalamate creatinine combined creatinine–cystatin c equation performed better equations based either markers alone may useful confirmatory test chronic kidney disease indicationsapplications assess renal function using gfr limitations accurate results depend accurately timed complete collection incomplete urine collections result underestimation creatinine excretion therefore gfr one major limitations creatinine clearance testing becomes less accurate gfr declines increasing tubular secretion creatinine results gfr overestimated sex race alter creatinine clearance women lower serum creatinine values less muscle mass lower rate creatinine production lower values latinos higher values blacks probably indicate greater lesser muscle mass creatinine production respectively creatinine production differs time individuals significant variations dietary intake eg vegetarian diet creatine supplementation reduction muscle mass eg amputation muscle wasting malnutrition produce different amounts creatinine general population amputees reduced creatinine production proportional amount muscle removed eg lower extremity significant upper extremity drugs increase serum creatinine level decreasing creatinine secretion drugs include trimethoprim usually combined sulfamethoxazole advanced kidney failure extrarenal intestinal creatinine elimination increases serum creatinine concentration lower would expected gfr result intestinal bacterial overgrowth increased bacterial creatininase activity colorimetric serum creatinine assay alkaline picrate method crossreacts noncreatinine chromogens particularly acetoacetate patients diabetic ketoacidosis start media serum vacuette 6ml tube serum vacuette 6ml tube author rakesh vadde mbbs fellow pulmonary medicine interfaith medical center rakesh vadde mbbs member following medical societies american college chest physicians american college physicians american thoracic society disclosure nothing disclose coauthors frances j schmidt md chief pulmonary medicine pulmonary fellowship program teaching attending physician department medicine interfaith medical center frances j schmidt md member following medical societies american college chest physicians american college physicians disclosure nothing disclose bikash bhattarai md fellow pulmonary medicine interfaith medical center bikash bhattarai md member following medical societies american college chest physicians american college physicians american thoracic society disclosure nothing disclose chief editor eric b staros md associate professor pathology st louis university school medicine director clinical laboratories director cytopathology department pathology st louis university hospital eric b staros md member following medical societies american medical association american society clinical pathology college american pathologists association molecular pathology disclosure nothing disclose rose bd post tw clinical physiology acidbase electrolyte disorders perrone rd madias ne levey serum creatinine index renal function new insights old concepts clin chem medline kim ke onesti g ramirez brest swartz c creatinine clearance renal disease reappraisal br med j medline full text levey measurement renal function chronic renal disease kidney int medline stevens la levey measured gfr confirmatory test estimated gfr j soc nephrol medline lubowitz h slatopolsky e shankel rieselbach bricker ns glomerular filtration rate determination patients chronic renal disease jama medline walser creatinine excretion measure protein nutrition adults varying age jpen j parenter enteral nutr medline levey perrone rd madias ne serum creatinine renal function annu rev med medline van acker ba koomen gc koopman mg de waart dr arisz l creatinine clearance cimetidine administration measurement glomerular filtration rate lancet medline guyton ac hall je gutyon hall textbook medical physiology inker la schmid ch tighiouart h et al estimating glomerular filtration rate serum creatinine cystatin c n engl j med medline dunn sr gabuzda gm superdock kr kolecki rs schaedler rw simenhoff ml induction creatininase activity chronic renal failure timing creatinine degradation effect antibiotics j kidney dis medline mayo medical laboratories creatinine clearance available httpwwwmayomedicallaboratoriescomtestinfopediatricrefvaluesreferencephpunitcode8500

Article 19:
chads2 score stroke risk assessment atrial fibrillation chads2 score stroke risk assessment atrial fibrillation chads2 score stroke risk assessment atrial fibrillation chads2 score stroke risk assessment atrial fibrillation chads2 score stroke risk assessment atrial fibrillation overview chads2 score stroke risk assessment atrial fibrillation chads2 score stroke risk assessment atrial fibrillation overview 2172597overview may 20 2014 201506052104 1 protocols 2002 tables protocols table 1 2 content 2172597 508 390 2 ssg jun 04 2015 table tables protocols protocols protocols protocolsprotocols tables protocols first published 2001 chads2 index congestive heart failure hypertension age 75 years diabetes mellitus stroke developed accurately predict risk stroke patients nonvalvular atrial fibrillation index derived combining risk factors prior studies testing validity coho 0 chads2 score stroke risk assessment atrial fibrillation chads2 score stroke risk assessment atrial fibrillation first published 2001 chads2 index congestive heart failure hypertension age 75 years diabetes mellitus stroke developed accurately predict risk stroke patients nonvalvular atrial fibrillation table 1 chads 2 score chads 2 1 point congestive heart failure 1 point hypertension 1 point age 75 years 1 point diabetes mellitus 2 points stroketransient ischemic attack table 2 treatment recommendations based chads 2 chads 2 risk recommendation 0 low aspirin 81325 mg daily 1 intermediate aspirin 81325 mg daily warfarin inr 20–30 based patient preference 2 high chads 2 2 warfarin inr 2030 unless reasons avoid table 3 chads 2 chads 2 annual stroke risk 0 19 1 28 2 4 3 59 4 85 5 125 6 182 see also medscapes atrial fibrillation chads2 score stroke risk author ethan levine director cardiac electrophysiology arnot ogden medical center ethan levine member following medical societies american college cardiology american heart association heart rhythm society disclosure nothing disclose gage bf waterman ad shannon w boechler rich mw radford mj validation clinical classification schemes predicting stroke results national registry atrial fibrillation jama medline atrial fibrillation investigators risk factors stroke efficacy antithrombotic therapy atrial fibrillation analysis pooled data five randomized controlled trials arch intern med medline stroke prevention atrial fibrillation iii writing committee patients nonvalvular atrial fibrillation low risk stroke treatment aspirin stroke prevention atrial fibrillation iii study spaf iii writing committee stroke prevention atrial fibrillation investigators jama medline

Article 20:
hyponatremia hyponatremia practice essentials background pathophysiology hyponatremia clinical presentation history physical causes hyponatremia differential diagnoses hyponatremia workup laboratory studies imaging studies hyponatremia treatment management approach considerations medical care diet hyponatremia medication diuretics antibiotics arginine vasopressin antagonists hyponatremia followup inpatient care complications prognosis hyponatremia practice essentials background pathophysiology hyponatremia clinical presentation history physical causes hyponatremia differential diagnoses hyponatremia workup laboratory studies imaging studies hyponatremia treatment management approach considerations medical care diet hyponatremia medication diuretics antibiotics arginine vasopressin antagonists hyponatremia followup inpatient care complications prognosis overview practice essentials background pathophysiology frequency mortalitymorbidity presentation history physical causes differential diagnoses workup laboratory studies imaging studies treatment approach considerations medical care diet medication followup inpatient care complications prognosis patient education hyponatremia overview hyponatremia clinical presentation hyponatremia differential diagnoses hyponatremia workup hyponatremia treatment hyponatremia medication hyponatremia followup 242166overview jul 09 2015 201508131723 0 nephrology 2002 diseases conditions condition 1 2 content 242166 502 678 44 ssg jul 09 2015 condition diseases conditions nephrology nephrology nephrologyacidbase acidbase fluid electrolyte disorders hyponatremia siadh electrolyte electrolytes electrolyte imbalance sodium deficiency furosemide hypertonic hyponatremia hyponatraemia hyponatremia treatment hyponatremia causes hyponatremia correction tolvaptan conivaptan cerebral salt wasting normotonic hyponatremia hypotonic hyponatremia normovolemic hypotonic hyponatremia euvolemic hypotonic hyponatremiaabnormal electrolyte level abnormal electrolyte distribution congestive heart failure liver failure renal failure hyperlipidemia paraproteinemia pseudohyponatremia liver cirrhosis nephrotic syndrome severe hypoproteinemia syndrome inappropriate adh secretion severe hypothyroidism adrenal insufficiency hyponatremia defined serum sodium level less 135 meql considered severe serum level 125 meql many medical illnesses congestive heart failure liver failure renal failure pneumonia may associated hyponatremia 0 hyponatremia overview practice essentials hyponatremia defined serum sodium level less 135 meql considered severe serum level 125 meql many medical illnesses congestive heart failure liver failure renal failure pneumonia may associated hyponatremia signs symptoms symptoms range nausea malaise mild reduction serum sodium lethargy decreased level consciousness headache severe seizures coma overt neurologic symptoms often due low serum sodium levels usually 115 meql resulting intracerebral osmotic fluid shifts brain edema hyponatremia classified according volume status follows hypovolemic hyponatremia decrease total body water greater decrease total body sodium euvolemic hyponatremia normal body sodium increase total body water hypervolemic hyponatremia increase total body sodium greater increase total body water hyponatremia subclassified according effective osmolality follows hypotonic hyponatremia isotonic hyponatremia hypertonic hyponatremia see clinical presentation diagnosis three essential laboratory tests evaluation patients hyponatremia together history physical examination help establish primary underlying etiologic mechanism urine osmolality serum osmolality urinary sodium concentration urine osmolality urine osmolality helps differentiate conditions associated impaired freewater excretion primary polydipsia urine osmolality greater 100 mosmkg indicates impaired ability kidneys dilute urine serum osmolality serum osmolality readily differentiates true hyponatremia pseudohyponatremia latter may secondary hyperlipidemia hyperproteinemia may hypertonic hyponatremia associated elevated glucose mannitol glycine posturologic postgynecologic procedure sucrose maltose contained igg formulations urinary sodium concentration urinary sodium concentration helps differentiate hyponatremia secondary hypovolemia syndrome inappropriate antidiuretic hormone secretion siadh siadh saltwasting syndrome urine sodium greater 2040 meql hypovolemia urine sodium typically measures less 25 meql however sodium intake patient siadh saltwasting happens low urine sodium may fall 25 meql see workup management hypotonic hyponatremia accounts clinical cases hyponatremia treated fluids acute hyponatremia duration 48 hours safely corrected quickly chronic hyponatremia treatment hypertonic pseudohyponatremia directed underlying disorder absence symptoms intravenous fluids water restriction administer isotonic saline patients hypovolemic replace contracted intravascular volume patients hypovolemia secondary diuretics may also need potassium repletion like sodium osmotically active treat patients hypervolemic salt fluid restriction plus loop diuretics correction underlying condition use v2 receptor antagonist may considered euvolemic asymptomatic hyponatremic patients free water restriction 1 lday generally treatment choice role hypertonic saline patients treating patients overtly symptomatic hyponatremia eg seizures severe neurologic deficits hypertonic 3 saline used pharmacologic treatment conivaptan v1a v2 vasopressin receptor antagonist available intravenous use approved use hospital setting euvolemic hypervolemic hyponatremia contraindicated hypovolemic patients induces water sodium diuresis improvement plasma sodium levels see treatment medication background hyponatremia important common electrolyte abnormality seen isolation often case complication medical illnesses sodium dominant extracellular cation cannot freely cross cell membrane homeostasis vital normal physiological function cells normal serum sodium level 135145 meql hyponatremia defined serum level less 135 meql considered severe serum level 125 meql joint european guidelines classify hyponatremia adults follows mild serum sodium concentration 130134 mmoll moderate serum sodium concentration 125129 mmoll profound serum sodium concentration 125 mmoll article reviews epidemiology pathophysiology differential diagnosis evaluation treatment disorder pathophysiology hypoosmolality serum osmolality 280 mosmkg always indicates excess total body water relative body solutes excess water relative solute extracellular fluid ecf water moves freely intracellular extracellular compartments imbalance due solute depletion solute dilution combination normal conditions renal handling water sufficient excrete much 1520 l free water per day bodys response decreased osmolality decreased thirst thus hyponatremia occur condition impairs normal free water excretion recommendations treatment hyponatremia rely current understanding cns adaptation altered serum osmolality setting acute drop serum osmolality neuronal cell swelling occurs due water shift extracellular space intracellular space ie starling forces swelling brain cells elicits following two osmoregulatory responses inhibits arginine vasopressin secretion neurons hypothalamus hypothalamic thirst center leads excess water elimination dilute urine immediate cellular adaptation loss electrolytes next days gradual loss organic intracellular osmolytes therefore correction hyponatremia must take account chronicity condition acute hyponatremia duration 48 h safely corrected quickly chronic hyponatremia correction serum sodium rapid precipitate severe neurologic complications individuals present diagnosis versus individuals develop inpatient setting hyponatremia time condition chronic correction proceed accordingly frequency united states incidence hyponatremia depends largely patient population criteria used establish diagnosis among hospitalized patients 1520 serum sodium level 135 meql 14 serum sodium level less 130 meql prevalence hyponatremia lower ambulatory setting mortalitymorbidity severe hyponatremia 125 meql high mortality rate instances serum sodium level less 105 meql mortality 50 especially alcoholics meld score calculator race hyponatremia affects races sex sexual predilection exists hyponatremia however symptoms likely occur young women men age hyponatremia common elderly persons increased incidence comorbid conditions eg cardiac hepatic renal failure complicated clinical presentation history patients may present medical attention symptoms related low serum sodium concentrations however many patients present due manifestations medical comorbidities hyponatremia recognized secondarily many people therefore recognition entirely incidental patients may develop clinical symptoms due cause hyponatremia hyponatremia many medical illnesses congestive heart failure liver failure renal failure pneumonia may associated hyponatremia patients frequently present primary disease symptomatology eg dyspnea jaundice uremia cough symptoms range nausea malaise mild reduction serum sodium lethargy decreased level consciousness headache severe seizures coma overt neurologic symptoms often due low serum sodium levels usually 115 meql resulting intracerebral osmotic fluid shifts brain edema neurologic symptom complex lead tentorial herniation subsequent brain stem compression respiratory arrest resulting death severe cases severity neurologic symptoms correlates well rate degree drop serum sodium gradual drop serum sodium even low levels may tolerated well occurs several days weeks neuronal adaptation presence underlying neurologic disease like seizure disorder nonneurologic metabolic abnormalities like hypoxia hypercapnia acidosis also affects severity neurologic symptoms interviewing patient obtaining detailed medication history including information overthecounter otc drugs patient using important many medications may precipitate hyponatremia eg antipsychotic medications diuretics dietary history reference salt protein water intake useful well patients hospitalized reviewing records parenteral fluids administered crucial physical examination include orthostatic vital signs accurate assessment volume status determination ie hypervolemic euvolemic hypovolemic often guides treatment decisions full assessment medical comorbidities also essential particular attention paid cardiopulmonary neurologic components examination causes although differential diagnosis quite broad hyponatremia divided following clinically useful groupings hypertonic hyponatremia patients hypertonic hyponatremia normal total body sodium dilutional drop measured serum sodium due presence osmotically active molecules serum causes water shift intracellular compartment extracellular compartment glucose produces drop serum sodium level 16 meql 100 mgdl serum glucose greater 100 mgdl relationship nonlinear greater reduction plasma sodium concentrations glucose concentrations 400 mgdl making 24 meql 100 mgdl increase glucose 100 mgdl accurate correction factor glucose greater 400 mgdl examples osmotically active molecules include mannitol often used treat brain edema maltose used intravenous immunoglobulin administration normotonic hyponatremia severe hyperlipidemia paraproteinemia lead low measured serum sodium concentrations normal serum osmolality normally plasma water comprises 9294 plasma volume plasma water fraction falls increase fats proteins measured sodium concentration total plasma volume respectively reduced although plasma water sodium concentration plasma osmolality unchanged artifactual low sodium socalled pseudohyponatremia secondary measurement flame photometry avoided direct ionselective electrode measurement hyponatremia posttransurethral resection prostate turp hysteroscopy caused absorption irrigants glycine sorbitol mannitol contained nonconductive flushing solutions used degree hyponatremia related quantity rate fluid absorbed plasma osmolality also variable changes time presence relatively large osmolal gap due excess organic solute diagnostic appropriate clinical setting symptomatic patients treated depending plasma osmolality volume status hypertonic saline hypoosmolar state loop diuretic volumeoverloaded patients normal renal function hemodialysis correct hyponatremia remove glycine toxic metabolites used patients endstage renal disease use isotonic saline irrigant instead glycine new bipolar resectoscope turp highrisk patients large prostates require lengthy resection could avoid complication making disorder diagnosis past hypotonic hyponatremia hypotonic hyponatremia always reflects inability kidneys handle excretion free water match intake divided pathophysiologically following categories according effective intravascular volume hypovolemic hypervolemic euvolemic clinically relevant groupings aid determination likely underlying etiology guide treatment hypovolemic hypotonic hyponatremia usually indicates concomitant solute depletion patients presenting orthostatic symptoms pathophysiology underlying hypovolemic hypotonic hyponatremia complex involves interplay carotid baroreceptors sympathetic nervous system reninangiotensin system antidiuretic hormone adh secretion vasopressin renal tubular function setting decreased intravascular volume eg severe hemorrhage severe volume depletion secondary gi renal loss diuretic use owing decreased stretch baroreceptors great veins aortic arch carotid bodies increased sympathetic tone maintain systemic blood pressure generally occurs increased sympathetic tone along decreased renal perfusion secondary intravascular volume depletion results increased renin angiotensin excretion turn results increased sodium absorption proximal tubules kidney consequent decreased delivery solutes distal diluting segments causing impairment renal free water excretion also concomitant increase serum adh production impairs free water excretion angiotensin also potent stimulant thirst free water intake increased time water excretion limited together changes lead hyponatremia cerebral salt wasting csw seen intracranial disorders subarachnoid hemorrhage carcinomatous infectious meningitis metastatic carcinoma especially neurologic procedures disruption sympathetic neural input kidney normally promotes salt water reabsorption proximal nephron segment various indirect direct mechanisms might cause renal salt wasting resulting reduced plasma volume plasma renin aldosterone levels fail rise appropriately patients csw despite reduced plasma volume disruption sympathetic nervous system addition release 1 natriuretic factors could also play role renal salt wasting seen csw volume depletion leads elevation plasma vasopressin levels impaired free water excretion distinguishing csw syndrome inappropriate adh secretion siadh challenging considerable overlap clinical presentation vigorous salt replacement required patients csw whereas fluid restriction treatment choice patients siadh infusion isotonic saline correct volume depletion usually effective reversing hyponatremia cerebral salt wasting since euvolemia suppress release adh disorder usually transient resolution occurring within 34 weeks disease onset saltwasting nephropathy causing hypovolemic hyponatremia may rarely develop range renal disorders eg interstitial nephropathy medullary cystic disease polycystic kidney disease partial urinary obstruction low salt intake diuretics may induce hypovolemic hyponatremia note thiazide diuretics contrast loop diuretics impair diluting mechanism without limiting concentrating mechanism thereby impairing ability excrete free water load thus thiazides prone causing hyponatremia loop diuretics particularly elderly persons already impaired diluting ability hypervolemic hypotonic hyponatremia characterized clinically detectable edema ascites signifies increase total body water sodium paradoxically however decrease effective circulating volume critical tissue perfusion stimulates pathophysiologic mechanism impaired water excretion kidney observed hypovolemic hypotonic hyponatremia commonly encountered examples include liver cirrhosis congestive heart failure nephrotic syndrome severe hypoproteinemia albumin level 152 gdl normovolemic euvolemic hypotonic hyponatremia common cause hyponatremia patients hospitalized associated nonosmotic nonvolume related vasopressin adh secretion ie siadh secondary variety clinical conditions including cns disturbances major surgery trauma pulmonary tumors infection stress certain medications common medications associated siadh follows chlorpropamide potentiating renal action adh carbamazepine possesses antidiuretic property cyclophosphamide marked water retention secondary siadh potentially fatal hyponatremia may ensue selected cases use isotonic saline rather free water maintain high urine output prevent hemorrhagic cystitis minimize risk vincristine vinblastine amitriptyline haloperidol selective serotonin reuptake inhibitors particularly elderly patients monoamine oxidase mao antidepressants circumstances ability kidney dilute urine setting serum hypotonicity reduced hyponatremia relatively common adverse effect desmopressin vasopressin analogue acts pure v2 agonist common use treatment central diabetes insipidus von willebrand disease nocturia adults enuresis children requires regular monitoring serum sodium levels diagnostic criteria siadh follows normal hepatic renal cardiac function clinical euvolemia absence intravascular volume depletion normal thyroid adrenal function hypotonic hyponatremia urine osmolality greater 100 mosmkg generally greater 400500 mosmkg normal renal function urinary sodium concentrations also typically greater 20 meql normal salt diet sodium excretion reflect dietary sodium intake serum uric acid levels generally reduced due reduced tubular uric acid reabsorption parallels decrease proximal tubular sodium reabsorption associated central volume expansion findings also found renal salt wasting process similarity makes differentiation salt wasting siadh difficult except renal wasting one would expect find hypovolemic state reset osmostat another important cause normovolemic hypotonic hyponatremia may occur elderly patients pregnancy patients regulate serum osmolality around reduced set point however contrast patients siadh also downward resetting osmotic threshold thirst severe hypothyroidism unknown mechanism possibly secondary low cardiac output glomerular filtration rate adrenal insufficiency also associated nonosmotic vasopressin release impaired sodium reabsorption leading hypotonic hyponatremia hyponatremia associated cortisol deficiency primary secondary hypoadrenalism commonly presents subtly may go undiagnosed random cortisol level check especially acute illness misleading level normal high testing adrenal insufficiency hypothyroidism part hyponatremic workup disorders respond promptly hormone replacement depending etiology mineralocorticoid also need replacement hospitalized patients infected human immunodeficiency virus hiv high incidence hyponatremia individuals hyponatremia usually due least one following three disorders associated increased adh level increased release adh due malignancy occult symptomatic infection central nervous system pneumonia resulting infection pneumocystis carinii effective volume depletion secondary fluid loss gastrointestinal tract due primarily infectious diarrhea adrenal insufficiency often due adrenalitis abnormality may infectious origin perhaps induced cytomegalovirus mycobacterium aviumintracellulare causes causes fit neatly categories may may associated elevated levels adh simply overwhelm capacity kidneys properly excrete excess water common precipitant hyponatremia patients surgery severe malnutrition seen weightconscious women low protein high water intake diet special condition markedly decreased intake solutes occurs limits ability kidney handle free water mandatory solute loss 50100 mosmkg urine exists free water intake excess solute needs produce hyponatremia compulsive intake large amounts free water exceeding diluting capacity kidneys 20 ld even normal solute intake 600900 mosmd may also result hyponatremia contrast siadh urine maximally dilute addition central defect thirst regulation plays important role pathogenesis primary polydipsia different abnormalities adh regulation identified psychotic patients impairing free water excretion transient stimulation adh release acute psychotic episodes increase net renal response adh downward resetting osmostat antipsychotic medication may contribute limiting water intake rapidly raise plasma sodium concentration excess water readily excreted dilute urine acute hyponatremia associated ultraendurance athletes marathon runners women making higher percentage strongest single predictor weight gain race correlating excessive fluid intake longer racing time body mass index extremes also associated hyponatremia whereas composition fluids consumed plain water rather sports drinks containing electrolytes oxidization glycogen triglyceride race associated production bound water becomes endogenous electrolytefree water infusion contributing hyponatremia induced water ingestion excess water losses noted collapsed runners normonatremic even hypernatremic nonsteroidal antiinflammatory drug nsaid use may increase risk development hyponatremia strenuous exercise inhibiting prostaglandin formation prostaglandins natriuretic effect prostaglandin depletion increases nacl reabsorption thick ascending limb henle ultimately increasing medullary tonicity adh action collecting duct leading impaired free water excretion symptomatic potentially fatal hyponatremia develop rapid onset ingestion designer drug ecstasy methylenedioxymethamphetamine mdma amphetamine marked increase water intake via direct thirst stimulation well inappropriate secretion adh contributes hyponatremia seen even small amount drug intake nephrogenic syndrome inappropriate antidiuresis nsiad siadhlike clinical laboratory picture seen male infants present neurologic symptoms secondary hyponatremia undetectable plasma arginine vasopressin avp levels hereditary disorder secondary mutations v2 vasopressin receptor resulting constitutive activation receptor elevated camp production collecting duct principle cells treatment nsiad poses challenge water restriction improves serum sodium levels osmolality infants limits calorie intake formulafed infants use demeclocycline lithium potentially limited adverse effects current therapy choice fluid restriction use oral urea induce osmotic diuresis hyponatremic hypertensive syndrome rare condition consists severe hypertension associated renal artery stenosis hyponatremia hypokalemia severe thirst renal dysfunction characterized natriuresis hypercalciuria renal glycosuria proteinuria angiotensinmediated thirst coupled nonosmotic release vasopressin provoked angiotensin ii andor hypertensive encephalopathy likely mechanisms syndrome sodium depletion due pressure natriuresis potassium depletion due hyperaldosteronism high plasma renin activity also likely play role pathogenesis hyponatremia abnormalities resolve correction renal artery stenosis using retrospective case note analysis irish study examined incidence hyponatremia variety neurologic conditions p p p p investigators also determined median hospital stay patients hyponatremia 19 days compared median stay 12 days studys patients differential diagnoses diagnostic considerations problems consider differential diagnosis follows hyperlipidemia paraproteinemia pseudohyponatremia adrenal crisis alcoholism cardiogenic pulmonary edema cirrhosis hypothyroidism workup laboratory studies three essential laboratory tests evaluation patients hyponatremia together history physical examination help establish primary underlying etiologic mechanism general etiology hyponatremia directs management tests follows urine osmolality serum osmolality urinary sodium concentration urine osmolality helps differentiate conditions associated impaired free water excretion primary polydipsia water excretion normal provided intact kidney function primary polydipsia malnutrition severe decreased solids intake reset osmostat urine osmolality maximally dilute generally less 100 mosmkg urine osmolality greater 100 mosmkg indicates impaired ability kidneys dilute urine usually secondary elevated vasopressin antidiuretic hormone adh levels appropriate inappropriate serum osmolality readily differentiates true hyponatremia pseudohyponatremia secondary hyperlipidemia hyperproteinemia hypertonic hyponatremia sources hypertonic hyponatremia include elevations following glucose mannitol glycine urologic gynecologic procedures sucrose maltose contained igg formulations urinary sodium concentration helps differentiate hyponatremia secondary hypovolemia syndrome inappropriate adh secretion ancillary tests serum uric acid levels important supportive information typically reduced siadh also reduced salt wasting correction hyponatremia hypouricemia corrects siadh remains saltwasting process thyroidstimulating hormone tsh serum cortisol levels measured hypothyroidism hypoadrenalism suspected serum albumin triglycerides serum protein electrophoresis also may indicated particular patients imaging studies head computed tomography ct scanning chest radiography used assess underlying etiology select patients suspected siadh cerebral salt wasting treatment management approach considerations recommendations treatment hyponatremia rely current understanding central nervous system cns adaptation alteration serum osmolality setting acute fall serum osmolality neuronal cell swelling occurs due water shift extracellular space intracellular space ie starling forces therefore correction hyponatremia take account limited capacity adaptation mechanism respond acute alteration serum tonicity degree brain edema consequent neurologic symptoms depend much rate duration hypotonicity magnitude panel united states experts hyponatremia issued guidelines diagnosis evaluation treatment hyponatremia 2007 guidelines updated 2013 severe symptoms 100 ml 3 nacl infused intravenously 10 minutes × 3 needed mild moderate symptoms patients low risk herniation 3 nacl infused 05–2 mlkgh avoid osmotic demyelination syndrome ods patients chronic hyponatremia known duration 48 hours recommendations include following minimum correction serum sodium 48 mmoll per day lower goal 46 mmoll per day risk ods high patients high risk ods maximum correction 8 mmoll 24hour period patients normal risk ods maximum correction 1012 mmoll 24hour period 18 mmoll 48hour period patients inappropriate antidiuretic hormone secretion siadh fluid restriction goal 500 mld 24hour urine volume generally firstline therapy pharmacologic treatment strongly considered patients urinary parameters indicate low renal electrolytefree water excretion serum sodium concentration correct 2448 hours fluid restriction pharmacologic options include demeclocycline label use urea vasopressin receptor antagonists vaptans vaptans used hypovolemic hyponatremia conjunction treatments hyponatremia european society intensive care medicine european society endocrinology european renal association–european dialysis transplant association released guidelines diagnosis classification treatment true hypotonic hyponatremia treatment recommendations include following serious symptomatic hyponatremia first line treatment prompt intravenous infusion hypertonic saline target increase 6 mmoll 24 hours exceeding 12 mmoll additional 8 mmoll every 24 hours thereafter patient’s serum sodium concentration reaches 130 mmoll firstline treatment patients siadh moderate profound hyponatremia fluid restriction secondline treatments include increasing solute intake 025–050 gkg per day urea combined treatment lowdose loop diuretics oral sodium chloride patients reduced circulating volume extracellular volume restored intravenous infusion 09 saline balanced crystalloid solution 05 10 mlkg per hour lithium demeclocycline vaptans recommended patients moderate profound hyponatremia consultation either nephrologist critical care specialist often considerable value managing patients symptomatic refractory hyponatremia medical care intravenous fluids water restriction faced patient hyponatremia first decision type fluid given treatment hypertonic pseudohyponatremia directed underlying disorder absence symptoms hypotonic hyponatremia accounts clinical cases hyponatremia first step approach evaluation hypotonic hyponatremia determine whether emergency therapy warranted following three factors guide treatment patients volume status duration magnitude hyponatremia degree severity clinical symptoms asymptomatic patient following treatments may use hypovolemic hyponatremia administer isotonic saline patients hypovolemic replace contracted intravascular volume thereby treating cause vasopressin release patients hypovolemia secondary diuretics may also need potassium repletion like sodium osmotically active correction volume repletion turns stimulus adh secretion large water diuresis may ensue leading rapid correction hyponatremia desired hypotonic fluid d5½ normal saline may need administered see normovolemic hyponatremia guidelines hypervolemic hyponatremia treat patients hypervolemic salt fluid restriction plus loop diuretics correction underlying condition use v2 receptor antagonist may considered see normovolemic euvolemic asymptomatic hyponatremic patients free water restriction 1 ld generally treatment choice role hypertonic saline patients base volume restriction patients renal diluting capacity instance fluid restriction 1 ld enough raise serum sodium patients may exceed renal free water excretion capacity others necessitating severe restriction approach recommended initial treatment patients asymptomatic siadh however many patients adhere fluid restriction definition asymptomatic changing due recognition subtle significant deficits gait may present therefore pharmacologic treatment may considered see treating patients overtly symptomatic hyponatremia eg seizures severe neurological deficits hypertonic 3 saline used place initial treatment aquaretics see note normal saline exacerbate hyponatremia patients siadh may excrete sodium retain water liter normal saline contains 154 meq sodium chloride nacl 3 saline 513 meq nacl management decisions also factor ongoing renal free water solute losses alternately combination intravenous normal saline diuresis loop diuretic eg furosemide also elevates serum sodium concentration latter approach often useful patients high urine osmolality loop diuretic acts reduce urine osmolality concomitant use loop diuretics increases free water excretion decreases risk fluid overload following equation helps estimate expected change serum sodium na respect characteristics infusates used therapy close monitoring serum electrolytes ie every 24 h avoid overcorrection essential acute hyponatremia duration 48 h safely corrected quickly chronic hyponatremia severely symptomatic patient acute hyponatremia danger brain edema contrast symptomatic patient chronic hyponatremia risk rapid correction hyponatremia overly rapid correction serum sodium precipitate severe neurologic complications central pontine myelinosis produce spastic quadriparesis swallowing dysfunction pseudobulbar palsy mutism symptomatic patient unknown duration hyponatremia challenging warranting prompt controlled limited correction hyponatremia symptoms resolve however fear osmotic demyelination deter prompt definitive treatment patients acutely symptomatic duration 48 h surgery treatment goal increase serum sodium level approximately 12 meqlh 34 hours neurologic symptoms subside plasma sodium concentration 120 meql chronic severe symptomatic hyponatremia rate correction exceed 051 meqlh total increase exceed 812 meqld 18 meql first 48 h sodium concentration must corrected safe range usually greater 120 meql rather normal value noted spontaneous diuresis secondary adh suppression intravascular volume repletion could lead unintended overcorrection pharmacologic treatment pharmacologic agents used cases refractory siadh allowing liberal fluid intake demeclocycline drug choice increase diluting capacity kidneys achieving vasopressin antagonism functional diabetes insipidus treatment requires 34 days maximal effect demeclocycline contraindicated cirrhotic patients agents lithium used variable success lithium also associated several untoward effects including thyroid dysfunction interstitial kidney disease overdosage cns dysfunction make use problematic treatment psychogenic polydipsia difficult may require psychiatric pharmacologic fluid intervention aquaretics new class drugs avp receptor antagonists designed specifically promote aquaresis ie electrolytesparing excretion free water evaluated clinical trials treatment hyponatremia addition effects patients renal hepatic impairment well studied caution advised use population several drug interactions need close monitoring use conivaptan cyp3a4 inhibitors contraindicated tolvaptan selective v2 receptor antagonist taken orally approved use treatment euvolemic hypervolemic hyponatremia including cases associated cirrhosis heart failure tolvaptan treatment must initiated hospital avoid possibility rapid correction although reported cases shows great promise requirement hospitalization initiation reintroduction expense drug use time limited also interacts cyp3a inhibitors use drugs contraindicated april 2013 fda limited use tolvaptan 30 days indicated used patients underlying liver disease decision based reports liver injury including potentially leading liver transplant death use vaptans limited exact benefits yet determined reports even mild hyponatremia cause gait instability possibly increase risk falls hip fractures setting vaptans may beneficial improve hyponatremia gait diet free water restriction often appropriate patients normovolemic hypotonic hyponatremia individuals undernourished need maintain appropriate solute intake fact patients siadh high protein intake increases solute load excretion thereby removing free water although unpalatable oral urea used achieve effect patients hyperglycemia hyperlipidemia receive appropriate nutritional counseling medication medication summary primary treatments used management hyponatremic patients rely use intravenous sodiumcontaining fluids normal saline hypertonic saline fluid restriction less commonly loop diuretics eg furosemide demeclocycline used new class drugs avp receptor antagonists eg conivaptan available diuretics class summary loop diuretics occasionally used patients hyponatremia increase renal free water excretion furosemide lasix highceiling diuretic prompt onset action acts upon ascending limb loop henle inhibit sodiumpotassiumchloride cotransport system thereby increasing solute delivery distal renal tubules acts increase free water excretion lead increased aldosterone production resulting increased sodium absorption absorbed readily gi tract also available parenteral preparations diuresis begins 3060 min oral vs 5 min iv administration potassium excretion also increased elderly patients may greater sensitivity effects furosemide antibiotics class summary certain antibiotics may affect renal adh action demeclocycline declomycin cause insensitivity distal renal tubules action adh produce nephrogenic diabetes insipidus effects seen within 5 days reversed within 26 days following cessation therapy arginine vasopressin antagonists class summary treats hyponatremia v2 antagonism avp renal collecting ducts effect results aquaresis excretion free water conivaptan vaprisol arginine vasopressin antagonist v1a v2 indicated euvolemic dilutional hypervolemic hyponatremia increases urine output mostly free water little electrolyte loss 80 conivaptan excreted feces rest urine tolvaptan samsca selective vasopressin v2receptor antagonist indicated hypervolemic euvolemic hyponatremia ie serum sodium level 125 meql lessmarked hyponatremia symptomatic resisted correction fluid restriction used hyponatremia associated congestive heart failure liver cirrhosis syndrome inappropriate antidiuretic hormone secretion initiate reinitiate hospital environment duration use limited 30 days minimize risk liver injury followup inpatient care patients hyponatremia cause require close attention electrolyte fluid status patients symptomatic hyponatremia actively treated often require several daily measurements serum sodium avoid rate correction rapid acute treatment followup generally dictated underlying etiology hyponatremia complications clinical manifestations include clouding consciousness confusion stupor coma seizures commonly occur rapid reductions serum sodium serum sodium concentrations less 115120 meql unknown reasons premenopausal women seem less efficient osmotic adaptation increases susceptibility severe hyponatremia rapid progression minimal symptoms eg headache nausea respiratory arrest cerebral edema herniation found autopsy correction hyponatremia rapid may cause permanent neurologic impairment central pontine myelinolysis cpm extrapontine myelinolysis epm complications excessive correction chronic hyponatremia diagnosed diffusionweighted magnetic resonance imaging mri note conventional ct mri scan findings typically lag behind clinical manifestations myelinosis 24 weeks clinical course patients features initial encephalopathy secondary hyponatremia improvement plasma na concentration increases finally deterioration several days later disorder resolve completely result permanent disability death typical clinical course called osmotic demyelination syndrome ods clinical neurologic picture may confusing may include variety findings psychiatric behavioral movement disorders dysphagia flaccid spastic quadriparesis depending involvement extrapontine central pontine myelinolysis disruption bloodbrain barrier presumed play important role pathogenesis osmotic demyelination increased susceptibility osmotic demyelination also observed cirrhotic patients setting myoinositol abundant organic osmolyte depleted glutamine hyponatremiainduced brain cell swelling cpm common often fatal complication orthotopic liver transplantation affecting 10 patients hyponatremic prior transplant prognosis prognosis patients hyponatremia predicated upon underlying etiology study doshi et al found hyponatremia among patients cancer associated extended hospital stays higher mortality rates however whether longterm correction hyponatremia would improve outcomes unclear metaanalysis 15 studies encompassing 13816 patients found improvement hyponatremia associated reduced risk overall mortality odds ratio or057 eight studies reported threshold serum sodium improvement 130 mmoll association even stronger or051 reduction mortality risk persisted 12month followup or055 reduced mortality evident older patients patients lower serum sodium levels enrollment patient education patients treated fluid restriction often require education regarding free water content foods explanation need limit intake liquids predetermined level start media central pontine myelinolysis mri flair central pontine myelinolysis mri flair extrapontine myelinolysis t2 extrapontine myelinolysis t2 author eric e simon md professor medicine chief section nephrology hypertension tulane university school medicine director nephrology training medical director dialysis clinic inc canal street eric e simon md member following medical societies american federation medical research american heart association american physiological society american society nephrology central society clinical translational research international society nephrology national kidney foundation phi beta kappa american society cell biology southern society clinical investigation disclosure nothing disclose coauthors seyed mehrdad hamrahian md assistant professor medicine jefferson medical college thomas jefferson university seyed mehrdad hamrahian md member following medical societies american society nephrology international society nephrology national kidney foundation disclosure nothing disclose federico j teran md instructor clinical medicine section nephrology hypertension tulane university school medicine federico j teran md member following medical societies american college physicians american medical association american society nephrology louisiana state medical society national kidney foundation renal physicians association disclosure nothing disclose pharmacy editor francisco talavera pharmd phd adjunct assistant professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure received salary medscape employment medscape managing editor eleanor lederer md professor medicine chief nephrology division director nephrology training program director metabolic stone clinic kidney disease program university louisville school medicine consulting staff louisville veterans affairs hospital eleanor lederer md member following medical societies american association advancement science international society nephrology american society biochemistry molecular biology american federation medical research american society bone mineral research american society nephrology american society transplantation kentucky medical association national kidney foundation phi beta kappa disclosure received grantresearch funds dept veterans affairs research received salary american society nephrology asn council position received salary university louisville employment received salary university louisville physicians employment received contract payment american physician institute advanced professional studies llc independent contractor received contract payment healthcare quality strategies inc independent cont chief editor vecihi batuman md facp fasn huberwald professor medicine section nephrologyhypertension tulane university school medicine chief renal section southeast louisiana veterans health care system vecihi batuman md facp fasn member following medical societies american college physicians american society hypertension american society nephrology international society nephrology disclosure nothing disclose additional contributors james h sondheimer md facp fasn associate professor medicine wayne state university school medicine medical director hemodialysis harper university hospital detroit medical center medical director davita greenview dialysis southfield james h sondheimer md facp fasn member following medical societies american college physicians american society nephrology disclosure received dialysis unit medical director fee davita independent contractor barclay l nainggolan l new european guidelines address hyponatremia management medscape medical news available httpwwwmedscapecomviewarticle821130 guideline spasovski g vanholder r allolio b annane ball bichet et al clinical practice guideline diagnosis treatment hyponatraemia nephrol dial transplant medline zenenberg rd carluccio al merlin hyponatremia evaluation management hosp pract minneap medline zeidel ml hyponatremia mechanisms newer treatments endocr pract medline singhi jayashre free water excess main cause hyponatremia critically ill children receiving conventional maintenance fluids indian pediatr medline gross p reimann henschkowski j damian treatment severe hyponatremia conventional novel aspects j soc nephrol medline dubois gd arieff ai treatment hyponatremia case rapid correction narins rg ed controversies nephrology hypertension goldberg hammerman h petcherski et al prognostic importance hyponatremia acute stelevation myocardial infarction j med medline heuman dm abouassi sg habib williams lm stravitz rt sanyal aj persistent ascites low serum sodium identify patients cirrhosis low meld scores high risk early death hepatology medline kim baik sk yea cj et al hepatic venous pressure gradient predict development hepatocellular carcinoma hyponatremia decompensated alcoholic cirrhosis eur j gastroenterol hepatol medline bettari l fiuzat shaw lk wojdyla dm metra felker gm et al hyponatremia longterm outcomes chronic heart failurean observational study duke databank cardiovascular diseases j card fail medline hillier ta abbott rd barrett ej hyponatremia evaluating correction factor hyperglycemia j med medline issa mm young mr bullock ar bouet r petros ja dilutional hyponatremia turp syndrome historical event 21st century urology medline palmer bf hyponatraemia neurosurgical patient syndrome inappropriate antidiuretic hormone secretion versus cerebral salt wasting nephrol dial transplant medline palmer bf hyponatremia patients central nervous system disease siadh versus csw trends endocrinol metab medline smith moore k tormey w baylis ph thompson cj downward resetting osmotic threshold thirst patients siadh j physiol endocrinol metab medline skippen p adderley r bennett et al iatrogenic hyponatremia hospitalized children avoided paediatr child health medline full text thaler sm teitelbaum berl beer potomania nonbeer drinkers effect low dietary solute intake j kidney dis medline goldman mb luchins dj robertson gl mechanisms altered water metabolism psychotic patients polydipsia hyponatremia n engl j med medline kratz siegel aj verbalis jg et al sodium status collapsed marathon runners arch pathol lab med medline almond cs shin ay fortescue eb et al hyponatremia among runners boston marathon n engl j med medline hewbutler almond c ayus jc et al consensus statement 1st international exerciseassociated hyponatremia consensus development conference cape town south africa 2005 clin j sport med medline baker j cotter jd gerrard df bell ml walker rj effects indomethacin celecoxib renal function athletes med sci sports exerc medline feldman bj rosenthal sm vargas ga et al nephrogenic syndrome inappropriate antidiuresis n engl j med medline trivelli ghiggeri gm canepa oddone bava g perfumo f hyponatremichypertensive syndrome extensive reversible renal defects pediatr nephrol medline sherlock osullivan e agha et al incidence pathophysiology severe hyponatraemia neurosurgical patients postgrad med j medline guideline verbalis jg goldsmith sr greenberg korzelius c schrier rw sterns rh et al diagnosis evaluation treatment hyponatremia expert panel recommendations j med medline adrogue hj madias ne hyponatremia n engl j med medline vachharajani tj zaman f abreo kd hyponatremia critically ill patients j intensive care med medline dixon mb lien yh tolvaptan potential treatment hyponatremia ther clin risk manag medline full text farmakis filippatos g kremastinos dt gheorghiade vasopressin vasopressin antagonists heart failure hyponatremia curr heart fail rep medline fda drug safety communication fda limits duration usage due possible liver injury leading organ transplant death available httpwwwfdagovsafetymedwatchsafetyinformationsafetyalertsforhumanmedicalproductsucm350185htm ayus jc wheeler jm arieff ai postoperative hyponatremic encephalopathy menstruant women ann intern med medline ruzek ka campeau ng miller gm early diagnosis central pontine myelinolysis diffusionweighted imaging ajnr j neuroradiol medline yu j zheng ss liang tb shen wang wl ke qh possible causes central pontine myelinolysis liver transplantation world j gastroenterol medline doshi sm shah p lei x lahoti salahudeen ak hyponatremia hospitalized cancer patients impact clinical outcomes j kidney dis medline corona g giuliani c verbalis jg forti g maggi peri hyponatremia improvement associated reduced risk mortality evidence metaanalysis plos one medline full text budisavljevic mn stewart l sahn sa ploth dw hyponatremia associated 34methylenedioxymethylamphetamine ecstasy abuse j med sci medline fda limits use samsca tolvaptan due liver injury risk medscape medical news available httpwwwmedscapecomviewarticle803356 gines p berl bernardi et al hyponatremia cirrhosis pathogenesis treatment hepatology medline glassock rj cohen ah danovitch g parsa kp human immunodeficiency virus hiv infection kidney ann intern med medline konstam gheorghiade burnett jc jr grinfeld l maggioni ap swedberg k effects oral tolvaptan patients hospitalized worsening heart failure everest outcome trial jama medline lowes r tolvaptan poses risk serious liver damage fda warns medscape medical news january 25 2013 available httpwwwmedscapecomviewarticle778200 pham pc pham pm pham pt vasopressin excess hyponatremia j kidney dis medline salahudeen ak ali n george lahoti palla tolvaptan hospitalized cancer patients hyponatremia doubleblind randomized placebocontrolled clinical trial efficacy safety cancer wiley online library available httponlinelibrarywileycomdoi101002cncr28468abstract santos bc chevaile hebert mj zagajeski j gullans sr combination nacl urea enhances survival imcd cells hyperosmolality j physiol medline saunders r tolvaptan corrects hyponatremia cancer patients medscape serial online available httpwwwmedscapecomviewarticle814821 schrier rw abraham wt hormones hemodynamics heart failure n engl j med medline schrier rw gross p gheorghiade et al tolvaptan selective oral vasopressin v2receptor antagonist hyponatremia n engl j med medline silver sm kozlowski sa baer je rogers sj sterns rh glycineinduced hyponatremia rat model postprostatectomy syndrome kidney int medline silver sm schroeder bm bernstein p sterns rh brain adaptation acute hyponatremia young rats j physiol medline sterns rh syndrome inappropriate antidiuretic hormone secretion unknown origin j kidney dis medline mccall b us europe differ use vaptans hyponatremia medscape medical news available httpwwwmedscapecomviewarticle845338

Article 21:
hysterectomy hysterectomy background history procedure problem hysterectomy workup laboratory studies hysterectomy treatment management medical therapy surgical therapy postoperative details hysterectomy background history procedure problem hysterectomy workup laboratory studies hysterectomy treatment management medical therapy surgical therapy postoperative details overview background history procedure problem epidemiology presentation indications relevant anatomy contraindications workup laboratory studies treatment medical therapy surgical therapy postoperative details followup complications future controversies hysterectomy overview hysterectomy workup hysterectomy treatment 267273overview jan 22 2015 201508131504 0 clinical procedures 2002 procedures procedure 1 2 content 267273 503 3003432 16 sexo jun 04 2015 procedure procedures clinicalprocedures clinical procedures clinicalproceduresobgyn obstetric gynecologic uterine disease gynecologic dysfunction sterility total abdominal hysterectomy tah fibroids leiomyomas lavh vaginal hysterectomy vh benign uterine tumor endometriosis genital prolapse uterine prolapse pelvic relaxation uterine cancer uterus cancer cancer uterus endometrial cancer cervical cancer cervix cancer radical hysterectomy vaginectomy uae da vinci hysterectomy endometrial ablation progesteronecontaining iud hysterectomy common non–pregnancyrelated major surgery performed women united states surgical procedure involves removal uterus cervix conditions fallopian tubes ovaries 0 bso tah hysterectomy overview background hysterectomy common non–pregnancyrelated major surgery performed women united states surgical procedure involves removal uterus cervix conditions fallopian tubes ovaries reasons choosing operation treatment uterine cancer various common noncancerous uterine conditions fibroids endometriosis prolapse leads disabling levels pain discomfort uterine bleeding emotional stress although procedure highly successful curing disease concern surgical alternative accompanying risks morbidity mortality operative procedure carries leads sterility women premenopausal patient may hospitalized several days may require 612 weeks convalescence complications excessive bleeding infection injury adjacent organs also may occur related information see medscapes womens sexual health history procedure november 1843 charles clay performed first hysterectomy manchester england 1929 richardson md performed first total abdominal hysterectomy tah entire uterus cervix removed problem epidemiology fibroids fibroids leiomyomas account one third hysterectomies one fifth gynecological visits create annual cost 12 billion frequency fibroid appearance african american women 23 times higher white women women obese experience menarche younger 12 years increased risk fibroid development due prolonged exposure estrogen women children lesser risk fibroid development women never pregnant fibroid arises single monoclonal cell line smoothmuscle cells myometrium asymptomatic fibroids relatively slow growing characterize tumors found patients previously uterine size consisting asymptomatic fibroids equivalent 12 weeks gestation 280 g standard threshold recommending hysterectomy thus asymptomatic fibroids smaller size handled via observation annual pelvic examination andor transvaginal ultrasonography currently surgical procedures recommended fibroids based uterine size alone absence symptoms according reiter et al increased incidence perioperative morbidity existed posthysterectomy women fibroid uterus larger 12 weeks gestational size compared women fibroid uterus smaller 12 weeks gestational size patients experience symptoms fibroids symptoms related size location number fibroids within uterus many one third patients symptomatic uterine fibroids experience abnormal bleeding cramping prolonged heavy menstrual periods result anemia growth fibroids large sizes may cause pressure local organs thus presenting symptoms may include pelvic pain pressure pain sexual intercourse reduced urinary capacity due increased bladder pressure constipation due increased colon pressure infertility late miscarriages epidemiology endometriosis endometriosis responsible approximately one fifth hysterectomies affects women reproductive years currently cure exists endometriosis although many women seek hysterectomy pain relief provide definite cure women one ovaries preserved may continue experience problems endometriosis left behind epidemiology pelvic relaxation genital prolapse indication approximately 15 hysterectomies various stresses pelvic muscles ligaments cause significant weakening thus uterine prolapse prime cause insult pelvic support structures childbirth therefore multiple pregnancies vaginal deliveries increase risk uterine prolapse less dramatic causes increased pelvic pressure include straining bowel movements chronic coughing obesity also significant pelvic structure weakening occurs postmenopause estrogen pelvic tissues need maintain tonicity present significant amounts menopause women mild pelvic relaxation may free symptoms however patients moderatetosevere relaxation may experience symptoms include heaviness pressure vaginal area low back pain leakage urine worsen heavy lifting coughing laughing sneezing urinary tract infections retention urine problems sexual intercourse epidemiology cancer reproductive organs cancer uterus endometrial cancer common gynecological cancer united states estimated 36100 new cases 2000 stage 1 endometrial cancer confined corpus body uterus symptoms may include bleeding periods cases spotting patients menopause stage 1 endometrial cancer slow growing highly curable hysterectomy preferred method treatment uterus removed ovaries fallopian tubes also removed ovaries possible site cancer may secrete hormones play synergistic role growth cancer surgical menopause due bilateral oophorectomy compared natural menopause increase allcause cardiovascular cancer mortality stage 2 endometrial cancer cancer spread cervix approximately 12800 new cases cervical cancer diagnoses occur annually united states stage 3a endometrial cancer cancer spread ovaries fallopian tubes may treated tah bilateral salpingooophorectomy removal uterus fallopian tubes ovaries along chemotherapy radiotherapy needed stage 3b cancer spread vagina case vaginectomy radical hysterectomy must performed along chemotherapy radiotherapy needed stage 3c cancer entered lymph nodes case lymph node dissection hysterectomy treatment choice along chemotherapy radiotherapy needed epidemiology frequency approximately 600000 hysterectomies performed annually united states cost approximately 5 billion per year us centers disease control prevention cdc estimated 31 million us women hysterectomy 20002004 hysterectomy rate decreased slightly 541000 2000 511000 2004 20002004 rates hysterectomy differed age overall rates highest among women aged 4044 years lowest among women aged 1524 years hysterectomy rates among women aged 5054 years decreased significantly 891000 2000 671000 2004 hysterectomy rates also differed geographic region overall rate highest women living south 631000 lowest northeast 431000 hysterectomy rates northeast decreased 491000 2000 371000 2004 20002004 common medical reasons undergoing hysterectomy included benign fibroid tumors endometriosis uterine prolapse uterine cancer common important reason undergoing hysterectomy proportion hysterectomies indication uterine leiomyoma decreased 442 2003 387 2004 relative proportions hysterectomies performed laparoscopically assisted vaginal hysterectomy lavh peaked 13 1995 steadily declined 39 2003 p 0001 p presentation preoperative evaluation includes following complete history physical evaluate detail comorbid conditions diabetes mellitus hypertension cardiac disease asthma medication history use aspirin oral hypoglycemics heparin warfarin pap smear endometrial sampling ultrasonography cbc count blood type cross match depending upon age risk factors ecg chest radiograph case malignancy preoperative staging determined help biopsies cat scans ivp cystoscopy barium enema etc indications reasons choosing hysterectomy treatment uterine cancer ovarian cancer cervical cancer endometriosis uterine prolapse relevant anatomy various hysterectomy procedures available including following total abdominal hysterectomy involves removal uterus cervix abdominal incision supracervical subtotal hysterectomy removal uterus abdominal incision sparing cervix radical hysterectomy extensive surgery addition removal uterus cervix might include removal lymph nodes loose areolar tissue near major blood vessels upper vagina omentum oophorectomy salpingooophorectomy oophorectomy surgical removal ovary salpingooophorectomy removal ovary fallopian tube vaginal hysterectomy removal uterus cervix vagina laparoscopyassisted vaginal hysterectomy vaginal hysterectomy help laparoscopy uterus inverted pearshaped female reproductive organ lies midline body within pelvis bladder rectum dynamic female reproductive organ responsible several reproductive functions including menses implantation gestation labor delivery responsive hormonal milieu within body allows adaptation different stages woman’s reproductive life uterus adjusts reflect changes ovarian steroid production menstrual cycle displays rapid growth specialized contractile activity pregnancy childbirth also remain relatively quiescent state prepubertal postmenopausal years ovaries small ovalshaped grayish color uneven surface actual size ovary depends woman’s age hormonal status ovaries covered modified peritoneum approximately 35 cm length childbearing years become much smaller atrophic menopause occurs crosssection ovary reveals many cystic structures vary size structures represent ovarian follicles different stages development degeneration information relevant anatomy see female reproductive organ anatomy uterus anatomy ovary anatomy contraindications vaginal hysterectomy contraindicated 1020 cases eg uterine size greater 280 g workup laboratory studies lab studies related hysterectomy include cbc count papanicolaou test endometrial sampling ultrasonography blood type cross match cases chest radiography ecg cat scan mri cystoscopy barium enema ivp blood chemistry tumor markers treatment management medical therapy although hysterectomy often definitive treatment many pelvic pathologies nonsurgical alternatives always attempted elective cases hormonal therapy gonadotropinreleasing hormone antagonists progesteronecontaining iud endometrial ablation focused ultrasonographic surgery cryotherapy uterine artery embolization used success 6 states studied diffusion endometrial ablation varying impact hysterectomy rates among women benign uterine conditions however endometrial ablation used additive medical technology rather substitute surgical therapy please see algorithm algorithm selecting route hysterectomy algorithm selecting route hysterectomy abdominal hysterectomy november 1843 charles clay performed first hysterectomy manchester england earliest hysterectomies supracervical subtotal hysterectomies body uterus removed cervix remained intact 1929 richardson md performed first tah entire uterus removed prior abdominal hysterectomy patient undergoes regional general anesthetic patient remains awake regional anesthetic part body numbed prevent pain given general anesthetic patient unconscious absence contraindications neuraxial anesthesia provides better quality recovery general anesthesia abdominal hysterectomy begins via surgical incision 68 inches long made either vertically running navel pubic bone horizontally running along top pubic hairline cut exposes ligaments blood vessels surrounding uterus ligaments blood vessels separated uterus cervix process blood vessels tied prevent bleeding help healing uterus cervix cut superior portion vagina removed top vaginal cuff closed sutures surgical wound closed layers abdominal hysterectomy may performed conjunction salpingooophorectomy adnexa removed needed possible complications include surgical wound infection excessive bleeding injury bowel bladder ureter nerve damage urinary tract infection candidates surgery include fibroids abnormal heavy bleeding chronic pelvic pain endometriosis adenomyosis endometrial tissue infiltrated myometrium uterine prolapse cancer reproductive organs pelvic inflammatory disease vaginal hysterectomy vaginal hysterectomy uterus removed vaginal introitus prior surgery patient given regional general anesthetic skin surrounding vagina prepped antibacterial solution surgical incision made circular fashion around cervix upper vagina expose tissue blood vessels around cervix uterus tissues vessels cut tied uterus cervix removed top vagina upper part vagina surgical incision made sutured possible complications include surgical wound infection excessive bleeding injury bowel bladder ureter nerve damage urinary tract infection often colporrhaphy reconstructive surgery performed repair prevent cystocele rectocele andor vaginal vault prolapse candidates surgery include fibroids abnormal heavy bleeding adenomyosis uterine prolapse earlystage cancer reproductive organs precancerous conditions reproductive organs laparoscopically assisted vaginal hysterectomy laparoscopically assisted vaginal hysterectomy lavh procedure uses laparoscopic surgical techniques instruments remove uterus cervix andor fallopian tubes ovaries vagina prior surgery patient usually given general anesthetic abdomen vagina prepared antibacterial solution lavh begins several small abdominal incisions inferior belly button allow insertion laparoscope surgical tools order surgeon observe inside body clearly peritoneal cavity inflated gas usually carbon dioxide camera attached laparoscope captures produces continuous image magnified projected onto television screen using laparoscopic surgical tools tissues vessels surrounding uterus cut tied uterus cervix removed vagina top vaginal cuff sutured fallopian tubes ovaries also may removed surgical procedure possible complications include surgical wound infection excessive bleeding injury bowel bladder ureter nerve damage urinary tract infection candidates surgery include previous abdominal surgery large fibroids chronic pelvic pain endometriosis pelvic inflammatory disease want oophorectomy today robotic laparoscopic surgery procedures involving da vinci surgical robot also refined evaluate performance lavh laparoscopic hysterectomy laparoscopic hysterectomy lh procedure uterus cervix dissected ligated ligaments tissues vagina blood vessels removed entirely small abdominal incisions help instruments like morcellator procedure requires good surgical technique intra extracorporal sutures different hemostatic devices metaanalysis showed difference total lh vaginal hysterectomy benign disease perioperative complications supracervical hysterectomy supracervical hysterectomy defined removal uterine corpus preservation cervix performed abdominal laparoscopic robotic approaches supracervical hysterectomy removal corpus internal os along ablation endocervical canal laparoscopic robotically assisted hysterectomy morcellation uterine fundus performed facilitate removal port site incisions women known suspected gynecological cancer current recent cervical dysplasia endometrial hyperplasia candidates supracervical procedure evidence regarding potential benefits procedure like less blood loss shorter operating time fewer complications limited retrospective series patients counseled need longterm follow possibility future trachelectomy lack data demonstrating clear benefits total hysterectomy hence recommended surgeon superior technique hysterectomy benign diseases robotassisted hysterectomy da vinci surgical system approved use gynecological surgery fda 2005 da vinci hysterectomy involves robotic system surgeons hands naturally positioned fingers grasp controls display movements transferred real time surgical instruments inside patient system useful surgery involves dissection difficult situation near ureters bladder blood vessels current system consists 4 components 1 console surgeon sits views screen controls robotic instruments 2 robotic cart interactive arms 3 camera vision system 4 wristed instruments computer interfaces advantages 3dimensional visualization improved depth perception improved dexterity less blood loss shorter hospital stay less pain less risk wound infection disadvantages include high cost increased operating time associated set docking lack tactile feedback inability reposition patient robotic arms attached bulkiness system comparisons hysterectomy procedures various hysterectomy procedures available physicians must limit healthcare dollars associated surgical procedures maintaining quality health care patients various studies performed decide surgical procedure suitable terms economics patient health severity pathological disorder must key standard selecting type hysterectomy order maintain optimum surgical practice studies performed united states france united kingdom strict guidelines based severity pathological disorder implemented patients underwent successful vaginal hysterectomy without abdominal laparoscopic assistance study gimbel et al subtotal hysterectomy faster perform less perioperative bleeding seems less intra postoperative complications significantly improved outcomes suggest vaginal hysterectomy vh performed preference abdominal hysterectomy ah possible vh possible lh may avoid need ah however length surgery increases extent surgery performed laparoscopically increases particularly uterine arteries divided laparoscopically also laparoscopic approaches require greater surgical expertise fouryear followup data indicate patients underwent laparoscopic hysterectomy reported better quality life compared underwent ah laparoscopic hysterectomy considered patients vh possible postoperative details early feeding oral intake fluids food within 24 h surgery irrespective bowel sounds major abdominal gynecological surgery safe associated reduced length hospital stay increased nausea studies focus cost effectiveness patient satisfaction physiological changes followup surgery takes 46 weeks recover recovery earlier cases vaginal hysterectomy laparoscopically assisted vaginal hysterectomy lifting anything heavy 6 weeks surgery case oophorectomy premenopausal women patients experience menopausal symptoms like hot flashes vaginal dryness mood disturbances return normal sexual activities expected 6 weeks surgery excellent patient education resources see emedicinehealths patient education articles cervical cancer female sexual problems pain intercourse complications possible complications hysterectomy include surgical wound infection excessive bleeding injury bowel bladder ureter major blood vessel urinary tract infection nerve damage postoperative thromboembolism atelectasis early onset menopause loss ovarian function 2012 prospective study hysterectomy bilateral oophorectomy compared hysterectomy ovarian conservation natural menopause associated greater increases bmi years following procedure hur et al found 10year cumulative incidence dehiscence type hysterectomy 024 135 total laparoscopic hysterectomies study dessources et al found postoperative complications strongest risk factors 30day hospital readmission following hysterectomy including women uterine cancer underwent hysterectomy benign conditions complications related readmission included wound complications infections pulmonary emboli myocardial infarctions 30day readmission rate 61 among women uterine cancer 34 benign disease future controversies pharmacologic invasive radiologic interventions become available number hysterectomies performed united states abroad continue decrease compared hysterectomy uterine artery embolization uae associated higher rates minor postprocedural complications vaginal discharge postpuncture hematoma postembolization syndrome pain fever nausea vomiting well higher unscheduled visits readmission rates discharge evidence shows benefit uae surgeryhysterectomymyomectomy satisfaction currently ongoing trials rest uk emmy yet report longterm followup surgical techniques continue updated improved preoperative postoperative interventions improve morbidity mortality quality life uterus associated femininity women experience sense loss hysterectomy however women find hysterectomy enhances quality life provides relief symptoms definite contraception hysterectomy whether total subtotal may improve quality life psychological outcome start media algorithm selecting route hysterectomy algorithm selecting route hysterectomy author hetal b gor md facog obstetriciangynecologist private practice hetal b gor md facog member following medical societies american college obstetricians gynecologists society laparoendoscopic surgeons disclosure nothing disclose chief editor michel e rivlin md former professor department obstetrics gynecology university mississippi school medicine michel e rivlin md member following medical societies american college obstetricians gynecologists american medical association mississippi state medical association royal college surgeons edinburgh royal college obstetricians gynaecologists disclosure nothing disclose acknowledgements gloria bachmann md disclosure wyeth grantresearch funds pi research bayer grantresearch funds pi research gsk grantresearch funds pi research duramed grantresearch funds pi research novartis grantresearch funds pi research pfizer grantresearch funds pi research boehringeringelheim grantresearch funds pi research johnson johnson grantresearch funds pi research roche grantresearch funds pi research boston scientific grantresearch funds pi research novo nordisk grantresearch funds pi research proctor gamble grantresearch funds pi research merck grantresearch funds pi research xanodyne grantresearch funds pi research hormos grantresearch funds pi research francisco talavera pharmd phd disclosure medscape reference salary employment johns supracervical versus total hysterectomy clin obstet gynecol medline lepine la hillis sd marchbanks pa hysterectomy surveillanceunited states 19801993 mor mortal wkly rep cdc surveill summ medline zhao sz wong jm arguelles lm hospitalization costs associated leiomyoma clin ther medline goodwin sc wong gc uterine artery embolization uterine fibroids radiologists perspective clin obstet gynecol medline kjerulff kh erickson ba langenberg pw chronic gynecological conditions reported us women findings national health interview survey 1984 1992 j public health medline guarnaccia mm rein ms traditional surgical approaches uterine fibroids abdominal myomectomy hysterectomy clin obstet gynecol medline demello ab uterine artery embolization aorn j medline townsend de sparkes rs baluda mc unicellular histogenesis uterine leiomyomas determined electrophoresis glucose6phosphate dehydrogenase j obstet gynecol medline gross kl morton cc genetics development fibroids clin obstet gynecol medline reiter rc gambone jc lench jb appropriateness hysterectomies performed multiple preoperative indications obstet gynecol medline lee nc dicker rc rubin gl confirmation preoperative diagnoses hysterectomy j obstet gynecol medline weir e public health toll endometriosis cmaj greenlee rt murray bolden cancer statistics 2000 ca cancer j clin medline duan l xu x koebnick c lacey jv jr sullivanhalley j templeman c et al bilateral oophorectomy associated increased mortality california teachers study fertil steril medline full text sawaya gf brown ad washington ae clinical practice current approaches cervicalcancer screening n engl j med medline kovac sr route hysterectomy evidencebased outcomes guide selection postgrad med medline catroalves lj de azevedo vl de freitas braga tf goncalves ac de oliveira gs jr effect neuraxial versus general anesthesia techniques postoperative quality recovery analgesia abdominal hysterectomy prospective randomized controlled trial anesth analg medline gendy r walsh ca walsh sr karantanis e vaginal hysterectomy versus total laparoscopic hysterectomy benign disease metaanalysis randomized controlled trials j obstet gynecol medline acog committee opinion 388 november 2007 supracervical hysterectomy obstet gynecol medline acog technology assessment obstetrics gynecology 6 robotassisted surgery obstet gynecol medline kovac sr guidelines determine role laparoscopically assisted vaginal hysterectomy j obstet gynecol medline gimbel h total subtotal hysterectomy benign uterine diseases metaanalysis acta obstet gynecol scand medline johnson n barlow lethaby tavender e curr e garry r surgical approach hysterectomy benign gynaecological disease cochrane database syst rev medline nieboer te hendriks jc bongers vierhout kluivers kb quality life laparoscopic abdominal hysterectomy randomized controlled trial obstet gynecol medline charoenkwan k phillipson g vutyavanich early versus delayed traditional oral fluids food reducing complications major abdominal gynaecologic surgery cochrane database syst rev medline gibson cj thurston rc el khoudary sr suttontyrrell k matthews ka body mass index following natural menopause hysterectomy without bilateral oophorectomy int j obes lond medline hur hc donnellan n mansuria barber guido r lee vaginal cuff dehiscence different modes hysterectomy obstet gynecol medline dessources k hou jy tergas ai et al factors associated 30day hospital readmission hysterectomy obstet gynecol medline gupta jk sinha lumsden hickey uterine artery embolization symptomatic uterine fibroids cochrane database syst rev medline thakar r ayers georgakapolou clarkson p stanton manyonda hysterectomy improves quality life decreases psychiatric symptoms prospective randomised comparison total versus subtotal hysterectomy bjog medline farquhar cm naoom steiner ca impact endometrial ablation hysterectomy rates women benign uterine conditions united states int j technol assess health care medline jacobson gf shaber armstrong hung yy hysterectomy rates benign indications obstet gynecol medline

Article 22:
esophageal cancer esophageal cancer practice essentials background pathophysiology esophageal cancer clinical presentation history physical examination esophageal cancer workup approach considerations imaging studies staging esophageal cancer treatment management approach considerations surgical indications contraindications esophagectomy esophageal cancer medication antineoplastics antimetabolite antineoplastics alkylating antineoplastics antimicrotubular antineoplastics anthracycline antineoplastics topoisomerase inhibitors antineoplastics esophageal cancer practice essentials background pathophysiology esophageal cancer clinical presentation history physical examination esophageal cancer workup approach considerations imaging studies staging esophageal cancer treatment management approach considerations surgical indications contraindications esophagectomy esophageal cancer medication antineoplastics antimetabolite antineoplastics alkylating antineoplastics antimicrotubular antineoplastics anthracycline antineoplastics topoisomerase inhibitors antineoplastics overview practice essentials background pathophysiology etiology epidemiology prognosis presentation history physical examination workup approach considerations imaging studies staging treatment approach considerations surgical indications contraindications esophagectomy chemoradiotherapy palliative care postoperative care followup prevention esophageal cancer medication esophageal cancer overview esophageal cancer clinical presentation esophageal cancer workup esophageal cancer treatment esophageal cancer medication 277930overview mar 03 2015 201508041734 0 oncology 2002 diseases conditions condition 1 2 content 277930 502 5005286 7 ssg jun 04 2015 condition diseases conditions oncology oncology oncologygastrointestinal gastrointestinal cancers esophageal cancer esophagus cancer barrett epithelium barretts epithelium barrett esophagus barretts esophagus gastrointestinal reflux disease gerd esophageal adenocarcinoma esophagus adenocarcinoma esophagus carcinoma esophageal carcinoma squamous cell carcinoma esophageal cancer devastating disease although patients cured treatment esophageal cancer protracted diminishes quality life lethal significant number cases 0 esophageal cancer overview practice essentials esophageal cancer disease epidemiologic transition 1970s common type esophageal cancer united states squamous cell carcinoma smoking alcohol consumption risk factors since progressive increase incidence esophageal adenocarcinoma common predisposing factor gastroesophageal reflux disease gerd see image cascade events lead gastroesophageal reflux disease adenocarcinoma cascade events lead gastroesophageal reflux disease adenocarcinoma signs symptoms presenting signs symptoms esophageal cancer include following dysphagia common initially solids eventually progressing include liquids weight loss second common bleeding epigastric retrosternal pain bone pain metastatic disease hoarseness persistent cough physical findings include following typically normal examination results unless cancer metastasized hepatomegaly hepatic metastases lymphadenopathy laterocervical supraclavicular areas reflecting metastasis see clinical presentation diagnosis laboratory studies focus principally patient factors may affect treatment eg nutritional status imaging studies used diagnosis staging include following esophagogastroduodenoscopy allows direct visualization biopsies tumor endoscopic ultrasonography eus sensitive test n staging computed tomography abdomen chest assessing lung liver metastasis invasion adjacent structures positron emission tomography pet scanning staging bronchoscopy help exclude invasion trachea bronchi laparoscopy thoracoscopy staging regional nodes barium swallow sensitive detecting strictures intraluminal masses rarely used current tnm classification follows staging detailed table 1 tis carcinoma situhighgrade dysplasia t1 lamina propria submucosa t1a lamina propria muscularis mucosae t1b submucosa t2 muscularis propria t3 adventitia t4 adjacent structures t4a pleura pericardium diaphragm adjacent peritoneum t4b adjacent structures eg aorta vertebral body trachea n0 regional lymph node metastasis n1 12 regional lymph nodes n1 site dependent n2 36 regional lymph nodes n3 6 regional lymph nodes m0 distant metastasis m1 distant metastasis m1a m1b site dependent table 1 staging classification stage ia t1 n0 m0 stage ib t2 n0 m0 stage iia t3 n0 m0 stage iib t1t2 n1 m0 stage iiia t4a n0 m0 t3 n1 m0 t1t2 n2 m0 stage iiib t3 n2 m0 stage iiic t4a n1n2 m0 t4b n m0 n3 m0 stage iv n m1 see workup management treatment esophageal cancer varies disease stage follows stage – consideration endoscopic therapy eg mucosal resection submucosal dissection particularly tis t1an0 eus consideration initial surgery t1b n stages iiiii – consideration chemoradiation followed surgery trimodality therapy stage iv – chemotherapy symptomatic supportive care indications surgical treatment esophageal cancer include following diagnosis esophageal cancer patient candidate surgery highgrade dysplasia patient barrett esophagus cannot adequately treated endoscopically contraindications surgical treatment include following metastasis n2 celiac cervical supraclavicular nodes solid organs eg liver lungs invasion adjacent structures eg recurrent laryngeal nerve tracheobronchial tree aorta pericardium severe associated comorbid conditions eg cardiovascular disease respiratory disease impaired cardiac respiratory function surgical options include following transhiatal esophagectomy transthoracic esophagectomy tte minimally invasive esophagectomy endoscopic mucosal resection emr neoadjuvant therapy esophageal cancer follows combination radiotherapy chemotherapy usually administered 45day period esophageal resection approximately 4 weeks chemotherapy agents esophageal cancer used offlabel palliative care options patients candidates surgery follows chemotherapy radiotherapy laser therapy stents see treatment medication background esophageal cancer devastating disease although patients cured treatment esophageal cancer protracted diminishes quality life lethal significant number cases principal histologic types esophageal cancer squamous cell carcinoma diagnosis common presenting symptom esophageal cancer dysphagia see presentation esophagogastroduodenoscopy allows direct visualization biopsies tumor endoscopic ultrasonography sensitive test determining depth penetration tumor presence enlarged periesophageal lymph nodes patients appear localized esophageal cancer positron emission tomography pet scanning may useful part baseline staging imaging studies may valuable selected patients see workup treatment surgery traditionally treatment esophageal carcinoma first successful resection performed 1913 torek esophagectomies ideal treatment localized esophageal cancer sometimes debated across practice cultures subspecialties defendants surgical treatment argue resection treatment modality offer curative intent defendants nonsurgical approach claim esophagectomy prohibitive index mortality esophageal cancer incurable disease differentials esophageal lesions cancer cause dysphagia include peptic strictures gastroesophageal reflux benign esophageal tumors principally esophageal leiomyoma achalasia esophageal stricture gastric cancer patient education patient education information see heartburn gerd center esophageal cancer cancer esophagus anatomy esophagus muscular tube extends level 7th cervical vertebra 11th thoracic vertebra esophagus divided following anatomic parts cervical esophagus thoracic esophagus abdominal esophagus blood supply cervical esophagus derived inferior thyroid artery blood supply thoracic esophagus comes bronchial arteries aorta abdominal esophagus supplied branches left gastric artery inferior phrenic artery venous drainage cervical esophagus inferior thyroid vein thoracic esophagus drains via azygous vein hemiazygous vein bronchial veins abdominal esophagus drains coronary vein esophagus characterized rich network lymphatic channels submucosa facilitate longitudinal spread neoplastic cells along esophageal wall lymphatic drainage cervical nodes tracheobronchial mediastinal nodes gastric celiac nodes pathophysiology progression barrett metaplasia adenocarcinoma associated several changes gene structure gene expression protein structure tp53 erb casson colleagues identified mutations tp53 etiology etiology esophageal carcinoma thought related exposure esophageal mucosa noxious toxic stimuli resulting sequence dysplasia carcinoma situ carcinoma western cultures retrospective evidence implicated cigarette smoking chronic alcohol exposure common etiologic factors squamous cell carcinoma high body mass index gerd resultant barrett esophagus often associated factors esophageal adenocarcinoma nutritional deficiencies recognized contributing factors highrisk regions parts china iran deficiencies vitamins eg riboflavin micronutrients may play role causation variety factors may promote esophageal cancer include following caustic injuries certain foodstuffs eg betel nut drinking scaldinghot liquids environmental contributors eg nitrosamines soil certain fungi molds yeasts acquired conditions eg achalasia genomewide association study wu et al identified seven susceptibility loci chromosomes 5q11 6p21 10q23 12q24 21q22 suggesting involvement multiple genetic loci geneenvironment interaction development esophageal cancer bisphosphonate use result esophagitis suggested risk factor esophageal carcinoma however large study found significant difference frequency esophageal gastric cancers bisphosphonate cohort control group smoking alcohol use netherlands cohort study prospective study 120852 participants demonstrated combined effects smoking alcohol consumption risk squamous cell carcinoma esophagus associations found alcohol consumption esophageal adenocarcinoma contrast risk squamous cell carcinoma adenocarcinoma esophagus increased among current smokers study steevens et al found among current smokers increased consumption specific groups vegetables fruits inversely associated esophageal squamous cell carcinoma esophageal adenocarcinoma risk infections human papillomavirus hpv infection recognized contributing factor esophageal cancer however sitas et al reported limited serologic evidence association esophageal squamous cell carcinoma hpv study 4000 subjects study could exclude possibility certain hpv types may involved small subset cancers although hpv appear important risk factor helicobacter pylori adenocarcinoma gerd gerd cascade events lead gastroesophageal reflux disease adenocarcinoma cascade events lead gastroesophageal reflux disease adenocarcinoma 1952 morson belcher published first description patient adenocarcinoma esophagus arising columnar epithelium goblet cells nationwide populationbased casecontrol study performed sweden found odds ratio 77 adenocarcinoma among persons recurrent symptoms reflux compared persons without symptoms odds ratio 435 among patients longstanding severe symptoms reflux although annual risk developing esophageal adenocarcinoma people gerd reported 05 studies found lower risk data northern ireland barrett esophagus register one largest populationbased registries world found malignant progression among patients barrett esophagus 022 per year suggests current surveillance approaches may cost effective study hvidjensen et al examined large danish registry 11028 patients median 52 found incidence esophageal adenocarcinoma 12 cases per 1000 personyears 012 annual risk lowgrade dysplasia detected index endoscopy associated incidence rate 51 cases per 1000 personyears compared 1 per 1000 personyears among without dysplasia epidemiology united states statistics esophageal cancer seventh common cause cancer death males american cancer society estimates 17990 new cases esophageal cancer 14440 men 3550 women occur united states 2013 15210 persons 12220 men 2990 women expected die disease incidence rate adenocarcinoma esophagus united states showed average annual increase 17 men 19 women 1999 2008 epidemiology esophageal carcinoma changed markedly past several decades united states last 4 decades incidence adenocarcinoma distal esophagus gastroesophageal junction increased progressively currently accounts 70 new cases esophageal cancer international statistics esophageal cancer seventh leading cause cancer death worldwide regions areas northern iran areas southern russia northern china incidence esophageal carcinoma may high 800 cases per 100000 population unlike united states squamous cell carcinoma responsible 95 esophageal cancers worldwide sex agerelated demographics esophageal cancer generally common men women maletofemale ratio 341 esophageal cancer occurs commonly sixth seventh decades life disease becomes common advancing age 20 times common persons older 65 years individuals age prognosis survival patients esophageal cancer depends stage disease squamous cell carcinoma adenocarcinoma stagebystage appear equivalent survival rates lymph node solid organ metastases associated low survival rates 20012007 overall 5year survival rate esophageal cancer 19 fiveyear survival esophageal cancer based tnm stage fiveyear survival esophageal cancer based tnm stage report 1085 patients underwent transhiatal esophagectomy cancer showed operation associated 4 operative mortality rate 23 5year survival rate better 5year survival rate 48 identified subgroup patients complete response ie disappearance tumor following preoperative radiation chemotherapy ie neoadjuvant therapy transhiatal transthoracic esophagectomies equivalent longterm survival rates imaging prognosis suzuki et al found higher initial standardized uptake value positron emission tomography pet scanning associated poorer overall survival among patients esophageal gastroesophageal carcinoma receiving chemoradiation authors suggested pet scanning may become useful individualizing therapy study gillies et al also found petcomputed tomography ct scanning used predict survival study presence fluorodeoxyglucose fdgavid lymph nodes independent adverse prognostic factor her2 prognosis study prins et al human epidermal growth factor 2 her2 protein overexpression her2 clinical presentation history physical examination history dysphagia common presenting symptom esophageal cancer initially experienced solids eventually progresses include liquids complaint dysphagia adult always prompt endoscopy help rule presence esophageal cancer barium swallow study also indicated cases symptoms include following weight loss second common symptom occurs 50 people esophageal carcinoma bleeding patients may experience bleeding tumor pain pain may felt epigastric retrosternal area pain bony structures indicates metastatic disease hoarseness caused invasion recurrent laryngeal nerve sign cancer progressed beyond point surgical resection remains possible persistent cough respiratory symptoms caused aspiration undigested food direct invasion tracheobronchial tree tumor latter also sign unresectability physical examination physical examination findings patients esophageal cancer typically normal unless cancer metastasized neck nodes liver lymphadenopathy laterocervical supraclavicular area presence hepatomegaly often indicates unresectable disease workup approach considerations goals workup establish diagnosis stage cancer esophagogastroduodenoscopy allows direct visualization biopsies tumor see image endoscopy demonstrating intraluminal esophageal cancer endoscopy demonstrating intraluminal esophageal cancer laboratory studies patients esophageal cancer focus principally patient factors may affect treatment nutritional status evaluated patients dysphagia liver function studies performed alcoholic patients 2013 society thoracic surgeons released clinical practice guidelines assist diagnosis treatment localized esophageal cancer recommendations include following diagnosis esophageal cancer flexible endoscopy biopsy primary method earlystage esophageal cancer ct chest abdomen optional test staging locoregionalized esophageal cancer ct chest abdomen recommended test staging earlystage esophageal cancer pet optional test staging locoregionalized esophageal cancer pet recommended test staging patients without metastatic disease endoscopic ultrasonography recommended improve accuracy staging patients small discrete nodules areas dysplasia disease appears limited mucosa submucosa assessed endoscopic ultrasonography endoscopic mucosal resection considered diagnosticstaging tool patients locally advanced t3t4 adenocarcinoma esophagogastric junction infiltrating anatomic cardia siewart type iii esophagogastric tumors laparoscopy recommended improve accuracy staging imaging studies ultrasonography endoscopic ultrasonography eus sensitive test determining depth tumor penetration staging presence enlarged periesophageal lymph nodes n staging ct scanning abdominal chest computed tomography ct scans useful helping exclude presence metastases staging lungs liver may useful helping determine whether adjacent structures invaded chest ct scan showing invasion trachea esophageal cancer chest ct scan showing invasion trachea esophageal cancer pet scanning positron emission tomography pet scanning also useful baseline imaging technique see image increasingly becoming standard staging esophageal cancer may particularly useful detecting occult distant lymph node metastases bone spread addition intensity radiopharmaceutical uptake pet scans may reflect biology cancer thus may prognostic significance bronchoscopy bronchoscopy indicated cancers middle upper third thoracic esophagus help exclude invasion trachea bronchi laparoscopy thoracoscopy greater 92 accuracy staging regional nodes barium swallow barium swallow sensitive detecting strictures see first image intraluminal masses see second image allow staging biopsy rarely used may helpful studying distal anatomy obstructive tumors inaccessible endoscopy barium swallow demonstrating stricture due cancer barium swallow demonstrating stricture due cancer barium swallow demonstrating endoluminal mass mid esophagus barium swallow demonstrating endoluminal mass mid esophagus information see medscape reference article esophageal carcinoma imaging staging esophageal cancer staging follows tumornodemetastasis tnm classification american joint cancer committeeunion international cancer control ajccuicc classification staging scheme changed 7th edition ajccuicc manual published 2010 completely satisfactory method available clinically stage esophageal cancer difficulty clinically assessing disease reflected changes time ajcc staging system 1983 system based length intraluminal esophageal tumor presence esophageal obstruction involvement palpable lymph nodes clinical staging system proved limited 1988 revision defined clinical pathologic staging system based entirely depth esophageal wall invasion presence absence local nodal involvement neither parameters assessed easily clinical basis hofstetter et al therefore proposed incorporating number involved lymph nodes regional nonregional node location 2010 tnm classification esophageal cancer follows staging detailed table 1 tis carcinoma situhighgrade dysplasia t1 lamina propria submucosa t1a lamina propria muscularis mucosae t1b submucosa t2 muscularis propria t3 adventitia t4 adjacent structures t4a pleura pericardium diaphragm adjacent peritoneum t4b adjacent structures eg aorta vertebral body trachea n0 regional lymph node metastasis n1 12 regional lymph nodes n1 site dependent n2 36 regional lymph nodes n3 6 regional lymph nodes m0 distant metastasis m1 distant metastasis m1a m1b site dependent table 1 staging classification stage ia t1 n0 m0 stage ib t2 n0 m0 stage iia t3 n0 m0 stage iib t1t2 n1 m0 stage iiia t4a n0 m0 t3 n1 m0 t1t2 n2 m0 stage iiib t3 n2 m0 stage iiic t4a n1n2 m0 t4b n m0 n3 m0 stage iv n m1 esophageal tumors well tumors epicenters within 5 cm esophagogastric junction also extend esophagus classified staged according ajccuicc esophageal scheme tumors epicenter stomach 5 cm esophagogastric junction within 5 cm esophagogastric junction without extension esophagus staged using gastric carcinoma scheme classifications—such japanese society esophageal diseases widely used asia—differ ajccuicc especially regarding lymph node distribution nomenclature treatment management approach considerations treatment esophageal cancer varies disease stage patients t1b n surgery may initial treatment however patients stages beyond t1b undergo multidisciplinary evaluation considered multimodality therapy trimodality chemoradiation followed surgery recommended treatment patients tolerate regimen option supported strong level 1 evidence preoperative chemotherapy followed surgery another option however evidence approach weak chance increase 2year overall survival less 6 compared approximately 13 trimodality therapy stage iv disease treated chemotherapy symptomatic supportive care indicated patients clinical condition owing advanced disease candidates curative treatment goal therapy palliation dysphagia patients eat single method palliation best every situation patients require 1 kind palliative treatment sustain esophageal patency course disease surgical indications contraindications surgery remains cornerstone treatment esophageal cancer indications surgery include following esophageal cancer patient candidate surgery highgrade dysplasia patient barrett esophagus cannot adequately treated endoscopically contraindications surgery include following metastasis n2 nodes ie cervical supraclavicular lymph nodes solid organs eg liver lungs treatment patients celiac lymph node involvement remains controversial invasion adjacent structures eg recurrent laryngeal nerve tracheobronchial tree aorta pericardium addition presence severe associated comorbid conditions eg cardiovascular disease respiratory disease decrease patients chances surviving esophageal resection consequently cardiac respiratory function must carefully evaluated preoperatively forced expiratory volume 1 second less 12 l left ventricular ejection fraction less 04 relative contraindications operation esophagectomy esophageal resection esophagectomy remains critical component multimodality therapy patients tumors stage endoscopic mucosal resection experimental approach patients t1a disease highgrade dysplasia limited certain centers performed protocol esophagectomy longer used palliation symptoms treatment modalities become available relieving dysphagia esophagectomy performed using abdominal cervical incision blunt mediastinal dissection esophageal hiatus ie transhiatal esophagectomy using abdominal right thoracic incision ie transthoracic esophagectomy tte offers advantage avoiding chest incision cause prolonged discomfort aggravate condition patients compromised respiratory function removal esophagus continuity gastrointestinal tract usually reestablished using stomach authors questioned validity cancer operation part operation performed direct vision fewer lymph nodes removed tte however many retrospective studies 2 prospective ones shown difference survival operations suggesting factor influencing survival type operation rather stage cancer time operation performed morbidity mortality complications esophagectomy occur approximately 40 patients morbidity associated surgery consists mostly respiratory cardiac septic complications including following respiratory complications 1520 include atelectasis pleural effusion pneumonia cardiac complications 1520 include cardiac arrhythmias myocardial infarction septic complications 10 include wound infection anastomotic leak breakdown new connection stomach esophagus pneumonia anastomotic leaks stricture may require dilatation 20 leaks may treated endoscopic placement selfexpanding removable plastic stents leak rates vary depending whether anastomosis performed chest 312 neck 1025 retrospective review 1223 esophagectomies cancer found surgical management intrathoracic leaks increase patient mortality rate effect longterm survival complex operations eg cardiac operations resection pancreas liver lowest mortality rate esophagectomy achieved procedure performed highvolume centers highvolume surgeons california 19901994 instance 5 highvolume centers mortality rate 5 less esophageal resection cancer state’s average mortality rate surgery approximately 18 better results highvolume centers due team approach facilities expert surgeons work intensivists cardiologists pulmonologists radiologists nurses experience expertise transthoracic esophagectomy tte patient placed supine operating room table arterial line central venous catheter foley catheter duallumen endotracheal tube placed preoperative antibiotics administered upper midline incision made exploring peritoneal cavity metastatic disease metastases found operation continued stomach mobilized right gastric right gastroepiploic arteries preserved short gastric vessels left gastric artery divided next gastroesophageal junction mobilized esophageal hiatus enlarged pyloromyotomy performed feeding jejunostomy placed postoperative nutritional support closure abdominal incision patient repositioned left lateral decubitus position right posterolateral thoracotomy performed fifth intercostal space azygos vein divided allow full mobilization esophagus stomach delivered chest hiatus divided approximately 5 cm gastroesophageal junction anastomosis handsewn stapled performed esophagus stomach apex right chest cavity chest incision closed transhiatal esophagectomy preoperative details similar tte except singlelumen rather doublelumen endotracheal tube used neck prepared operative field abdominal part operation identical tte however dissection esophagus performed enlarged esophageal hiatus without opening right chest esophagus mobilized fashion way thoracic inlet 6cm incision made left side neck internal jugular vein carotid artery retracted laterally esophagus identified isolated posterior airway prevent injury left recurrent laryngeal nerve mechanical retractors used retract trachea next resection proximal stomach thoracic esophagus remaining stomach pulled posterior mediastinum reaches remaining esophagus cervical level handsewn anastomosis performed small drain placed neck alongside anastomosis abdominal neck incisions closed see image transhiatal esophagectomy abdominal incision b cervical incision transhiatal esophagectomy abdominal incision b cervical incision c stomach stretching abdomen neck minimally invasive surgery techniques esophagectomy use laparoscopic thoracoscopic techniques revolutionized treatment benign esophageal disorders achalasia gastroesophageal reflux disease gerd advantages minimally invasive surgery include shorter hospital stay less postoperative discomfort much faster recovery time open surgery techniques finding place treatment esophageal cancer videoassisted thoracoscopy vats used many centers thoracic mobilization esophagus reducing size chest incision addition laparoscopy used mobilize gastric conduit abdomen reducing abdominal incision size well study uenosono et al found sentinel node mapping applied patients clinical t1 n0 esophageal cancer use technique may facilitate less invasive surgery reduction lymphadenectomy endoscopic mucosal resection emr modern attractive option treatment superficial esophageal cancers highgrade dysplasia mucosalimited neoplasms candidates emr low risk node metastasis cases populationbased study 1618 patients grade tis t1a t1b esophageal cancer found overall survival times esophagealcancerspecific survival times endoscopic therapy similar surgery adjustment patient tumor factors salvage endoscopic resection patients local failure definitive chemoradiotherapy crt esophageal squamous cell carcinoma escc salvage endoscopic treatment set may viable option according study reported 2014 gastrointestinal cancers symposium curative resection achieved 88 patients underwent endoscopic resection complete response achieved 575 underwent photodynamic therapy chemoradiotherapy chemotherapy radiotherapy esophageal cancer delivered preoperatively survival benefit obtained radiation chemotherapy administered postoperatively however postoperative continuance chemotherapy started preoperatively may beneficial chemotherapy currently used treatment esophageal cancer including alkylating antimetabolite anthracycline antimicrotubular agents approved indication us food drug administration fda chemotherapy squamous cell esophageal carcinoma squamous cell carcinomas general based cisplatin chemotherapy esophageal adenocarcinoma extrapolated experience patients adenocarcinoma stomach neoadjuvant chemotherapy alone appears offer limited benefit best north american randomized trial found preoperative chemotherapy combination cisplatin fluorouracil improve overall survival among patients squamous cell cancer adenocarcinoma esophagus larger trial british investigators found preoperative chemotherapy 2 agents resulted 5year survival rate 230 compared 171 surgery alone contrast chemoradiotherapy oesophageal cancer followed surgery study cross demonstrated considerable benefit preoperative chemoradiation surgery alone selected patients esophageal esophagogastricjunction cancer tumor stage t1n1 t2–t3 n analysis data cross ii showed preoperative chemoradiotherapy crt plus surgery superior surgery alone preventing local regional distant recurrence particularly hematogenous metastasis peritoneal carcinomatosis neoadjuvant therapy consists combination radiotherapy approximately 45 gy chemotherapy cisplatin 5fluorouracil radiotherapy acts locally tumor site chemotherapy acts tumor cells already spread combination therapy usually administered 45day period esophageal resection performed interval approximately 4 weeks rohatgi et al reported response preoperative chemoradiotherapy correlated strongly overall survival diseasefree survival patients esophageal cancer review 235 cases survival decreased progressively patients achieved pathologic complete response partial response 150 residual carcinoma resected specimen response greater 50 residual carcinoma study rao et al identified groups esophageal tumors distinct gene expression profiles future may allow tailored treatment protocols trial involving 111 patients undergoing chemoradiotherapy headandneck esophageal cancer indicated enteral nutrition enriched n3 fatty acids helps preserve body mass improve nutritional functional status parameters chemoradiotherapy palliative care patients clinical condition advanced disease candidates surgery treatment focuses control dysphagia appropriate method control dysphagia determined patient individually depending tumor characteristics patient preference specific expertise physician following treatment modalities available help achieve goal chemotherapy radiotherapy laser therapy stents chemotherapy chemotherapy single modality limited use patients achieve modest shortlived response phase 3 study united kingdom suggests docetaxel may useful secondline treatment patients esophageal cancer progressed firstline chemotherapy survival patients measured months quality life important consideration uk study qualityoflife questionnaires demonstrated differences 2 groups global functioning scores indicate improvement symptom scores docetaxel group reporting less pain 2006 cochrane review tried assess effectiveness chemotherapy versus best supportive care well different chemotherapy regimens metastatic esophageal carcinoma authors found consistent benefit specific chemotherapy regimen radiotherapy radiation therapy successful relieving dysphagia approximately 50 patients patients advanced esophageal cancer preoperative combination chemotherapy radiotherapy shown good results large multicenter study herskovic colleagues reported 2year survival rate 38 median survival period 125 months patients treated radiotherapy combination chemotherapy fluorouracil cisplatin compared 2yearsurvival rate 10 median survival period 85 months patients treated radiotherapy alone study folkert et al found highdoserate hdr endoluminal brachytherapy well tolerated medically inoperable patients superficial primary recurrent esophageal cancer course 3 years 14 patients treated hdr intraluminal brachytherapy 10 recurrent esophageal cancer 4 previously unirradiated lesions overall freedom failure offf overall survival os rate 18 months 308 727 respectively patients recurrent disease 111 offf 556 os rate 18 months patients previously unirradiated disease offf 75 os rate 100 laser therapy laser therapy ndyag laser help achieve temporary relief dysphagia many 70 patients multiple sessions usually required keep esophageal lumen patent photosensitizer porfimer photofrin fda approved palliation patients completely obstructing esophageal cancer partially obstructing cancer cannot satisfactorily treated ndyag laser therapy intravenous injection porfimer followed 40–50 hours later delivery 630 nm wavelength laser light second laser light treatment may given 96–120 hours injection stents patients may intubated expandable metallic stents deployed endoscopy fluoroscopic guidance keep esophageal lumen patent stents particularly useful patients tracheoesophageal fistula postoperative care followup average length postoperative hospital stay patients esophageal cancer 914 days patients usually spend first postoperative night intensive care unit icu patients extubated immediately operation mechanical ventilation continued concerns respiratory status present respiratory complications eg atelectasis pleural effusion pneumonia cardiac complications eg cardiac arrhythmias usually occur first postoperative days patients leave icu transferred surgical ward respiratory status cardiac status satisfactory feeding feeding jejunostomy begins postoperative day 1 postoperative day 6 swallow study performed check anastomotic leakage leak present patients start oral feedings leak present drainage tubes left place nutrition provided entirely feeding jejunostomy leak closes spontaneously approximately 8590 patients go home discharge remaining patients may need additional time skilled nursing facility live alone cannot take care patients seen responsible surgeon 2 weeks 4 weeks discharge hospital subsequently every 6 months oncologist patients return regular level activities within 2 months prevention esophageal cancer squamous cell carcinoma prevention consists smoking cessation efforts reduce alcohol abuse consumption diet containing adequate amount fruits vegetables vitamins esophageal adenocarcinomas prevention involves stopping sequence events leading gastroesophageal reflux disease gerd barrett esophagus adenocarcinoma better control gastroesophageal reflux prevent development barrett metaplasia patients gerd discourage development highgrade dysplasia patients metaplasia endoscopic followup evaluations performed 1 2year intervals detect presence dysplasia allowing intervention cancer develops dysplasia barrett esophagus treated endoscopic ablation using radiofrequency ablation rfa photodynamic therapy pdt cryotherapy highgrade dysplasia develop esophagectomy indicated operation must performed experienced surgeons highvolume centers order keep mortality rate less 5 radiofrequency ablation rfa gaining popularity treatment barrett esophagus dysplasia shaheen et al reported complete eradication dysplasia 2 years rfa 101 106 patients 95 3 years dysplasia remained eradicated 85 patients without maintenance rfa rate serious adverse events 34 rate esophageal stricture 76 photodynamic therapy pdt involves administration photosensitizing chromophores selectively retained dysplastic malignant tissue light delivered area photosensitizer absorbs photons becomes photoexcited transfers energy chemical substrate causes biologic damage abnormal tissue drawback pdt formation esophageal strictures 34 patients photosensitizer porfimer fda approved ablation highgrade dysplasia barrett esophagus medication medication summary chemotherapy squamous cell carcinoma esophagus like squamous cell malignancies general based cisplatin chemotherapeutic choices esophageal adenocarcinoma extrapolated chemotherapy experience patients adenocarcinoma stomach chemotherapy regimens currently used treatment esophageal cancer including alkylating antimetabolite anthracycline antimicrotubular agents approved us food drug administration fda antineoplastics antimetabolite class summary agents inhibit cell growth proliferation interfere dna synthesis blocking methylation deoxyuridylic acid fluorouracil adrucil fluorouracil pyrimidine antimetabolite several mechanisms action proposed including inhibition thymidylate synthase inhibition rna synthesis agent also potent radiosensitizer capecitabine xeloda capecitabine pyrimidine antimetabolite prodrug fluorouracil forms active moiety fluorouracil undergoing hydrolysis liver tissues capecitabine used treatment esophageal cancer offlabel indication antineoplastics alkylating class summary agents inhibit cell growth proliferation interfering dna synthesis formation dna crosslinks alkylating agents serious adverse effects bone marrow suppression anaphylacticlike reactions ototoxicity renal toxicity vomiting cisplatin intrastrand crosslinking dna inhibition dna precursors among proposed mechanisms action cisplatin agent used combination radiation therapy cisplatin black box warnings adverse reactions including anaphylacticlike reactions ototoxicity renal toxicity carboplatin carboplatin platinum alkylating agent interferes function dna producing interstrand dna crosslinks used combination paclitaxel treatment esophageal cancer offlabel indication carboplatin black box warnings including bone marrow suppression anaphylactic reactions vomiting oxaliplatin eloxatin oxaliplatin platinum alkylating agent inhibits dna replication transcription resulting cell death used combination chemotherapy treatment esophageal cancer offlabel indication black box warning anaphylactic reactions managed epinephrine corticosteroids antihistamines antineoplastics antimicrotubular class summary agents prevent cell growth proliferation work enhancing tubulin dimers stabilizing existing microtubules inhibiting microtubule disassembly docetaxel taxotere docefrez docetaxel inhibits depolymerization tubulin inhibits dna rna protein synthesis used combination cisplatin fluorouracil treatment esophageal cancer offlabel indication several black box warnings bone marrow suppression fluid retention hypersensitivity reactions use docetaxel recommended certain patients hepatic impairment patients receiving treatment docetaxel premedicated corticosteroids day administration help reduce fluid retention hypersensitivity reactions paclitaxel paclitaxel promotes microtubule assembly interferes g2 mitotic phase inhibits cell replication although fda approved used combination chemotherapy treatment esophageal cancer paclitaxel offlabel indication treatment adenocarcinoma black box warnings drug include bone marrow suppression hypersensitivity reactions antineoplastics anthracycline class summary anthracycline antineoplastics inhibit dna rna synthesis steric obstruction intercalate dna base pairs trigger dna cleavage topoisomerase ii epirubicin ellence epirubicin inhibits dna rna synthesis used label part combination chemotherapy regimen treatment esophageal cancer several black box warnings including bone marrow suppression extravasation myocardial toxicity secondary malignancy dosage reduction recommended patients mild moderate hepatic impairment antineoplastics topoisomerase inhibitors class summary agents prevent cell growth proliferation work binding topoisomerase causing singlestrand dna breaks irinotecan camptosar irinotecan binds reversibly topoisomerase i–dna complex prevents ligation cleaved dna strand used part combination chemotherapy treatment esophageal cancer offlabel indication black box warnings irinotecan include bone marrow suppression diarrhea antineoplastics class summary category includes miscellaneous antineoplastic agents cause cytotoxic activity various mechanisms action porfimer photofrin porfimer photodynamic therapy causes cytotoxic activity producing oxygen freeradicals presence laser light also release thromboxane a2 leading necrosis vascular occlusion indicated palliation patients partially completely obstructing esophageal cancer start media endoscopy demonstrating intraluminal esophageal cancer endoscopy demonstrating intraluminal esophageal cancer cascade events lead gastroesophageal reflux disease adenocarcinoma cascade events lead gastroesophageal reflux disease adenocarcinoma barium swallow demonstrating stricture due cancer barium swallow demonstrating stricture due cancer barium swallow demonstrating endoluminal mass mid esophagus barium swallow demonstrating endoluminal mass mid esophagus chest ct scan showing invasion trachea esophageal cancer chest ct scan showing invasion trachea esophageal cancer transhiatal esophagectomy abdominal incision b cervical incision transhiatal esophagectomy abdominal incision b cervical incision c stomach stretching abdomen neck fiveyear survival esophageal cancer based tnm stage fiveyear survival esophageal cancer based tnm stage h e high power showing junction benign glands lower right barretts columnar h e high power showing junction benign glands lower right barretts columnar cell metaplasia large goblet cell containing blue mucin lower center adenocarcinoma left macroscopic image resection gastroesophageal junction right non macroscopic image resection gastroesophageal junction right nonneoplastic esophagus consisting tan smooth mucosa left nonneoplastic rugal folds stomach center picture ulcer yellowgreen fibrinous exudate surrounded irregular heapedup margins almost cobblestone appearance latter represents mucosal adenocarcinoma probably barretts metaplasia background h e high power demonstrating invasive esophageal squamous cell carcinoma carcinoma h e high power demonstrating invasive esophageal squamous cell carcinoma carcinoma form glands instead shows features squamous differentiation including keratinization intercellular bridges macroscopic image esophageal resection polypoid squamous cell carcinoma visible macroscopic image esophageal resection polypoid squamous cell carcinoma visible protruding esophageal mucosal surface left center specimen positron emission computed tomography pet scan esophageal cancer evident positron emission computed tomography pet scan esophageal cancer evident golden lesion chest author keith baldwin imph assistant professor surgery boston university school medicine endocrine surgical oncologist department general surgery roger williams cancer center keith baldwin member following medical societies american college surgeons society surgical oncology american association endocrine surgeons americas hepatopancreatobiliary association society international humanitarian surgeonssurgeons overseas sos disclosure nothing disclose coauthors marco g patti md professor surgery director center esophageal diseases university chicago pritzker school medicine marco g patti md member following medical societies american association advancement science american surgical association american college surgeons american gastroenterological association american medical association association academic surgery society surgery alimentary tract society american gastrointestinal endoscopic surgeons southwestern surgical congress western surgical association disclosure nothing disclose n joseph espat md ms facs harold j wanebo professor chief surgical oncology director adele r decof cancer center vicechair department surgery roger williams medical center boston university school medicine n joseph espat md ms facs member following medical societies alpha omega alpha american association cancer research american college surgeons american medical association american society parenteral enteral nutrition association academic surgery central surgical association chicago medical society international hepatopancreatobiliary association sigma xi society surgery alimentary tract society american gastrointestinal endoscopic surgeons society surgical oncology society university surgeons southeastern surgical congress southern medical association americas hepatopancreatobiliary association american society clinical oncology surgical infection society society leukocyte biology pancreas club disclosure nothing disclose fernando herbella md phd tcbc affiliate professor attending surgeon gastrointestinal surgery esophagus stomach division department surgery federal university sao paulo brazil private practice medical examiner sao paulos medical examiners office headquarters brazil fernando herbella md phd member following medical societies society surgery alimentary tract disclosure nothing disclose chief editor jules e harris md facp frcpc clinical professor medicine section hematologyoncology university arizona college medicine arizona cancer center jules e harris md facp frcpc member following medical societies american association advancement science american society hematology central society clinical translational research american society clinical oncology disclosure nothing disclose acknowledgements philip schulman md philip schulman md member following medical societies american association cancer research american college physicians american society hematology medical society state new york disclosure nothing disclose francisco talavera pharmd phd disclosure medscape salary employment edwards mj gable dr lentsch ab et al rationale esophagectomy optimal therapy barretts esophagus highgrade dysplasia ann surg medline ferguson mk durkin longterm survival esophagectomy barretts adenocarcinoma endoscopically surveyed nonsurveyed patients j gastrointest surg medline torek f first successful resection thoracic portion esophagus carcinoma surg gynecol obstet ohsawa surgery esophagus arch jpn chir marshall sf carcinoma esophagus successful resection lower end esophagus reestablishment esophageal gastric continuity surg clin north amer tilanus hw changing patterns treatment carcinoma esophagus scand j gastroenterol suppl medline jankowski ja wright na meltzer sj et al molecular evolution metaplasiadysplasiaadenocarcinoma sequence esophagus j pathol medline koppert lb wijnhoven bp van dekken h et al molecular biology esophageal adenocarcinoma j surg oncol medline casson ag manolopoulos b troster et al clinical implications p53 gene mutation progression barretts epithelium invasive esophageal cancer j surg medline lagergren j bergstrom r lindgren et al symptomatic gastroesophageal reflux risk factor esophageal adenocarcinoma n engl j med medline wu c hu z z et al genomewide association study identifies three new susceptibility loci esophageal squamouscell carcinoma chinese populations nat genet medline cardwell cr abnet cc cantwell mm murray lj exposure oral bisphosphonates risk esophageal cancer jama medline full text steevens j schouten lj goldbohm ra van den brandt pa alcohol consumption cigarette smoking risk subtypes oesophageal gastric cancer prospective cohort study gut medline steevens j schouten lj goldbohm ra van den brandt pa vegetables fruits consumption risk esophageal gastric cancer subtypes netherlands cohort study int j cancer medline sitas f egger urban mi et al interscope study associations esophageal squamous cell carcinoma human papillomavirus serological markers j natl cancer inst medline full text morson bc belcher jr adenocarcinoma oesophagus ectopic gastric mucosa br j cancer medline naef ap savary ozzello l columnarlined lower esophagus acquired lesion malignant predisposition report 140 cases barretts esophagus 12 adenocarcinomas j thorac cardiovasc surg medline bhat coleman hg yousef f et al risk malignant progression barretts esophagus patients results large populationbased study j natl cancer inst medline hvidjensen f pedersen l drewes et al incidence adenocarcinoma among patients barretts esophagus n engl j med medline american cancer society cancer facts figures 2013 available httpwwwcancerorgacsgroupscontentepidemiologysurveilancedocumentsdocumentacspc036845pdf siegel r naishadham jemal cancer statistics 2012 ca cancer j clin medline full text kirby tj rice tw epidemiology esophageal carcinoma changing face disease chest surg clin n medline orringer mb marshall b iannettoni md transhiatal esophagectomy clinical experience refinements ann surg medline chang ac ji h birkmeyer nj et al outcomes transhiatal transthoracic esophagectomy cancer ann thorac surg medline chu km law sy fok et al prospective randomized comparison transhiatal transthoracic resection lowerthird esophageal carcinoma j surg medline suzuki xiao l hayashi et al prognostic significance baseline positron emission tomography importance clinical complete response patients esophageal gastroesophageal junction cancer treated definitive chemoradiotherapy cancer medline full text gillies rs middleton mr han c et al role positron emission tomography–computed tomography predicting survival neoadjuvant chemotherapy surgery oesophageal adenocarcinoma brit j surg prins mj ruurda jp van diest pj van hillegersberg r ten kate fj significance her2 status esophageal adenocarcinoma survival immunohistochemical situ hybridization study ann oncol medline nelson r new clinical guidelines issued esophageal cancer medscape medical news available httpwwwmedscapecomviewarticle807141 varghese tk jr hofstetter wl rizk np low de darling ge watson tj et al society thoracic surgeons guidelines diagnosis staging patients esophageal cancer ann thorac surg medline dittler hj siewert jr role endoscopic ultrasonography esophageal carcinoma endoscopy medline odonovan pb radiographic evaluation patient esophageal carcinoma chest surg clin n medline rice tw rusch vw ishwaran h blackstone eh cancer esophagus esophagogastric junction datadriven staging seventh edition american joint committee cancerinternational union cancer cancer staging manuals cancer medline full text hofstetter w correa bekele n et al proposed modification nodal status ajcc esophageal cancer staging system ann thorac surg medline herbella fa del grande jc colleoni r japanese society disease esophagus anatomical analysis mediastinal lymph nodes normal brazilian subjects according classification japanese society diseases esophagus surg today medline nccn clinical practice guidelines oncology esophageal esophagogastric junction cancers excluding proximal 5 cm stomach available httpwwwnccnorgprofessionalsphysicianglspdfesophagealpdf cooper js guo md herskovic et al chemoradiotherapy locally advanced esophageal cancer longterm followup prospective randomized trial rtog 8501 radiation therapy oncology group jama medline forastiere aa orringer mb pereztamayo c et al preoperative chemoradiation followed transhiatal esophagectomy carcinoma esophagus final report j clin oncol medline sjoquist km burmeister bh smithers bm zalcberg jr simes rj barbour et al survival neoadjuvant chemotherapy chemoradiotherapy resectable oesophageal carcinoma updated metaanalysis lancet oncol medline le prise e etienne pl meunier b et al randomized study chemotherapy radiation therapy surgery versus surgery localized squamous cell carcinoma esophagus cancer medline leichman l steiger z seydel hg et al preoperative chemotherapy radiation therapy patients cancer esophagus potentially curative approach j clin oncol medline nygaard k hagen hansen hs et al preoperative radiotherapy prolongs survival operable esophageal carcinoma randomized multicenter study preoperative radiotherapy chemotherapy second scandinavian trial esophageal cancer world j surg medline reynolds jv muldoon c hollywood ravi n rowley obyrne k et al longterm outcomes following neoadjuvant chemoradiotherapy esophageal cancer ann surg medline full text schomas da quevedo jf donahue jm nichols fc 3rd romero miller rc prognostic importance pathologically involved celiac node metastases nodepositive patients carcinoma distal esophagus gastroesophageal junction surgical series mayo clinic dis esophagus medline gluch l smith rc bambach cp et al comparison outcomes following transhiatal ivor lewis esophagectomy esophageal carcinoma world j surg medline goldminc maddern g le prise e et al oesophagectomy transhiatal approach thoracotomy prospective randomized trial br j surg medline hankins jr attar coughlin tr jr et al carcinoma esophagus comparison results transhiatal versus transthoracic resection ann thorac surg medline stiles bm altorki nk traditional techniques esophagectomy surg clin north dai chopra ss kneif hunerbein management esophageal anastomotic leaks perforations fistulae selfexpanding plastic stents j thorac cardiovasc surg medline martin lw swisher sg hofstetter w et al intrathoracic leaks following esophagectomy longer associated increased mortality ann surg medline patti mg corvera cu glasgow et al hospitals annual rate esophagectomy influences operative mortality rate j gastrointest surg medline nguyen nt roberts p follette dm et al thoracoscopic laparoscopic esophagectomy benign malignant disease lessons learned 46 consecutive procedures j coll surg medline uenosono arigami yanagita et al sentinel node navigation surgery acceptable clinical t1 n0 esophageal cancer ann surg oncol medline ngamruengphong wolfsen hc wallace mb survival patients superficial esophageal adenocarcinoma endoscopic treatment vs surgery clin gastroenterol hepatol medline brooks endoscopic therapy good option early esophageal cancer medscape serial online available httpwwwmedscapecomviewarticle814817 novak b salvage endoscopy viable esophageal cancers medscape medical news full text cunningham allum wh stenning sp et al perioperative chemotherapy versus surgery alone resectable gastroesophageal cancer n engl j med medline allum wh stenning sp bancewicz j clark pi langley longterm results randomized trial surgery without preoperative chemotherapy esophageal cancer j clin oncol medline van hagen p hulshof mc van lanschot jj steyerberg ew van berge henegouwen mi wijnhoven bp et al preoperative chemoradiotherapy esophageal junctional cancer n engl j med medline brooks preop chemoradiation benefits confirmed esophageal cancer medscape medical news full text oppedijk v van der gaast van lanschot jj van hagen p van os r van rij cm et al patterns recurrence surgery alone versus preoperative chemoradiotherapy surgery cross trials j clin oncol medline mamon hj tepper je combination chemoradiation therapy whole sum parts j clin oncol medline rohatgi pr swisher sg correa wu tt liao z komaki r et al failure patterns correlate proportion residual carcinoma preoperative chemoradiotherapy carcinoma esophagus cancer medline full text rao welsh l cunningham et al correlation overall survival gene expression profiles prospective study resectable esophageal cancer clin colorectal cancer medline alexander bm wang xz niemierko weaver dt mak rh roof ks et al dna repair biomarkers predict response neoadjuvant chemoradiotherapy esophageal cancer int j radiat oncol biol phys medline fietkau r lewitzki v kuhnt et al diseasespecific enteral nutrition formula improves nutritional status functional performance patients head neck esophageal cancer undergoing chemoradiotherapy results randomized controlled multicenter trial cancer medline tailored enteral formula chemoradiotherapy curbs body mass loss medscape full text guideline wong rk malthaner ra zuraw l rumble rb combined modality radiotherapy chemotherapy nonsurgical management localized carcinoma esophagus practice guideline int j radiat oncol biol phys medline chustecka z secondline docetaxel affirmed esophagogastric cancer medscape medical news jan 23 2013 available httpwwwmedscapecomviewarticle778031 ford h marshall wadsley j et al cougar02 randomized phase iii study docetaxel versus active symptom control advanced esophagogastric adenocarcinoma j clin oncol homs v gaast siersema pd et al chemotherapy metastatic carcinoma esophagus gastroesophageal junction cochrane database syst rev medline herskovic martz k alsarraf et al combined chemotherapy radiotherapy compared radiotherapy alone patients cancer esophagus n engl j med medline folkert mr cohen gn wu aj et al endoluminal highdoserate brachytherapy early stage recurrent esophageal cancer medically inoperable patients brachytherapy medline shaheen nj overholt bf sampliner wolfsen hc wang kk fleischer de et al durability radiofrequency ablation barretts esophagus dysplasia gastroenterology medline full text conroy galais mp raoul jl et al definitive chemoradiotherapy folfox versus fluorouracil cisplatin patients oesophageal cancer prodige5accord17 final results randomised phase 23 trial lancet oncol medline gebski v burmeister b smithers bm et al survival benefits neoadjuvant chemoradiotherapy chemotherapy oesophageal carcinoma metaanalysis lancet oncol medline kelsen dp ginsberg r pajak tf sheahan dg gunderson l mortimer j et al chemotherapy followed surgery compared surgery alone localized esophageal cancer n engl j med medline knyrim k wagner hj bethge n keymling vakil n controlled trial expansile metal stent palliation esophageal obstruction due inoperable cancer n engl j med medline lowry f folfox convenient esophageal cancer medscape medical news full text scheer rv fakiris aj johnstone pa quantifying benefit pathologic complete response neoadjuvant chemoradiotherapy treatment esophageal cancer int j radiat oncol biol phys medline

Article 23:
bipolar affective disorder bipolar affective disorder practice essentials background pathophysiology bipolar affective disorder clinical presentation history physical examination bipolar affective disorder differential diagnoses bipolar affective disorder workup approach considerations blood studies substance alcohol screening bipolar affective disorder treatment management approach considerations indications inpatient management considerations partial hospitalization day treatment bipolar affective disorder medication anxiolytics benzodiazepines mood stabilizers anticonvulsants antipsychotics 2nd generation antipsychotics 1st generation antipsychotics phenothiazine antiparkinson agents dopamine agonists bipolar affective disorder practice essentials background pathophysiology bipolar affective disorder clinical presentation history physical examination bipolar affective disorder differential diagnoses bipolar affective disorder workup approach considerations blood studies substance alcohol screening bipolar affective disorder treatment management approach considerations indications inpatient management considerations partial hospitalization day treatment bipolar affective disorder medication anxiolytics benzodiazepines mood stabilizers anticonvulsants antipsychotics 2nd generation antipsychotics 1st generation antipsychotics phenothiazine antiparkinson agents dopamine agonists overview practice essentials background pathophysiology etiology epidemiology prognosis patient education presentation history physical examination differential diagnoses workup approach considerations blood studies substance alcohol screening magnetic resonance imaging electrocardiography electroencephalography treatment approach considerations indications inpatient management considerations partial hospitalization day treatment considerations outpatient treatment pharmacologic therapy electroconvulsive therapy dietary activity measures complications prevention longterm monitoring medication bipolar affective disorder overview bipolar affective disorder clinical presentation bipolar affective disorder differential diagnoses bipolar affective disorder workup bipolar affective disorder treatment bipolar affective disorder medication 286342overview mar 16 2015 201506200127 0 psychiatry 2002 diseases conditions condition 1 2 content 286342 502 877 12 r458f31f33 jun 04 2015 condition diseases conditions psychiatry psychiatry psychiatryadult adult bipolar depression bipolar disorder bipolar symptoms bipolar treatment manic depression affective disorder mood disorder bipolar affective disorder bipolar disorder bipolar bipolar ii subthreshold bipolar disorders bi polar disorder bipolar treatment bipolar symptoms manicdepressive disorder manicdepressive illness mdi manic depression bpi bpii bp1 bp2 schizophrenia psychosis mood disorders cyclothymia suicide mania electroconvulsive therapy ect electroshock hypomania psychomotor agitation grandiosity inflated selfesteem racing thoughts flight ideas distractibility hypersomnia insomnia depression mental status examination mse aggression bipolar affective disorder manicdepressive illness mdi common severe persistent mental illness condition serious lifelong struggle challenge 0 bipd li mdd bipolar affective disorder overview practice essentials bipolar affective disorder manicdepressive illness mdi common severe persistent mental illness condition serious lifelong struggle challenge signs symptoms bipolar affective disorder characterized periods deep prolonged profound depression alternate periods excessively elevated irritable mood known mania manic episodes feature least 1 week profound mood disturbance characterized elation irritability expansiveness referred gateway criteria least 3 following symptoms must also present grandiosity diminished need sleep excessive talking pressured speech racing thoughts flight ideas clear evidence distractibility increased level goalfocused activity home work sexually excessive pleasurable activities often painful consequences hypomanic episodes characterized elevated expansive irritable mood least 4 consecutive days’ duration least 3 following symptoms also present grandiosity inflated selfesteem diminished need sleep pressured speech racing thoughts flight ideas clear evidence distractibility increased level goalfocused activity home work sexually engaging activities high potential painful consequences major depressive episodes characterized 2 weeks person experiences 5 following symptoms least 1 symptoms either depressed mood characterized loss pleasure interest depressed mood markedly diminished pleasure interest nearly activities significant weight loss gain significant loss increase appetite hypersomnia insomnia psychomotor retardation agitation loss energy fatigue feelings worthlessness excessive guilt decreased concentration ability marked indecisiveness preoccupation death suicide see clinical presentation diagnosis examination patients suspected bipolar affective disorder includes evaluation using mental status examination well assessment following appearance affectmood thought content perception suicideselfdestruction homicideviolenceaggression judgmentinsight cognition physical health testing although bipolar disorder diagnosed based patient’s history clinical course laboratory studies may necessary rule potential causes patient’s signs symptoms well baseline results administering certain medications laboratory tests may helpful include following cbc count esr levels fasting glucose levels electrolyte levels protein levels thyroid hormone levels creatinine blood urea nitrogen levels liver lipid panel substance alcohol screening depending patient’s presentation laboratory tests may indicated may include following urinary copper levels antinuclear antibody testing hiv testing vdrl testing electrocardiography important elderly patients antidepressant therapy electroencephalography andor mri may appropriate selected patients see workup management treatment bipolar affective disorder directly related phase episode ie depression mania severity phase may involve combination psychotherapy medication always evaluate patients mania hypomania mixed episode bipolar depression suicidality acute chronic psychosis unstable dangerous conditions pharmacotherapy medications used manage patients bipolar disorder include following benzodiazepines eg lorazepam clonazepam antimanic agents eg lithium anticonvulsants eg carbamazepine valproate sodium valproic acid divalproex sodium lamotrigine topiramate firstgeneration antipsychotics eg inhaled loxapine haloperidol secondgeneration antipsychotics eg asenapine ziprasidone quetiapine risperidone aripiprazole olanzapine olanzapine fluoxetine clozapine paliperidone phenothiazine antipsychotics eg chlorpromazine dopamine agonists eg pramipexole nonpharmacotherapy psychotherapy may help decrease relapse rates improve quality life andor increase functioning favorable symptom improvement electroconvulsive therapy may useful selected patients bipolar disorder see treatment medication background bipolar affective disorder manicdepressive illness mdi common severe persistent mental illness condition serious lifelong struggle challenge bipolar disorder characterized periods deep prolonged profound depression symptoms mania include decreased sleep time accompanied decreased need sleep pressured speech increased libido reckless behavior without regard consequences grandiosity severe thought disturbances may may include psychosis highs lows many patients adequately medicated usually experience periods higher functionality lead productive life unipolar major depressive disorder bipolar disorder share depressive symptoms bipolar disorder defined episodes mania hypomania community lifetime prevalence 4 bpi bpii disorder combined suggested costs bipolar disorder include direct costs treatment along even significant indirect costs excess unemployment decreased productivity excess mortality severely impairing illness affects many aspects patients lives 5th edition diagnostic statistical manual mental disorders dsm5 pathophysiology pathophysiology bipolar affective disorder manicdepressive illness mdi determined objective biologic markers correspond definitively disease state however twin family adoption studies indicate bipolar disorder significant genetic component fact firstdegree relatives person bipolar disorder approximately 7 times likely develop bipolar disorder rest population heritability bipolar disorder bpi recently estimated 073 genetics genetic component bipolar disorder appears complex condition likely caused multiple different common disease alleles contributes relatively low degree risk disease genes difficult find without large sample sizes order thousands subjects genetics bipolar disorder first studied less precise tools available still yielded interesting information many loci known associated development bipolar disorder loci grouped major affective disorder mafd loci numbered order discovery mafd loci mafd1 mafd2 mafd3 trpm2 mafd4 mafd5 mafd6 mafd5 mafd6 mafd7 xbp1 xbp1 mafd8 ank3 mafd9 mafd8 cacna1c ank3 genomewide association studies first series genomewide association studies gwass bipolar disorder published 2007 2008 ank3 cacna1c ank3 ank3 evidence association bipolar disorder cacna1c cacna1c joint analysis bipolar gwas data carried including gwas data another largescale study schizophrenia published issue ank3 cacna1c schizophrenia diagnostic statistical manual mental disorders fourth edition text revision dsmivtr 2013 crossdisorder group psychiatric genomics consortium published results large gwas study psychiatric disorders reporting specific singlenucleotide polymorphisms snps associated range childhood adultonset psychiatric disorders specific expression common genetic variants different times development different regions brain concert genetic variants could help explain differences disease phenotypes genetic markers 4 regions associated 5 disorders including variants cacna1c cacnb2 cacna1c cacnb2 although first gwas bipolar disorder used much smaller sample size subsequent attempts including initial sample 461 patients bipolar disorder national institute mental health nimh consortium followup sample 563 patients collected germany still yielded interesting observations need followed larger samples mentioned earlier dgkh dgkh three associated genes study also interact wnt signaling pathway upstream downstream glycogen synthase kinase 3beta gsk3β lithiummediated inhibition gsk3β thought result downregulation molecules involved cell death upregulation neuroprotective factors additionally gsk3β central regulator circadian clock lithiummediated modulation circadian periodicity thought critical component lithium’s therapeutic effect fact another major coup bipolar disorder research finding dominantnegative mutation clock furthermore experimenters able abolish manic behaviors rescuing expression normal clock although largescale association studies bipolar disorder beginning yield results one greatest obstacles finding genes complex behavior imprecision inherent diagnosis disorder objective criteria lacking therefore exciting recent research focused defining heritable quantitative diagnostic measures capture specific features bipolar disorder termed endophenotypes refine search responsible genes newer gwass continue find additional genes interest appear associated increased risk bipolar disorder one study showed association bipolar disorder ncan ncan ncan although present research stratify sex recent study looked association estrogen receptor binding site variation bipolar disorder females particular association transglutaminase 2 tgm2 additional interest number studies suggest certain large copy number variants greater 100 kb includes deletions duplications associated psychiatric disease bipolar disease schizophrenia commonly associated investigators looked microarray results 1001 patients bipolar disorder 1033 controls quantify risk deletions throughout genome patients bipolar disorder found 162 patients bipolar disorder deletions whereas 123 controls deletions addition patients bipolar disorder deletions frequently onset mania age 18 years gene expression studies gene expression studies one way measuring relative activity inactivity genes already proven useful illuminating pathophysiology psychiatric disorders including bipolar disorder example studies comparing specific regions postmortem brain tissue persons bipolar disorder tissue control subjects consistently shown levels expression oligodendrocytemyelin–related genes appear decreased brain tissue persons bipolar disorder oligodendrocytes produce myelin membranes wrap around insulate axons permit efficient conduction nerve impulses brain therefore loss myelin thought disrupt communication neurons leading thought disturbances observed bipolar disorder related illnesses brain imaging studies persons bipolar disorder also show abnormal myelination several brain regions associated illness interestingly gene expression neuroimaging studies persons schizophrenia major depression also demonstrate similar findings indicating mood disorders schizophrenia may share biologic underpinnings possibly related psychosis types data may also lead future revision psychiatric diagnostic manuals based new understanding etiology disorders another approach delineating pathophysiology bipolar disorder involves studying changes gene expression induced rodent brains administration pharmacologic agents used treat bipolar disorder example investigators demonstrated 2 chemically unrelated drugs lithium valproate used treat bipolar disorder upregulate expression cytoprotective protein bcl2 frontal cortex hippocampus rat brains postmortem study konradi et al hippocampus patients bipolar disorder healthy persons found 2 groups differ total number hippocampal neurons neuroimaging studies individuals bipolar disorder mood disorders also suggest evidence cell loss atrophy brain regions thus another suggested cause bipolar disorder damage cells critical brain circuitry regulates emotion according hypothesis mood stabilizers antidepressants thought alter mood stimulating cell survival pathways increasing levels neurotrophic factors improve cellular resiliency 2008 mathew et al published review novel drugs therapeutic targets severe mood disorders focus increasing neuroplasticity cellular resiliency post et al previously proposed mechanism involving electrophysiologic kindling behavioral sensitization processes resonates neuronal injury hypothesis post et al’s formulation helps explain effective role anticonvulsant medications eg carbamazepine valproate prevention highs lows bipolar disorder also supports clinical observations episodes person experiences future underscoring need longterm treatment information see medscape reference topic genetics bipolar disorder etiology number factors contribute bipolar affective disorder manicdepressive illness mdi including genetic biochemical psychodynamic environmental factors genetic factors bipolar disorder especially bipolar type bpi disorder major genetic component involvement ank3 cacna1c clock firstdegree relatives people bpi approximately 7 times likely develop bpi general population remarkably offspring parent bipolar disorder 50 chance another major psychiatric disorder one logitudinal study found subthreshold manic hypomanic episodes diagnostic risk factor development subsequent manic mixed hypomanic episodes offspring parents bipolar disorder highrisk offspring compared offspring parents without bipolar disorder also higher rates adhd disruptive behavior disorders anxiety disorders substance use disorders twin studies demonstrate concordance 3390 bpi identical twins identical twins share 100 dna studies also show environmental factors involved guarantee person develop bipolar disorder even carry susceptibility genes adoption studies prove common environment factor makes bipolar disorder occur families children whose biologic parents either bpi major depressive disorder remain increased risk developing affective disorder even reared home adopted parents affected frey colleagues’ work supports genetic contributions bipolar affective disorder using probands maudsley twin register london cardno colleagues showed schizophrenic schizoaffective manic syndromes share genetic risk factors genetic liability schizoaffective disorder gene expression studies also demonstrate persons bipolar disorder major depression schizophrenia share similar decreases expression oligodendrocytemyelinrelated genes abnormalities white matter various brain regions biochemical factors multiple biochemical pathways likely contribute bipolar disorder detecting one particular abnormality difficult number neurotransmitters linked disorder largely based patients’ responses psychoactive agents following examples blood pressure drug reserpine depletes catecholamines nerve terminals noted incidentally cause depression led catecholamine hypothesis holds increase epinephrine norepinephrine causes mania decrease epinephrine norepinephrine causes depression drugs used treat depression drugs abuse eg cocaine increase levels monoamines including serotonin norepinephrine dopamine potentially trigger mania implicating neurotransmitters etiology agents exacerbate mania include ldopa implicates dopamine serotoninreuptake inhibitors turn implicate serotonin evidence mounting contribution glutamate bipolar disorder major depression postmortem study frontal lobes individuals disorders revealed glutamate levels increased calcium channel blockers used treat mania may also result disruption intracellular calcium regulation neurons suggested experimental genetic data proposed disruption calcium regulation may caused various neurologic insults excessive glutaminergic transmission ischemia interestingly valproate specifically upregulates expression calcium chaperone protein grp 78 may one chief mechanisms cellular protection hormonal imbalances disruptions hypothalamicpituitaryadrenal axis involved homeostasis stress response may also contribute clinical picture bipolar disorder neurophysiologic factors addition structural neuroimaging studies look volumetric changes brain regions regardless brain activity functional neuroimaging studies performed find regions brain specific cortical networks either hypoactive hyperactive particular illness example metaanalysis houenou et al found decreased activation diminution gray matter corticalcognitive brain network associated regulation emotions patients bipolar disorder psychodynamic factors many practitioners see dynamics manicdepressive illness linked single common pathway see depression manifestation losses ie loss selfesteem sense worthlessness therefore mania serves defense feelings depression melanie klein one major proponents formulation study barnett et al found personality disturbances extraversion neuroticism openness often noted patients bipolar disorder may enduring characteristics environmental factors instances cycle may directly linked external stresses external pressures may serve exacerbate underlying genetic biochemical predisposition example pregnancy particular stress women manicdepressive illness history increases possibility postpartum psychosis nature work certain individuals periods high demands followed periods requirements example landscaper gardener busy spring summer fall became relatively inactive winter except plowing snow consequently appeared manic good part year would crash hibernate cold months epidemiology united states statistics lifelong prevalence bipolar affective disorder manicdepressive illness mdi including subsyndromal forms united states noted range 37 39 international statistics globally lifelong prevalence rate bipolar disorder 0315 crosssectional facetoface household surveys 61000 adults across 11 countries merikangas et al using world mental health version world health organization composite international diagnostic interview version 30 determined aggregate lifetime prevalences 06 bpi 04 bpii 14 subthreshold bipolar disorder 24 bipolar spectrum agerelated differences incidence age onset bipolar disorder varies greatly bpi bpii age range childhood 50 years mean age approximately 21 years cases bipolar disorder commence individuals aged 1519 years second frequent age range onset 2024 years patients diagnosed recurrent major depression may indeed bipolar disorder go develop first manic episode older 50 years individuals may family history bipolar disorder however patients onset mania people older 50 years lead investigation medical neurologic disorders cerebrovascular disease information see medscape reference article pediatric bipolar affective disorder sexrelated differences incidence bpi occurs equally sexes however rapidcycling bipolar disorder ≥4 episodesy common women men incidence bpii higher females males studies report nearly equal maletofemale ratio prevalence bipolar disorder however studies also report increased risk women bpiihypomania rapid cycling mixed episodes prognosis bipolar affective disorder manicdepressive illness mdi significant morbidity mortality rates united states early part 1990s cost lost productivity resulting disorder estimated approximately 155 billion annually approximately 2550 individuals bipolar disorder attempt suicide 11 successfully commit suicide additionally 2011 study united kingdom suggested patients bipolar disorder mortality 1 year hospital discharge also higher general population natural causes chiefly respiratory circulatory disorders patients bpi fare worse patients major depression within first 2 years initial episode 4050 patients experience another manic attack 5060 patients bpi lithium gain control symptoms 7 patients symptoms recur 45 patients experience episodes 40 go persistent disorder often cycling depression mania accelerates age factors suggesting worse prognosis include following poor job history substance abuse psychotic features depressive features periods mania depression evidence depression male sex pattern depressionmaniaeuthymia factors suggesting better prognosis include following length manic phases short duration late age onset thoughts suicide psychotic symptoms medical problems patient education treatment patients bipolar affective disorder manicdepressive illness mdi involves initial ongoing patient education end strong therapeutic alliance essential educational efforts must directed toward patient also toward family support system furthermore evidence continues mount educational efforts increase patient compliance knowledge disease also quality life explanation biology disease must provided decreases feelings guilt promotes medication compliance information provided monitor illness terms appreciation early warning signs reemergence symptoms recognition changes serve powerful preventive step education must also encompass dangers stressors helping individual identify work stressors provides critical aspect patient family awareness efforts made educate patient relapses within total context disorder individual stories help patients families national institute mental health nimh story person manicdepressive illness help patient see struggle challenge another perspective important resources patients families gain information dealing manicdepressive illness include following national institute mental health nimh nimhinfonihgov nimh bipolar disorder webpage nimh bipolar disorder booklet webmd bipolar disorder health center balanced mind foundation infothebalancedmindorg national alliance mental illness nami depression bipolar support alliance dbsa international foundation research education depression ifred infoifredorg mental health america mha bipolar focus bipolar disorder support groups clinical presentation history correct diagnosis disorder leads proper effective treatment nowhere relevant diagnosing patient bipolar affective disorder manicdepressive illness mdi perform thorough clinical assessment patients manic hypomanic mixed episode bipolar depression episode including information patient’s clinical psychosocial status medical psychiatric comorbidities current past medications well medication compliance substance use diagnosis bipolar disorder type bpi requires presence manic episode least 1 week’s duration leads hospitalization significant impairment occupational social functioning episode mania cannot caused another medical illness substance abuse criteria based specifications dsmv manic episodes feature least 1 week profound mood disturbance characterized elation irritability expansiveness referred gateway criteria least 3 following symptoms must also present grandiosity diminished need sleep excessive talking pressured speech racing thoughts flight ideas clear evidence distractibility increased level goalfocused activity home work sexually excessive pleasurable activities often painful consequences mood disturbance sufficient cause impairment work danger patient others mood result substance abuse medical condition hypomanic episodes characterized elevated expansive irritable mood least 4 consecutive days’ duration least 3 following symptoms also present grandiosity inflated selfesteem diminished need sleep pressured speech racing thoughts flight ideas clear evidence distractibility increased level goalfocused activity home work sexually engaging activities high potential painful consequences mood disturbance observable others mood result substance abuse medical condition episode severe enough cause social occupational impairment major depressive episodes characterized 2 weeks person experiences 5 following symptoms least 1 symptoms either depressed mood characterized loss pleasure interest depressed mood markedly diminished pleasure interest nearly activities significant weight loss gain significant loss increase appetite hypersomnia insomnia psychomotor retardation agitation loss energy fatigue feelings worthlessness excessive guilt decreased concentration ability marked indecisiveness preoccupation death suicide symptoms cause significant impairment distress result substance abuse medical condition mixed symptomatology quite common patients presenting bipolar symptomatology often causes diagnostic dilemma dsm5 interest investigating bipolar mixed states swann colleagues concluded although controversy exists regarding definitions properties mixed states concept mixed states characteristics range clinical definitions diagnostic methods remained consistent addition wellknown differences manic hypomanic episodes key differences exist bpi bpii may used help distinguish 2 types conditions data 1429 bipolar patients included national epidemiological survey alcohol related conditions showed significant differences bpi bpii patients unemployment history suicide attempt depressive symptoms eg weight gain feelings worthlessness presence specific phobias physical examination use mental status examination mse aid diagnosing bipolar affective disorder manicdepressive illness mdi section highlights major findings person bipolar disorder help support diagnosis patient’s mental status depends whether depressed hypomanic manic mixed following discussions various areas mse include consideration particular phases appearance persons experiencing depressed episode may demonstrate poor eye contact clothes may unkempt unclean holed unironed illfitting person lost significant weight garments may fit loosely personal hygiene individuals experiencing depressed episode reflects low mood evidenced poor grooming lack shaving lack washing women fingernails may show different layers polish one layer partially removed may paid attention hair men may exhibit dirty fingernails hands individuals move depressed affect demonstrated move slowly little show psychomotor retardation may talk low tones depressed monotone voice persons experiencing hypomanic episode busy active involved energy always go always planning things others notice energy levels mood changes many ways behavior patient manic phase opposite person depressed phase patients experiencing manic phase hyperactive might hypervigilant restless energized active talk act fast attire also reflects mania clothes might put haste disorganized alternately garments often bright colorful garish individuals stand crowd dress frequently attracts attention affectmood persons experiencing depressed episode sadness dominates affect individuals feel sad depressed lost vacant isolated 2 hs— h h persons experiencing hypomanic episode mood expansive often irritable persons experiencing manic episode mood inappropriately joyous elated jubilant individuals euphoric also may demonstrate annoyance irritability especially mania present significant length time persons experiencing mixed episode exhibit depression mania within brief period ≤1 wk thought content patients experiencing depressed episode thoughts reflect sadness preoccupied negative ideas nihilistic concerns tend see glass half empty likely focus death morbid persons many think suicide patients experiencing hypomanic episode optimistic forward thinking positive attitude patients experiencing manic episode expansive optimistic thinking may excessively selfconfident grandiose often rapid production ideas thoughts perceive minds active see highly engaging creative individuals highly distractible quickly shift one person another patients experiencing mixed episode oscillate dramatically depression euphoria often demonstrate marked irritability perceptions two forms major depression described one psychotic features without psychosis patient experiences delusions hallucinations either consistent inconsistent mood patient’s delusions sinned accompanied guilt remorse patient feels utterly worthless live total deprivation degradation hence delusional content remains consistent depressed mood patients experience delusions inconsistent depression paranoia persecutory delusions definition patients experiencing hypomanic episode experience hallucinations although milder manic syndromes may accompanied symptoms approximately three fourths patients experiencing manic episode delusions major depression delusional content either consistent inconsistent mania manic delusions reflect perceptions power prestige position selfworth glory patients experiencing mixed episode might exhibit delusions hallucinations consistent either depression mania congruent suicideselfdestruction patients experiencing depressed episode high rate suicide individuals attempt succeed killing query patients determine thoughts hurting suicidal ideation plans specific plan higher danger dubovsky reported highest lifetime suicide risk 1708 men bipolar disorder deliberate selfharm patients emerge period depression suicide risk may increase may illness remits executive functions improved point person capable making carrying plan subjective feeling depression accompanying suicidal thoughts persist patients experiencing hypomanic manic episode low incidence suicide mixed episodes depressed phases put patient risk suicide information see medscape reference article suicide homicideviolenceaggression patients experiencing depressed episode suicide generally remains paramount issue however certain persons depths depression see world hopeless helpless also others frequently perspective create lead homicide followed suicide example 42yearold mother 2 experiencing significant depression part bipolar disorder believed earth doomed terrible place dwell furthermore thought died children would left wretched place view planned kill 2 children fortunately family recognized state affairs led emergency intervention hospitalization patients hypomanic frequently show evidence irritability aggressiveness pushy impatient others persons experiencing manic episode openly combative aggressive patience tolerance others highly demanding violently assertive highly irritable homicidal element particularly likely emerge individuals delusional content mania individuals act grandiose belief others must obey commands wishes directives may become violent toward comply demands example patient believing oneself king command others fully completely immediately follow commands lack compliance may make patient violentif delusions become persecutory nature may defend others homicidal fashion persons experiencing mixed episode may exhibit aggression especially manic phases volavka reported relative general population statistically significant increase risk violence individuals schizophrenia bipolar disorder judgmentinsight persons experiencing depressive episode depression clouds dims judgment colors insights fail make important plansactions preoccupied plight individuals see tomorrow therefore planning difficult frequently persons middle depression done things forgetting pay income taxes time little insight behavior often others persuade seek therapy lack insight persons experiencing hypomanic episode generally act expansively may demonstrate poor judgment taking many tasks becoming overinvolved often distractibility impairs judgment little insight driven qualities see productive conscientious hypomanic patients experiencing manic episode judgment seriously impaired persons make terrible decisions work family example may invest family fortune questionable programs become professionally overinvolved work activities coworkers start dramatically unsound fiscal professional ventures individuals ignore feedback suggestions advice friends family colleagues insight extreme nature demands plans behavior often commitment proves way contain persons experiencing mixed episode major shifts affect short lengths time severely impair judgment interfere insight cognition impairments orientation memory seldom observed patients bipolar disorder unless psychotic know time location recognize people remember immediate recent distant events cases hypomanic even manic episodes ability recall information extremely vivid expanded however later course illness cognition becomes impaired extremes depression mania individuals may experience difficulty concentrating focusing similar subcortical dementia depression impairs cognition physical health although mse used article highlight key aspects examination clinician must pay particular attention patient’s physical health fagiolini pointed patients bipolar disorder high incidence endocrine disorders cardiovascular disorders obesity differential diagnoses diagnostic considerations diagnosis bipolar affective disorder manicdepressive illness mdi based patient’s history clinical course conditions considered include following epilepsy fahr disease acquired immunodeficiency syndrome aids medications eg antidepressants propel patient mania medications may include baclofen bromide bromocriptine captopril cimetidine corticosteroids cyclosporine disulfiram hydralazine isoniazid levodopa methylphenidate metrizamide procarbazine procyclidine circadian rhythm desynchronization cyclothymic disorder multiple personality disorder oppositional defiant disorder children substance abuse disorders eg alcohol amphetamines cocaine hallucinogens opiates anxiety disorders head trauma hyperthyroidism hypothyroidism iatrogenic cushing syndrome lyme disease multiple sclerosis neurosyphilis pediatric attention deficit hyperactivity disorder physical medicine rehabilitation systemic lupus erythematosus posttraumatic stress disorder schizoaffective disorder schizophrenia seasonal affective disorder workup approach considerations number reasons exist obtaining selected laboratory studies patients bipolar affective disorder manicdepressive illness mdi extensive range tests indicated bipolar disorder encompasses depression mania significant number medical causes state exists basic principle remains miss treatable medical cause mental status second condition necessitates use number medications require certain body systems working properly example lithium requires intact genitourinary gu system affect certain systems certain anticonvulsants suppress bone marrow third bipolar illness lifelong disorder performing certain baseline studies important establish longterm effects medications number infections especially chronic infections produce presentation depression patient encephalitis dramatically manifest changes mental status rare situations present bipolar features blood studies complete blood count complete blood count cbc differential used rule anemia cause depression bipolar affective disorder manicdepressive illness mdi treatment especially certain anticonvulsants may depress bone marrow—hence need check red blood cell rbc white blood cell wbc counts signs bone marrow suppression lithium may cause reversible increase wbc count erythrocyte sedimentation rate erythrocyte sedimentation rate esr determined look underlying disease process lupus infection elevated esr often indicates underlying disease process fasting glucose cases fasting glucose level indicated rule diabetes addition atypical antipsychotics associated weight gain problems blood glucose regulation patients diabetes therefore baseline fasting glucose obtained electrolytes serum electrolyte concentrations measured help diagnose electrolyte problems especially sodium related depression treatment lithium lead renal problems electrolyte problems low sodium levels lead higher lithium levels lithium toxicity hence screening candidates lithium therapy well lithium therapy checking electrolytes indicated serum calcium assessed diagnose hypercalcemia hypocalcemia associated mental status changes eg hyperparathyroidism elevated calcium blood level cause depression mania hyperparathyroidism evidenced elevated calcium blood level produces depression certain antidepressants nortriptyline affect heart therefore checking calcium levels important proteins low serum protein levels found patients depressed may result eating low levels increase availability certain medications drugs less protein bind thyroid hormones thyroid tests performed rule hyperthyroidism mania hypothyroidism depression treatment lithium cause hypothyroidism hypothyroidism may cause rapid cycling mood especially women study assess relationship bipolar affective disorder thyroid dysfunction krishna et al found elevated t3 hormone statistically significantly association bipolar disorder creatinine blood urea nitrogen kidney failure present depression treatment lithium affect urinary clearances serum creatinine blood urea nitrogen bun levels increase however signs symptoms kidney failure appear first carefully regularly monitor renal function liver lipid panel antipsychotics agents also associated changes patients’ lipid profiles potentially resulting dyslipidemia eg hypertriglyceridemia well liver damagedysfunction laboratory tests although routine screening test bipolar disorder unnecessary patients normal liver function test results urine copper level testing may performed rule wilson disease produces mental changes wilson disease rare condition easily missed antinuclear antibody testing used rule lupus testing human immunodeficiency virus hiv may helpful acquired immunodeficiency syndrome aids causes changes mental status including dementia depression obtaining venereal disease research laboratory vdrl test may indicated selected patients syphilis especially later stage alters mental status substance alcohol screening alcohol abuse abuse wide variety drugs present either mania depression example speed ie amphetamines cocaine abuse present manialike disorder barbiturate abuse present depressionlike disorder number patients bipolar affective disorder manicdepressive illness mdi also drug alcohol addiction dual diagnoses indeed relative mental illnesses individuals bipolar disorder disproportionately high rate substance use disorders cooccurrence associated significant morbidity mortality performing substance screen helps make dual diagnosis patient dual diagnosis addictionfocused treatment coordinated treatment bipolar disorder magnetic resonance imaging total value performing magnetic resonance imaging mri patient bipolar affective disorder manicdepressive illness mdi remains unclear however couple reasons exist performing imaging study manicdepressive illness lifelong disease strong battery studies rules medical etiology establishes baseline investigators report patients mania demonstrate hyperintensity temporal lobes electrocardiography many antidepressants especially tricyclic agents antipsychotics affect heart cause conduction problems lithium also lead changes reversible flattening inversion waves electrocardiography ecg older patients bipolar affective disorder manicdepressive illness mdi lithium tricyclic antidepressant therapy pretreatment ecg important electroencephalography generally routine electroencephalography eeg unnecessary evaluation bipolar affective disorder manicdepressive illness mdi however reasons ordering eeg patients bipolar illness may appropriate include following eeg provides baseline helps rule neurologic problems use test rule seizure disorder brain tumor electroconvulsive therapy ect contemplated eeg may helpful eeg monitoring ect used determine occurrence duration seizure studies shown abnormalities eeg findings indicative anticonvulsant effectiveness specifically abnormal eeg finding may predict response valproate patients may seizures medications especially antidepressants addition lithium cause diffuse slowing throughout brain treatment management approach considerations always evaluate patients mania hypomania mixed episode bipolar depression suicidality acute chronic psychosis unstable dangerous conditions treatment bipolar affective disorder manicdepressive illness mdi directly related phase episode ie depression mania severity phase example person extremely depressed exhibits suicidal behavior requires inpatient treatment contrast individual moderate depression still work would treated outpatient fortunately patients recover first manic episode course beyond variable important determine whether current medications may causing patient’s manic hypomanic mixed manic episode patients discontinue antidepressants maniainducing agents however antidepressants known associated discontinuation syndromes tapered several weeks evaluate closely monitor patients bipolar depression risk mood destabilization switching mania presence emergent symptoms following initiation pharmacotherapy depressive episode patient’s response treatment may depend number previous episodes bipolar disorder report analyzed pooled data importance early intervention demonstrated better treatment responses individuals earlier stages illness patient shortterm inpatient care unit made significant progress reevaluate management strategy transfer longterm inpatient care unit might also considered patient depressed manic phase responding medications transfer patient facility electroconvulsive therapy ect administered additionally consultation psychiatric colleague psychopharmacologist always appropriate patient respond conventional treatment medication patients bipolar disorder need outpatient monitoring medications psychotherapy addition individuals need education regarding condition schedule must regular great flexibility need extra sessions 2010 veterans administrationdepartment defense vadod clinical practice guideline management bipolar disorder recommends reassessing patients start treatment acute bipolar mania hypomania mixed episodes every 12 weeks least 6 weeks evaluate patient’s response treatment standardized tool followup visits changes therapy periodic assessments complete remission reached httpwwwcqaimhorgstablehtml surgical care indicated bipolar disorder historically treatment attempted psychosurgical procedures prefrontal lobotomy however lobotomy longer used clinical care patients bipolar disorder indications inpatient management patients diagnosed bipolar mania depression severe symptoms must referred urgentemergent mental health intervention danger self danger others delirium marked psychotic symptoms total inability function total loss control eg excessive spending undertaking dangerous trip medical conditions warrant medication monitoring eg substance withdrawalintoxication patients possible diagnosis bipolar depression must also referred urgentemergent mental health intervention present serious delusion visualauditory hallucinations confusion catatonic behavior extreme negativismmutism andor inappropriate affect bizarre odd quality patient bipolar disorder especially one depressive episode may present significant risk suicide especially early onset symptoms goldstein associates followed mental health 413 youths diagnosed bipolar disorders found 76 18 attempted suicide least within 5 years study youths 31 8 overall group 41 attempted suicide made many attempts patients bipolar disorder also become threat others example patient experiencing severe depression believed world bleak planned kill children spare world’s misery sometimes patient’s behaviors totally control particular concern manic episode situation patients’ behaviors beyond limits destroy career harmful around example delusional patient manic episode believed everyone searched rifle order defend “get them” “got” patients bipolar disorder medical conditions medication monitoring warranted example patients certain cardiac conditions medical environment effects psychotropic medications monitored observed closely clearest case bipolardepressed phase patient suicidal homicidal situations result homicide followed suicide scenarios institutioinal commitment order indicated situations depression led inability patient work eat function hospitalization also indicated cases situation patient bipolarmanic phase although patient show clear dramatic evidence homicide suicide pattern poor judgment impairment emerges behavior manic phase person often major damage finances career position community type selfdestructive mania calls containment good documentation family support considerations partial hospitalization day treatment general patients bipolar affective disorder manicdepressive illness mdi candidates partial hospitalization day treatment experience severe symptoms level control stable living environment example patient severe depression thoughts suicide plans act upon high degree motivation get well given great deal interpersonal support especially day help involved supportive family family needs home every night concerned patient’s care partial hospitalization also offers bridge return work returning directly work often difficult patients severe symptoms partial hospitalization provides support interpersonal relationships considerations outpatient treatment outpatient treatment patients bipolar affective disorder manicdepressive illness mdi 4 major goals follows look areas stress find ways handle stresses stem family work accumulate propel person mania depression form psychotherapy monitor support medication medications make incredible difference key obtain benefits avoiding adverse effects patients ambivalent medications—although recognize drugs help prevent hospitalizations also resent need goal address feelings allow continue medications develop maintain therapeutic alliance one many reasons practitioner deal patient’s ambivalence medications time strength alliance helps keep patient’s symptoms minimum helps patient remain community provide education see patient education clinician must help educate patient family bipolar illness patients families need aware dangers substance abuse situations would lead relapse essential role medications support groups patients families tremendous importance psychotherapy helps patients bipolar disorder cure disorder schottle colleagues looked psychotherapy patients family caregivers found although results heterogeneous studies demonstrated relevant positive results regard decreased relapse rates improved quality life increased functioning favorable symptom improvement somatic health issues individuals bipolar disorder ubiquitous underrecognized suboptimally treated patients chronic medical illnesses depression treated comprehensive approach involving patient family support team physician professionals community resources models called collaborative chronic care models ccms developed improve outcomes chronically ill patients treated primary care setting also suffer depression ccms defined priori interventions least 3 6 components improving chronic illness care initiative follows patient selfmanagement support clinical information systems delivery system redesign decision support organizational support community resource linkages woltmann et al examined approach patients bipolar disorder concluded ccms improve mental physical outcomes patients mental disorders across wide range care settings pharmacologic therapy appropriate medication depends stage bipolar affective disorder manicdepressive illness mdi patient experiencing thus number drugs indicated acute manic episode primarily antipsychotic agents valproate benzodiazepines eg lorazepam clonazepam choice agent depends presence symptoms psychotic symptoms agitation aggression sleep disturbance see list medications bipolar disorder table 1 patients bipolar affective disorder depressed phase medscape reference article depression table 1 fdaapproved bipolar treatment regimens generic name trade name manic mixed maintenance depression valproate depakote x carbamazepine extended release equetro x x lamotrigine lamictal x lithium x x aripiprazole abilify x x x ziprasidone geodon x x risperidone risperdal x x asenapine saphris x x quetiapine seroquel x x chlorpromazine thorazine x olanzapine zyprexa x x x olanzapinefluoxetine combination symbyax x fda united states food drug administration source httpwwwmedscapeorgviewarticle554128 bauer colleagues suggested 2 approaches treatment options bipolar patients one cautionary note interest post colleagues found different antidepressant trials patient bipolar disorder received less responsive become treatment inhaled loxapine adasuve first noninjectable therapy approved fda treat acute agitation associated schizophrenia bipolar disorder type bpi fda approval based 2 phase iii studies 658 individuals statistically significant reductions agitation apparent starting 10 minutes following administration compared placebo effects sustained 2 hours severe mania mixed episodes combined therapy antipsychotic agent another antimanic medication recommended patients severe mania mixed episodes without psychotic features despite serious side effects associated clozapine veterans administrationdepartment defense vadod suggest drug may added existing medications successfully used previously severe mania mixed episodes antipsychotic agents unsuccessful reevaluate nonhospitalized patients treated severe mania mixed episodes every 25 days symptomatic improvement adjust medication dosages regimens needed maniahypomania mixed episodes initiate lithium valproate carbamazepine aripiprazole olanzapine quetiapine risperidone ziprasidone patients mania recommended topiramate lamotrigine gabapentin used treat patients mania mixed episodes bipolar depression american psychiatric associations apa 2005 guideline watch treatment patients bipolar disorder noted monotherapy vadod considers firstline monotherapy adult patients bipolar depression include quetiapine lamotrigine lithium although vadod found insufficient evidence use valproate carbamazepine topiramate risperidone ziprasidone clozapine managing bipolar depression advise aripiprazole monotherapy patients acute bipolar depression except cases combination therapy patients whose bipolar depression unresponsive monotherapy consider combination lithium lamotrigine severe mania severe mixed episodes consider adding clozapine augmentation closely monitor patient metabolic adverse effects vadod found insufficient evidence use augmentation aripiprazole olanzapine risperidone haloperidol oxcarbazepine topiramate ziprasidone valproate carbamazepine bipolar depression dosing medication adjustments switch another effective treatment patient intolerance side effects patients switch mania hypomania enter mixed manic state follow recommendations discussed maniahypomania mixed episodes reevaluate patients every 12 weeks minimum 6 weeks noted earlier therapeutic range lithium serum trough concentration 0612 meql valproate 50125 mcgml carbamazepine 412 mcgml patients partial treatment response response 24 weeks initiation adequate medication dose consider augmenting medication additional agents discussed combination therapydiscontinuing current drug tapered withdrawal monitoring antidepressant syndrome mood destabilization switching another effective agent electroconvulsive therapy ect multiple trials switching medicationsaugmentation strategies unsuccessful considerations study bauer et al suggested lithium may also neuroprotective role atypical antipsychotics increasingly used treatment acute mania mood stabilization broad range antidepressants ect used acute depressive episode ie major depression however ect may also considered patients severe mania treatmentresistant mania prefer ect pregnant women severe mania diazgranados colleagues reported patients treatmentresistant bipolar depression impressive swift antidepressant effects occurred single intravenous iv dose n although antidepressant medications often prescribed patients bipolar disorder experiencing acute depression study found antidepressants statistically superior placebo current standard treatment bipolar depression clinical experiences shown patients bipolar disorder fewer episodes mania depression treated moodstabilizing drugs atypical antipsychotics including ziprasidone quetiapine risperidone aripiprazole olanzapine asenapine also frequently used stabilize acute mania—or even treat bipolar depression cases treatment depression associated bipolar disorder type ii swartz associates reported 95 relevant trials published later 2005 maintenance role mood stabilizers antipsychotic medications maintaining patients bipolar disorder well documented popovic et al suggested use polarity index guide choice maintenance therapy bipolar patients risperidone 1209 aripiprazole 438 ziprasidone 391 olanzapine 298 lithium 139 quetiapine 114 lamotrigine 040 note popovic et al indicated respective polarity indices valproate oxcarbazepine potentially unreliable owing failure maintenance trials concerns ziprasidone may adverse effects body weight fasting lipids fasting glucose pappadopulos et al looked comprehensive set analyses metabolic alternations patients medication found significant differences ziprasidone placebo groups levels fasting triglycerides total cholesterol lowdensity lipoprotein cholesterol highdensity lipoprotein cholesterol glucose controlled studies according multiple treatments metaanalysis treatments acute mania efficacious treatments haloperidol risperidone olanzapine significantly outperforming primary mood stabilizers antipsychotic medications outlined apa’s 2002 clinical practice guideline children adolescents bipolar disorder particularly challenging treat discussion beyond scope article see medscape reference article pediatric bipolar affective disorder evidence risperidone may best firstline treatment childhood mania shown randomized controlled trial patients aged 6 15 years diagnostic statistical manual mental disorders fourth edition text revision dsmivtr caution polyantipsychotic therapy bipolar disorder august 2010 fda announced lamotrigine carries risk aseptic meningitis study sought evaluate safety tolerability secondgeneration antipsychotic sga polytherapy compared monotherapy patients bipolar disorder receiving open naturalistic treatment 22site systematic treatment enhancement program bipolar disorder stepbd brooks et al concluded although polytherapy fairly common bipolar disorder also associated increased side effects eg dry mouth sexual dysfunction constipation increased health service use almost threefold improved clinical status function electroconvulsive therapy electroconvulsive therapy ect useful number instances patients bipolar affective disorder manicdepressive illness mdi following rapid definitive medicalpsychiatric treatment needed risks ect less treatments bipolar disorder refractory adequate trial treatment strategies patient prefers treatment modality often severity patient’s symptoms lack response medications presence contraindications certain medications necessitates use ect treatment modality proven highly effective treatment acute mania 2010 department veterans affairsdepartment defense vadod clinical practice guideline management bipolar disorder indicates ect primary therapy bipolar disorder patients present psychotic symptoms catatonia severe suicidality food refusal leading nutritional compromise history previous positive response ect dietary activity measures unless patient bipolar affective disorder manicdepressive illness mdi monoamine oxidase inhibitors maois special diet required patients advised make significant changes salt intake increased salt intake may lead reduced serum lithium levels reduced efficacy reduced intake may lead increased levels toxicity although metaanalysis starris et al found strong evidence bipolar depressive symptoms may improved adjunctive use omega3 omega3 improve bipolar mania patients depressed phase encouraged exercise individuals try develop regular daily schedule major activities especially times going bed waking propose regular exercise schedule patients especially bipolar disorder exercise regular schedule keys surviving illness however increases exercise level increased perspiration lead increased serum lithium levels lithium toxicity complications main complications bipolar affective disorder manicdepressive illness mdi suicide homicide addictions previously currently suicidal patients remain risk suicide patients emerging depression thought increased risk suicide risk selfdestructive behavior death lifelong hong et al’s study demonstrated genetic link bipolar disorder suicidal behavior especially white individuals european mania bipolar longitudinal evaluation medication emblem study 2year prospective observational study suggested following characteristics found patients bipolar disorder suicidal may help identify subjects risk suicidal behavior female sex history alcohol abuse history substance abuse young age first treatment mood episode longer disease duration greater depressive symptom severity 5item hamilton depression rating scale hamd5 total score current benzodiazepine use higher overall symptom severity clinical global impressionbipolar disorder cgibp mania overall score poor compliance homicidal patients often manic phase demanding grandiose context angered others immediately comply wishes turn dramatically violent addition individuals become homicidal acting delusions individuals bipolar disorder risk addiction creates problem dual diagnosis therefore complicates treatment one area major concern relationship violent crime bipolar disorder danger particularly present prominent patients substance abuse problem quality life qol important way look effects mental illness bipolar disorder type bpi results diminished quality life measured health utility qol utilitybased healthrelated quality life qol losses patients bpi less persons schizophrenia patients depression sustained greatest loss qol study fiedorowicz et al hypomania symptoms frequently associated progression bipolar disorder even symptoms low intensity however patients hypomania symptoms baseline challenging situations involve children adolescents severe emotional lability often psychiatrists applied bipolar diagnosis group leibenluft reviewed situation concluded children increasingly diagnosed bipolar disorder severe mood dysregulation syndrome formulated describe symptoms children clearly meet criteria bipolar disorder leibenluft’s findings revealed nonepisodic irritability youths common associated elevated risk anxiety unipolar depressive disorders bipolar disorders adulthood fact data suggest children adolescents severe mood dysregulation lower familiar rates bipolar disorder children adolescents bipolar disorder prevention longterm monitoring prevention key longterm treatment bipolar affective disorders manicdepressive illness mdi follows first use medications lithium serve mood stabilizers second psychoeducation instituted patient patient’s family critical patient patient’s family understand recognize importance medication compliance early signs mania depression regardless pharmacologic regimen chosen individual patients acute bipolar mania hypomania mixed episodes bipolar depression reevaluate treatment response every 12 weeks minimum 6 weeks depressive symptoms changes suicidalhomicide ideation neurovegetative symptoms newonsetchange psychotic symptoms manichypomanic symptoms illicit substance use medication side effects compliance medical stability significant psychosocial changes reevaluate patients treatment response 48 weeks change treatment periodically full remission achieved treat adult patients acute manic episode minimum 6 months initial episode controlled encourage individuals—as well 1 manic episode 1 manic 1 depressive episode 3 depressive episodes—to continue lifelong prophylactic pharmacotherapy medication medication summary appropriate medication managing bipolar affective disorder manicdepressive illness mdi depends stage patient experiencing choice agent depends presence symptoms psychotic symptoms agitation aggression sleep disturbance drug categories include mood stabilizers anticonvulsants antipsychotics anxiolytics benzodiazepines class summary binding specific receptor sites benzodiazepines appear potentiate effects gammaaminobutyric acid gaba facilitate inhibitory gaba neurotransmission action inhibitory transmitters lorazepam ativan lorazepam anxiolytic hypnotic intermediate onset effects relatively intermediate halflife increasing action gaba major inhibitory neurotransmitter brain may depress levels central nervous system cns including limbic reticular formation clonazepam klonopin clonazepam longacting benzodiazepine increases presynaptic gaba inhibition reduces monosynaptic polysynaptic reflexes suppresses muscle contractions facilitating inhibitory gaba neurotransmission inhibitory transmitters mood stabilizers class summary lithium drug commonly used prophylaxis treatment manic episodes 2012 study suggested lithium may also neuroprotective role lithium associated significant reduction renal function patients risk endstage renal failure low furthermore recognizing patients bipolar affective disorder risk suicide lithium may also antisuicidal action report lewitka bauer suggest lithium may option patients affective disorders risk suicide however caution lithium still medication requires careful assessment monitoring patient adherence essential lithium carbonate lithobid lithium considered firstline agent longterm prophylaxis bipolar illness especially classic bipolar disorder euphoric mania also used treat acute mania although cannot titrated effective level quickly valproate evidence suggests lithium unlike mood stabilizer may specific antisuicide effect monitoring blood levels critical medication serum levels determined twice weekly acute phase serum level clinical condition patient stabilized anticonvulsants class summary anticonvulsants effective preventing mood swings associated bipolar disorder especially patients known rapid cyclers depressed phase mood stabilizers lithium lamotrigine preferred antidepressants may propel patient manic episode exacerbate irritability mixedsymptom mania gabapentin although mood stabilizer also may anxiolytic propertiesthe widely used anticonvulsants carbamazepine valproate lamotrigine recently topiramate oxcarbazepine also tried note department veterans affairsdepartment defense vadod recommend lamotrigine topiramate gabapentin patients mania mixed episodes carbamazepine equetro carbamazepine effective patients clinical response lithium therapy rapidcycling bipolar disorder efficacy well established longterm use therefore periodically reevaluate longterm risks benefits carbamazepine individual patients drug also act inhibit seizures induced kindling effect thought occur way repeated limbic stimulation valproate sodium valproic acid divalproex sodium depakene depakote depakote er depacon stavzor valproate proven effectiveness treating preventing mania classified mood stabilizer used alone combination lithium agent useful treating patients rapidcycling bipolar disorders used treat aggressive behavioral disorders combination valproic acid valproate effective treating persons manic phase success rate 49 lamotrigine lamictal lamictal odt lamictal xr lamotrigine anticonvulsant appears effective treatment depressed phase bipolar disorders used maintenance treatment bipolar disorder delay time occurrence mood episodes depression mania hypomania mixed episodes adults treated acute mood episodes standard therapy topiramate topamax topiramate offlabel indication treatment bipolar disease small retrospective review marked improvement occurred 62 patients topiramate added current regimen antipsychotics 2nd generation class summary secondgeneration atypical antipsychotics increasingly used treatment acute mania mood stabilization patients bipolar disease asenapine saphris asenapine indicated monotherapy acute treatment manic mixed episodes associated bipolar disorder also indicated adjunctive therapy lithium valproate acute treatment manic mixed episodes associated bipolar disease efficacy asenapine thought mediated combination antagonist activity dopamine 2 serotonin 5ht2 receptors ziprasidone geodon ziprasidone approved treatment acute mixed episodes associated bipolar disorder used maintenance treatment adjunct lithium valproate quetiapine seroquel seroquel xr quetiapine indicated acute treatment manic immediate release extended release xr mixed xr episodes associated bipolar disorder used monotherapy adjunctively agents lithium divalproex risperidone risperdal risperdal consta risperdal mtab risperidone indicated shortterm treatment acute manic mixed episodes associated bipolar disorder used alone combination lithium valproate risperidone used adults adolescents aged 1017 years bipolar disorder aripiprazole abilify abilify discmelt aripiprazole indicated acute maintenance treatment manic mixed episodes associated bipolar disorder used alone combination lithium valproate olanzapine zyprexa zyprexa zydis olanzapine used acute maintenance treatment manic mixed episodes associated bipolar disorder used alone combination lithium valproate olanzapine used adults adolescents aged 1317 years bipolar disorder olanzapine fluoxetine symbyax drug combination includes olanzapine secondgeneration antipsychotic fluoxetine selective serotonin reuptake inhibitor drug indicated acute treatment depressive episodes associated bipolar disorder adults clinical effects agent studied patients younger 18 years clozapine clozaril fazaclo odt clozapine offlabel indication treatment acute manic episodes associated bipolar disorder treatment refractory bipolar mania agent demonstrates weak d2 receptor d1 receptor blocking activity clozapine also acts antagonist adrenergic cholinergic histaminergic serotonergic receptors paliperidone invega paliperidone may used refractory moderate severe mania alone combination lithium valproate agent typically reserved patients decline electroconvulsive therapy ect respond medication combinations involving lithium valproate plus aripiprazole haloperidol another firstgeneration antipsychotic antipsychotics 1st generation class summary firstgeneration antipsychotics also known conventional typical antipsychotics efficacious treating psychotic nonpsychotic manic mixed episodes well hypomania agents strong dopamine d2 antagonists however drug class various effects receptors 5ht2 serotonin alpha1 histaminic muscarinic receptors loxapine inhaled adasuve mechanism action loxapine unknown theorized antagonize central dopamine d2 serotonin 5ht2a receptors inhaled dosage form indicated acute treatment agitation associated schizophrenia bipolar disorder adults haloperidol haldol haloperidol used acute treatment mania mixed episodes patients bipolar disorder used alone combination lithium valproate adult patient haloperidol blocks postsynaptic dopamine receptors d2 mesolimbic system increases dopamine turnover blockade d2 somatodendritic autoreceptor antipsychotics phenothiazine class summary phenothiazine antipsychotics classified firstgeneration antipsychotics efficacious treating psychotic nonpsychotic manic mixed episodes well hypomania chlorpromazine thorazine chlorpromazine used treat manic mixed episodes patients bipolar disorder used alone combination lithium valproate chlorpromazine blocks postsynaptic dopamine receptors d2 mesolimbic system increases dopamine turnover blockade d2 somatodendritic autoreceptor antiparkinson agents dopamine agonists class summary dopamine agonists nonergot agents bind d2 d3 dopamine receptors striatum substantia nigra pramipexole mirapex mirapex er pramipexole used addon therapy patients whose condition refractory combination therapy bipolar depression pramipexole nonergot full dopamine agonist binds d2 d3 dopamine receptors author stephen soreff md president education initiatives nottingham nh faculty boston university boston daniel webster college nashua nh stephen soreff md member following medical societies acmha college behavioral health leadership disclosure nothing disclose coauthors lynne alison mcinnes md ms associate clinical professor psychiatry university california san francisco school medicine lynne alison mcinnes md ms member following medical societies alpha omega alpha american psychiatric association american society human genetics disclosure nothing disclose chief editor iqbal ahmed mbbs frcpsych uk faculty department psychiatry tripler army medical center clinical professor psychiatry uniformed services university health sciences clinical professor psychiatry clinical professor geriatric medicine university hawaii john burns school medicine iqbal ahmed mbbs frcpsych uk member following medical societies academy psychosomatic medicine american neuropsychiatric association american society clinical psychopharmacology american association geriatric psychiatry american psychiatric association disclosure nothing disclose acknowledgements francisco talavera pharmd phd disclosure medscape salary employment bowden c singh v longterm management bipolar disorder available httpwwwmedscapecomviewprogram2686 american psychiatric association diagnostic statistical manual mental disorders fifth edition washington dc american psychiatric association 2013 69 management bipolar disorder working group vadod clinical practice guideline management bipolar disorder adults washington dc department veterans affairs department defense 2010 available httpguidelinegovcontentaspxid16314 zhang cheng l qian allieyrodriguez n kelsoe jr greenwood et al singleton deletions throughout genome increase risk bipolar disorder mol psychiatry medline full text price al marzaninissen gr bipolar disorders review fam physician medline ketter ta diagnostic features prevalence impact bipolar disorder j clin psychiatry medline edvardsen j torgersen røysamb e lygren skre onstad et al heritability bipolar spectrum disorders unity heterogeneity j affect disord medline berrettini wh ferraro tn goldin lr weeks de deterawadleigh nurnberger ji jr et al chromosome 18 dna markers manicdepressive illness evidence susceptibility gene proc natl acad sci u medline full text reich clayton pj winokur g family history studies v genetics mania j psychiatry medline lin pi mcinnis mg potash jb willour vl mackinnon df miao k et al assessment effect age onset linkage bipolar disorder evidence chromosomes 18p 21q j hum genet medline full text mcquillin bass nj kalsi g lawrence j puri v choudhury k et al fine mapping susceptibility locus bipolar genetically related unipolar affective disorders region containing c21orf29 trpm2 genes chromosome 21q223 mol psychiatry medline ekholm jm kieseppä hiekkalinna partonen paunio perola et al evidence susceptibility loci 4q32 16p12 bipolar disorder hum mol genet medline abou jamra r fuerst r kaneva r orozco diaz g rivas f mayoral f et al first genomewide interaction locusheterogeneity linkage scan bipolar affective disorder strong evidence epistatic effects loci chromosomes 2q 6q j hum genet medline full text kelsoe jr spence loetscher e foguet sadovnick ad remick ra et al genome survey indicates possible susceptibility locus bipolar disorder chromosome 22 proc natl acad sci u medline full text kakiuchi c iwamoto k ishiwata bundo kasahara kusumi et al impaired feedback regulation xbp1 genetic risk factor bipolar disorder nat genet medline ferreira odonovan mc meng ya jones ir ruderfer dm jones l et al collaborative genomewide association analysis supports role ank3 cacna1c bipolar disorder nat genet medline full text largescale genomewide association analysis bipolar disorder identifies new susceptibility locus near odz4 nat genet medline full text baum ae akula n cabanero cardona corona w klemens b et al genomewide association study implicates diacylglycerol kinase eta dgkh several genes etiology bipolar disorder mol psychiatry medline full text genomewide association study 14000 cases seven common diseases 3000 shared controls nature medline full text sklar p smoller jw fan j ferreira perlis rh chambert k et al wholegenome association study bipolar disorder mol psychiatry medline full text mcquillin rizig gurling hm microarray gene expression study molecular pharmacology lithium carbonate mouse brain mrna understand neurobiology mood stabilization treatment bipolar affective disorder pharmacogenet genomics medline national institutes healthnih news schizophrenia bipolar disorder share genetic roots available httpwwwnihgovnewshealthjul2009nimh01htm identification risk loci shared effects five major psychiatric disorders genomewide analysis lancet medline full text post rm speer hough cj xing g neurobiology bipolar illness implications future study therapeutics ann clin psychiatry medline roybal k theobold graham dinieri ja russo sj krishnan v et al manialike behavior induced disruption clock proc natl acad sci u medline full text coyle jt clock mutation mice tell us bipolar disorder proc natl acad sci u medline full text bearden ce freimer nb endophenotypes psychiatric disorders ready primetime trends genet medline american college neuropsychopharmacology american college neuropsychopharmacology 2010 annual meeting abstracts december 59 2010 miami beach fla potash jb toolan j steele j miller eb pearl j zandi pp et al bipolar disorder phenome database resource genetic studies j psychiatry medline cichon mühleisen tw degenhardt fa mattheisen miró x strohmaier j et al genomewide association study identifies genetic variation neurocan susceptibility factor bipolar disorder j hum genet medline full text graae l karlsson r paddock significant association estrogen receptor binding site variation bipolar disorder females plos one medline full text grozeva kirov g ivanov jones ir jones l green ek et al rare copy number variants point rarity genetic risk bipolar disorder schizophrenia arch gen psychiatry medline aston c jiang l sokolov bp transcriptional profiling reveals evidence signaling oligodendroglial abnormalities temporal cortex patients major depressive disorder mol psychiatry medline davis kl haroutunian v global expressionprofiling studies oligodendrocyte dysfunction schizophrenia bipolar disorder lancet medline prabakaran swatton je ryan mm huffaker sj huang jt griffin jl et al mitochondrial dysfunction schizophrenia evidence compromised brain metabolism oxidative stress mol psychiatry medline tkachev mimmack ml ryan mm wayland freeman jones pb et al oligodendrocyte dysfunction schizophrenia bipolar disorder lancet medline adler cm holland sk schmithorst v wilke weiss kl pan h et al abnormal frontal white matter tracts bipolar disorder diffusion tensor imaging study bipolar disord medline adler cm adams j delbello mp holland sk schmithorst v levine et al evidence white matter pathology bipolar disorder adolescents experiencing first episode mania diffusion tensor imaging study j psychiatry medline bartzokis g neuroglialpharmacology myelination shared mechanism action psychotropic treatments neuropharmacology medline full text chen g zeng wz yuan px huang ld jiang ym zhao zh et al moodstabilizing agents lithium valproate robustly increase levels neuroprotective protein bcl2 cns j neurochem medline konradi c zimmerman ei yang ck lohmann km gresch p pantazopoulos h et al hippocampal interneurons bipolar disorder arch gen psychiatry medline full text mathew sj manji hk charney ds novel drugs therapeutic targets severe mood disorders neuropsychopharmacology aug 20083392300 huge project research program genes environment health multiethnic genome wide association study bipolar disorder kaiser permanente full text axelson goldstein b goldstein monk k yu h hickey mb et al diagnostic precursors bipolar disorder offspring parents bipolar disorder longitudinal study j psychiatry medline frey bn andreazza ac houenou j jamain goldstein bi frye et al biomarkers bipolar disorder positional paper international society bipolar disorders biomarkers task force aust n z j psychiatry medline columbia bipolar genetic study bipolar disorder genetics available httpbipolarhscolumbiaedudisgenethtm cardno ag rijsdijk fv sham pc murray rm mcguffin p twin study genetic relationships psychotic symptoms j psychiatry medline berrettini wh schizophrenic bipolar disorders related review family molecular studies biol psychiatry medline hashimoto k sawa iyo increased levels glutamate brains patients mood disorders biol psychiatry medline houenou j frommberger j carde glasbrenner diener c leboyer et al neuroimagingbased markers bipolar disorder evidence two metaanalyses j affect disord medline barnett jh huang j perlis rh young mm rosenbaum jf nierenberg aa et al personality bipolar disorder dissecting state trait associations mood personality psychol med medline chaudron lh pies rw relationship postpartum psychosis bipolar disorder review j clin psychiatry medline guideline hirschfeld rma guideline watch practice guideline treatment patients bipolar disorder review synthesis available evidence somatic treatments acute manic mixed episodes 2nd ed arlington va american psychiatric association full text calabrese jr overview patient care issues treatment bipolar spectrum bipolar ii disorder j clin psychiatry medline merikangas kr jin r jp et al prevalence correlates bipolar spectrum disorder world mental health survey initiative arch gen psychiatry 2011683241251 yutzy sh woofter cr abbott cc melhem im parish bs increasing frequency mania bipolar disorder causes potential negative impacts j nerv ment dis medline full text diflorio jones sex important gender differences bipolar disorder int rev psychiatry medline hoang u stewart r goldacre mj mortality hospital discharge people schizophrenia bipolar disorder retrospective study linked english hospital episode statistics 19992006 bmj medline full text dogan sabanciogullari effects patient education lithium therapy quality life compliance arch psychiatr nurs medline national institute mental health story bipolar disorder manicdepressive illness full text webb years silence past father’s life bipolar disorder j psychiatry dec 1 2003160122257 frye diagnostic dilemmas clinical correlates mixed states bipolar disorder j clin psychiatry medline american psychiatric association mixed features specifier available httpwwwdsm5orgproposedrevisionspagesproposedrevisionaspxrid483 swann ac lafer b perugi g frye bauer bahk wm et al bipolar mixed states international society bipolar disorders task force report symptom structure course illness diagnosis j psychiatry medline bega schaffer goldstein b levitt differentiating bipolar disorder types ii results national epidemiologic survey alcohol related conditions nesarc j affect disord medline dubovsky real risk suicide mental disorders medscape news today available httpwwwmedscapecomviewarticle754885 bellivier f yon l luquiens azorin jm bertsch j gerard et al suicidal attempts bipolar disorder results observational study emblem bipolar disord medline volavka j violence schizophrenia bipolar disorder psychiatr danub medline fagiolini medical monitoring patients bipolar disorder review data j clin psychiatry medline keck pe jr evaluating treatment decisions bipolar depression available httpwwwmedscapecomviewprogram2571 krishna vn thunga r unnikrishnan b kanchan bukelo mj mehta rk et al association bipolar affective disorder thyroid dysfunction asian j psychiatr medline kenneson funderburk js maisto sa risk factors secondary substance use disorders people childhood adolescentonset bipolar disorder opportunities prevention compr psychiatry medline tohen zarate ca jr hennen j khalsa hm strakowski sm gebremedhin p et al mcleanharvard firstepisode mania study prediction recovery first recurrence j psychiatry medline berk brnabic dodd kelin k tohen malhi gs et al stage illness impact treatment response bipolar disorder empirical treatment data implication staging model early intervention bipolar disord medline goldstein tr ha w axelson da goldstein bi liao f gill mk et al predictors prospectively examined suicide attempts among youth bipolar disorder arch gen psychiatry medline full text mcintyre rs soczynska jk beyer jl woldeyohannes ho law cw miranda et al medical comorbidity bipolar disorder reprioritizing unmet needs curr opin psychiatry medline bradford dw kim mm braxton le marx ce butterfield elbogen eb access medical care among persons psychotic major affective disorders psychiatr serv medline woltmann e grogankaylor perron b georges h kilbourne bauer ms comparative effectiveness collaborative chronic care models mental health conditions across primary specialty behavioral health care settings systematic review metaanalysis j psychiatry medline gutman da nemeroff c medscape education atypical antipsychotics bipolar disorder available httpwwwmedscapeorgviewarticle554128 bauer ritter p grunze h pfennig treatment options acute depression bipolar disorder bipolar disord medline post rm leverich gs altshuler frye suppes mcelroy sl et al relationship prior antidepressant exposure longterm prospective outcome bipolar disorder outpatients j clin psychiatry medline kwentus j riesenberg ra marandi manning ra allen mh fishman rs et al rapid acute treatment agitation patients bipolar disorder multicenter randomized placebocontrolled clinical trial inhaled loxapine bipolar disord medline lesem md tranjohnson tk riesenberg ra feifel allen mh fishman r et al rapid acute treatment agitation individuals schizophrenia multicentre randomised placebocontrolled study inhaled loxapine br j psychiatry medline bauer alda priller j young lt implications neuroprotective effects lithium treatment bipolar neurodegenerative disorders pharmacopsychiatry medline mcknight rf adida budge k stockton goodwin gm geddes jr lithium toxicity profile systematic review metaanalysis lancet medline ansari osser dn psychopharmacology algorithm project harvard south shore program update bipolar depression harv rev psychiatry medline diazgranados n ibrahim l brutsche ne newberg kronstein p khalife et al randomized addon trial nmethyldaspartate antagonist treatmentresistant bipolar depression arch gen psychiatry medline full text sidor mm macqueen gm antidepressants acute treatment bipolar depression systematic review metaanalysis j clin psychiatry medline geddes jr goodwin gm rendell j azorin jm cipriani ostacher mj et al lithium plus valproate combination therapy versus monotherapy relapse prevention bipolar disorder balance randomised openlabel trial lancet medline kessing lv hellmund g geddes jr goodwin gm andersen pk valproate v lithium treatment bipolar disorder clinical practice observational nationwide registerbased cohort study br j psychiatry medline swartz ha thase pharmacotherapy treatment acute bipolar ii depression current evidence j clin psychiatry medline smith la cornelius v warnock bell young ah effectiveness mood stabilizers antipsychotics maintenance phase bipolar disorder systematic review randomized controlled trials bipolar disord medline popovic reinares goikolea jm bonnin cm gonzalezpinto vieta e polarity index pharmacological agents used maintenance treatment bipolar disorder eur neuropsychopharmacol medline pappadopulos e newcomer jw kolluri changes weight plasma lipids glucose adults treated ziprasidone comprehensive analysis pfizerinitiated clinical trials j clin psychiatry medline cipriani barbui c salanti g rendell j brown r stockton et al comparative efficacy acceptability antimanic drugs acute mania multipletreatments metaanalysis lancet medline tohen goldberg jf gonzalezpinto arrillaga azorin jm vieta e hardybayle mc et al 12week doubleblind comparison olanzapine vs haloperidol treatment acute mania arch gen psychiatry medline tohen baker rw altshuler zarate ca suppes ketter ta et al olanzapine versus divalproex treatment acute mania j psychiatry medline tohen chengappa kn suppes zarate ca jr calabrese jr bowden cl et al efficacy olanzapine combination valproate lithium treatment mania patients partially nonresponsive valproate lithium monotherapy arch gen psychiatry medline sachs gs grossman f ghaemi sn okamoto bowden cl combination mood stabilizer risperidone haloperidol treatment acute mania doubleblind placebocontrolled comparison efficacy safety j psychiatry medline full text yatham ln grossman f augustyns vieta e ravindran mood stabilisers plus risperidone placebo treatment acute mania international doubleblind randomised controlled trial br j psychiatry medline guideline hirschfeld rma bowden cl gitlin mj et al work group bipolar disorder practice guideline treatment patients bipolar disorder second edition american psychiatric association available httpwwwpsychiatryonlinecompracguidepracticepdfsbipolar2einactivated041609pdf hamrin v iennaco jd psychopharmacology pediatric bipolar disorder expert rev neurother medline geller b luby jl joshi p wagner kd emslie g walkup jt et al randomized controlled trial risperidone lithium divalproex sodium initial treatment bipolar disorder manic mixed phase children adolescents arch gen psychiatry medline full text jeffrey fda warns aseptic meningitis risk lamotrigine fda warns aseptic meningitis risk lamotrigine available httpwwwmedscapecomviewarticle726845 brooks jo 3rd goldberg jf ketter ta et al safety tolerability associated secondgeneration antipsychotic polytherapy bipolar disorder findings systematic treatment enhancement program bipolar disorder j clin psychiatry feb 20117222407 medline mukherjee sackeim ha schnur db electroconvulsive therapy acute manic episodes review 50 years experience j psychiatry medline sarris j mischoulon schweiter omega3 bipolar disorder metaanalyses use mania bipolar depression j clin psychiatry 2011online ahead print hong cj huo sj yen fc tung cl pan gm tsai sj association study brainderived neurotrophicfactor genetic polymorphism mood disorders age onset suicidal behavior neuropsychobiology medline ilgen bohnert ignacio rv mccarthy jf valenstein mm kim hm et al psychiatric diagnoses risk suicide veterans arch gen psychiatry medline bellivier f yon l luquiens azorin jm bertsch j gerard et al suicidal attempts bipolar disorder results observational study emblem bipolar disord medline fazel lichtenstein p grann goodwin gm långström n bipolar disorder violent crime new evidence populationbased longitudinal studies systematic review arch gen psychiatry medline saarni si viertiö perälä j koskinen lönnqvist j suvisaari j quality life people schizophrenia bipolar disorder psychotic disorders br j psychiatry medline fiedorowicz jg endicott j leon ac solomon da keller mb coryell wh subthreshold hypomanic symptoms progression unipolar major depression bipolar disorder j psychiatry medline full text leibenluft e severe mood dysregulation irritability diagnostic boundaries bipolar disorder youths j psychiatry medline full text marcotte use topiramate new antiepileptic mood stabilizer j affect disord medline american psychiatric association bipolar related disorders available httpwwwdsm5orgproposedrevisionpagesbipolarandrelateddisordersaspx american psychiatric association diagnostic statistical manual mental disorders fourth edition text revision dsmivtr washington dc american psychiatric association 2000 american psychiatric association dsm5 future psychiatric diagnosis available httpwwwdsm5orgpagesdefaultaspx angst j azorin jm bowden cl perugi g vieta e gamma et al prevalence characteristics undiagnosed bipolar disorders patients major depressive episode bridge study arch gen psychiatry medline angst j gamma bowden cl azorin jm perugi g vieta e et al diagnostic criteria bipolarity based international sample 5635 patients dsmiv major depressive episodes eur arch psychiatry clin neurosci medline lepping p menkes db abuse dosulepin induce mania addiction medline lewitzka u bauer role lithium play suicide treatmentprevention psychiatric times available httpwwwpsychiatrictimescomspecialreportswhatroledoesshouldlithiumplayinsuicidetreatmentprevention schöttle huber cg bock meyer td psychotherapy bipolar disorder review recent studies curr opin psychiatry medline wolkenstein l bruchmüller k schmid p meyer td misdiagnosing bipolar disorderdo clinicians show heuristic biases j affect disord medline

Article 24:
phobic disorders phobic disorders practice essentials background pathophysiology phobic disorders clinical presentation history physical examination complications phobic disorders differential diagnoses phobic disorders workup approach considerations phobic disorders treatment management approach considerations pharmacotherapy psychotherapy phobic disorders medication antidepressants ssris antidepressants snris benzodiazepines antianxiety agents antihypertensive agents antidepressants tcas antidepressants mao inhibitors anticonvulsants phobic disorders practice essentials background pathophysiology phobic disorders clinical presentation history physical examination complications phobic disorders differential diagnoses phobic disorders workup approach considerations phobic disorders treatment management approach considerations pharmacotherapy psychotherapy phobic disorders medication antidepressants ssris antidepressants snris benzodiazepines antianxiety agents antihypertensive agents antidepressants tcas antidepressants mao inhibitors anticonvulsants overview practice essentials background pathophysiology etiology epidemiology prognosis patient education presentation history physical examination complications differential diagnoses workup approach considerations treatment approach considerations pharmacotherapy psychotherapy diet activity prevention consultations longterm monitoring medication phobic disorders overview phobic disorders clinical presentation phobic disorders differential diagnoses phobic disorders workup phobic disorders treatment phobic disorders medication 288016overview jul 30 2014 201506200128 0 psychiatry 2002 diseases conditions condition 1 2 content 288016 502 1440 12 f41f40f33 jun 04 2015 condition diseases conditions psychiatry psychiatry psychiatryadult adult phobic disorders phobias simple phobia specific phobia anxiety disorders social phobia social anxiety disorder agoraphobia panic phobic neurosis phobic reaction fear mood disorders phobia defined irrational fear produces conscious avoidance feared subject activity situation affected person usually recognizes reaction excessive 0 phobic disorders overview practice essentials collectively phobic disorders including social anxiety disorder social phobia specific phobia agoraphobia common forms psychiatric illness surpassing rates mood disorders substance abuse severity range mild unobtrusive severe result incapacity work travel interact others signs symptoms obtaining history patient symptoms phobic disorder physician inquire following anxiety disorders depression suicidal ideation substancerelated disorders caffeine intake alcohol intake difficulties social situations suspected social anxiety disorder irrational outofproportion fear avoidance particular objects situations suspected specific phobia intense anxiety reactions exposure specific situations suspected agoraphobia anxiety common feature phobic disorders manifestations include following elevated heart rate elevated blood pressure tremor palpitations diarrhea sweating dyspnea paresthesias dizziness anxiety manifests number physical symptoms patient presents de novo complaint physical symptoms suggestive anxiety disorder undergo physical examination help rule medical conditions might present anxietylike symptoms patient suspected phobic disorder mental status examination include assessment following appearance behavior ability cooperate examination level activity speech mood affect thought processes content insight judgment findings patient phobic disorder may include following neurovegetative signs anxious affect upon abrupt confrontation object phobia anxious mood ability identify reason anxiety thought content significant phobic ideation unrealistic outofproportion fears preserved insight usually may impaired especially exposure comorbid conditions present possible suicidal homicidal ideation see presentation diagnosis rule anxiety secondary medical conditions following tests may helpful thyroid function tests fasting glucose calcium 24hour urine 5hydroxyindoleacetic acid 5hiaa drug screen electrocardiography ecg cardiac enzyme tests electroencephalography eeg seizure disorders conditions may mimic anxiety medical illness seizure disorder suspected following imaging studies may considered computed tomography ct head magnetic resonance imaging mri echocardiography positron emission tomography pet see workup f management treatment phobic disorders usually consists pharmacotherapy psychotherapy combination thereof pharmacotherapy social anxiety disorder may include following paroxetine sertraline fdaapproved venlafaxine fdaapproved escitalopram fluoxetine fluvoxamine phenelzine moclobemide approved united states tricyclic antidepressants tcas betablockers eg propranolol selected anticonvulsants eg gabapentin pregabalin valproic acid topiramate tiagabine controlled studies demonstrated efficacy psychopharmacologic intervention specific phobias asneeded administration shortacting benzodiazepine may useful temporary anxiety relief specific situations agents may considered agoraphobia include following ssris eg escitalopram citalopram fluoxetine fluvoxamine paroxetine sertraline venlafaxine reboxetine tcas eg clomipramine imipramine benzodiazepines eg alprazolam lorazepam diazepam clonazepam mirtazapine moclobemide psychotherapeutic interventions may helpful treating phobic disorders include following social anxiety disorder social phobia selfexposure monotherapy computerbased exposure training clinicianled exposure combination therapies eg selfexposure cognitivebehavioral therapy cbtselfhelp manual specific phobia cbtbased approach including gradual desensitization relaxation breathing control techniques exposure therapy agoraphobia combination exposure therapy relaxation breathing retraining see treatment medication background phobia defined irrational fear produces conscious avoidance feared subject activity situation affected person usually recognizes reaction excessive collectively phobic disorders common forms psychiatric illness surpassing rates mood disorders substance abuse severity range mild unobtrusive severe result incapacity work travel interact others treatment phobic disorders usually consists pharmacotherapy psychotherapy combination thereof rule selected medication regimen continued least 612 months symptoms resolved patient experiencing excessive stress physician gradually taper patient medication psychotherapy usually helps make transition away medication successful diagnostic criteria dsm5 according american psychiatric association’s diagnostic statistical manual mental disorders fifth edition dsm5 social anxiety disorder social phobia specific phobia overwhelming persisting fear object situation differs anxiety disorders fear anxiety induced presence phobic situation object agoraphobia fear alone public places particularly places rapid exit would difficult help might available course panic attack embarrassing symptoms social anxiety disorder social phobia specific dsm5 marked fear anxiety 1 social situations individual might scrutinized others social interactions eg conversation meeting unfamiliar people observed eg eating drinking performing front others eg giving speech children anxiety may occur peer settings interactions adults individual fears acting way showing anxiety symptoms negatively evaluated eg humiliating embarrassing lead rejection offend others social situation almost always provokes immediate fear anxiety children anxiety may expressed crying tantrums freezing clinging shrinking failing speak social situations social situations actively avoided endured intense fear anxiety fear anxiety proportion actual threat posed social situation sociocultural context fear anxiety avoidance persists typically 6 months longer fear anxiety avoidance causes clinically significant distress impairment social occupational important areas functioning fear anxiety avoidance cannot attributed physiologic effects substance eg drug abuse medication another medical condition fear anxiety avoidance cannot better explained symptoms another mental disorder eg panic disorder body dysmorphic disorder autism spectrum disorder another medical condition eg parkinson disease obesity disfigurement caused burn injury present fear anxiety avoidance clearly unrelated excessive performanceonly subtype specified fear restricted speaking performing public individuals performanceonly social phobia fear avoid nonperformance generic social situations phobic reaction typically restricted professional performance eg musicians dancers performers athletes public speaking specific phobia specific dsm5 marked fear anxiety specific object situation eg flying heights animals receiving injection seeing blood children fear anxiety may expressed crying tantrums freezing clinging phobic object situation almost always provokes immediate fear anxiety phobic object situation actively avoided endured intense fear anxiety fear anxiety proportion actual danger posed specific object situation sociocultural context fear anxiety avoidance persists typically 6 months longer fear anxiety avoidance causes clinically significant distress impairment social occupational important areas functioning disturbance cannot better explained symptoms another mental disorder including fear anxiety avoidance situations associated paniclike symptoms incapacitating symptoms agoraphobia objects situations related obsessions obsessivecompulsive disorder ocd reminders traumatic events posttraumatic stress disorder ptsd separation home attachment figures separation anxiety disorder social situations social anxiety disorder following specifiers used according phobic stimulus present animal fear dogs cynophobia cats ailurophobia bees apiphobia spiders arachnophobia snakes ophidiophobia animals natural environment fear heights acrophobia water hydrophobia thunderstorms astraphobia bloodinjectioninjury fear needles invasive medical procedures situational fear flying elevators enclosed spaces fear situations may lead choking vomiting children loud sounds costumed characters many individuals multiple specific phobias average individual specific phobia fears 3 objects situations approximately 75 individuals specific phobia fear 1 situation object instances multiple specific phobia diagnoses diagnostic code reflecting phobic stimulus applied agoraphobia specific dsm5 marked fear anxiety least 2 following 5 situations 1 using public transportation eg automobiles buses trains ships planes 2 open spaces eg parking lots marketplaces bridges 3 enclosed places eg shops theaters cinemas 4 standing line crowd 5 outside home alone individual avoids situations thoughts escape might difficult help unavailable paniclike symptoms embarrassing symptoms eg fear falling elderly fear incontinence develop agoraphobic situations almost always provokes immediate fear anxiety agoraphobic situations actively avoided necessitate presence companion endured intense fear anxiety fear anxiety proportion actual threat posed agoraphobic situation sociocultural context fear anxiety avoidance persists typically 6 months longer fear anxiety avoidance causes clinically significant distress impairment social occupational important areas functioning another medical condition eg inflammatory bowel disease parkinson disease present fear anxiety avoidance clearly excessive fear anxiety avoidance cannot better explained symptoms another mental disorder—for example symptoms confined specific phobia situational type involve social situations social anxiety disorder related exclusively obsessions ocd perceived defects flaws physical appearance body dysmorphic disorder reminders traumatic events ptsd fear separation separation anxiety disorder although agoraphobia may associated panic disorder diagnosed irrespective presence panic disorder cases presentation meets criteria panic disorder agoraphobia diagnoses applied pathophysiology several biologic theories postulated pathogenesis phobic disorders focusing dysregulation endogenous biogenic amines sympathetic nervous system activation common phobic disorders resulting elevations heart rate blood pressure well symptoms tremor palpitations sweating dyspnea dizziness paresthesias psychological theories range explaining anxiety displacement intrapsychic conflict psychodynamic models conditioning learned paradigms cognitivebehavior models many theories capture portions disorder psychoanalyst would likely conceptualize social anxiety symptom deeper conflict—for instance low selfesteem unresolved conflicts internal objects treatment uses exploration goal understanding underlying conflict behaviorist would see phobia learned conditioned response resulting past association situation negative emotional valence time association eg social situations avoided intense anxiety originally experienced setting even danger posed social encounters avoidance response linked situations treatment perspective aims weaken eventually separate specific response stimulus genetic factors seem play role social anxiety disorder social phobia specific phobia basis family twin studies risks specific phobia social anxiety disorder appear moderately heritable preliminary neuroimaging evidence indicates different patterns brain activation might associated different phobias etiology neurobiologic psychological theories well familial patterns contributed understanding underlying causes phobic disorders neurobiologic theories social anxiety disorder social phobia functional brain imaging studies individuals engaged public speaking suggest patients social anxiety disorder tend overactivate circuit involving amygdala related face recognition negative emotions hippocampus may substrate exaggerated fear response positron emission tomography pet shown lower serotonin 5ht 1a binding amygdala mesiofrontal areas negative correlations cortisol plasma levels 5ht1a binding amygdala hippocampus retrosplenial cortex reported patients social anxiety disorder review 48 neuroimaging articles involving social anxiety disorder concluded increased activity limbic paralimbic regions consistent finding across imaging techniques social anxiety disorder specific phobia phobic reactions may result activation object recognition emotional processing areas occurring conjunction inhibition prefrontal areas responsible cognitive control emotiontriggering pet study showed phobic response spider phobia spp snake phobia snp phobia increased regional cerebral blood flow rcbf right amygdala cerebellum left visual cortex reduced rcbf prefrontal orbitofrontal ventromedial primary somatosensory cortex well auditory cortices positive correlation amygdala activation subjective fear response emphasizes importance amygdala fearphobia circuit partially distinct neurobiologic substrates suggested different types phobias functional magnetic resonance imaging fmri study patients spp bloodinjectioninjury phobia biip reported similar activation several common regions across 2 groups thalamus cerebellum occipitotemporal regions also groupspecific activation dorsal anterior cingulate gyrus anterior insula patients spp increased fmri activation dorsal anterior cingulate cortex acc insula thalamus visual areas well bed nucleus stria terminalis reported patients spp compared normal controls anticipatory task phobiarelevant versus neutral stimulation psychological theories social anxiety disorder initiated traumatic social experience eg embarrassment socialskills deficits produce recurring negative experiences hypersensitivity rejection perhaps related serotonergic dopaminergic dysfunction present theorized social anxiety disorder represents interaction biologic genetic factors environmental events specific phobia acquired conditioning modeling traumatic experience may even genetic component eg bloodinjury phobia agoraphobia may result repeated unexpected panic attacks turn may linked cognitive distortions conditioned responses abnormalities noradrenergic serotonergic gammaaminobutyric acid gaba–related neurotransmission familial patterns familial pattern reported social anxiety disorder specific phobia generalized social anxiety disorder increases risk familial transmission respect specific phobia firstdegree relatives appear increased risk subtype phobia rather specific trigger example given family may exhibit increased rate animal phobias rather share phobia specific animal epidemiology united states statistics 12month prevalence rates united states estimated follows social anxiety disorder social phobia 7 specific phobia 79 agoraphobia 17 international statistics social anxiety disorder appears less common much world united states 12month prevalence estimates clustering range 0520 median prevalence europe 23 prevalence estimates specific phobia european countries close united states 6 generally lower asian african latin american countries 24 agerelated demographics united states social anxiety disorder tends start early life 75 patients experiencing onset ages 8 15 years median age onset 13 years general specific phobia appears earlier either social anxiety disorder agoraphobia phobias develop childhood eventually disappear estimated prevalence specific phobia approximately 5 younger children 12month prevalence agoraphobia adolescents adults approximately 17 sexrelated demographics phobic disorders appear higher incidence among women higher rates social anxiety disorder found females general population femaletomale ratios ranging 151 221 females frequently affected specific phobia males rate approximately 21 though rates vary across different phobic stimuli animal natural environment situational specific phobias predominately experienced females whereas bloodinjectioninjury phobia experienced equally 2 sexes agoraphobia femaletomale ratio 231 racerelated demographics prevalence social anxiety disorder united states higher american indians lower persons asian latino african american afrocaribbean descent compared nonhispanic white individuals prevalence figures specific phobia agoraphobia appear vary substantially across cultural racial groups prognosis patients respond treatment good resolution symptoms patients specific phobia often regain highest level functioning whereas agoraphobia social anxiety disorders may residual symptoms run greater risk relapse even successful treatment fact patients social anxiety disorders extensive deficits social skills may respond well treatment one study social anxiety disorder smallest probability recovery 12 years followup prognosis determined several factors including following severity diagnosis level functioning onset symptoms degree motivation treatment level support eg family friends work school ability comply medication regimens psychotherapeutic regimens considerable evidence shows social anxiety disorder results significant functional impairment decreased quality life phobias highly comorbid social anxiety disorder particular comorbid social anxiety disorders specific phobias temporally primary whereas comorbid agoraphobia temporally secondary comorbid phobias generally severe pure phobias social anxiety disorder also frequently comorbid major depressive disorder controversy regarding whether anxiety disorders current evidence suggests even adjustment sociodemographic factors mental disorders baseline presence anxiety disorder—including agoraphobia social anxiety disorder specific phobia—is significantly associated suicidal ideation suicide attempts additionally presence anxiety disorderagain including phobic disorder combination mood disorder appears increase likelihood suicide attempts would expected mood disorder alone significant morbidity also possible terms work relationships especially social phobia agoraphobia patients severe agoraphobia may housebound therefore unable seek medical attention needed patients concomitant panic attacks higher risk substance abuse suicide patient education treating physician begin process education patient also family friends may confused diagnosis need treatment commonplace abilities socializing gatherings riding small elevator taken granted people patients experience phobias may tremendous difficulty areas greatly helped significantly caring support system family friends encourage patients confront fears help necessary eg medication compliance also assist learning stay way allow patients venture forth numerous books selfhelp groups available addition patient advocacy groups exist nationwide provide patients information give presentations hold conferences following web sites helpful social phobiasocial anxiety association american psychiatric association anxiety disorders association america medlineplus phobias mayocliniccom phobias us food drug administration fda fighting phobias things go bump mind patient education information see mental health center anxiety panic attacks hyperventilation clinical presentation history phobic disorders disabling cause severe emotional distress leading anxiety disorders depression suicidal ideation substancerelated disorders especially alcohol abuse dependence physician must inquire areas well inquire amount caffeine intake including coffee caffeinated teas sodas considering overall noradrenergic hyperdrive group patients even moderate amounts coffee might exacerbate anxiety response symptoms social anxiety disorder social phobia suspected ask patient difficulties social situations speaking public eating restaurant using public washrooms fear scrutiny others embarrassed humiliated commonly described people disorder specific phobia suspected ask irrational outofproportion fear avoidance particular objects situations eg animals insects blood needles flying heights assess intensity course fear agoraphobia suspected inquire intense anxiety avoidance feared objectsituation following exposure specific situations heights animals small spaces storms areas inquiry include fear trapped without escape eg outside home alone crowd unfamiliar people bridge tunnel moving vehicle physical examination anxiety common feature phobic disorders manifestations include following asked assessed elevated heart rate elevated blood pressure tremor palpitations diarrhea sweating dyspnea paresthesias dizziness anxiety manifests number physical symptoms patient presents de novo complaint physical symptoms suggestive anxiety disorder undergo physical examination help rule medical conditions might present anxietylike symptoms see differentials patient presents repeat visit similar complaints medical contributors ruled careful mental status examination considering anxiety primary suspect physician always remember time patients anxiety likely develop medical conditions patients accordingly diagnosis anxiety though changing threshold investigation physical symptoms keep patient receiving regular followup examinations otherwise indicated 75 patients bloodinjectioninjury type phobia report history fainting situations presented trigger initial increases heart rate blood pressure followed decreases parameters resulting fainting physiologic response differs typical response seen phobias exposure followed increased heart rate blood pressure mental status examination physician assess patient’s appearance behavior ability cooperate examination level activity speech mood affect thought processes content insight judgment situation patient abruptly confronted object phobia mental status examination significant anxious affect restricted range neurovegetative signs eg tremor diaphoresis may present patient also reports feeling anxious mood clearly identify reason hisher anxiety thought content thought content significant phobic ideation unrealistic outofproportion fears insight may impaired especially exposure cases insight preserved although patients still report cannot control feelings also acknowledge severity fears justified time mental status patient phobic disorder within normal limits except thought content positive phobic ideation phobic ideas may remain undisclosed unless specific questions phobias asked phobic disorders present suicidal homicidal ideation comorbid conditions commonly associated eg depression anxiety disorders often comorbid conditions exist suicidal homicidal risk also specifically assessed complications left untreated social anxiety disorder agoraphobia result tremendous morbidity patient becomes restricted familiar surroundings eg house trusted people eg family member spouse ability work relate people substantially impaired addition considerable risk substance abuse degree isolation specific phobia associated increased risk suicide attempts possibly suicidal ideation differential diagnoses diagnostic considerations anxiety secondary medical conditions must excluded many anxiety attack symptoms resemble found lifethreatening medical disorders eg myocardial infarction must ruled first phobic disorders general higher female preponderance though higher percentage men tend seek treatment social anxiety disorder earlier median ages illness onset reported specific phobia social anxiety disorder agoraphobia addition conditions listed differential diagnosis problems considered include following alcoholism body dysmorphic disorder bulimia nervosa delusional disorder depersonalization disorder depression eating disorder anorexia hyperhidrosis hypochondriasis hypoglycemia mitral valve prolapse paruresis pervasive developmental disorder pheochromocytoma schizophrenia seizure somatoform disorders stimulants ventricular premature complexes vertigo vestibular dysfunction angina pectoris anxiety disorders hyperparathyroidism hyperthyroidism panic disorder pediatric social phobia selective mutism personality disorders posttraumatic stress disorder separation anxiety school refusal workup approach considerations patient presents new complaint physical symptoms suggesting anxiety disorder undergo basic laboratory workup help rule medical conditions might present anxietylike symptoms differential diagnosis see differentials rule anxiety secondary medical conditions following laboratory tests may helpful thyroid function tests hypothyroidism hyperthyroidism fasting glucose hypoglycemia calcium hyperparathyroidism 24hour urine 5hydroxyindoleacetic acid 5hiaa pheochromocytoma drug screen substanceinduced anxiety following studies may also considered electrocardiography ecg cardiac enzyme tests myocardial infarction arrhythmia electroencephalography eeg seizure disorders conditions may mimic anxiety present provocation studies carbon dioxide sodium lactate yohimbine reserved research purposes imaging studies limited presentations medical illness seizure disorder suspected computed tomography ct head suspected intracranial abnormality magnetic resonance imaging mri intracranial abnormality echocardiography mitral valve prolapse positron emission tomography pet currently reserved research purposes treatment management approach considerations anxiety often significantly pathologic condition simply physiologic reaction expected occur stressful life circumstances anxiety reactions result dysfunction disability remit spontaneously time addition high placebo response rates documented across range anxiety disorders treatment phobic disorders usually consists pharmacotherapy psychotherapy combination thereof pharmacotherapy social anxiety disorder social phobia present 3 drugs approved us food drug administration fda treatment social anxiety disorder follows selective serotonin reuptake inhibitors ssris paroxetine sertraline selective serotoninnorepinephrine reuptake inhibitor snri venlafaxine addition placebocontrolled randomized controlled trials systematic reviews show social anxiety disorder responds following agents ssris escitalopram monoamine oxidase inhibitor maoi phenelzine reversible inhibitor monoamine oxidase rima moclobemide approved united states overall ssris appear effective maois treatment social anxiety disorder antihypertensive betablocker therapy used augmentation strategy propranolol may useful circumscribed treatment situationalperformance anxiety asneeded basis selected anticonvulsants eg gabapentin pregabalin valproic acid topiramate tiagabine shown effective social anxiety disorder mostly openlabel uncontrolled clinical trials acute treatment treatment social anxiety disorder initiated ssri titrated minimum effective dosage response partial nonexistent 6 weeks dosage may increased may done every 2 weeks maximum dose reached patients ssri therapy fails sometimes respond treatment highpotency benzodiazepine eg clonazepam alpha2delta calcium channel blocker eg gabapentin pregabalin antiepileptic levetiracetam antipsychotic olanzapine may also respond combined ssribenzodiazepine therapy buspirone betablocker atenolol tca imipramine unproven efficacy setting longterm treatment longterm treatment data doubleblind randomized controlled trials addressing social anxiety disorder show continuing ssri venlafaxine therapy 6 months result increased treatment response rates betablockers clonidine buspirone usually helpful longterm treatment social anxiety disorder 612 months full response slow tapering pharmacotherapy considered symptoms recur tapering therapy restarted continued indefinitely specific phobia date controlled studies demonstrated efficacy psychopharmacologic intervention specific phobias clinical lore suggests asneeded administration shortacting benzodiazepine might useful temporary anxiety relief specific situations eg right boarding plane patients fear flying agoraphobia randomized doubleblind placebocontrolled trials shown agoraphobia specifically panic symptoms responds treatment ssris eg escitalopram citalopram fluoxetine fluvoxamine paroxetine sertraline acute treatment treatment agoraphobia started ssri low dosage titrated minimum dosage effectively controls patient’s panic benzodiazepines used either adjunct primary treatment however usually chosen firstline therapy potential abuse response minimal nonexistent 6 weeks ssri dosage may increased every 2 weeks response achieved maximal dosage reached response partial absent highest ssri dosage following alternatives considered switch different ssri switch agent different drug class eg venlafaxine reboxetine tca longacting benzodiazepines eg diazepam clonazepam prescribed standing rather asneeded basis preferred reduced addictive potential dosage increased every 23 days either panic symptoms controlled maximum dosage reached shortacting agent alprazolam may considered shortterm use control acute symptoms panic agents unproven efficacy setting include buspirone propranolol antihistaminic drugs antipsychotic agents longterm treatment doubleblind studies show continuing ssri clomipramine 12 52 weeks results increased treatment response rates pediatric adolescent young adult suicidality suicide risk must always considered particularly treatment child adolescent mood disorder physicians advised aware following information use appropriate caution considering treatment ssris pediatric geriatric populations october 2003 fda issued public health advisory regarding reports suicidality pediatric patients treated antidepressant medications major depressive disorder advisory reported suicidality ideation attempts clinical trials various antidepressant drugs pediatric patients fda asked additional studies performed suicidality occurred treated untreated patients major depression thus could definitively linked drug treatment december 2003 uk medicines healthcare products regulatory agency mhra issued advisory stating ssris suitable use persons younger 18 years treatment “depressive illness” review mhra decided risks ssri therapy posed pediatric patients outweighed benefits except case fluoxetine appeared positive riskbenefit ratio treatment depressive illness patients younger 18 years psychotherapy controlled studies found behavioral therapy cognitive behavioral therapy cbt effective treating phobic disorders psychodynamic therapy insightoriented therapy rarely indicated exclusive treatment phobias mostly reserved cases phobic disorders overlap personality disorders deciding treatment combination treatments prescribe depends careful interview assessment patient’s goals level pathology social anxiety disorder social phobia treatment social anxiety disorder selfexposure monotherapy shown work well computerbased exposure training clinicianled exposure combination therapies selfexposure cbtselfhelp manual specific phobia cbtbased approach including gradual desensitization commonly used treatment specific phobia treatments include relaxation breathing control techniques randomized controlled clinical trials indicate specific phobias respond exposure therapy one study successful completion 4session cbt course patients specific phobias longer showed significant functional magnetic resonance imaging fmri activation prefrontal parahippocampal areas another study single 4hour cbt session combined vivo exposure modeling resulted increasedimproved medial orbitofrontal cortex activity decreasedimproved activation amygdala insula patients specific phobias compared untreated control subjects agoraphobia 2010 metaanalysis showed combination exposure therapy relaxation breathing retraining worked better psychological interventions panic disorder without agoraphobia diet activity patient’s intake caffeine eg coffee caffeinated teas sodas assessed even moderate amounts caffeine may exacerbate anxiety response symptoms small doubleblind placebocontrolled study tryptophanrich diet shown positive effect social anxiety disorder activity restricted patients encouraged confront anxietyproducing stimuli context behavioral therapy treatment plan prevention overwhelming exposure early childhood eg frightening experience aggressive dog may predispose child development phobic symptoms intervention eg psychotherapy medication early stages symptom development may beneficial preventing worsening symptoms consultations physicians without expertise conducting behavioral therapy may want consult psychiatric center specializing treatment anxiety disorders either guidance developing treatment plan difficult cases referral consultation internist neurologist may helpful sorting nonpsychiatric differential diagnosis especially rare disorders pheochromocytoma suspected see differentials longterm monitoring inpatient treatment indicated patients severe phobic disorder presenting acute suicidal ideation attempts addition inpatient treatment including detoxification rehabilitation may recommended treatment secondary drug alcohol abuse dependence outpatient followup usually required patient’s symptoms resolved resolution symptoms physician attempt taper pharmacotherapy well monitor relapse medication medication summary pharmacotherapy phobic disorders ie social anxiety disorder specific phobia agoraphobia includes antidepressant agents eg selective serotonin reuptake inhibitors ssris selective serotoninnorepinephrine reuptake inhibitors snris benzodiazepines serotonin 5ht 1 agonists antihypertensive agents tricyclic antidepressants tcas monoamine oxidase inhibitors maois antidepressants ssris class summary ssris help prevent panic attacks alleviate symptoms anxiety depression drugs may require 26 weeks daily use become effective usually side effects appearing first ssris shown effective controlled clinical trials class medications tend fewest adverse effects however ssris produce drugdrug interactions inhibiting cytochrome p450 enzymes displacing drugs proteinbinding sites ssris greatly preferred classes antidepressants treatment anxiety disorders appear similarly efficacious choice ssri depends adverse effects drug interactions history previous response relatively benign adverse effect profile ssris including minimal anticholinergic effects facilitates compliance common adverse effects include insomnia ejaculation disorder primarily ejaculatory delay nausea sweating fatigue somnolence sexual dysfunction ssris carry cardiac arrhythmia risk associated tcas citalopram hydrobromide celexa citalopram enhances serotonin activity selective reuptake inhibition neuronal membrane agent approved us food drug administration fda treatment anxiety disorders data randomized controlled trials support use treatment agoraphobia escitalopram oxalate lexapro escitalopram senantiomer citalopram onset depression relief may obtained 12 weeks sooner relief obtained antidepressants suggesting escitalopram may work faster similar drugs although agent approved fda treatment phobic disorders class membership good tolerability make attractive option longterm treatment offlabel use escitalopram anxiety disorders includes social anxiety disorder social phobia panic disorder obsessivecompulsive disorder ocd escitalopram approved use children younger 12 years paroxetine hydrochloride paxil paxil cr pexeva paroxetine potent selective inhibitor neuronal serotonin reuptake weak effect norepinephrine dopamine neuronal reuptake agent lowaffinity antagonist subtypes muscarinic acetylcholine receptors nitric oxide synthase inhibitor anticholinergic effects paroxetine may result sedation cardiovascular effects paroxetine fdaapproved use social anxiety disorder social phobia panic disorder generalized anxiety disorder ocd major depressive disorder mdd premenstrual dysphoric disorder pmdd posttraumatic stress disorder ptsd sertraline hydrochloride zoloft sertraline selectively inhibits presynaptic serotonin reuptake lowpotency dopamine norepinephrine reuptake inhibitor isfda approved use social anxiety disorder panic disorder major depressive disorder ocd adults children adolescents pmdd ptsd fluoxetine prozac prozac weekly fluoxetine selectively inhibits presynaptic serotonin reuptake minimal effect reuptake norepinephrine dopamine common side effect sexual dysfunction may impact longterm compliance fluoxetine fdaapproved use panic disorder without agoraphobia ocd well disorders fluvoxamine luvox cr fluvoxamine enhances serotonin activity selective reuptake inhibition neuronal membrane drug significantly bind alphaadrenergic histamine cholinergic receptors fewer side effects tcas fluvoxamine fdaapproved treating ocd children 817 years adults also approved treating social anxiety disorder fluvoxamine may helpful anxiety disorders well antidepressants snris class summary snris help prevent panic attacks alleviate symptoms anxiety depression venlafaxine hydrochloride effexor xr venlafaxine reuptake inhibitor serotonin norepinephrine fdaapproved extendedrelease capsule treatment social phobia panic disorder without agoraphobia generalized anxiety disorder benzodiazepines class summary general category medication prescribed patients history alcoholdrug abuse emotional dependence psychiatrists feel longeracting benzodiazepines eg diazepam clonazepam advantages less frequent dosing consistent levels throughout day slowly taper benzodiazepines usually 6 mo avoid withdrawal avoid precipitating panic alprazolam xanax xanax xr niravam alprazolam beststudied benzodiazepine rapid onset 20 minutes short halflife contribute increased dependency tapering attempts alprazolam fda approved use panic disorder without agoraphobia generalized anxiety disorder anxiety disorders immediaterelease tablet lorazepam ativan lorazepam sedative hypnotic short onset effects relatively long halflife increasing action gamma aminobutyric acid gaba major inhibitory neurotransmitter brain lorazepam may depress levels central nervous system cns including limbic reticular formation agent fdaapproved use anxiety disorders patient must sedated longer 24 hours lorazepam excellent choice significantly metabolized liver administered either intravenously iv intramuscularly im clonazepam klonopin clonazepam longacting benzodiazepine increases presynaptic gaba inhibition reduces monosynaptic polysynaptic reflexes drug also suppresses muscle contractions facilitating inhibitory gaba neurotransmission inhibitory transmitters clonazepam reaches peak plasma concentration 24 hours oral rectal administration clonazepam multiple indications including suppression myoclonic akinetic petit mal seizure activity focal generalized dystonias eg tardive dystonia agent fdaapproved use anxiety disorders diazepam diastat acudial diastat pediatric valium diazepam modulates postsynaptic effects gabaa transmission thereby bringing increase presynaptic inhibition agent appears act part limbic system thalamus hypothalamus induce calming effect also found effective adjunct relief skeletal muscle spasm caused upper motor neuron disorders agent fdaapproved use anxiety disorders diazepam rapidly distributed body fat stores avoid adverse effects diazepam dosage individualized increased cautiously serum concentration drug drops 20 peak value 20 minutes initial iv infusion antianxiety agents class summary serotonin agonists buspirone may used treat anxiety buspirone buspirone antianxiety agent chemically pharmacologically related benzodiazepines barbiturates sedative anxiolytic drugs rather 5ht1 agonist serotonergic neurotransmission dopaminergic effects cns buspirone anxiolytic effect may take 23 weeks reach full efficacy buspirone approved treatment anxiety disorders shortterm relief symptoms anxiety antihypertensive agents class summary antihypertensive agents useful circumscribed treatment situationalperformance anxiety asneeded basis betaadrenergic blockers reduce inotropic state left ventricle lv decrease diastolic dysfunction increase lv compliance thereby reducing pressure gradient across lv outflow tract decreasing myocardial oxygen consumption reduces myocardial ischemia potential lowering heart rate reduces myocardial oxygen consumption myocardial ischemia potential atenolol tenormin atenolol acts selectively blocking beta1 receptors little effect beta2 receptors betablockers affect blood pressure via multiple mechanisms including negative chronotropic effect decreases heart rate rest exercise negative inotropic effect decreases cardiac output reduction sympathetic outflow cns suppression renin release kidneys atenolol used improve preserve hemodynamic status acting myocardial contractility reducing congestion decreasing myocardial energy expenditure iv administration patients blood pressure heart rate electrocardiogram ecg must carefully monitored propranolol inderal la innopran xl propranolol recommended situational social anxiety stage fright asneeded basis oral po dose 1020 mg given antidepressants tcas class summary tricyclic antidepressants tcas clomipramine imipramine demonstrated efficacy treatment panic disorder without agoraphobia also relatively inexpensive medications however due broad spectrum action inhibition multiple neurotransmitter systems tcas side effects anticholinergic cardiovascular side effects therefore agents present problems longterm treatment treatment response tcas occurs order selective serotonin reuptake inhibitors ssris within 26 weeks tcas black box warning states patients major depressive disorder mdd adult pediatric may experience worsening depression andor emergence suicidal ideation behavior suicidality unusual changes behavior whether taking antidepressant medications clomipramine hydrochloride anafranil clomipramine dibenzazepine compound belongs tca family acts inhibiting membrane pump mechanism responsible norepinephrine serotonin uptake adrenergic serotonergic neurons clomipramine affects serotonin uptake also affects norepinephrine uptake converted metabolite desmethylclomipramine clomipramine acts antagonist muscarinic acetylcholine receptors also antagonist histamine h1 receptors clomipramine approved fda use treatment ocd adult pediatric age ≥10 years imipramine hydrochloride tofranil tofranilpm imipramine hydrochloride inhibits reuptake norepinephrine serotonin presynaptic neuron agent antagonist histamine h1 alpha1 adrenoceptors well m2 muscarinic acetylcholine receptors parenteral administration used starting therapy patients unable unwilling use oral medication antidepressants mao inhibitors class summary maois commonly prescribed patients social anxiety disorder social phobia main advantages low risk dependence lesser anticholinergic effect seen tcas main disadvantage higher number adverse effects including sexual difficulty hypotension weight gain diet low tyramine must followed avoid hypertensive crisis use concomitant medications including overthecounter medications great caution high risk serotonin syndrome hypertensive crisis maois contraindicated patients taking selective serotonin reuptake inhibitors dual serotonin norepinephrine reuptake inhibitors tricyclic antidepressants bupropion wellbutrin mirtazapine remeron buspirone buspar certain analgesics vasoconstrictors sympathomimetics anticonvulsants phenelzine nardil phenelzine commonly used maoi anxiety disorders tranylcypromine 3060 mgday also effective phenelzine usually reserved patients cannot tolerate respond tcas ssris selegiline emsam selegiline selective maob inhibitor lower therapeutic doses target dose 6 mg per 24 hours special dietary restrictions needed addition selegiline transdermal patch advantage avoiding first pass effect decreases impact cyp highlowmetabolizer status terms medication effects tolerability anticonvulsants class summary selected anticonvulsants shown effective social anxiety disorder mostly openlabel uncontrolled clinical trials may also useful treatment phobic disorders gabapentin neurontin gralise gabapentin membrane stabilizer structural analogue inhibitory neurotransmitter gammaaminobutyric acid gaba paradoxically thought exert effects gaba receptors appears exert action via alpha2delta1 alpha2delta2 auxiliary subunits voltagegated calcium channels apparent anxiolytic properties pregabalin lyrica pregabalin structural derivative gaba mechanism action unknown binds high affinity alpha2delta calcium channel subunits vitro reduces calciumdependent release several neurotransmitters possibly modulating calcium channel function valproic acid depakote depakote er depakene stavzor mechanism action valproic acid established activity may related increased brain levels gaba enhanced gaba action valproic acid may also potentiate postsynaptic gaba responses affect potassium channel exert direct membranestabilizing effect author adrian preda md health sciences clinical professor psychiatry human behavior university california irvine school medicine adrian preda md member following medical societies society biological psychiatry international congress schizophrenia research schizophrenia international research society disclosure nothing disclose chief editor iqbal ahmed mbbs frcpsych uk faculty department psychiatry tripler army medical center clinical professor psychiatry uniformed services university health sciences clinical professor psychiatry clinical professor geriatric medicine university hawaii john burns school medicine iqbal ahmed mbbs frcpsych uk member following medical societies academy psychosomatic medicine american neuropsychiatric association american society clinical psychopharmacology american association geriatric psychiatry american psychiatric association disclosure nothing disclose acknowledgements mohammed memon md mohammed memon md member following medical societies american association geriatric psychiatry american medical association american psychiatric association disclosure nothing disclose francisco talavera pharmd phd disclosure medscape salary employment american psychiatric association diagnostic statistical manual mental disorders fourth edition text revision dsmivtr mathew sj coplan jd gorman jm neurobiological mechanisms social anxiety disorder j psychiatry medline kendler ks karkowski lm prescott ca fears phobias reliability heritability psychol med medline fyer aj mannuzza chapman tf liebowitz mr klein df direct interview family study social phobia arch gen psychiatry medline van houtem cm laine ml boomsma di ligthart l van wijk aj de jongh review metaanalysis heritability specific phobia subtypes corresponding fears j anxiety disord medline lebeau rt glenn liao b et al specific phobia review dsmiv specific phobia preliminary recommendations dsmv depress anxiety medline linares im trzesniak c chagas mh hallak je nardi ae crippa ja neuroimaging specific phobia disorder systematic review literature rev bras psiquiatr medline tillfors furmark marteinsdottir fredrikson cerebral blood flow anticipation public speaking social phobia pet study biol psychiatry medline tillfors furmark marteinsdottir fischer h pissiota långström b et al cerebral blood flow subjects social phobia stressful speaking tasks pet study j psychiatry medline lanzenberger rr mitterhauser spindelegger c wadsak w klein n mien lk et al reduced serotonin1a receptor binding social anxiety disorder biol psychiatry medline lanzenberger r wadsak w spindelegger c mitterhauser akimova e mien lk et al cortisol plasma levels social anxiety disorder patients correlate serotonin1a receptor binding limbic brain regions int j neuropsychopharmacol medline freitasferrari mc hallak je trzesniak c filho machadodesousa jp chagas mh et al neuroimaging social anxiety disorder systematic review literature prog neuropsychopharmacol biol psychiatry medline ahs f pissiota michelgård frans furmark appel l et al disentangling web fear amygdala reactivity functional connectivity spider snake phobia psychiatry res medline caseras x giampietro v lamas brammer vilarroya carmona et al functional neuroanatomy bloodinjectioninjury phobia comparison spider phobics healthy controls psychol med medline straube mentzel hj miltner wh waiting spiders brain activation anticipatory anxiety spider phobics neuroimage medline kessler rc petukhova sampson na zaslavsky wittchen hu twelvemonth lifetime prevalence lifetime morbid risk anxiety mood disorders united states int j methods psychiatr res medline full text lewisfernández r hinton de laria aj et al culture anxiety disorders recommendations dsmv depress anxiety medline kessler rc berglund p demler jin r merikangas kr walters ee lifetime prevalence ageofonset distributions dsmiv disorders national comorbidity survey replication arch gen psychiatry medline wolitzkytaylor kb castriotta n lenze ej stanley craske mg anxiety disorders older adults comprehensive review depress anxiety medline ruscio brown ta chiu wt sareen j stein mb kessler rc social fears social phobia usa results national comorbidity survey replication psychol med medline full text ollendick th king nj muris p fears phobias children phenomenology epidemiology aetiology child adolesc ment health wittchen hu jacobi f rehm j et al size burden mental disorders disorders brain europe 2010 eur neuropsychopharmacol medline beesdo k knappe pine ds anxiety anxiety disorders children adolescents developmental issues implications dsmv psychiatr clin north medline full text kessler rc chiu wt jin r ruscio shear k walters ee epidemiology panic attacks panic disorder agoraphobia national comorbidity survey replication arch gen psychiatry medline full text fehm l pelissolo furmark wittchen hu size burden social phobia europe eur neuropsychopharmacol medline wittchen hu stein mb kessler rc social fears social phobia community sample adolescents young adults prevalence risk factors comorbidity psychol med medline wittchen hu gloster beesdobaum k fava ga craske mg agoraphobia review diagnostic classificatory position criteria depress anxiety medline bruce se yonkers ka otto mw eisen jl weisberg rb pagano et al influence psychiatric comorbidity recovery recurrence generalized anxiety disorder social phobia panic disorder 12year prospective study j psychiatry medline schneier fr heckelman lr garfinkel r campeas r fallon ba gitow et al functional impairment social phobia j clin psychiatry medline lochner c mogotsi du toit pl kaminer niehaus dj stein dj quality life anxiety disorders comparison obsessivecompulsive disorder social anxiety disorder panic disorder psychopathology medline matza ls revicki da davidson jr stewart jw depression atypical features national comorbidity survey classification description consequences arch gen psychiatry medline sareen j cox bj afifi de graaf r asmundson gj ten et al anxiety disorders risk suicidal ideation suicide attempts populationbased longitudinal study adults arch gen psychiatry medline stein mb stein dj social anxiety disorder lancet medline beesdo k bittner pine ds stein mb höfler lieb r et al incidence social anxiety disorder consistent risk secondary depression first three decades life arch gen psychiatry medline magee wj eaton ww wittchen hu mcgonagle ka kessler rc agoraphobia simple phobia social phobia national comorbidity survey arch gen psychiatry medline liotti g phobias attachmentrelated inner states psychotherapy adult survivors childhood complex trauma j clin psychol medline baldwin ds anderson im nutt dj bandelow b bond davidson jr et al evidencebased guidelines pharmacological treatment anxiety disorders recommendations british association psychopharmacology j psychopharmacol medline de beurs e van balkom aj van dyck r lange longterm outcome pharmacological psychological treatment panic disorder agoraphobia 2year naturalistic followup acta psychiatr scand medline pelissolo efficacy tolerability escitalopram anxiety disorders review encephale medline national prescribing service limited escitalopram lexapro esipram generalised anxiety disorder social anxiety disorder social phobia nps radar available httpbitlydoarmj stein dj ipser jc van balkom aj pharmacotherapy social anxiety disorder cochrane review westenberg hg recent advances understanding treating social anxiety disorder cns spectr medline ravindran ln stein mb pharmacologic treatment anxiety disorders review progress j clin psychiatry medline davidson jr pharmacotherapy social anxiety disorder evidence tell us j clin psychiatry medline offidani e guidi j tomba e fava ga efficacy tolerability benzodiazepines versus antidepressants anxiety disorders systematic review metaanalysis psychother psychosom medline van ameringen allgulander c bandelow b greist jh hollander e montgomery sa et al wca recommendations longterm treatment social phobia cns spectr medline practice guideline treatment patients panic disorder work group panic disorder american psychiatric association j psychiatry medline pohl rb wolkow rm clary cm sertraline treatment panic disorder doubleblind multicenter trial j psychiatry medline michelson lydiard rb pollack mh tamura rn hoog sl tepner r et al outcome assessment clinical improvement panic disorder evidence randomized controlled trial fluoxetine placebo fluoxetine panic disorder study group j psychiatry medline uhlenhuth eh balter mb ban ta yang k international study expert judgment therapeutic use benzodiazepines psychotherapeutic medications vi trends recommendations pharmacotherapy anxiety disorders 19921997 depress anxiety medline shear mk beidel dc psychotherapy overall management strategy social anxiety disorder j clin psychiatry medline guideline mayor nice advocates computerised cbt bmj medline full text barlow jh ellard dr hainsworth jm jones fr fisher review selfmanagement interventions panic disorders phobias obsessivecompulsive disorders acta psychiatr scand medline masia warner c fisher ph shrout pe rathor klein rg treating adolescents social anxiety disorder school attention control trial j child psychol psychiatry medline bunnell beidel dc mesa f randomized trial attention training generalized social phobia attention training change social behavior behav ther medline ayala es meuret ae ritz treatments bloodinjuryinjection phobia critical review current evidence j psychiatr res medline rothbaum bo anderson p zimand e hodges l lang wilson j virtual reality exposure therapy standard vivo exposure therapy treatment fear flying behav ther medline paquette v lévesque j mensour b leroux jm beaudoin g bourgouin p et al change mind change brain effects cognitivebehavioral therapy neural correlates spider phobia neuroimage medline schienle schäfer hermann rohrmann vaitl symptom provocation reduction patients suffering spider phobia fmri study exposure therapy eur arch psychiatry clin neurosci medline sánchezmeca j rosaalcázar ai marínmartínez f gómezconesa psychological treatment panic disorder without agoraphobia metaanalysis clin psychol rev medline hudson c hudson mackenzie j proteinsource tryptophan efficacious treatment social anxiety disorder pilot study j physiol pharmacol medline

Article 25:
benign positional vertigo emergency medicine benign positional vertigo emergency medicine background pathophysiology epidemiology benign positional vertigo emergency medicine clinical presentation history physical causes benign positional vertigo emergency medicine differential diagnoses benign positional vertigo emergency medicine workup laboratory studies imaging studies tests benign positional vertigo emergency medicine treatment management emergency department care consultations benign positional vertigo emergency medicine medication antiemetic agents antiemetics selective 5ht3 antagonist benzodiazepines benign positional vertigo emergency medicine followup outpatient care inpatient care inpatient outpatient medications benign positional vertigo emergency medicine background pathophysiology epidemiology benign positional vertigo emergency medicine clinical presentation history physical causes benign positional vertigo emergency medicine differential diagnoses benign positional vertigo emergency medicine workup laboratory studies imaging studies tests benign positional vertigo emergency medicine treatment management emergency department care consultations benign positional vertigo emergency medicine medication antiemetic agents antiemetics selective 5ht3 antagonist benzodiazepines benign positional vertigo emergency medicine followup outpatient care inpatient care inpatient outpatient medications overview background pathophysiology epidemiology presentation history physical causes differential diagnoses workup laboratory studies imaging studies tests procedures treatment emergency department care consultations medication followup outpatient care inpatient care inpatient outpatient medications deterrenceprevention complications prognosis patient education benign positional vertigo emergency medicine overview benign positional vertigo emergency medicine clinical presentation benign positional vertigo emergency medicine differential diagnoses benign positional vertigo emergency medicine workup benign positional vertigo emergency medicine treatment benign positional vertigo emergency medicine medication benign positional vertigo emergency medicine followup 791414overview may 28 2015 201508042154 0 emergency medicine 2002 diseases conditions condition 1 2 content 791414 502 45 ssg jun 05 2015 condition diseases conditions emergencymedicine emergency medicine emergencymedicineneurology neurology benign positional vertigo benign paroxysmal positional vertigo bpv vertigo dizziness dizziness symptoms dizziness treatment inner ear hallpike test epley maneuver lightheadedness canalolithiasis theory otoliths brandt exercise daroff exercise nearsyncope dysequilibrium disequilibrium orthostatic hypotension vasovagal episode neurocardiogenic syncope disorder thevestibular proprioceptive system labyrinthitis vestibular neuronitis nystagmus torsional nystagmus rotatory nystagmus dizzy headhanging maneuvers labyrinthine disease otoconia psychophysiologic dizziness benign positional vertigo bpv common cause vertigo vertigo illusion motion illusion misperception real stimulus represents disorder vestibular proprioceptive system 0 benign positional vertigo emergency medicine overview background benign positional vertigo bpv common cause vertigo vertigo illusion motion illusion misperception real stimulus represents disorder vestibular proprioceptive system bpv first described adler 1897 bárány 1922 however dix hallpike coin term benign paroxysmal positional vertigo information see benign positional vertigo pathophysiology benign positional vertigo bpv caused calcium carbonate particles called otoliths otoconia inappropriately displaced semicircular canals vestibular labyrinth inner ear otoliths normally attached hair cells membrane inside utricle saccule otoliths denser surrounding endolymph changes vertical head movement causes otoliths tilt hair cells sends signal brain letting brain know head tilting utricle connected 3 semicircular canals otoliths may become displaced utricle aging head trauma labyrinthine disease occurs otoliths potential enter semicircular canals usually enter posterior semicircular canal dependent inferior 3 canals anatomy semicircular canals anatomy semicircular canals according canalolithiasis theory widely accepted theory pathophysiology benign positional vertigo otoliths freefloating within semicircular canal changing head position causes otoliths move canal endolymph dragged along movement otoliths stimulates hair cells cupula affected semicircular canal causing vertigo otoliths stop moving endolymph also stops moving hair cells return baseline position thus terminating vertigo nystagmus reversing head maneuver causes particles move opposite direction producing nystagmus axis reversed direction rotation patient may describe room spinning opposite direction repeating head maneuvers otoliths tend become dispersed thus progressively less effective producing vertigo nystagmus hence concept fatigability epidemiology frequency united states incidence benign positional vertigo bpv 64 cases per 100000 population per year conservative estimate international one study japan found incidence 11 cases per 100000 population per year patients counted examined subspecialist referral center mortalitymorbidity b benign sex women affected twice often men age bpv general disease elderly persons although onset occur age several large studies show average age onset mid 50s vertigo young patients likely caused labyrinthitis associated hearing loss vestibular neuronitis normal hearing clinical presentation history asked dizziness patients benign positional vertigo bpv characteristically describe room world spinning however descriptions rocking tilting somersaulting like also possible matters illusion motion caused misperception stimulus otoliths diagnosis bpv based characteristic history positive hallpike test episodic vertigo may occur following head movements rolling bed lying sitting leaning forward turning head horizontal plane symptoms bpv usually worse morning otoliths likely clump together patient sleeps exert greater effect patient gets morning mitigate day progresses otoliths become dispersed head movement nausea typically present vomiting less common history head trauma may present especially young patients bpv head trauma may dislodge otoliths hair cells within utricle allowing opportunity enter semicircular canals eliciting individual episodes vertigo bpv last seconds time important patients may describe continuous vertigo reality repeated episodes episode typically lasting seconds less minute patients vestibular neuritis labyrinthitis interview patient states room spinning patients head still prior manipulative tests highly unlikely patient bpv vertigo bpv lasts seconds time occurs head movement physical addition patients history diagnosis benign positional vertigo bpv confirmed positive hallpike test see video hallpike test example right posterior semicircular canal tested note head extends edge gurney thumb used help keep eyelids open since noting direction nystagmus important test patient placed headhanging position turning head 45 degrees one side short delay seconds nystagmus reproduction vertigo occurs typically resolves within 3060 seconds general hallpike test positive one side side otoliths posterior semicircular canal negative side neurologic examination otherwise unremarkable nystagmus classic nystagmus occurs patients head dependent turned affected side nystagmus torsional rotatory headhanging position fast phase beat toward forehead upbeat direction affected side ipsilateral although describe fast phase terms clockwise counterclockwise experts avoid terminology unclear clock viewed patients physicians perspective nystagmus usually occurs within 10 seconds positioning may present late 40 seconds hence history classic observe patient least 40 seconds headhanging position hallpike test duration observed nystagmus varies seconds minute parallels sensation vertigo response fatigues patient repeatedly placed provoking position due dispersion otoliths note patient classic history bpv short delay room spins revolves 2030 seconds rooms spins opposite direction sits back nystagmus seen hallpike test experts would agree treat patient modified epley maneuver nystagmus may blocked fixation suppression emergency physicians access frenzel lenses specialists use block fixation suppression see treatment one study showed treating patients epley maneuver still effective despite lack nystagmus patients classic history symptomatic hallpike testing perform hallpike test follows caution patients cervical spondylosis may advisable extend neck however head dependent important effect achieved gurney placed trendelenburg position patients first warn patient symptoms vertigo likely reproduced resolve seconds seat patient close enough end gurney lies supine head extend backward additional 3045° instruct patient keep eyes open want observe direction nystagmus examiner may need use thumb hold eyelid open patients may involuntarily close eyes even instructed keep open test left posterior canal follow steps turn patients head 45° left position orients head left posterior semicircular canal going plane upcoming head movement next step provocative way move otoliths indeed posterior semicircular canal result positive test hands either side patients head lay patient head dependent hanging edge gurney note step need performed rapidly check reproduction symptoms nystagmus cases fast phase nystagmus upbeat toward forehead ipsilateral example toward patients left return patient upright position nystagmus may observed opposite direction patient may describe world spinning opposite direction test right posterior canal repeat hallpike test head turned 45° right side general patient bpv one side test positive hallpike test although bilateral posterior semicircular canal bpv possible unlikely suggest horizontal canal involvement vestibular neuritislabyrinthitis central cause note many patients experience mild dizziness brought headhanging position sitting position important confuse dizziness lightheaded character true vertigo patients head cannot extended edge gurney 2 additional options exist first place patient trendelenburg position gurney allows position available alternative use sidelying test patient sits legs one side gurney test left posterior semicircular canal turn patients head 90° opposite side case right side lay patient left side turning patients head right left posterior semicircular canal aligned plane sideways movement hallpike test allow greatest chance otoliths move indeed located posterior semicircular canal neurologic examination findings otherwise normal strongly consider alternative diagnoses causes several disorders affecting peripheral vestibular system may precede onset benign positional vertigo bpv idiopathic 5060 infection viral neuronitis head trauma especially younger patients degeneration peripheral end organ surgical damage labyrinth differential diagnoses diagnostic considerations acoustic schwannoma chronic otomastoiditis congenital malformation inner ear medications alcohol phenytoin diuretics salicylates quinidine quinine barbiturates antibiotics otosclerosis ototoxicity polyarteritis nodosa posttraumatic injuries posterior fossa neurosurgery postsurgery general postsurgery ear vertebrobasilar insufficiency labyrinthitis meniere disease idiopathic endolymphatic hydrops migraine headache multiple sclerosis stroke hemorrhagic stroke ischemic systemic lupus erythematosus sle vestibular neuronitis workup laboratory studies pathognomonic laboratory test benign positional vertigo bpv exists laboratory tests may performed rule pathology imaging studies currently imaging study demonstrate presence otoliths head ct scanning mri indicated diagnosis doubt tests although patients benign positional vertigo bpv posterior semicircular canal involvement patients horizontal canal involvement canal suspected patient bilateral symptoms hallpike test use roll test formally diagnose horizontal canal bpv use barbque treatment treat horizontal canal bpv roll test patient lie supine position gurney unlike hallpike test head need hang edge gurney turn patients head 90° one side patient experience reproduction symptoms presence horizontal nystagmus fast phase beat toward earth geotropic turn patients head 180° 90° opposite side patient experience reproduction symptoms presence horizontal nystagmus fast phase beats toward earth note changed direction known directionchanging nystagmus nystagmus changes direction based turning head different gazeevoked nystagmus nystagmus changes direction depending patient looking dilantin toxicity note sides nystagmus reproduction symptoms one side much symptomatic demonstrate stronger nystagmus side considered involved side positive roll test treated barbque treatment see treatment video barbque maneuver maneuver used treat horizontal canal benign positional vertigo example right horizontal canal treated position held least 2030 seconds headthrust test headimpulse test headthrust test used diagnose vestibular neuritis labyrinthitis test patient told look examiners nose examiner places hands patients head rapidly turns approximately 1015° one side vestibular apparatus functioning properly patient able maintain focus examiners nose vestibular apparatus working properly patients eyes deviate side quickly jerk back view examiners nose jerking eye movement called saccade indicates positive headthrust test general rule positive headthrust test rules peripheral hence benign cause vertigo reported cases however positive headthrust tests central causes vertigo procedures hallpike test along patients history confirms diagnosis bpv see physical details procedure modified epley maneuver used treat posterior canal bpv see treatment well video demonstration epley maneuver example left posterior semicircular canal treated clip maneuvers performed quickly real patient position held least 30 seconds resolution nystagmus vertigo treatment management emergency department care history physical examination typical evaluation necessary emergency physician may proceed modified epley maneuver described see video epley maneuver example left posterior semicircular canal treated clip maneuvers performed quickly real patient position held least 30 seconds resolution nystagmus vertigo history physical examination findings atypical consider causes positional vertigo may occur tumor infarcts posterior fossa contraindications performing epley maneuver include ongoing cns disease ie stroke transient ischemic attack information diagnosis treatment guidelines recommendations available american academy neurology american academy otolaryngologyhead neck surgery foundation goal epley maneuver move otoliths posterior semicircular canal back utricle belong success rate epley maneuver approximately 80 fails authors experience either incorrectly applied patients vestibular neuritis labyrinthitis patient raised hisher head high 3 rd epley maneuver general guidelines head must dependent headhanging position maneuver work patient tolerate position put gurney trendelenburg position simulate headhanging position maintain position symptoms nystagmus disappeared least 30 seconds patient cannot tolerate maneuver vomiting severity vertigo premedicate vestibular sedative 4 mg iv ondansetron zofran epley maneuver steps patient sit upright gurney head turned 45° affected side recall affected side predetermined using hallpike test make sure patient sitting far enough back gurney head hang edge gurney patient laid back make sure guardrail opposite side lowered patient eventually sit legs overhang edge gurney see image epley maneuver move patient back gurney lies head epley maneuver move patient back gurney lies head hang edge gurney emphasize patient keep eyes open position nystagmus observed lower guardrails gurney opposite side patients head turned place hands either side patients head guide patient head dependent hallpike test see image epley maneuver turn patients head 45° side prominent symptoms epley maneuver turn patients head 45° side prominent symptoms hallpike test example patients head turned 45° left hands holding patients head gently lay patient supine position head hanging edge bed note maneuver need performed rapidly epley maneuver positional positioning rotate head 90° opposite side patients face upward sure maintain headdependent position head hanging edge gurney ask patient roll onto side holding head position rotate head facing downward tell patient look ground see images epley maneuver ask patient turn onto shoulder epley maneuver ask patient turn onto shoulder epley maneuver guide patients head looking ground epley maneuver guide patients head looking ground wait least 30 seconds raise patient sitting position maintaining head rotation author finds sitting patient sitting legs hanging edge gurney easier side guardrails need lowered procedure started see images epley maneuver patients head needs regripped patient needs sit epley maneuver patients head needs regripped patient needs sit legs hanging side gurney guardrails need lowered start procedure epley maneuver patient sitting upright epley maneuver patient sitting upright simultaneously rotate head central position move 45° forward semont maneuver liberatory maneuver maneuver primarily used europe although used treat classic posterior canal bpv united states usually reserved treat cupulolithiasis form bpv otoliths freefloating instead attached cupula posterior semicircular canal somewhat violent nature fact patients bpv elderly author advocate use includes complete sidelying test patient sits edge gurney head turned opposite involved side patient brought rapidly onto side serves dislodge otoliths cupula patient rapidly brought side maintaining head position patients face facing gurney patient brought original sitting position see video semont maneuver generally reserved cupulolithiasis form benign positional vertigo otoliths attached cupula semicircular canal maneuver performed rapidly effective recommended elderly persons example right posterior semicircular canal treated consultations neurologic consultation indicated cases positional vertigo nystagmus satisfy criteria bpv example downbeat fast phase beating towards feet nystagmus likely indicate central cause vertigo opposed peripheral vertigo caused anterior semicircular canal involvement latter extremely rare medication medication summary medical treatment benign positional vertigo bpv generally ineffective may used lessen symptoms use vestibular suppressants based sensory conflict theory sensory input compared different systems conflict exists vertigo nausea vomiting result time habituation occurs several main neurotransmitters mediate functions gaba acetylcholine histamineserotonin antiemetic agents class summary antihistaminic antiemetics block emetic response patients severe vertigo vomiting intravenous promethazine phenergan used drug choice however medication recently received black box warning fda recommended given intramuscularly prochlorperazine compazine alternative antiemetic meclizine given orally work fast enough effective acutely antiemetics anticholinergic activity well promethazine phenergan anergan prorex antidopaminergic agent used treat emesis blocks postsynaptic mesolimbic dopaminergic receptors brain reduces stimuli brainstem reticular system also cross reactivity cholinergic receptors meclizine antivert antrizine dramamine decreases excitability middle ear labyrinth blocks conduction middle ear vestibularcerebellar pathways effects associated relief nausea vomiting scopolamine isopto scopace tablet blocks action acetylcholine parasympathetic sites smooth muscle secretory glands cns antagonizes histamine serotonin action transdermal scopolamine may effective agent motion sickness use treatment bpv limited slow onset action dimenhydrinate dimetabs dramamine mixture 11 salt consisting 8chlorotheophylline diphenhydramine believed useful particularly treatment vertigo diminishes vestibular stimulation depresses labyrinthine function central anticholinergic effects however prolonged treatment may decrease rate recovery vestibular injuries antiemetics selective 5ht3 antagonist class summary agents option treating emesis associated bpv may administered iv im orally including orally disintegrating tablet oral soluble film ondansetron zofran zofran odt zuplenz ondansetron selective 5ht3 receptor antagonist binds 5ht3 receptors periphery cns primary effects gi tract effect dopamine receptors therefore cause extrapyramidal symptoms benzodiazepines class summary agents block gaba receptors serve brakes system although used acutely ed recommended longterm use interfere process vestibular rehabilitation lorazepam ativan sedative hypnotic benzodiazepine class short time onset relatively long halflife depresses levels cns including limbic reticular formation probably increased action gaba major inhibitory neurotransmitter followup outpatient care head exercise therapy positional exercises brandt daroff promotes central accommodation may helpful bpv although patients difficulty tolerating maneuvers patient perform following therapy sit edge bed near middle legs hanging turn head 45° right side quickly lie left side head still turned touch bed portion head behind ear maintain position every subsequent position 30 seconds sit quickly lie right side turning head 45° toward left side sit 610 repetitions 3 times per day patient becomes confused direction turn head tell patient nose always point toward ceiling inpatient care patients persistent vomiting intractable vertigo may require admission hydration vestibular suppressant medication surgical elimination posterior canal function restricted rare cases longstanding refractory benign positional vertigo bpv inpatient outpatient medications meclizine common outpatient medication medication indicated vertigo given categories dizziness nearsyncope dysequilibrium lightheadedness deterrenceprevention avoid provocative movements limit activities complications complications eg neck injury vertebral dissection vomiting reported use epley maneuver prognosis benign positional vertigo bpv tends resolve spontaneously several days weeks italian researcher removed otoliths animal placed petri dish full endolymph noted otoliths dissolved approximately 100 hours patients may experience recurrences months years later otoliths got variants range single shortlived episode decades vertigo short remissions study kim et al assessed patients discharged home ed diagnosis isolated dizziness vertigo determined stroke occurs less 1 500 patients within first month patient education see list excellent patient education resources visit emedicines brain nervous system center benign positional vertigo start media anatomy semicircular canals anatomy semicircular canals epley maneuver move patient back gurney lies head epley maneuver move patient back gurney lies head hang edge gurney emphasize patient keep eyes open position nystagmus observed lower guardrails gurney opposite side patients head turned epley maneuver turn patients head 45° side prominent symptoms epley maneuver turn patients head 45° side prominent symptoms hallpike test example patients head turned 45° left hands holding patients head gently lay patient supine position head hanging edge bed note maneuver need performed rapidly epley maneuver positional positioning epley maneuver patients head 45° hanging edge bed observe epley maneuver patients head 45° hanging edge bed observe patients eyes look torsional nystagmus keep patient position least 30 seconds nystagmus symptoms resolve epley maneuver patients head turned 90° direction epley maneuver patients head turned 90° direction physician needs move head gurney regrip patients head fingers pointing toward patients feet epley maneuver turn patients head 90° opposite direction case patient epley maneuver turn patients head 90° opposite direction case patients head facing right observe nystagmus hold position least 30 seconds nystagmus symptoms resolve epley maneuver closeup view step shown media file 6 epley maneuver closeup view step shown media file 6 epley maneuver ask patient turn onto shoulder epley maneuver ask patient turn onto shoulder epley maneuver guide patients head looking ground epley maneuver guide patients head looking ground wait least 30 seconds epley maneuver closeup view shown media file 9 epley maneuver closeup view shown media file 9 epley maneuver patients head needs regripped patient needs sit epley maneuver patients head needs regripped patient needs sit legs hanging side gurney guardrails need lowered start procedure epley maneuver patient sitting upright epley maneuver patient sitting upright epley maneuver move patients head slightly forward completes epley maneuver epley maneuver move patients head slightly forward completes epley maneuver maneuver may performed multiple times hallpike test example right posterior semicircular canal tested note head extends edge gurney thumb used help keep eyelids open since noting direction nystagmus important epley maneuver example left posterior semicircular canal treated clip maneuvers performed quickly real patient position held least 30 seconds resolution nystagmus vertigo semont maneuver generally reserved cupulolithiasis form benign positional vertigo otoliths attached cupula semicircular canal maneuver performed rapidly effective recommended elderly persons example right posterior semicircular canal treated barbque maneuver maneuver used treat horizontal canal benign positional vertigo example right horizontal canal treated position held least 2030 seconds author andrew k chang md associate professor department emergency medicine albert einstein college medicine montefiore medical center andrew k chang md member following medical societies american academy emergency medicine american academy neurology american college emergency physicians society academic emergency medicine disclosure nothing disclose pharmacy editor francisco talavera pharmd phd adjunct assistant professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure received salary medscape employment medscape managing editor j stephen huff md facep professor emergency medicine neurology department emergency medicine university virginia school medicine j stephen huff md facep member following medical societies american academy neurology american college emergency physicians society academic emergency medicine disclosure nothing disclose chief editor robert e oconnor md mph professor chair department emergency medicine university virginia health system robert e oconnor md mph member following medical societies american academy emergency medicine american college emergency physicians american association physician leadership american heart association medical society delaware society academic emergency medicine wilderness medical society american medical association national association ems physicians disclosure nothing disclose additional contributors edward bessman md mba chairman clinical director department emergency medicine john hopkins bayview medical center assistant professor department emergency medicine johns hopkins university school medicine edward bessman md mba member following medical societies american academy emergency medicine american college emergency physicians society academic emergency medicine disclosure nothing disclose froehling da silverstein md mohr dn beatty cw offord kp ballard dj benign positional vertigo incidence prognosis populationbased study olmsted county minnesota mayo clin proc medline guideline bhattacharyya n baugh rf orvidas l barrs bronston lj cass et al clinical practice guideline benign paroxysmal positional vertigo otolaryngol head neck surg medline full text furman jm cass sp benign paroxysmal positional vertigo n engl j med medline hilton mp pinder dk epley canalith repositioning manoeuvre benign paroxysmal positional vertigo cochrane database syst rev medline guideline fife td iverson dj lempert furman jm baloh rw tusa rj et al practice parameter therapies benign paroxysmal positional vertigo evidencebased review report quality standards subcommittee american academy neurology neurology medline full text epley jm particle repositioning benign paroxysmal positional vertigo otolaryngol clin north medline kim fullerton hj johnston sc risk vascular events emergency department patients discharged home diagnosis dizziness vertigo ann emerg med medline baloh rw dizziness vertigo samuels feske office practice neurology brandt daroff rb physical therapy benign paroxysmal positional vertigo arch otolaryngol medline chang ak schoeman g hill randomized clinical trial assess efficacy epley maneuver treatment acute benign positional vertigo acad emerg med medline froehling da bowen jm mohr dn et al canalith repositioning procedure treatment benign paroxysmal positional vertigo randomized controlled trial mayo clin proc medline kim js zee ds clinical practice benign paroxysmal positional vertigo n engl j med medline lempert gresty bronstein benign positional vertigo recognition treatment bmj medline marill ka walsh mj nelson bk intravenous lorazepam versus dimenhydrinate treatment vertigo emergency department randomized clinical trial ann emerg med medline massoud ea ireland dj posttreatment instructions nonsurgical management benign paroxysmal positional vertigo j otolaryngol medline troost bt patton jm exercise therapy positional vertigo neurology medline

Article 26:
cleft lip palate mouth pharynx deformities cleft lip palate mouth pharynx deformities overview embryology cleft lip palate classification cleft lip palate cleft lip palate mouth pharynx deformities overview embryology cleft lip palate classification cleft lip palate overview overview embryology cleft lip palate classification cleft lip palate functional anatomy cleft lip palate management cleft lip palate velopharyngeal insufficiency selected mouth pharynx deformities cleft lip palate mouth pharynx deformities overview 837347overview apr 17 2015 201508041847 1 otolaryngology facial plastic surgery 2002 procedures procedure 1 2 content 837347 503 6000001 48 ssg jun 04 2015 procedure procedures otolaryngology otolaryngology facial plastic surgery otolaryngologycongenital congenital malformations head neck cleft lip cleft palate congenital mouth malformations pharynx malformations cleft palate repair cleft lip repair mouth pharynx congenital malformations mouth deformities cleft lip palate velopharyngeal insufficiency vpi robin sequence macroglossia ankyloglossia epignathus lingual thyroid lip pits commissural lip pits van der woude syndrome micrognathia article primarily reviews cleft lip palate clp issues directly related anomalies including secondary deformities velopharyngeal insufficiency vpi cleft lip palate deformity distinguished isolated cleft palate cp basis epidemiologic embryonic genetic factors 0 cleft lip palate mouth pharynx deformities overview article primarily reviews cleft lip palate clp issues directly related anomalies including secondary deformities velopharyngeal insufficiency scope field precludes indepth discussion surgical techniques controversies miscellaneous deformities robin sequence macroglossia ankyloglossia epignathus briefly highlighted image depicts embryonic formation primary palate illustration depicts fusion lateral nasal medial nasal maxillary prominences illustration depicts fusion lateral nasal medial nasal maxillary prominences form primary palate two thirds cases clefting involve lip without involvement palate whereas one third cases occur isolated deformity palate males predominate within cleft lip palate clp group 6080 cases whereas females constitute majority within cleft palate cp group cleft lip palate deformity strongly associated bilateral cleft lips cls 86 cases association decreases 68 unilateral cleft lip left side commonly involved unilateral cleft lip cases interracial differences exist incidence cleft lip palate versus cleft palate mean incidence cleft lip palate 21 cases per 1000 live births among asians 1 case per 1000 live births among white people 041 cases per 1000 live births among black people high incidence cleft lip palate seen north american populations asian descent indians southwestern united states west coast canada incidence isolated cleft palate constant among 3 racial groups 05 cases per 1000 live births incidence cleft lip palate also rises increased parental age older mothers additional parity increased incidence children cleft palate relatives children cleft lip palate incidence cleft lip palate significantly increased however isolated cleft palate anomaly occurs frequency general population relatives children isolated cleft palate also higher risk anomaly without increased risk cleft lip palate deformity overall 5 patients cleft lip palate isolated cleft palate identifiable syndromes associated syndromes common among patients isolated cleft palate among others following image depicts normal palate anatomy normal anatomy palate normal anatomy palate go cleft lip bilateral cleft lip repair cleft palate repair unilateral cleft lip repair embryology cleft lip palate overall development palate involves formation primary palate followed formation secondary palateat approximately 3037 days gestational age ga primary palate forms growth fusion medial nasal lateral nasal maxillary processes see image maxillary process derived proximal half first arch grows meet fuse nasal processes grown moved association olfactory placode general opinion holds mesodermal penetration underlies formation primary palate mesodermal reinforcement along lines fusion important epithelial breakdown clefting thought result lack reinforcement illustration depicts fusion lateral nasal medial nasal maxillary prominences illustration depicts fusion lateral nasal medial nasal maxillary prominences form primary palate secondary palate arises 2 palatal shelves initially vertical position interposed tongue extension head 7 weeks ga mandibular growth tongue withdrawn palatal shelves swing horizontal midline position fusion formation hard soft palate see following image cleft hard palate soft palate thought occur intervening tongue impedes elevation palatal shelves formation secondary palate formation secondary palate classification cleft lip palate various classification schemes devised last 70 years cleft lip palate received widespread clinical acceptance four accepted schemes highlighted davis ritchie classification davis ritchie classification divides cleft lip palate 2 groups subdivided extent cleft eg 13 12 follows group clefts anterior alveolus unilateral median bilateral cleft lip group ii postalveolar clefts cleft palate alone soft palate alone soft palate hard palate submucous cleft veau classification veau classification system divides cleft lip palate 4 groups follows illustrated image group – defects soft palate group ii – defects involving hard palate soft palate group iii – defects involving soft palate alveolus usually involving lip group iv – complete bilateral clefts veau classification cleft lip palate group defects soft palate b veau classification cleft lip palate group defects soft palate b group ii defects involving hard palate soft palate c group iii defects involving soft palate alveolus usually involving lip group iv complete bilateral clefts kernahan stark symbolic classification kernahan stark classification highlights anatomic embryonic importance incisive foramen formed weeks 47 gestational age ga secondary palate forms roof mouth incisive foramen uvula weeks 712 ga see image formation secondary palate formation secondary palate system provides graphic classification scheme using yconfiguration divided 9 areas follows see also image areas 1 4 – lip areas 2 5 – alveolus areas 3 6 – palate alveolus incisive foramen areas 7 8 – hard palate area 9 – soft palate kernahan stark symbolic classification cleft lip palate r right l left kernahan stark symbolic classification cleft lip palate r right l left international confederation plastic reconstructive surgery classification international confederation plastic reconstructive surgery classification system uses embryonic framework divide clefts 3 groups subdivisions denote unilateral bilateral cases follows group – defects lip alveolus group ii – clefts secondary palate hard palate soft palate group iii – combination clefts involving primary secondary palates koul introduced method documenting types cleft lip cleft palate data storage communication functional anatomy cleft lip palate comprehension anatomic deformities central understanding principles surgical repair following section briefly describes anatomic abnormalities patient cleft lip palate clp discussing muscular neurovascular structural nasal deformities failure muscles meet counterparts embryonic development leads functional abnormalities clefts lip palate cleft lip orbicularis oris muscle primary muscle lip divided functionally anatomically 2 parts see image muscular defects unilateral deformity muscular defects unilateral deformity complete cleft lip cl deep fibers orbicularis oris muscle interrupted cleft end either side defect instead making way around mouth addition superficial component orbicularis oris turns upward along margins cleft ends beneath ala columella incomplete cleft lip behaves similar manner except cleft less two thirds height lip blood vessels parallel course muscle fibers run along margins cleft toward columella alar base form anastomoses nearby vessels bilateral deformity anatomic characteristics determined degree completeness cleft symmetry cleft may involve primary palate alone conjunction secondary palate although prolabium varies size usually retracted lacks muscle fibers addition columella absent prolabium appears attached top nose cases size position premaxilla vary effectively excluded collapse alveolar arch extent nasal deformity associated cleft lip varies patient patient although characteristic appearance following features deflection nasal tip towards noncleft side retroplacement cleft alar cartilage dome obtuse angle medial lateral crura lower lateral cartilage cleft side buckling ala cleft side absence alarfacial groove cleft side attachment ala face obtuse angle apparent real bony deficiency maxilla cleft side larger nares cleft side shorter columella cleft side positioning entire columella slant toward noncleft side inferior displacement medial crus within columella dislocation caudal portion septum noncleft side nasal spine downward rotation alar cartilage cleft side bilateral deformity nasal tip appears large flat bifid alae rotated downward spread apart cleft palate incisive foramen key landmark bony palate see image premaxilla lies anterior incisive foramen includes 2 premaxillary bones alveolus incisors normal anatomy palate normal anatomy palate softtissue structures primary palate include nasal tip upper central lip size composition configuration premaxilla vary full development complement teeth 4 primary 4 secondary underdevelopment 2 incisors premaxilla unrestrained intrauterine neonatal period protrude arch maxillary arches may collapse potentially exclude premaxilla arch posterior incisive foramen lies secondary palate comprising hard palate soft palate hard palate forms palatine processes maxilla anteriorly palatine bones posteriorly posterior bony hard palate lies soft palate soft palate plays important role speech swallowing paired muscle sides midline see following image form musculature soft palate levator veli palatini important muscle production speech velopharyngeal competence paired muscles soft palate function sling origin undersurface temporal bone aponeurosis across midline elevate soft palate toward posterior pharyngeal wall palatopharyngeus supplements posterior movement soft palate contraction superior pharyngeal constrictor contributes closure velopharyngeal opening lateral posterior pharyngeal wall primary function tensor veli palatini dilate eustachian tube maintain integrity uvular muscle thought minimal contribution normal speech muscles soft palate muscles soft palate clefts palate cps associated bony well softtissue abnormalities clefts secondary palate may isolated associated clefts primary palate although clefts secondary palate midline defects see image involving primary palate usually asymmetric vomer attached noncleft side dental arch noncleft side usually splays outward due lack restraining force lip palate foreshortened anteroposterior direction case complete bilateral clefts entire premaxilla protrudes adjacent alveolar ridges collapse palatine shelves posterior premaxilla possible rotation premaxilla prevented rejoining arch left attached solely vomer variations cleft palate variations cleft palate softtissue defects cleft palate include hypoplasia velar musculature addition anomalous insertions muscular components see following image normal midline insertion transverse orientation levator palatini substituted aberrant longitudinal orientation insertion along bony cleft margin posterior palatine bones palatal muscles affected similarly dysfunction results speech pathology velopharyngeal incompetence eustachiantube obstruction resultant middleear effusion infections possible hearing loss underlying defect musculature cleft palate underlying defect musculature cleft palate using conebeam computed tomography ct scanning study celikoglu et al found least one maxillary dental anomaly 50 patients nonsyndromic cleft lip palate tooth agenesis frequent study 22 28 patients bilateral unilateral cleft lip palate respectively found tooth agenesis 864 bilateral patients 925 unilateral patients unilateral group incidence tooth agenesis canine impaction greater cleft side mouth normal side study datana et al indicated prevalence upper cervical vertebrae anomalies three times greater persons cleft lippalate without condition prevalence 203 cleft group overall compared 64 control group patients unilateral cleft lip palate prevalence 222 bilateral cleft lip palate prevalence 191 patients cleft palate prevalence upper cervical vertebrae anomalies 166 study involved 128 patients cleft lippalate 125 controls management cleft lip palate neonatal management unilateral bilateral cleft lip repair presurgical orthodontics cleft palate repair discussed section neonatal management minority patients particularly robin sequence see robin sequence selected mouth pharynx deformities present respiratory distress securing airway priority patients however feeding difficulty primary problem patients cleft lip palate clp although patients normal sucking swallowing reflexes difficulty generating enough negative pressure nurse adequately result babys nutrition must delivered bottle feeding via nipples large openings facilitate delivery breast milk formula multidisciplinary approach required assist patients families comprehensive care children responsibility care shared team pediatricians plastic surgeons otolaryngologists pedodontists orthodontists nurses speech therapists audiologists social workers unilateral cleft lip repair repair unilateral cleft lip cl usually performed first year life although surgeons advocate immediate repair follow “rules 10” hemoglobin 10 g age older 10 weeks weight 10 lb patients satisfy criteria better tolerate general anesthesia discussion merits individual surgical procedures correction cleft lip cl beyond scope review contemporary procedures use local tissue flaps reconstruction closure congenital anomaly interested readers urged refer surgical atlases following cleft lip unilateral cleft lip repair presurgical orthodontics presurgical orthodontics facilitate repositioning palatal segments normal alignment use appliance bilateral cleft lip repair bilateral cleft lip deformity unique management postoperative results affected status premaxillary segment degree symmetry completeness deformity goals surgical correction bilateral cleft lip include correction cleft lip cl nasal deformity addition establishment normal relationship premaxilla alveolar arches presurgical orthodontics used realign maxillary arch premaxilla minimize tension placed lip closure elkassaby et al 2013 published retrospective comparative study nonsyndromic patients complete bilateral cleft lip palate discussion surgical procedures used repair bilateral cleft lip please refer plastic surgery texts following cleft lip bilateral cleft lip repair cleft palate repair goals cleft palate cp repair include closure palatal defect attainment normal speech hearing dental occlusion facial palatal growth timing surgical correction remains controversial factors considered repair must take account known postulated affects facial growth speech development trauma sustained surgical intervention thought play role underdevelopment midface persistence cleft deformity per se believed affect normal craniofacial growth patients cleft deformities left surgically uncorrected observed normal maxillary growth development speech somewhat independent craniofacial growth vocalization begins birth well known addition intact speech mechanism required ensure correct neural programming needed integration musculature involved speech occurs process thought transpire within first year life established compensatory speech patterns difficult change common opinion maintains although early palatal repair associated superior speech hearing negative effects facial growth operative intervention younger age also technically challenging small size structures limitations instruments centers north america perform palatal closure age 1218 months patients age group larger anatomy facilitates surgical intervention addition common belief asserts normal speech development impeded age surgical repair cleft palate falls 2 categories first singlestage repair involving closure mucoperiosteal flaps second involves multistage approach soft palate closed initially followed delayed closure hard palate 2008 retrospective study khosla et al concluded furlow zplasty yielded excellent speech results primary cleft palate repair minimal acceptable rates fistula formation velopharyngeal insufficiency need additional corrective surgery distraction osteogenesis information regarding cleft palate repair see cleft palate repair velopharyngeal insufficiency competent velopharyngeal mechanism required normal speech velopharyngeal sphincter functions concert mouth larynx speech production palate separates nasal cavity vocal tract forms part velopharyngeal sphincter closure sphincter accomplished movement soft palate tension elevation well lateral posterior movement posterior pharyngeal wall velopharyngeal insufficiency vpi results inability completely close velopharyngeal sphincter velopharyngeal insufficiency characterized hypernasality nasal emission adaptive changes articulations pharyngeal fricatives sound substitution glottal stops goal palatal repair restore accurate phonation functional anatomy techniques palatal repair result 2030 incidence velopharyngeal insufficiency diagnosis child found velopharyngeal insufficiency based speech derangement additional quantitative dynamic measurements required pressure airflow measurements oral nasal generally used screening tools provide details sphincter function order compare nasendoscopy ne multiview fluoroscopy mvf assessment velopharyngeal gap size determine relationship assessments velopharyngeal insufficiency severity lam et al demonstrated ne mvf assessments provide complementary information correlated radiologic methods assessment include softtissue radiography videofluoroscopy radiography provides 2dimensional 2d image relationship soft palate posterior pharyngeal wall dynamic technique conversely videofluoroscopy provides dynamic information regarding sphincter mechanism flexible rigid endoscopy also used assess velopharyngeal insufficiency advantage endoscopy allows direct observation sphincter function vpi surgically corrected use pharyngeal flaps yang et al 2013 published retrospective review 503 patients p p leclerc et al 2013 published anatomical measurements cleft palate predict occurrence vpi palatal cleft repair selected mouth pharynx deformities robin sequence macroglossia ankyloglossia epignathus lingual thyroid conditions briefly discussed section robin sequence robin sequence includes cleft palate cp small mouth retrognathia retrognathism results functional abnormality tongue musculature manifests airway obstruction sleep tongue falls posteriorly addition respiratory difficulties feeding difficulties result failure thrive severity airway compromise dictates management mild cases conservative treatment consists placing patient prone position intensive monitoring surgery indicated improvement occurs 7 days surgery involves either tracheostomy repositioning tongue information see pierre robin syndrome macroglossia congenital macroglossia may secondary tumors eg dermoids muscular hypertrophy hyperplasia beckwithwiedemann syndrome hemihypertrophy vascular malformation common cause macroglossia lymphangiomas common vascular malformations tongue surgical biopsy relatively minor trauma patient lymphangioma result massive swelling difficulty closing mouth times airway compromise increased swelling occur superimposed lymphangitis early life conservative treatment recommended includes avoidance trauma prompt use antibiotics first sign infection surgery usually delayed child older 45 decrease likelihood postoperative airway problems macroglossia feature syndrome etiology believed reactive hypertrophy due muscular hypotonia combination macroglossia small oral cavity patients results glossoptosis partial glossectomy usually successful returning tongue oral cavity removing visible stigma mental retardation macroglossia also associated syndromes treacher collins mandibulofacial dysostosis franceschettizwahlenklein syndrome ankyloglossia ankyloglossia due presence frenulum tethering tip tongue floor mouth commonly used term describe ankyloglossia tonguetied surgical intervention indicated articulation problems feeding difficulties poor suckling dental problems spreading lower incisor teeth requests patients parents release may involve simple division involved band tissue zplasty lengthening procedure injury wharton duct avoided epignathus epignathi rare teratomas histologically contain tissue 3 germcell lines newborn epignathus patient intubated birth newborn epignathus patient intubated birth prenatal ultrasonography usually demonstrates mass protruding fetal face management involves emergently securing airway intubation formal tracheostomy magnetic resonance image mri computed tomography ct scan required surgical intervention rule encephalocele intracranial extension lesion extent mass adequately determined tumor excised oral cavity lingual thyroid lingual thyroid due undescended thyroid tongue base common symptoms include dysphagia dysphonia occasionally dyspnea thyroid ultrasonography replaced radioisotope thyroid scanning evaluation amount active thyroid tissue present management depends functional metabolic factors patient euthyroid observation careful followup advised suppressive thyroid hormone therapy initiated hypothyroid status develops lingual swelling increases surgical excision replacement therapy indicated conditions lip pits represent vestigial remnants lateral sulci mandible 75 125mm stage embryo van der woude syndrome autosomal dominant syndrome 90 penetrance lip pits paramedian usually bilateral vary depth millimeters 3 centimeters communication may exist minor salivary glands lower lip lip pits may also occur popliteal pterygium syndrome aganglionic megacolon cleft lip palate clp commissural lip pits occur frequently lip pits related syndromes described prevalence estimated 1 case per 300 white persons 1 case per 48 black persons micrognathia could associated numerous syndromes conditions adducted thumb atelosteogenesis types iii cerebrocostomandibular findings robin sequence aasesmith chitayatazouz chromosome 3 dup 3p chromosome 4 partial del 4p chromosome 7 term del 7q say shprintzen velocardiofacial syndromes discussion facial clefts see congenital malformations nose congenital malformations neck start media illustration depicts fusion lateral nasal medial nasal maxillary prominences illustration depicts fusion lateral nasal medial nasal maxillary prominences form primary palate formation secondary palate formation secondary palate veau classification cleft lip palate group defects soft palate b veau classification cleft lip palate group defects soft palate b group ii defects involving hard palate soft palate c group iii defects involving soft palate alveolus usually involving lip group iv complete bilateral clefts kernahan stark symbolic classification cleft lip palate r right l left kernahan stark symbolic classification cleft lip palate r right l left muscular defects unilateral deformity muscular defects unilateral deformity normal anatomy palate normal anatomy palate muscles soft palate muscles soft palate variations cleft palate variations cleft palate underlying defect musculature cleft palate underlying defect musculature cleft palate newborn epignathus patient intubated birth newborn epignathus patient intubated birth author ted l tewfik md professor otolaryngologyhead neck surgery professor pediatric surgery mcgill university faculty medicine senior staff montreal childrens hospital montreal general hospital royal victoria hospital ted l tewfik md member following medical societies american society pediatric otolaryngology canadian society otolaryngologyhead neck surgery disclosure nothing disclose coauthors naznin karsan md msc staff physician department otolaryngology mcgill university canada disclosure nothing disclose alyssa kanaan md fellow rhinology university pittsburgh medical center disclosure nothing disclose pharmacy editor francisco talavera pharmd phd adjunct assistant professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure received salary medscape employment medscape chief editor arlen meyers md mba professor otolaryngology dentistry engineering university colorado school medicine arlen meyers md mba member following medical societies american academy facial plastic reconstructive surgery american academy otolaryngologyhead neck surgery american head neck society disclosure served director officer partner employee advisor consultant trustee medvoytestappropriatecerescanempiricanrxrevubrreceived none allergy solutions inc board membership received honoraria rxrevu chief medical editor received salary medvoy founder president received consulting fee corvectra senior medical advisor received ownership interest cerescan consulting received consulting fee essiahealth advisor received consulting fee carespan advisor received consulting fee covidien consulting additional contributors michael j biavati md facs faap clinical assistant professor otolaryngology university texas southwestern medical center dallas southwestern medical school private practice ent care kids dallas tx michael j biavati md facs faap member following medical societies american academy otolaryngologyhead neck surgery american society pediatric otolaryngology society ear nose throat advances children american academy pediatrics american cleft palatecraniofacial association american college surgeons triological society texas medical association disclosure nothing disclose dionisopoulos williams hb congenital anomalies ear nose throat kernahan da striped ya symbolic classification cleft lip palate plast reconstr surg medline koul r describing cleft lip palate using new expression system cleft palate craniofac j medline fara musculature cleft lip palate mccarthy jg ed plastic surgery celikoglu buyuk sk sekerci ae et al maxillary dental anomalies patients cleft lip palate cone beam computed tomography study j clin pediatr dent medline datana bhalla kumar p et al comparative evaluation prevalence upper cervical vertebrae anomalies cleft lippalate patients retrospective study int j clin pediatr dent medline full text rutrick r black pw jurkiewicz mj bilateral cleft lip palate presurgical treatment ann plast surg medline elkassaby abdelrahman ni abbass premaxillary characteristics complete bilateral cleft lip palate predictor treatment outcome ann maxillofac surg medline full text brøndsted k liisberg wb orsted prytz foghandersen p surgical speech results following palatopharyngoplasty operations denmark 19591977 cleft palate j medline khosla rk mabry k castiglione cl clinical outcomes furlow zplasty primary cleft palate repair cleft palate craniofac j medline bevilacqua rg ritoli el kang c mabry k castiglione cl midmaxillary internal distraction osteogenesis ideal surgery mature cleft patient plast reconstr surg medline lam dj starr jr perkins ja lewis cw eblen le dunlap j et al comparison nasendoscopy multiview videofluoroscopy assessing velopharyngeal insufficiency otolaryngol head neck surg medline wójcicki p swidzinski p wójcicka g velopharyngeal incompentance treated pharyngeal flap orticochea pharyngoplastya comparison speech results otolaryngol pol medline yang li wu gu yin h long h et al velopharyngeal function patients cleft palate primary palatoplasty relevance sex age cleft type j craniofac surg medline leclerc je godbout gauthier ia lacour abel k mcconnell em predict post palatoplasty velopharyngeal insufficiency cleft palate patients laryngoscope medline vogel je mulliken jb kaban lb macroglossia review condition new classification plast reconstr surg medline pavlin je ogorman williams hb crépeau rj shapiro rs epignathus report two cases ann plast surg medline tonni g centini g inaudi p rosignoli l ginnaneschi c de felice c prenatal diagnosis severe epignathous twin case report review literature cleft palate craniofac j medline nora jj fraser fc bear j et al medical genetics principle practice

Article 27:
sleepdisordered breathing cpap sleepdisordered breathing cpap overview sleepdisordered breathing pathophysiology sdb etiology sdb sleepdisordered breathing cpap overview sleepdisordered breathing pathophysiology sdb etiology sdb overview overview sleepdisordered breathing pathophysiology sdb etiology sdb epidemiology sdb prognosis sdb clinical presentation sdb differential diagnosis sdb laboratory studies imaging studies epworth sleepiness scale polysomnography screening questionnaires home sleep testing ambulatory monitors acoustic snoring analysis histologic findings sleep endoscopy initial treatment sbd treatment nasal cpap oxygen pharmacologic treatments surgical management sdb outpatient care sleepdisordered breathing cpap overview 870192overview dec 17 2013 201508041853 1 clinical procedures 2002 procedures procedure 1 2 content 870192 503 3032210 13 ssg jun 04 2015 procedure procedures clinicalprocedures clinical procedures clinicalproceduresrespiratory lung respiratory sleepdisordered breathing sdb continuous positive airway pressure cpap ncpap apnea sleep apnea snoring obstructive sleep apnea osa sleep apnea snoring obstructive sleep apnea syndrome osas upper airway obstruction occurring sleep upper airway obstruction occurring sleep—that sleepdisordered breathing sdb—was first demonstrated 1960s sdb represents group physiopathologic conditions characterized abnormal respiratory pattern sleep isolated coexist respiratory nervous cardiovascular endo 0 sleepdisordered breathing cpap overview sleepdisordered breathing upper airway obstruction occurring sleep—that sleepdisordered breathing sdb—was first demonstrated 1960s sdb represents group physiopathologic conditions characterized abnormal respiratory pattern sleep isolated coexist respiratory nervous cardiovascular endocrine diseases sdb known widely prevalent general population responsible contributes numerous problems ranging fragmented sleep patterns hypertension traffic accidents sdb includes obstructive sleep apnea osa consists breathing cessations least 10 seconds occurring presence inspiratory efforts sleep central sleep apnea consists similar apneas instead take place absence inspiratory efforts obstructive sleep apnea syndrome osas potentially disabling condition characterized excessive daytime sleepiness risk factors sleep apnea include obesity increased neck circumference craniofacial abnormalities hypothyroidism acromegaly daytime consequences include excessive sleepiness also impaired cognitive performance disturbed moods reduced quality life excessive daytime sleepiness reported associated higher risk motor vehicle accidents work place injuries poor work performance general everyone sdb snores everyone snores sdb snoring absence sdb termed primary simple snoring however evidence indicates snoring one end clinical continuum opposite extreme severe osa health problems may associated even primary snoring upper airway resistance syndrome uars characterized snoring increased resistance upper airway resulting arousals sleep disturb sleep architecture point causing daytime somnolence distinct diagnostic criteria exist entity patients uars treated nasal continuous positive airway pressure ncpap treatment involves elimination contributing factors provision ncpap ncpap effective improving sleep quality reducing daytime sleepiness longterm treatment ncpap reduces mortality acute blood pressure elevation occurs sdb go obstructive sleep apnea pediatric sleep apnea snoring obstructive sleep apnea surgery obstructive sleep apnea home sleep monitoring snoring obstructive sleep apnea upper airway evaluation snoring obstructive sleep apnea oral appliances snoring obstructive sleep apnea physiologic approach patient education information see sleep disorders center snoring narcolepsy pathophysiology sdb factors decrease upper airway size patency sleep lead intermittent obstruction inspiration despite inspiratory effort obstruction sufficiently prolonged bloodoxygen levels drop patient arouses awakens arousals disrupt normal sleep architecture together oxygenation drops responsible severe accompaniments sleepdisordered breathing sdb including hypertension arrhythmias death factors affecting upper airway size patency include numerous anatomic variants abnormalities eg nasal obstruction retrognathia macroglossia obesity contributes sdb changing pharyngeal size shape fat storage neck may particularly associated risk sdb although subset patients sdb normal body weight many patients family history snoring sdb alcohol intake near bedtime cause worsen sdb reducing activity upper airway dilating muscles alcohol increases number duration apneic hypopneic events racial studies chromosomal mapping familial studies twin studies provided evidence possible link obstructive sleep apnea syndrome osas genetic factors genetic factors associated craniofacial structure body fat distribution neural control upper airway muscles likely interact produce osas phenotype although role specific genes influence development osas yet identified current researchers especially animal model suggest several genetic systems may important human leukocyte antigen hla–dqb10602 allele wellknown genetic risk factor narcolepsy described potential genetic factor influencing sleep physiology individuals diagnosed osas polymorphisms serotonin 5ht receptor gene alter transcription affecting number receptors serotoninergic system contributing osas etiology sdb important clinical risk factors sdb follows nasal obstruction craniofacial abnormalities mandibular retrognathia micrognathia narrowed tapered short maxillary arch overbite long soft palate modified mallampati grade iii iv macroglossia tonsillar hypertrophy neck circumference 17 inches men 16 inches women obesity problems contribute exacerbate sdb sedative alcohol use poor sleep hygiene small percentage patients sdb central rather obstructive sleep apnea central sleep apnea caused various neurologic disorders idiopathic epidemiology sdb epidemiological studies indicate sleep apnea common men women maletofemale ratio 23 1 sleep apnea occurs 4 men 2 women aged 3060 years retrospective study 830 patients obstructive sleep apnea syndrome osas reports maletofemale ratio mf increases gravity disease 221 mild osas 791 severe osas discrepancy lower prevalence obstructive sleep apnea osa greater frequency obesity smaller airway size women compared men suggests gender difference underlies condition men tend larger collapsible airway mandibular movement women part may play role positional dependency severity osa men another possible reason lower prevalence osas may reluctance part many women report symptoms mostly considered inappropriate like snoring reluctance may cause clinical underestimation problem females genderrelated protective effect decreases females postmenopausal hormone replacement therapy association age obstructive sleep apnea complex several studies shown higher prevalence osa elderly persons middleaged persons although daytime symptoms may less common advancing age sleep heart health study demonstrated influence male sex body mass index bmi obstructive sleep apnea tends wane age unclear reasons overall prevalence obstructive sleep apnea plateaus age 65 years prevalence osas among africanamerican persons seems least equal possibly greater among white persons prevalence among men urban india men women korea similar observed western countries researchers noticed increased incidence osa persons asian origin prognosis sdb excessive daytime sleepiness resulting sdb impact focus concentration causing decreased work effectiveness even mildtomoderate sdb increases reaction time causing performance decreases similar alcohol intoxication lead motor vehicle accidents serious accidents situations alertness required safety eg heavy machinery operators moderatetosevere obstructive sleep apnea osa associated earlier death cardiovascular sequelae untreated osa include hypertension cor pulmonale arrhythmias increased risk myocardial infarction stroke osa associated difficulttocontrol hypertension recent studies examined relationship osa glucose tolerance many shown direct independent relationship osa diabetes wisconsin sleep study cohort showed greater prevalence diabetes subjects increasing levels osa probable mechanisms connecting osa glucose tolerance type 2 diabetes mellitus includes increased sympathetic activity sympathovagal dysfunction alterations neuroendocrine function especially growth hormone gh cortisol levels high inflammatory state increase release proinflammatory cytokines clinical presentation sdb patient history first clue history patients sdb loud snoring accompanied breathing cessation gasping choking snorting frequent arousals sleep respiratory effort air nocturnal arrhythmias acute blood pressure increases may occur morning headaches dissipate day goes excessive daytime sleepiness poor concentration affect daytime performance disorder linked increased risk angina myocardial ischemia stroke motor vehicle crashes older men may report getting numerous times night urinate convinced awaken urge urinate truth often reverse awaken result sdb notice urge urinate patients often surprised decreased need nocturnal urination successful sdb treatment laryngopharyngeal reflux cause patient suddenly awaken sleep gasping breath feeling terror often present inadequate sleep time cause excessive daytime sleepiness may involuntary insomnia voluntary insomnia characterized inability fall asleep awakening night unable fall back sleep inadequate sleep time occurs voluntary reasons eg working one job family responsibilities patients hypothyroidism also present fatigue daytime somnolence obesity narcolepsy also cause excessive daytime sleepiness physical examination patients sdb overweight obese patient short thick neck may predisposed sdb scalloped indentations along lateral tongue teeth marker relative tonguemandibular arch size mismatch may predispose individuals sdb children obstructive sleep apnea syndrome osas likely present normal body weight tonsillar hypertrophy inattentiveness school classes complications adequately diagnosed treated osas associated severe complications hypertension strokes coronary disease neurobehavioral complaints probably predictor premature death least 50 patients heart failure sleep respiratory apneas patients moderatetosevere osas 3fold increased risk developing hypertension differential diagnosis sdb differential diagnosis sdb includes following simple snoring central sleep apnea disorders cause daytime sleepiness eg insufficient sleep circadianrhythm abnormality narcolepsy periodic limb movement disorder laboratory studies relation snoring obstructive sleep apnea hypothyroidism confirmed many authors thyroidstimulating hormone tsh levels determined patients newly diagnosed sdb sdb relatively common among patients hypothyroidism significant increases homocysteine levels observed obstructive sleep apnea syndrome osas patients cardiovascular disease imaging studies radiologic diagnostic studies used identify obstruction site direct surgical intervention predict outcomes sleep apnea surgery studies include lateral cephalometric radiographs computed tomography ct magnetic resonance imaging mri asleep fluoroscopy asleep awake endoscopy mueller maneuver upper airway manometry acoustic reflection techniques techniques limitations dynamic tridimensional evaluation mechanism occlusion investigation ultrafast mri provides reliable noninvasive method static dynamic evaluation soft tissue structures surrounding upper airway respiratory cycle wakefulness sleep epworth sleepiness scale epworth sleepiness scale questionnaire filled patient used provide standardized semiquantitative subjective assessment daytime sleepiness questionnaire patients instructed rate chance dozing number different situations choose appropriate ranking situations working would probably respond something actually done recently scoring epworth sleepiness scale shown table table 1 epworth sleepiness scale questionnaire scoring 0 would never doze 1 slight chance dozing 2 moderate chance dozing 3 high chance dozing score situation sitting reading watching tv sitting inactive public place eg theater meeting passenger car hour without break lying rest afternoon circumstances permit sitting talking someone sitting quietly lunch without alcohol car stopped minutes traffic total total score 05 supernormal 510 normal 1015 sleepy 1520 sleepy 20 dangerously sleepy arrange transportation patient polysomnography polysomnography psg criterion standard diagnostic test obstructive sleep apnea syndrome osas respiratory event suggestive osas defined decrease nasal oral airflow alone thoracoabdominal movements 90 apnea 50 less 90 hypopnea lasted least 10 seconds decrease arterial oxygen saturation 4 considered significant oxygen desaturation information psg reported form respiratory disturbance index rdi also referred apneahypopnea index ahi rdi number apneas hypopneas 10 seconds longer occurring per hour sleep normal rdi less 5 rdi less equal 5 considered suggestive simple snoring osas greater 5 less equal 15 suggestive mild osas 15 less equal 30 suggestive moderate osas finally 30 suggestive severe osas loudness persistence snoring constant versus intermittent usually reported body position also recorded one determine position usually supine sleep phase usually rapid eye movement rem sleep muscle tone relaxed patient respiratory events occur inlaboratory psg criterion standard diagnosing osas however psg several limitations including necessity performing test sleep laboratory high costs considerable technical expertise required long analyzing time needed operator addition examination often needs repeated interference monitoring electrodes physiological sleep patient “first night effect” therefore timely access psg often problem screening questionnaires psg expensive widely available extensive interest alternative diagnostic approaches clinical prediction rules portable monitors expressed limited number questionnaires available detect sleep disorders instruments achieve reliability psg remains recommended method assessing patients suspected sleep disorders role questionnaires mainly screening tool identifying patients risk osas many questionnaires developed screening osas rome questionnaire rq 7item questionnaire useful identifying adult patients risk obstructive sleep apnea syndrome rq together bmi reported useful tool select patients higher risk moderatesevere osas need prompt psg evaluation home sleep testing ambulatory monitors home sleep testing pursues goal simplify diagnosis sleep apnea retaining essential recording features psg recent studies suggested home sleep studies benefits terms time cost diagnostic reliability inlaboratory sleep study may required half cases various types ambulatory used home monitors measure parameters airflow chest abdomen movements indicators respiratory effort oxygen desaturations snoring pulse body position although data studies detailed accurate overnight psg studies often used differentiate primary snoring snoring apneas usually provide indication frequency apneas occurring contrast techniques measure one parameter eg home oximetry alone seem less accurate track several measurements edentrace portable monitor measures nasal oral air flow using thermistors chest wall impedance oxygen saturation finger pulse oximetry heart rate movement detected electrical comparison signals electrocardiography pulse oximetry mesam iv system evaluates sdb based analysis snoring heart rate saturation change even many studies good agreement rdi measured laboratory home sleep testing risk ambulatory diagnostic procedures may alter relationship patients disease andor medical staff subsequent compliance treatment may decreased nightwatch system ability calculate rdi records eye movement 1 channel piezo electrode leg movement 1 channel piezo electrode finger pulse oximeter nasal oral airflow thermistor chest abdominal movements piezo electrodes body position movement mercury gauge placed chest heart rate nightwatch system also ability send 2minute portions complete recording laboratory analysis signal quality assessed transducer function corrected needed however studies necessary technology put widespread use order develop simpler cheaper accessible method diagnosis osas peripheral arterial tonometer pat proposed new method ambulatory diagnosis osas portable monitoring device watchpat 200 detects obstructive events identifying changes sympathetic activity associated termination events wristworn device watchpat 200 compared standard polysomnography psg reported able detect osas based apneahypopnea index ahi comparable accuracy acoustic snoring analysis acoustic analysis snoring sounds may help differentiate primary snoring obstructive sleep apnea osa researchers investigated combination clinical variables neck chest circumference bmi resting room air oxygen saturation however none shown differentiate consistently primary snorers patients significant apneas desaturations sleep histologic findings histology soft palate uvula snorers patients obstructive sleep apnea syndrome osas investigated many authors authors observed similar contents glands muscle fat blood vessels epithelium uvula soft palate either osas control subjects sleep endoscopy druginduced sleep endoscopy dise safe reliable technique determine pattern upper airway obstruction contribution specific structures airway obstruction identifying site dynamic pattern obstruction mandatory therapeutical decisionmaking particular surgical therapy option taken consideration nose oropharynx hypopharynx larynx nohl classification could applied awake sleep endoscopy allows simple quick effective evaluation grade patterns upper airway collapse initial treatment sbd eliminating contributing factors first task treating patients sdb eliminate possible contributing factors includes weight loss patients obese elimination alcohol sedative use especially near bedtime benzodiazepines narcotics barbiturates worsen sdb sometimes initiate previously present 10 weight loss associated 26 decrease ahi rdi populationbased study weight loss recommended obese patients sleep apnea however weight loss takes time minority patients successfully maintains body positioning sleep body positioning sleep improve sdb patients lying supine allow gravity assist pulling lax tongue muscles back toward posterior pharyngeal wall patients sleep sides stomachs propped 60° positions improve sdb patients whose symptoms occur primarily supine avoidance supine sleeping easily accomplished sock tennis ball safety pins tennis ball sock pinned back pajamas positioning tennis ball scapulae patient rolls supine position sleep lump uncomfortable enough position immediately shifted usually without patient awakening thyroid hormone replacement therapy patients hypothyroidism sdb thyroid hormone replacement therapy usually accompanied improvement sdb using mouthpiece individuals mouthpiece may improve anatomy airway point snoring mild obstructive sleep apnea osa corrected many types oral appliances designed treatment sleep apnea custom fitted teeth dental arches reposition mandible enlarge retropalatal retrolingual airway space however consistent patient tolerance treatment relatively low less effective cpap reducing frequency apnea hypopnea consultations multidisciplinary sleep teams including pulmonologists otolaryngologists neurologists oralmaxillofacial surgeons may offer convenient comprehensive treatment patients dietary measures diet exercise counseling play major role initial therapy sdb weight reduction patient obesity dramatically improve sdb even modest weight loss quite beneficial effect frequency apneas hypopneas bariatric surgery may needed cases rapid weight loss occurs bariatric surgery successful dieting pressure overcoming apneas hypopneas likely decrease retesting recommended treatment nasal cpap none therapies appropriate helpful nasal continuous positive airway pressure ncpap effective method manage obstructive sleep apnea syndrome osas ncpap provides pneumatic stent upper airway eliminating airway collapse inspiration administered soft mask covers nose sufficient pressure introduced eliminate apneas hypopneas snoring image depicting cpap machine seen cpap machine cpap machine physicians agree patients respiratory disturbance index rdi higher 20 require treatment ncpap also useful patients lower rdi especially experience daytime sleepiness symptoms severity daytime symptoms epworth sleepiness scale score much greater would expected particular rdi trial ncpap help determine whether elimination sdb leads improvement daytime symptoms factors contribute daytime symptoms patients unlikely benefit ncpap include severe nasal obstruction ncpap cannot used patients extreme claustrophobia cannot tolerate nasal mask patients ncpap reliably eliminate apneas hypopneas snoring determination positive airway pressure required criterion standard determining amount pressure required restore upperairway patency traditionally determined polysomnography psg trained technicians centers performed splitnight study data first half night used diagnosis sdb diagnosis made rdi sufficient suggest benefit initiation ncpap usually rdi 20 higher second half night’s study used determine optimal amount pressure disadvantage splitnight approach second half full night study often reveals severe sleep apnea diagnostic study limited first half night underestimate disease severity amount pressure delivered reported cm water average starting point cpap would 810 cm water patients report pressures levels feel odd tolerable even beginning treatment become tolerable patients become accustomed treatment higher levels 15 cm water often well tolerated second overnight study logistically difficult clinicians empirically start patient ncpap pressure 810 cm water new generation ncpap machines basis patterns inspiratory airflow sense amount pressure needed overcome upper airway resistance patients sometimes started using machines without prior titration study alternatively autotitrating machine used several nights record amount pressure required suppress apneas hypopneas downloaded studied suitable nightly pressure determined fashion also amount pressure required suppress snoring used audible guide appropriate pressures patient routinely takes sedatives ingests alcohol evening intend change probably tested continuing usual nightly routine ncpap titration without sedatives alcohol likely lead undertreatment sdb home patterns resumed effects ncpap patients feel better daytime first day beginning ncpap first week treatment experience rebound sleep prolonged episodes rem sleep sleep patterns become normal first week reasons several weeks ncpap use may helpful normalization sleep patterns patients severe sleep apnea plan undergo surgery sleep patterns normalized prior planned surgery regular use ncpap improves patients’ bed partners’ quality life effects using cpap include increased vagal tone increased cardiac output increased stroke volume decreased systemic vascular resistance reduced risk cardiovascular mortality patients osa often increased arterial stiffness sympathovagal imbalance cpap therapy reported beneficial effects vascular function patients improvement sympathovagal balance cpap therapy may significantly related decreased stiffness central middlesized arteries independent changes blood pressure vascular endothelial status repetitive obstructive apnea produces acute impairment left ventricular longitudinal function suggesting development subendocardial ischemia cpap therapy decreases severity osa also ameliorates sleepinduced longitudinal left ventricular dysfunction problems ncpap one problem ncpap although ncpap provides good improvement symptoms physiologic parameters compliance treatment good regular use sometimes estimated low 30 46 one study defining use least 4 hd 5 dwk noncompliance categorized zoula et al tolerance problems psychological problems lack instruction support followup tolerance problems may due side effects ie dry mouth conjunctivitis rhinorrhea skin irritation pressure sores nasal congestion epistaxis mask leaks difficulty exhaling aerophagia chest discomfort bedpartner intolerance many patients report claustrophobia find sensation covering nose mask makes uncomfortable cannot tolerate wearing ncpap sometimes helped smaller transparent mask design use nasal pillows inserted nostrils instead formal nasal mask may allow patients tolerate ncpap patients trouble tolerating initial pressure especially higher pressures 1213 cm water required elimination apneas hypopneas level pressure may uncomfortable many ncpap machines builtin ramp gradual increase pressure using feature mask placed pressure begun low easily tolerated level 30 minutes pressure gradually builds full amount necessary often patient fall asleep time full pressure used patient actually asleep patients may experience nasal obstruction evaluation otolaryngologist reveals whether predominantly fixed skeletal obstruction soft tissue obstruction potentially modifiable without surgery marked septal deviation turbinate hypertrophy usually requires surgery resolution alar collapse may adequately treated internal external dilators eg breathe right strip nozovent surgery sometimes required repair marked alar collapse mucosal edema may due allergic rhinosinusitis vasomotor irritative rhinitis allergy testing treatment pharmacotherapy trials eg topical steroids antihistamines oral antihistamines decongestants may beneficial one way determine whether sufficient potentially reversible mucosal edema exists pursue avenue treatment topical decongestant test patient uses nasal topical decongestant eg oxymetazoline bedtime several days patient bed partner observing improvements snoring apneas marked improvement suggests potentially reversible mucosal edema main contributor nasal obstruction failure improve suggests fixed skeletal obstruction requires surgical correction sometimes dryness air temperature may irritating patient use inline humidification warming inspired air may alleviate patient discomfort number patients report facial nasal pain sometimes pain related poorly fitting mask many different types masks available different styles sizes tried select optimal fit individual anatomy mask pulled tight face edentulous anterior maxilla may provide resistance necessary good fit leaving dentures night help facial nasal pain persists despite mask refitting evaluation nasal obstruction chronic sinusitis may helpful cpap pro delivery method anchors tubing platform based upper retainer obviating need forehead strap patients may experience dry eye eye discomfort mask seal well egress pressurized air upper end mask toward eye may occur causing dry eye even exposure keratitis mask refitting usually eliminates problem patients may sleep mouth falling open awakening dry mouth sometimes chin strap required prevent mouth opening night commercially available disposable adhesive bandage may used pull chin toward lower cheeks patients may experience epistaxis may related highflow dry air may helped humidification warming inspired air patients experience nasal drying forced dry air irritating nose encouraging mucosal inflammation crusting use humidified air ncpap usually eliminates problem problems may also occur pneumopericardium reported ncpap rigorous patient education early reinforcing followup may improve longterm use ncpap considerations variations air pressure delivery sometimes make ncpap use comfortable patients autotitrating positive airway pressure apap continually adjusts pressure barely overcome collapsing forces bilevel positive airway pressure bipap provides higher pressure inspiration pneumatic splint needed prevent obstructive airway collapse lower pressure expiration cflex another autoadjusting delivery method increases pressure toward end expirations collapse would usually begin decreases pressure early expiration patients require higher pressures overcome obstructive apneas may tolerate devices better onelevel ncpap delivers higher pressure throughout entire respiratory cycle following treatment cpap patients obstructive sleep apnea remain sleepy despite effective cpap attention paid diagnoses associated sleepiness called “postcpap sleepiness” specific disorder may exist oxygen effects sleepdisordered breathing sdb due hypoxia sleep administration oxygen would seem like reasonable treatment although oxygen administration improves lowest bloodoxygen saturation level sleep improve arrhythmias occurring desaturation repeated studies demonstrated sustained clinically significant improvement sdb oxygen administration prolongation apneas also occurs particularly beginning therapy oxygen administration may beneficial subset patients patients coexistent pulmonary disorders may also benefit use oxygen conjunction nasal continuous positive airway pressure ncpap pharmacologic treatments protriptyline protriptyline tricyclic antidepressant medication studied treatment sdb yield improvement patients condition effect however appears mainly due suppression rapid eye movement rem sleep sleepdisordered breathing sdb often severe rem sleep less rem sleep mean fewer apneas modafinil modafinil wakepromoting medication used association continuous positive airway pressure cpap treat patients obstructive sleep apnea syndrome osas action similar sympathomimetic agents like amphetamine methylphenidate although pharmacologic profile identical sympathomimetic amines precise mechanism modafinil promotes wakefulness unknown headache nervousness adverse events reported benefit using modafinil patients osa compliant cpap administrated cases drugs drugs investigated treatment sleep apnea include progestational agents aminophylline acetazolamide ltryptophan naloxone baclofen bromocriptine chlorimipramine prochlorperazine none shown consistently helpful effect sleepdisordered breathing sdb surgical management sdb surgical care sleepdisordered breathing sdb discussed fully snoring obstructive sleep apnea surgery alcohol significantly worsens sdb eliminating use alcohol especially near bedtime improves sdb outpatient care nasal continuous positive airway pressure ncpap cure alter underlying obstructive sleep apnea osa rather provides daily relief apneas snoring hypoxias consequent daytime symptoms longterm ncpap use carryover effect often noted therefore polysomnography psg results first day two ncpap look remarkably improved however carryover short lived usually within week snoring apneas hypoxias daytime symptoms returned original level ncpap highly successful managing osa long used unfortunately compliance ncpap use great use least 4 hours night 5 7 nights occurring one half patients reason regular followup visits mandatory ensuring continued successful treatment physicians see patients 3 4month basis first year ncpap use yearly thereafter repeat sleep studies obtained major weight loss gain major change daytime symptoms many patients happily successfully use ncpap years others find sustained use impossible patients surgery may helpful even snorers whose psg show sdb monitored periodically progress sdb time even without weight gain start media cpap machine cpap machine author vittorio rinaldi md specialist otolaryngology division otolaryngology department clinical sciences community health university milan fondazione irccs cà granda ospedale maggiore policlinico milan italy disclosure nothing disclose coauthors fabrizio salvinelli md professor otolaryngology campus biomedico university rome disclosure nothing disclose manuele casale md specialist otolaryngology campus biomedico university rome school medicine disclosure nothing disclose francesco faiella md resident otolaryngology campus biomedico university rome school medicine disclosure nothing disclose marco pappacena md resident department otolaryngology campus biomedico university rome disclosure nothing disclose pharmacy editor francisco talavera pharmd phd adjunct assistant professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure received salary medscape employment medscape managing editor robert kellman md professor chair department otolaryngology communication sciences state university new york upstate medical university robert kellman md member following medical societies american academy facial plastic reconstructive surgery american head neck society american rhinologic society triological society american neurotology society american academy otolaryngologyhead neck surgery american college surgeons american medical association medical society state new york disclosure nothing disclose chief editor zab mosenifar md facp fccp geri richard brawerman chair pulmonary critical care medicine professor executive vice chairman department medicine medical director womens guild lung institute cedars sinai medical center university california los angeles david geffen school medicine zab mosenifar md facp fccp member following medical societies american college chest physicians american college physicians american federation medical research american thoracic society disclosure nothing disclose additional contributors jack coleman md consulting staff franklin surgical associates jack coleman md member following medical societies american academy facial plastic reconstructive surgery american academy sleep medicine american academy otolaryngic allergy american academy otolaryngologyhead neck surgery american bronchoesophagological association american college surgeons triological society american society laser medicine surgery association military surgeons us disclosure received honoraria accarent inc speaking teaching acknowledgements authors editors medscape reference gratefully acknowledge contributions previous author karen hall calhoun md development writing source article first author vittorio rinaldi gratefully thanks prof pgvisvanathan introduced snoring osa surgical management findley l unverzagt guchu r fabrizio buckner j suratt p vigilance automobile accidents patients sleep apnea narcolepsy chest medline teránsantos j jiménezgómez corderoguevara j association sleep apnea risk traffic accidents cooperative group burgossantander n engl j med medline caples sm gami somers vk obstructive sleep apnea ann intern med medline eastwood pr malhotra palmer lj kezirian ej horner rl ip ms et al obstructive sleep apnoea pathogenesis treatment current controversies future directions respirology medline flemons ww clinical practice obstructive sleep apnea n engl j med medline george cf diagnostic techniques obstructive sleep apnea prog cardiovasc dis medline thakkar k yao diagnostic studies obstructive sleep apnea otolaryngol clin north medline saletu sauter c lalouschek w saletu b kapfhammer g benesch et al excessive daytime sleepiness predictor carotid atherosclerosis sleep apnea atherosclerosis medline exar en collop na upper airway resistance syndrome chest medline hudgel dw hendricks c hamilton hb characteristics upper airway pressureflow relationship sleep j appl physiol medline j kryger mh zorick fj conway w roth mortality apnea index obstructive sleep apnea experience 385 male patients chest medline remmers je degroot wj sauerland ek anch pathogenesis upper airway occlusion sleep j appl physiol medline casale rinaldi v bressi f di peco v baptista p sadun b et al suitable test identifying high risk adult patients moderatesevere obstructive sleep apnea syndrome eur rev med pharmacol sci medline casale pappacena rinaldi v bressi f baptista p salvinelli f obstructive sleep apnea syndrome phenotype genetic basis curr genomics medline full text bekci tt kocak n kesli r distribution common methylenetetrahydrofolate reductase gene mutations patients obstructive sleep apnoea j int med res medline manzotte guindalini c mazzotti dr palombini l de souza al poyares et al human leucocyte antigen dqb10602 allele associated electroencephelograph differences individuals obstructive sleep apnoea syndrome j sleep res medline de carvalho tb suman molina fd piatto vb maniglia jv relationship obstructive sleep apnea syndrome 5ht2a receptor gene brazilian patients sleep breath medline oconnor c thornley ks hanly pj gender differences polysomnographic features obstructive sleep apnea j respir crit care med medline jordan mcevoy rd gender differences sleep apnea epidemiology clinical presentation pathogenic mechanisms sleep med rev medline mohsenin v effects gender upper airway collapsibility severity obstructive sleep apnea sleep med medline young shahar e nieto fj redline newman ab gottlieb dj et al predictors sleepdisordered breathing communitydwelling adults sleep heart health study arch intern med medline camposrodriguez f perezronchel j griloreina limaalvarez j benitez almeidagonzalez c longterm effect continuous positive airway pressure bp patients hypertension sleep apnea chest medline chowdhury adams whellan dj sleepdisordered breathing heart failure focus obstructive sleep apnea treatment continuous positive airway pressure j card fail medline fletcher ec treatment sleep apnea syndrome prevent cardiovascular consequences sleep medline haruki n takeuchi kanazawa tsubota n shintome r nakai h et al continuous positive airway pressure ameliorates sleepinduced subclinical left ventricular systolic dysfunction demonstration twodimensional speckletracking echocardiography eur j echocardiogr medline wolf j lewicka j narkiewicz k obstructive sleep apnea update mechanisms cardiovascular consequences nutr metab cardiovasc dis medline chami ha fontes jd vasan rs keaney jf jr oconnor gt larson mg et al vascular inflammation sleep disordered breathing communitybased cohort sleep medline oliveras schmieder clinical situations associated difficulttocontrol hypertension j hypertens mar medline cho er kim h seo hs suh lee sk shin c obstructive sleep apnoea risk factor silent cerebral infarction j sleep res medline young blustein j finn l palta sleepdisordered breathing motor vehicle accidents populationbased sample employed adults sleep medline harsch ia schahin sp radespieltröger weintz jahreiss h fuchs fs et al continuous positive airway pressure treatment rapidly improves insulin sensitivity patients obstructive sleep apnea syndrome j respir crit care med medline hassaballa ha tulaimat herdegen jj mokhlesi b effect continuous positive airway pressure glucose control diabetic patients severe obstructive sleep apnea sleep breath medline ip mokhlesi b sleep glucose intolerancediabetes mellitus sleep med clin medline full text babu ar herdegen j fogelfeld l shott mazzone type 2 diabetes glycemic control continuous positive airway pressure obstructive sleep apnea arch intern med medline reichmuth kj austin skatrud jb young association sleep apnea type ii diabetes populationbased study j respir crit care med medline full text sadikot sm overview obstructive sleep apnea metabolic syndrome ‘‘x’’ changed ‘‘zzz zzzz zzzz zzzzz zzz’’ diabetes metabolic syndrome misiolek marek b namyslowski g scierski w zwirskakorczala k kazmierczakzagorska z et al sleep apnea syndrome snoring patients hypothyroidism relation overweight j physiol pharmacol medline hoban tf sleep disorders children ann n acad sci medline ciscar juan g martínez v ramón lloret mínguez j et al magnetic resonance imaging pharynx osa patients healthy subjects eur respir j medline fry jm diphillipo curran k goldberg r baran full polysomnography home sleep medline chervin rd hedger k dillon je pituch kj pediatric sleep questionnaire psq validity reliability scales sleepdisordered breathing snoring sleepiness behavioral problems sleep med medline netzer nc stoohs ra netzer cm clark k strohl kp using berlin questionnaire identify patients risk sleep apnea syndrome ann intern med medline ohayon mm guilleminault c priest rg caulet snoring breathing pauses sleep telephone interview survey united kingdom population sample bmj medline full text roth zammit g kushida c doghramji k mathias sd wong jm et al new questionnaire detect sleep disorders sleep med medline abrishami khajehdehi chung f systematic review screening questionnaires obstructive sleep apnea j anaesth medline emsellem ha corson wa rappaport ba hackett smith lg hausfeld jn verification sleep apnea using portable sleep apnea screening device south med j medline stoohs r guilleminault c mesam 4 ambulatory device detection patients risk obstructive sleep apnea syndrome osas chest medline weimin l rongguang w dongyan h xiaoli l wei j shiming assessment portable monitoring device watchpat 200 diagnosis obstructive sleep apnea eur arch otorhinolaryngol medline berger g gilbey p hammel ophir histopathology uvula soft palate patients mild moderate severe obstructive sleep apnea laryngoscope medline namyslowski g scierski w zembalanozynska e nozynski j misiolek histopathologic changes soft palate snoring obstructive sleep apnea syndrome patients otolaryngol pol medline fishman g zemel derowe sadot e sivan koltai pj fiberoptic sleep endoscopy children persistent obstructive sleep apnea interobserver correlation comparison awake endoscopy int j pediatr otorhinolaryngol medline campanini canzi p de vito dallan montevecchi f vicini c awake versus sleep endoscopy personal experience 250 osahs patients acta otorhinolaryngol ital medline vicini c de vito benazzo frassineti campanini frasconi p et al nose oropharynx hypopharynx larynx nohl classification new system diagnostic standardized examination osahs patients eur arch otorhinolaryngol medline peppard pe young palta dempsey j skatrud j longitudinal study moderate weight change sleepdisordered breathing jama medline victor ld treatment obstructive sleep apnea primary care fam physician medline chan lee rw cistulli pa dental appliance treatment obstructive sleep apnea chest medline aloia ms stanchina arnedt jt malhotra millman rp treatment adherence outcomes flexible vs standard continuous positive airway pressure therapy chest medline full text berkani lofaso f chouaid c pia dortho theret grillierlanoir v et al cpap titration autocpap device based snoring detection clinical trial economic considerations eur respir j medline douglas nj systematic review efficacy nasal cpap thorax medline full text fleisher ke krieger ac current trends treatment obstructive sleep apnea j oral maxillofac surg medline grunstein rr sleeprelated breathing disorders 5 nasal continuous positive airway pressure treatment obstructive sleep apnoea thorax medline full text kawahara akashiba akahoshi horie nasal cpap improves quality life lessens depressive symptoms patients obstructive sleep apnea syndrome intern med medline lankford da proctor cd richard r continuous positive airway pressure cpap changes bariatric surgery patients undergoing rapid weight loss obes surg medline mcardle n devereux g heidarnejad h engleman hm mackay tw douglas nj longterm use cpap therapy sleep apneahypopnea syndrome j respir crit care med medline ryan mcnicholas w effect continuous positive airway pressure creactive protein levels patients obstructive sleep apnea syndrome chest medline schwartz dj kohler wc karatinos g symptoms depression individuals obstructive sleep apnea may amenable treatment continuous positive airway pressure chest medline stammnitz jerrentrup penzel peter jh vogelmeier c becker hf automatic cpap titration different selfsetting devices patients obstructive sleep apnoea eur respir j medline stradling jr hardinge smith dm novel simplified approach starting nasal cpap therapy osa respir med medline teschler h berthonjones intelligent cpap systems clinical experience thorax medline full text weaver te kribbs nb pack ai kline lr chugh dk maislin g et al nighttonight variability cpap use first three months treatment sleep medline lévy p pepin jl autocpap effective lowcost procedure management osas eur respir j medline morgenthaler ti aurora rn brown zak r alessi c boehlecke b et al practice parameters use autotitrating continuous positive airway pressure devices titrating pressures treating adult patients obstructive sleep apnea syndrome update 2007 american academy sleep medicine report sleep medline full text doherty ls kiely jl lawless g mcnicholas wt impact nasal continuous positive airway pressure therapy quality life bed partners patients obstructive sleep apnea syndrome chest medline flemons ww tsai w quality life consequences sleepdisordered breathing j allergy clin immunol medline moyer ca sonnad ss garetz sl helman ji chervin rd quality life obstructive sleep apnea systematic review literature sleep med medline ciftci tu ciftci b guven sf kokturk turktas h effect nasal continuous positive airway pressure uncontrolled nocturnal asthmatic patients obstructive sleep apnea syndrome respir med medline stradling jr smith crosby j postcpap sleepinessa specific syndrome j sleep res medline shiina k tomiyama h takata yoshida kato k saruhara h et al effects cpap therapy sympathovagal balance arterial stiffness obstructive sleep apnea respir med medline jean wiese h boethel c phillips b wilson jf peters j viggiano cpap compliance video education may help sleep med medline marshall ns neill campbell aj sheppard ds randomised controlled crossover trial humidified continuous positive airway pressure mild obstructive sleep apnoea thorax medline full text neill wai hs bannan sp beasley cr weatherall campbell aj humidified nasal continuous positive airway pressure obstructive sleep apnoea eur respir j medline bachour hurmerinta k maasilta p mouth closing device chinstrap reduces mouth leak nasal cpap sleep med medline mceachern rc patel rg pneumopericardium associated facemask continuous positive airway pressure chest medline souter stevenson sparks b drennan c upper airway surgery benefits patients obstructive sleep apnoea cannot tolerate nasal continuous positive airway pressure j laryngol otol medline

Article 28:
neonatal pustular melanosis neonatal pustular melanosis background epidemiology neonatal pustular melanosis clinical presentation physical causes neonatal pustular melanosis differential diagnoses neonatal pustular melanosis workup laboratory studies neonatal pustular melanosis treatment management medical care neonatal pustular melanosis medication neonatal pustular melanosis followup inpatient care prognosis neonatal pustular melanosis background epidemiology neonatal pustular melanosis clinical presentation physical causes neonatal pustular melanosis differential diagnoses neonatal pustular melanosis workup laboratory studies neonatal pustular melanosis treatment management medical care neonatal pustular melanosis medication neonatal pustular melanosis followup inpatient care prognosis overview background epidemiology presentation physical causes differential diagnoses workup laboratory studies treatment medical care medication followup inpatient care prognosis neonatal pustular melanosis overview neonatal pustular melanosis clinical presentation neonatal pustular melanosis differential diagnoses neonatal pustular melanosis workup neonatal pustular melanosis treatment neonatal pustular melanosis medication neonatal pustular melanosis followup 909753overview nov 04 2014 201508031734 0 pediatrics general medicine 2002 diseases conditions condition 1 2 content 909753 502 9 age12 jun 05 2015 condition diseases conditions pediatricsgeneral pediatrics general medicine pediatricsgeneraldermatology dermatology neonatal pustular melanosis transient pustular melanosis newborn pustular melanosis lesions vesicles macules rash pemphigus neonatorum lentiginosis neonatorum flaking epidermis macules skin rash diagnosis transient neonatal pustular melanosis benign selflimited condition unknown etiology historically disorder lumped together vesicular bullous lesions called pemphigus neonatorum 1 neonatal pustular melanosis overview background transient neonatal pustular melanosis benign selflimited condition unknown etiology ruptured pustules vesicles remaining characteristic collarette scale brown ruptured pustules vesicles remaining characteristic collarette scale brown hyperpigmented macules courtesy anthony j mancini md epidemiology frequency united states reports large numbers screened infants available however incidence reported much 22 white infants 44 black infants mortalitymorbidity neonatal pustular melanosis completely benign condition known cause longterm sequelae race transient neonatal pustular melanosis common black infants observed racial groups especially darker constitutive pigmentation latinos south asians mediterranean extraction age eruption almost always present birth clinical appearance stage may vary clinical presentation physical primary lesions neonatal pustular melanosis progress 3 stages development initially appear rather uniform round 2mm 4mm nonerythematous pustules clear vesicles rather contain milky purulent exudate pustules rupture easily frequently missed superficial usually wiped easily delivery suite newborn cleansed vernix pustules thicker areas skin knees palms may persist several days next delicate collarette thin white scale left around perimeter denuded pustule nearterm infants especially delivered cesarean delivery may exhibit unbroken pustules term infants may macules remaining usually telltale collarette flaking epidermis lastly within hours exposure terrestrial environment central pigmented brown macule becomes apparent macules round smooth distinct borders frequently confused freckles may profuse sparse typically found chin neck upper chest back buttocks occasionally palms soles scalp affected considering suspected neonatal pustular melanosis following also considered erythema toxicum neonatorum lesions small papules erythematous base contain predominantly eosinophils heal postinflammatory hyperpigmentation congenital cutaneous candidiasis pustules usually inflamed contain organisms laboratory smear biopsy impetigo congenital langherhans cell histiocytosis widely distributed papules pustules form adherent crusts frecklelike macules congenital varicella miliaria characterized clear vesicles crystallina pustules pustulosa erupt setting hyperthermia herpes simplex milia acropustulosis pustules predominate palms soles present birth causes etiology unknown reports described cases evolved erythema toxicum neonatorum differential diagnoses candidiasis emergency medicine miliaria pediatric acropustulosis pediatric erythema toxicum pediatric herpes simplex virus infection pediatric milia staphylococcus aureus infection workup laboratory studies appearance typical transient neonatal pustular melanosis workup indicated appearance typical potassium hydroxide preparation gram stain wrightgiemsa stain support diagnoses differential atypical cases pustules cultured bacteria clustering pustules prompt polymerase chain reaction identify possible herpes simplex wrightgiemsa stain pustule contents demonstrates predominance neutrophils eosinophils present brown macules true freckles lentigines skin biopsy shows pigment incontinence characteristic postinflammatory hyperpigmentation diagnosis langherhans cell histiocytosis made skin biopsy treatment management medical care treatment indicated reassure parents neonatal pustular melanosis benign finding disappears medication medication summary drug therapy currently component standard care condition followup inpatient care brown macules fade period several months prognosis neonatal pustular melanosis selflimited morbidity recognized start media ruptured pustules vesicles remaining characteristic collarette scale brown ruptured pustules vesicles remaining characteristic collarette scale brown hyperpigmented macules courtesy anthony j mancini md author robert silverman md clinical associate professor department pediatrics georgetown university medical center robert silverman md member following medical societies american academy dermatology society pediatric dermatology disclosure nothing disclose pharmacy editor mary l windle pharmd adjunct associate professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure nothing disclose managing editor robert schwartz md mph professor head dermatology professor pathology pediatrics medicine preventive medicine community health rutgers new jersey medical school visiting professor rutgers university school public affairs administration robert schwartz md mph member following medical societies alpha omega alpha new york academy medicine american academy dermatology american college physicians sigma xi disclosure nothing disclose chief editor dirk elston md professor chairman department dermatology dermatologic surgery medical university south carolina college medicine dirk elston md member following medical societies american academy dermatology disclosure nothing disclose additional contributors kevin p connelly clinical assistant professor department pediatrics division general pediatrics emergency care virginia commonwealth university school medicine medical director paws health pet visitation program richmond spca pediatric emergency physician emergency consultants inc chippenham medical center kevin p connelly member following medical societies american academy pediatrics american college osteopathic pediatricians american osteopathic association disclosure nothing disclose acknowledgements authors editors medscape reference gratefully acknowledge contributions previous author elaine b st john md original writing development article eichenfield lf frieden ij esterly nb eds neonatal dermatology oconnor nr mclaughlin mr ham p newborn skin part common rashes fam physician medline chia ps leung c hsu yl lo cy infant transient neonatal pustular melanosis presenting pustules pediatr neonatol medline goyal varshney bakshi sk incidence vesicobullous erosive disorders neonates much worry indian j pediatr medline morgan aj steen cj schwartz ra janniger ck erythema toxicum neonatorum revisited cutis medline farnaroff aa martin rj eds skin neonatalperinatal medicine diseases fetus infant ferrandiz c coroleu w ribera lorenzo jc natal sterile transient neonatal pustulosis precocious form erythema toxicum neonatorum dermatology medline merlob p metzker reisner sh transient neonatal pustular melanosis j dis child medline ramamurthy rs reveri esterly nb transient neonatal pustular melanosis j pediatr medline

Article 29:
physical child abuse physical child abuse practice essentials background pathophysiology physical child abuse clinical presentation history physical causes physical child abuse differential diagnoses physical child abuse workup laboratory studies imaging studies procedures physical child abuse treatment management medical care surgical care consultations physical child abuse followup patient education physical child abuse practice essentials background pathophysiology physical child abuse clinical presentation history physical causes physical child abuse differential diagnoses physical child abuse workup laboratory studies imaging studies procedures physical child abuse treatment management medical care surgical care consultations physical child abuse followup patient education overview practice essentials background pathophysiology epidemiology presentation history physical causes differential diagnoses workup laboratory studies imaging studies procedures treatment medical care surgical care consultations followup patient education physical child abuse overview physical child abuse clinical presentation physical child abuse differential diagnoses physical child abuse workup physical child abuse treatment physical child abuse followup 915664overview may 14 2015 201507021141 0 pediatrics developmental behavioral articles 2002 diseases conditions condition 1 2 content 915664 502 9 r458diet1f33f1age12 jul 02 2015 condition diseases conditions pediatricsdevelopment pediatrics developmental behavioral articles pediatricsdevelopmentdevelopment developmental behavioral articles physical abuse child maltreatment child abuse victimization physical maltreatment intentional injury nonaccidental injury inflicted injury fracture burn bruise subdural hematoma sdh abusive head trauma aht shaken baby syndrome sbs shakingimpact syndrome maltreatment domestic violence corporal punishment fractures corner fracture battered child syndrome whiplash syndrome smoking severe obesity physical inactivity depressed mood suicide attempts alcoholism drug abuse ischemic heart disease cancer stroke chronic bronchitis emphysema diabetes hepatitis skeletal fractures physical abuse subset child abuse defined various ways different states however common definitions presence injury child sustains hands caregiver 1 physical child abuse overview practice essentials physical child abuse ie nonaccidental injury child sustains hands caregiver result skeletal injury burns bruising see first image central nervous system injury head trauma see second image determine whether childs injury likely inflicted rather accidental clinician must establish full extent injury must understand childs developmental level abilities bruises inflicted belt image courtesy lawrence r ricci md bruises inflicted belt image courtesy lawrence r ricci md acute subdural shift image courtesy lawrence r ricci md acute subdural shift image courtesy lawrence r ricci md see pediatric concussion traumatic brain injuries also see 12 cantmiss findings pediatric imaging studies signs symptoms physical indicators raise suspicion maltreatment include following injury pattern inconsistent history provided multiple injuriesmultiple types injuries injuries various stages healing poor hygiene presence pathognomonic injuries including loop marks forced immersion burn pattern classic abusive head trauma findings subdural hematoma retina hemorrhage skeletal injuries bruising bony prominences common childhood patterns bruising raise concern possible abuse include following involvement multiple areas body beyond bony prominences bruising ears facial cheeks buttocks palms soles neck genitals bruises many stages healing bruises nonambulatory child patterned markings resembling objects grab marks slap marks human bites loop marks oral injury lingular labial frenula tears skeletal injuries children younger 2 years may obvious therefore skeletal survey screening recommended many fracture types accidental inflicted fractures raise high degree suspicion inflicted injury include following fracture nonambulatory infant without clear accidental consistent mechanism metaphyseal fractures multiple bilateral differently aged posterior rib fractures multiple complex skull fractures simple impact history spinous process fractures scapular fractures burn patterns may suggest physical maltreatment include following patterned contact burns clear shape hot object eg fork clothing iron curling iron cigarette lighter classic forced immersion burn pattern sharp stockingandglove demarcation sparing flexed protected areas splashspill burn patterns consistent history developmental level cigarette burns bilateral mirror image burns localized burns genitals buttocks perineum especially toilettraining stage evidence excessive delay seeking treatment presence forms injury see clinical presentation diagnosis history physical examination findings determine laboratory diagnostic imaging studies performed bleeding problem basic bleeding evaluation platelets prothrombin time pt activated partial thromboplastin time aptt genetic bone disease mineralization defect calcium magnesium phosphorus vitamin levels review radiographs pediatric radiologist genetic consultation available may warranted toxin drug ingestion toxicology screening screening abdominal injury recommended children younger 5 years abuse suspected even absence clear external evidence abdominal injury symptoms pain vomiting screening includes following markers liver injury aspartate aminotransferase ast alanine aminotransferase alt pancreatic injury amylase lipase levels urinary tract injury urine analysis red blood intestinal injury stool guaiac photodocumentation cutaneous injuries burns bite marks bruising injuries helpful cases child abuse see workup management treatment physical abuse complex endeavor involving interdisciplinary team approach nature injury determines form medical therapy follows skeletal fractures long bones may require casting orthopedics consulted burns vary severity treatments range cleansing area skin grafting plastic surgery consulted serious burns transfer burn unit may indicated severely injured children cns injury may require resuscitation need intensive care multitude specialists may need involved whenever abusive head trauma suspected ophthalmology consulted formal evaluation including examination eyes retinal hemorrhages psychosocial management requires significant amount coordination among various services providers including physician health care providers complements medical management details caregiving environment determine psychosocial supports needed keep child safe see treatment medication background physical abuse subset child abuse defined various ways different states however common definitions presence injury child sustains hands caregiver injuries also referred inflicted nonaccidental injuries states use broad definitions encompass wide range injuries states use narrow definitions include specific signs symptoms physical abuse produce various injuries injury patterns children article focuses several common examples inflicted injury dealing skeleton eg fractures skin eg burns bruises cns eg subdural hematoma sdh abusive head trauma aht shaken baby syndrome sbsshakingimpact syndrome definitions physical abuse federally funded fourth national incidence study nis4 congressionally mandated effort united states department health human services provide updated estimates incidence child abuse neglect united states measure changes incidence earlier studies advantage narrow definition objectively states physical abuse however clear delineation circumstances likely fails identify possible cases physical abuse eg pulling childs hair biting childs skin definitions may also attempt characterize seriousness injury however characterization difficult injuries vary greatly mild redness buttocks fades several hours injuries severe child dies recent medical definitions focus effect injury child less perceived intention caregiver additionally newer definitions also consider sociocultural context injury occurs folk healing practices may cause appearance nonaccidental injury child finally effect physical abuse may limited immediate injury findings national center child abuse neglect nccan estimated 37 children maltreatment injuries developed disability special need directly abusive actions omissions childs caregivers multifactorial nature physical abuse one single cause identified explains occurrence cases physical abuse multifactorial nature physical abuse requires comprehensive amalgam models conceptual frameworks account heterogeneous set cases classified physical abuse circumstances may give rise occurrence childs injury via physically abusive actions organized typology following 5 subtypes caregivers angry uncontrolled disciplinary response actual perceived misconduct child caregivers psychological impairment causes resentment rejection child caregiver perception child different provocative child left care babysitter abusive caregivers use substances disinhibit behavior caregivers entanglement domestic violence situation typology describes commonly observed circumstances may result nonaccidental injury children however shed light circumstance leads childs injury ecological model human development interaction impossible inadvisable consider physical abuse child isolated incident one cause one effect ecological model human development interaction generally regarded ideal conceptual framework approach complex interactions among caregiver child family social situation cultural values leading nonaccidental injury physical abuse child note image ecological model understanding violence ecological model understanding violence ecological model sees child functioning within family microsystem family functioning within community exosystem various communities linked together set sociocultural values influence macrosystem systems operating time chronosystem system components interactional nature affects one another similar events different effects depend period circumstances event occurs eg child interacts impact family family influences child environmental stress caregiver frustration helfer builds ecological viewpoint states physical maltreatment arises caregiver child interact around event given environment end result injury child child may certain characteristics make providing care complex however caution must used considering childs contribution abusive interactions difficult child justify abusive treatment caregiver specific factors may place child higher risk physical maltreatment include prematurity poor bonding caregiver medical fragility various special needs attention deficit hyperactivity disorder finally environment may contain stressors may make caregiving less ideal may overextend coping abilities caregiver exploring role environmental stress caregiver frustration occurrence child abuse straus kantor found complex interaction amount stress present family setting response caregivers straus kantor concluded human beings capacity acting violently outside family setting physical abuse result specific home situation arises relatively high degree stress baseline amount violence within eg spanking children pushing slapping spouse thus risk child abuse related response caregivers whose caregiving environment certain amount overall risk violent behavior caregivers level social connectedness nonrelatives seems role play childrens risk maltreatment caregivers high degrees stress participate clubs unions organizations ie socially isolated higher rates abusing children socially isolated however children whose caregivers many family members living nearby achieve protective effect nonfamilial social connectedness group domestic violence intimate partner violence corporal punishment child maltreatment relationship domestic violence intimate partner violence ipv child maltreatment receiving increasing attention year 33 10 million children witness episodes family violence 3059 mothers abused children victims domestic violence intimate partner violence additionally children whose mothers victims domestic violence intimate partner violence 615 times likely maltreated compared children living families mothers battered american academy pediatrics aap recommends pediatricians assess presence domestic violence intimate partner violence childs family observes intervening behalf victimized parent typically childs mother may effective childabuse prevention strategy overlap child maltreatment domestic violence overlap child maltreatment domestic violence relationship application corporal punishment risk maltreatment remains area concern corporal punishment defined discipline method uses physical force behavioral modifier corporal punishment nearly universal 90 us families report used spanking means discipline time corporal punishment roots personal cultural religious societal views children disciplined corporal punishment includes pinching spanking paddling shoving slapping shaking hair pulling choking excessive exercise confinement closed spaces denial access toilet credible evidence medical literature supports continued use corporal punishment spanking less effective time removal privileges decreasing undesired behavior children discipline however necessary component child rearing appropriate discipline aims limit setting teaching right wrong assisting decision making helping child develop sense selfcontrol physical force used discipline technique corporal punishment concern arises misconduct continues even corporal punishment applied caregiver may become angry frustrated reapply physical force physical force reapplied caregiver becoming increasingly angry potential emerges caregiver lose control injure child regardless whether injuring child intended outcome corporal punishment end result experienced injured child hurt caregivers use corporal punishment often angry irritable depressed fatigued stressed apply punishment time lost caregivers frequently express remorse agitation punishing children avoid risk harming child order model nonviolent behavior children many healthcare professionals advocate child discipline via consistent nonphysical force based approaches time loss privileges expressions parental disappointment grounding approximately one half us pediatricians report opposed generally use corporal punishment one third completely opposed use three fourths pediatricians reported spanked children pathophysiology form injury sustained child result physical abuse set biomechanics pathophysiology article looks specifically mechanisms injury skeletal injury burns bruising cns injury observed abusive head trauma skeletal fractures caused application force bone essential step evaluation injury children determining whether injury evaluated matches history provided caregiver process requires understanding mechanisms forces needed cause specific types fractures well specific characteristics infant childhood bone compared adult bone childs immature skeleton characterized poroustrabecular bone mature bone lessdense porous bone tolerates deformity adult bone accounts childhood bending buckling injuries observed green stick buckle injuries periosteum fibrous membrane covers bone thicker easily elevated bone children childs joint capsule ligaments strong relatively resistant stress bone cartilage accounts less joint dislocations ligamentous tears childhood finally bone healing rapid children adults makes dating childhood fractures complicated types fractures certain types fractures eg posterior rib scapular classic metaphyseal lesions common physical abuse accidental injury fracture pathognomonic child physical abuse fractures must carefully evaluated correlated childs medical history history given caregivers fractures classified location body eg skull vs long bone location bone eg diaphyseal vs metaphyseal posterior vs anterior rib certain fracture types seen developing immature bone eg greenstick classic metaphyseal lesions salterharris fractures specifically long bones fractures described based location type diaphyseal fractures breaks mid shaft long bones transverse fractures typically occur force applied perpendicular long axis bone spiral oblique fractures occur force applied rotational component buckle compression fractures occur commonly transition diaphysis metaphysis note images buckle fracture distal femur without healing acute buckle fracture distal femur without healing acute distal femur buckle fracture 2week followup film sclerotic fracture line periosteal distal femur buckle fracture 2week followup film sclerotic fracture line periosteal new bone healing metaphyseal fractures also called corner fractures bucket handle fractures microfractures immature part bone edge often appear like chips corner fractures radiographs metaphysis area rapid bone turnover growing infant toddler metaphyseal fractures specific infants involve immature physis caused shearing tensile stress seen rapid acceleration deceleration forces extremity skull bones may fractured result direct impact head solid surface object skull fractures typically occur site impact head owing oval shape head single point impact may result bilateral fractures remote site impact skull bones differ long bones develop within membrane cartilage long bones rib fractures may observed physical abuse well rib fractures occur result direct blows chest via anteroposterior compression abusive rib fractures posterior adjacent vertebral body rib levering transverse process vertebra bone healing dating injuries dating boney injuries particularly important evaluation physical abuse may assist investigators determining access child period injury estimated occurred body medical literature evaluating precision dating fractures evolved last decade classic teaching fractured long bones ribs heal predictable manner divided following 4 stages initial healing soft callus hard callus remodeling orthopedic aspects bone healing described forearm fractures traditional description bone healing included general timelines age injury based stage healing seen time injury identification young children bone healing tends occur rapidly older children adults newer studies dating fractures however emphasize classic descriptions eg soft callus hard callus based histiologic specimens rather plain film readings significant inconsistencies exist among radiologic interpretation healing phases metaphyseal fractures generally harder date relative lack disruption periosteum time fracture skull fractures heal differently long bones intramembranous nature heal large amount callus formation difficult date skills advice experienced pediatric radiologist consulted dating injuries becomes central maltreatment investigation burns burns arise application heat energy childs skin various sources hot liquids scalds hot objects contact dry flame flash chemicals electricity generate heat three concentric zones affected tissues identified coagulation direct contact heat source skin undergoes immediate coagulation necrosis proteins denature cellular repair possible stasis involves less heat energy exposure coagulation cells though injured potential repair hyperemia least direct injury cells greatest potential repair types depth burns encountered inflicted accidental burns children human skin composed 3 layers epidermis dermis subcutaneous tissue burns classified clinically depending depth injury involvement various skin layers superficial burns injure uppermost tissue epidermis present red painful areas without blisters complete healing expected superficial burns deeper burns extend epidermis upper levels dermis referred partial thickness burns present painful blistering areas healing partialthickness burns varies various degrees scarring depending level tissue damaged finally deepest burns fullthickness burns extend past epidermis dermis involve subcutaneous tissue burns essentially destroyed overlying skin blood vessels associated nerves present white insensitive areas destruction high degree scarring disfigurement result fullthickness burns evaluation suspicious burns children must include medical complaint detailed history caregiver child including developmental history ensure child capable contributing injury eg turned faucet physical examination include assessment burned area critical assessment burned versus spared areas skin helpful determining position child time burn note image series 3 photos likely accidental hot water scald burn leg infant sparing series 3 photos likely accidental hot water scald burn leg infant sparing skintoskin contact areas indicates child flexed knee ankle time injury consistent seated kitchen sink burn injuries require detailed scene investigation case investigators confirmed ease turning faucet high temperature water careful gathering information child wearing time time elapsed since burn symptom progression topical treatments area important determination cause many childhood burns involve hot water bathtubs heated liquids kitchen setting scene investigations child protective services andor law enforcement gather crucial information determining whether burn inflicted accidental burn eg temperature tap water height faucets floor ease turning handles food residue clothing scene note image pattern contact burn buttocks diapered child burn likely came metal grate pattern contact burn buttocks diapered child burn likely came metal grate surrounding heater bruising bruising occurs blunt mechanical force applied childs skin degree capillaries potentially larger vessels become disrupted resulting leakage blood subcutaneous tissue amount blood size location involved area account appearance bruise force applied via object bruise may reflect shape geometry object general bruise progresses series colors beginning deep red blue purple changes deep blue greenish finally resolves yellowish brown color various colors emanate breakdown extravascular blood components hemoglobin extravascular blood organizes resorbed certain patterns color change expected however caution advised clearly predictable chronology relied absolute certainty physicians cautious offering dating information suggest broad time ranges based clinical appearance stages healing bruise similar fractures recent data dating bruises indicate color poor predictor bruise age cns trauma cns trauma among serious forms injury observed context physical abuse cns trauma may result intracranial hemorrhage including 1 epidural hemorrhage bleeding space inner skull bone surface dura frequently due direct injury middle meningeal artery 2 subdural hemorrhage bleeding space inner surface dura arachnoid membranes typically caused sheering bridging vessels go brain surface dura 3 subarachnoid hemorrhage bleeding space inner surface arachnoid brain surface cns injuries may include contusions ie direct injury brain tissue intraparenchymal bleeding ie bleeding directly substance brain primary injuries obscured complicated anoxic brain injuries swelling frequently seen complex head injury whether accidental inflicted aht sbs shakingimpact syndrome discussing cns injury physical abuse inevitably leads discussion abusive head trauma aht previously referred shaken baby syndrome sbs shakingimpact syndrome aht extended include cases childs head impacted surface either soft hard may called aht diffuse serious brain injuries result external forces cause rotation brain center gravity forces exceed generated normal childcare activities different low velocity translational forces straightline movement commonly occur household falls immense angular deceleration forces may generated sudden striking childs head surface forces act brain tissue cerebral vessels generate deleterious effect specifically contact forces applied skull epidemiology frequency united states important understand sources data child maltreatment incidence national incidence study nis methodology views maltreated children investigated child protective services cps agencies representing tip iceberg thus children investigated cps included along maltreated children identified professionals wide range agencies representative communities fourth national incidence study nis4 uses data gathered nationally representative sample 122 counties cps agencies counties provide data children cases accept investigation 1 2 reference periods september 4 2005 december 3 2005 february 4 2006 may 3 2006 additionally professionals counties serve nis4 sentinels report data maltreated children identified following organizations elementary secondary public schools public health departments public housing authorities shortstay general childrens hospitals state county municipal policesheriff departments licensed daycare centers juvenile probation departments voluntary social services mental health agencies shelters runaway homeless youth shelters victims domestic violence 2009 approximately 33 million reports involving 59 million children made cps agencies 607 accepted needing investigation evaluated investigations concluded child abuse neglect affected approximately 695000 children included 754000 cases abuse ie children one episode substantiated abuse 176 total representing cases substantiated physical abuse common form substantiated abuse 2009 child neglect including medical neglect accounted 807 cases followed child sexual abuse 92 cases emotional maltreatment 81 cases nis4 reported approximately 125 million estimated annual cases child abuse approximately 323000 cases identified physical abuse important recognize numbers reflect changes harm standard defined nis relatively stringent generally requires act omission result demonstrable harm order classified abuse neglect nis4 also reported endangerment standard includes children meet harm standard adds others well central feature endangerment standard counts children yet harmed abuse neglect thought maltreatment endangered children cps investigation substantiated indicated maltreatment addition endangerment standard slightly lenient harm standard allowing broader array perpetrators including adult caretakers parents certain maltreatment categories teenage caretakers perpetrators sexual abuse comparing endangerment standard number physically abused children decreased estimated 614100 children 1993 476600 2006 22 decrease number 29 decline rate reasons behind decrease uncertain may result sample sizes technique data misinterpreted indication physical abuse endangerment children cured nis4 data report 1 child every 58 united states harmed harm standard definition including physical abuse sexual abuse neglect various clinical series skeletal fractures observed approximately 30 children burns observed 910 bruises quite common present approximately 40 child maltreatment cases inflicted cns injury observed 24 children treated head injury finkelhor jones shattuck analyzed trends reporting substantiation rates child abuse neglect 1990s 2010 identified decline number substantiated cases physical abuse us maltreatment trends 19902010 us maltreatment trends 19902010 mortalitymorbidity mortality according nis4 study estimated 2400 children known died result maltreatment 20052006 according prevent child abuse americas national center child abuse prevention research 2006 estimated 1530 known died result child maltreatment average 4 children day year child neglect 43 multiple forms maltreatment 314 physical abuse 224 psychological abuse 29 child sexual abuse 03 estimated death rate child abuse neglect united states 3 per 100000 children morbidity different forms injury different risks example cns injury occult abdominal injury younger children particularly serious bruises may superficial harbingers serious deeper injury burns observed child maltreatment cases tend highly severe finally skeletal injuries may isolated multiple nature may associated injuries discala colleagues conducted 10year retrospective medical records national pediatric trauma registry nptr 19881997 compared hospitalized injured children younger 5 years determine differences inflicted n 1997 accidental injuries n 16831 discalas group found compared children accidental injury children abused tended younger 128 mo vs 255 mo mainly injured battering 53 shaking 103 likely preinjury medical history medical problem condition unintentionally injured children mainly injured falls 584 motor vehicles 371 note image national pediatric trauma group registry findings national pediatric trauma group registry findings order fully comprehend morbidity victims child abuse victims necessary look beyond immediate period injury recovery looking potential longterm impacts health well felitti et al explored connection exposure childhood abuse connection household dysfunction subsequent health risks development illness adulthood series studies referred adverse childhood experiences ace studies order assess exposure child abuse neglect ace questionnaire asked categories child maltreatment specifically psychological physical sexual maltreatment asking physical abuse questionnaire asked patients parent adult household 1 often often pushed grabbed shoved slapped 2 often often hit hard marks injuries resulted order assess exposure household dysfunction ace questionnaire asked questions category dysfunction household member problems substance abuse eg problem drinker drug user mental illness eg psychiatric problem criminal behavior household eg incarceration mother treated violently assessing mother treated violently patient child respondents asked mother stepmother 1 sometimes often pushed grabbed slapped bitten hit fist hit something hard something thrown 2 ever repeatedly hit least minutes threatened hurt knife gun addition questionnaire information standardized medical examination adults assessed risk factors actual disease conditions risk factors included smoking severe obesity physical inactivity depressed mood suicide attempts alcoholism drug abuse high lifetime number sexual partners history sexually transmitted disease std disease conditions included ischemic heart disease cancer stroke chronic bronchitis emphysema diabetes hepatitis skeletal fractures data collected analyzed felitti et al found prevalent ace substance abuse 256 least prevalent ace criminal behavior 34 prevalence physical abuse 108 prevalence mother treated violently 125 overall 52 respondents one aces 62 4 aces following findings respondents experienced 4 aces compared none risk alcoholism drug abuse depression suicide attempt increased 412 fold rates smoking poor selfrated health high number sexual partners stds increased 24 fold physical inactivity severe obesity increased 1416 fold major finding ace studies graded relationship number exposures maltreatment household dysfunction childhood presence later life multiple risk factors several disease conditions associated death adulthood note image adverse child experiences pyramid adverse child experiences pyramid bentley widom 2009 found physical abuse childhood risk factor obesity adulthood prospective assessment comparing individuals documented histories childhood physical sexual abuse neglect matched cohort children without histories 30year followup showed childhood physical abuse led significantly higher body mass index bmi scores adulthood beta 014 p p race significant difference incidence physical abuse noted based race 1993 nis3 1986 nis2 child maltreatment 2010 nis4 compared 3 major categories white nonhispanic black nonhispanic hispanic found white black children differed significantly rates experiencing overall harm standard abuse 2005–2006 nis4 study year estimated 104 cases per 1000 black children suffered harm standard abuse nis44 study year compared 6 cases per 1000 white children 67 cases per 1000 hispanic children abuse rate black children 17 times white children 16 times hispanic children sex nis4 found significant difference boys’ girls’ rates experiencing serious harm harm standard since 1006 nis3 data incidence rates sexes declined boys’ rate declined girls boys’ rate declined 33 whereas girls’ rate declined 11 specific sexbased breakdown provided child maltreatment 2010 age nis4 incidence harm standard physical abuse significantly lower youngest children 25 cases per 1000 children aged 02 compared children aged 614 years 46 cases per 1000 higher fairly low incidence rates children younger 2 years may reflect detection problem children younger school age less observable community professionals abuse may avoid detection child maltreatment 2010 clinical presentation history childhood time accidental injuries understanding developmental level abilities child essential determining history provided parent caregiver possible plausible explanation childs injury full extent injury determined based physical examination radiology laboratory workup healthcare provider assess plausibility explanation offered parent caregiver history implausible based child level capable raise high degree concern possible maltreatment whenever child injured complete history circumstances surrounding injury well detailed injury history essential basic questions include following child last 100 well date time injury first noted injury occur witnessed injury happening prior injury child injury caregiver injury long injury caregiver wait seeking care child symptoms child exhibiting remedies caregiver attempt inquire specific details related injury height fall landing surface temperature water scald burn among others past medical history explored general health previous trauma hospitalizations well source healthcare developmental social aspects childs life cases maltreatment history often inaccurate misleading following historical elements raise concerns possible physical abuse details change additional scenarios suggested additional trauma identified cause trauma questioned details inconsistent among caregivers caregivers give implausible details congruent trauma observed examination caregivers describe minor trauma child displays major injury examination history trauma offered injury described selfinflicted possible given agedevelopmental abilities child caregivers demonstrate significant delay seeking treatment child serious injury blamed younger siblingplaymate caregiver frequently changes healthcare facilities pediatricians emergency departments physical physical examination child injury obviously important order complete examination determined presenting condition child children less severe injuries stable condition injured area examined last since area likely uncomfortable severely injured children critical condition require life saving measures first following standards care trauma lifesupport components examination follow point physical abuse often ongoing pattern unsafe care injury pattern inconsistent history provided multiple injuriesmultiple types injuries injuries various stages healing poor hygiene presence pathognomonic injuries including loop marks forced immersion burn pattern classic abusive head trauma findings subdural hematoma retina hemorrhage skeletal injuries bruising bony prominences common childhood patterns bruising raise concern possible abuse include following involvement multiple areas body beyond bony prominences bruising ears facial cheeks buttocks palms soles neck genitals see images bruises many stages healing see bruising pathophysiology bruises nonambulatory child patterned markings resembling objects grab marks slap marks human bites loop marks see images oral injury lingular labial frenula tears inflicted pinch mark shaft image courtesy lawrence r ricci md inflicted pinch mark shaft image courtesy lawrence r ricci md fingernail scratch child acute subdural shift image courtesy lawrence r ricci fingernail scratch child acute subdural shift image courtesy lawrence r ricci md example ear bruising ear bruising rare accidental injury 10monthold child example ear bruising ear bruising rare accidental injury 10monthold child intubated abusive head trauma aht spiral femur fracture ear bruising addition facial bruising linear inflicted bruising extending arm back inflicted belt child shown linear inflicted bruising extending arm back inflicted belt child shown back bruising overlying linear inflicted marks child disclosed came belt child overlying linear inflicted marks child disclosed came belt child shown image arm back pattern bruising extensive back bruising 4yearold child found dead home pattern bruising extensive back bruising 4yearold child found dead home reported history autopsy revealed duodenal hematoma perforation cause death skeletal injuries children younger 2 years may obvious therefore skeletal survey screening recommended see workup components skeletal survey fracture nonambulatory infant without clear accidental consistent mechanism metaphyseal fractures multiple bilateral differently aged posterior rib fractures see image multiple complex skull fractures simple impact history spinous process fractures scapular fractures radiograph multiple rib fractures radiographs also revealed old radius ulna fracture radiograph multiple rib fractures radiographs also revealed old radius ulna fracture child presented slap mark image courtesy lawrence r ricci md burn patterns may suggest physical maltreatment include following patterned contact burns clear shape hot object eg fork clothing iron curling iron cigarette lighter see image classic forced immersion burn pattern sharp stockingandglove demarcation sparing flexed protected areas splashspill burn patterns consistent history developmental level cigarette burns bilateral mirror image burns localized burns genitals buttocks perineum especially toilet training stage evidence excessive delay seeking treatment presence forms injury pattern contact burn buttocks diapered child burn likely came metal grate pattern contact burn buttocks diapered child burn likely came metal grate surrounding heater causes one single cause identified explains occurrence cases physical abuse differential diagnoses diagnostic considerations determining whether injury inflicted caregiver caused accidental means medical determination current future safety well child family stake many medical conditions may mimic findings observed physical abuse differential diagnoses consider differ depending types physical laboratory radiographic findings observed differential diagnoses worked carefully cases suspected inflicted injury suspected physical abuse diagnosed confidently caregivers inappropriately accused abuse injuries major differential diagnosis accidental inflicted injury determination accident versus abuse best accomplished pairing thoughtful thorough medical evaluation information gathered multidisciplinary investigation often involving child protective services cps law enforcement agencies child physical abuse guidelines american academy pediatrics aap updated 2015 include new information lasting effects abuse highlight risk factors abuse abusive injuries frequently overlooked bruises bruises differential diagnoses include following mongolian spots hemangiomas overgrowth capillaries eczema phytophotodermatitis cutaneous phototoxic cutaneous eruption erythema multiforme multishaped red lesions believed sensitivity reaction idiopathic thrombocytopenic purpura itp bleeding disorders eg hemophilia malignancy ehlersdanlos syndrome osteogenesis imperfecta folkhealing practices eg coining cupping see burns mongolian spots darkskinned child mongolian spots darkskinned child mongolian spots lightskinned child mongolian spots greenish cast depending mongolian spots lightskinned child mongolian spots greenish cast depending skin color child skeletal fractures skeletal fractures differential diagnoses include normal variants bone structure may appear suspicious findings radiographs congenital syphilis type common form autosomal dominant inheritance responsible 80 patients major findings type oi include mildly moderately severe bone fragility occasional fractures birth easy bruising short stature blue sclera type oi may associated family history hearing impairment type may easily confused maltreatment especially injuries skeletal nature thorough medical history family history essential type ii perinatal lethal form death typically occurs age 1 month multiple fractures birth type oi generally readily distinguishable child physical abuse type iii rare easily distinguished maltreatment severe bone fragility osteopenia triangular facies ligamentous laxity skeletal deformity abnormal appearance teeth type iv difficult distinguish maltreatment bones may appear normal first fracture develops usually characterized mildtomoderate bone fragility osteopenia wormian bones birth fractures approximately one third cases normal sclerae genetic consultation necessary pursue detailed workup oi characterization collagen disorder incidence oi types estimated 1 case 20000 live births oi much rarer child abuse burns differential diagnoses lesions appear burns include limited hypersensitivity reaction blistering friction blisters impetigo may appear circular confused cigarette burns phytophotodermatitis reddened areas erosions result sun exposure skin psoralen residue dermatitis herpetiformis immunobullous skin condition characterized blisters may erode folkhealing practices coining rubbing coin spoon repetitively skin cupping application heated cup skin resultant vacuum action cools moxibustion application heated incense skin physician look history supporting diagnosis diagnosis suspected physical abuse cns injuries differential diagnoses altered mental status findings observed cns injuries include various serious disorders meningitis neurologic conditions seizures component ingestions may simulate serious clinical features cns injury child cns injury often seriously ill presenting lifethreatening condition seizures respiratory arrest serious lifethreatening injury data support existence lucid period time injury onset symptoms rather acute subdural hematoma severe neurologic sequela clinical deterioration would expected immediately around time injury traumatic acute subdural hematomas especially lead death child occur subclinical insidious manner otherwise healthy infant abusive head trauma aht considering differential diagnoses findings aht differential diagnosis subdural hematoma retinal hemorrhages needs considered subdural hematoma differential diagnoses include accidental trauma coagulation disorders vascular malformations rare amino acid inborn error metabolism glutaric aciduria type associated acute encephalopathy chronic subdural hematoma folkhealing practice caida di mollera retinal hemorrhages retinal hemorrhages differential diagnoses include vasculitis vascular obstruction toxic febrile states associated serious infection working differential diagnoses workup reveal history physical examination findings supportive diagnosis physical abuse workup laboratory studies history physical examination findings determine laboratory diagnostic imaging studies necessary bleeding problem suspected basic bleeding evaluation platelets pt aptt valuable screening tool results may suggest need sophisticated bleeding evaluation andor hematology consultation available pattern mark highly suspicious bruising absence bruising common locations eg shins schoolage child likely require extensive bleeding workup genetic bone disease mineralization defect suspected screening calcium magnesium phosphorus vitamin levels indicated interpretation vitamin levels children complex due lack robust evidence establishing normal values thresholds bones would clinically susceptible fracture review radiographs pediatric radiologist ideal evaluate bones signs poor growth healing genetic consultation available may warranted toxicology screening indicated clinical situation suggests possible ingestion cause findings examination evaluation child presents household drug use production suspected confirmed screening abdominal injury recommended children younger age 5 years abuse suspected even absence clear external evidence abdominal injury symptoms pain vomiting note image faint abdominal bruising toddler elevated liver function test results liver faint abdominal bruising toddler elevated liver function test results liver laceration found abdominal ct scan upper lip frenulum tear note abdominal injury may present little bruising abdomen screening includes aspartate aminotransferase ast alanine aminotransferase alt markers liver injury amylase lipase levels pancreatic injury urine analysis red blood cells evaluate urinary tract injury stool guaiac intestinal injury basic guidelines appropriate evaluation child suspected victim physical abuse age shown guidelines assessment suspected physical abuse guidelines assessment suspected physical abuse imaging studies children younger 2 years suspected physically abused skeletal survey recommended rule skeletal injury new old retrospective study children assessed skeletal surveys evaluate missed physical abuse unsuspected fractures found 11 survey results positive previously unsuspected fracture skeletal survey results directly influenced making diagnosis abuse 50 children positive skeletal survey results wider use skeletal survey may justified especially highrisk populations 2014 multispecialty panel experts released skeletal survey guidelines help guide assessment whether fractures children 2 years age due abuse accidents skeletal survey performed children fractures resulting abuse domestic violence hit toy object skeletal survey performed children rib fractures without history fracture trauma except ambulatory children 12 months age older toddler fracture buckle fracture radiusulna tibiafibula abuse suspected skeletal survey performed cases distal spiral fracture tibiafibula children 1223 months old history falling runningwalking cases distal radialulna buckle fracture ambulatory children 1223 months old history falling onto outstretched hand skeletal survey performed children 12 months age depending history physical examination diagnostic imaging tests may indicated including following radionuclide bone scanning assists identifying new rib fractures subtle long bone fractures apparent skeletal survey ct scanning head indicated child suspected inflicted head trauma order image brain assess injury see guidelines image mri valuable adjunct head ct scanning define injury help identify different ages blood contained subdural hematoma ct scanning thorax abdomen may helpful view organs chest abdomen injury suspected ct scanning abdomen recommended suspected abuse victims abnormal values ast alt amylase lipase urine red blood cells indicated lab studies note images guidelines assessment suspected physical abuse guidelines assessment suspected physical abuse ct scan showing liver laceration child severe abdominal bruising see next image ct scan showing liver laceration child severe abdominal bruising see next image caregiver admitted repeatedly punching child abdomen abdominal bruising toddler also liver laceration also see previous ct scan abdominal bruising toddler also liver laceration also see previous ct scan procedures photodocumentation cutaneous injuries burns bite marks bruising injuries helpful cases child abuse photodocumentation used adjunct standard medical written documentation allows consulting physicians child protective services cps workers law enforcement personnel attorneys others view better comprehend injuries photographs injuries helpful legal proceedings protecting child determining guilt photodocumentation performed accordance institutional policies procedures treated protected health information health insurance portability accountability act hipaa treatment management medical care treatment physical abuse complex endeavor involving interdisciplinary team approach nature injury determines form medical therapy details caregiving environment determine psychosocial supports needed keep child safe medical issues skeletal fractures long bones may require casting orthopedics consulted assistance diagnosis management clinical consideration given possibility osteogenesis imperfecta oi genetics consultation may also valuable burns vary severity treatments range cleansing area skin grafting plastic surgery consulted assistance management serious burns transfer burn unit may indicated see initial evaluation management burn patient severely injured children cns injury may require resuscitation need intensive care multitude specialists may need involved order correctly evaluate treat seriously ill children whenever abusive head trauma suspected ophthalmology consulted formal evaluation including examination eyes retinal hemorrhages psychosocial management requires significant amount coordination among various services providers including physician healthcare providers complements medical management recommendations american academy pediatrics state pediatricians mandated reporters suspected abuse reports child protective service agencies required law physician reasonable suspicion abuse transferring child’s care another physician hospital relieve pediatrician reporting responsibilities addition thorough documentation medical records effective communication nonmedical investigators child protection may improve outcomes investigations protect vulnerable children child protective services cps agency community responsible performing investigations cases physical abuse suspected relies physicians provide details medical evaluation addition cps assesses caregivers background caregiving abilities potential environmental safety risk repeat abuse risk siblings variety cps service plan options available ranging periodic contact child family removal child home either temporarily permanently termination parental rights cps process child maltreatment cases typically involves following steps intake screening reports acceptance case initial risk assessment caregiver interviews medical information gathering home evaluation possibility contact law enforcement case planning determination safety child essentially 3 options 1 child goes home caregiver without services depending circumstances 2 child removed home family caregivers consent offered services assist working towards reunifying child 3 child removed home family without caregivers consent involving court action incorporation legal steps processes determine ultimate plan child surgical care cases severe multisystem trauma involvement pediatric surgeon may necessary care surgical treatment injuries consultations following consultations may warranted pediatric radiologist expertise important many abusive fractures infants subtle radiographs routine pediatric radiologist involvement ideal locations pediatric radiologists routinely available one consulted cases dating bone injuries become central maltreatment investigation concerns arise regarding osteogenesis imperfecta oi bone mineralization problems orthopedists assist diagnosis management cases skeletal fractures long bones hematologists assist diagnosis management bleeding disorders geneticists may needed detailed workup oi collagen disorders characterization collagen disorder plastic surgeons may needed assist management serious burns ophthalmologists involved whenever abusive head trauma aht suspected formal evaluation including examination eyes retinal hemorrhages via dilated direct ophthalmoscope examination ideally retinal photography allow independent peer review child psychiatrist behavioraldevelopmental pediatrician psychiatric social worker may needed assess mental health needs child family well coordinate overall psychosocial treatment plan followup patient education patient education resources see childrens health center child abuse bruises start media overlap child maltreatment domestic violence overlap child maltreatment domestic violence handprint face image courtesy lawrence r ricci md handprint face image courtesy lawrence r ricci md handprint leg image courtesy lawrence r ricci md handprint leg image courtesy lawrence r ricci md bruises inflicted belt image courtesy lawrence r ricci md bruises inflicted belt image courtesy lawrence r ricci md bruises inflicted switch image courtesy lawrence r ricci md bruises inflicted switch image courtesy lawrence r ricci md bruises inflicted switch image courtesy lawrence r ricci md bruises inflicted switch image courtesy lawrence r ricci md switch image courtesy lawrence r ricci md switch image courtesy lawrence r ricci md bruises inflicted wooden spoon image courtesy lawrence r ricci md bruises inflicted wooden spoon image courtesy lawrence r ricci md bruises inflicted belt image courtesy lawrence r ricci md bruises inflicted belt image courtesy lawrence r ricci md buckle fracture distal femur shaft image courtesy lawrence r ricci md buckle fracture distal femur shaft image courtesy lawrence r ricci md duodenal hematoma image courtesy lawrence r ricci md duodenal hematoma image courtesy lawrence r ricci md burn car seat image courtesy lawrence r ricci md burn car seat image courtesy lawrence r ricci md car seat image courtesy lawrence r ricci md car seat image courtesy lawrence r ricci md model femoral neck fracture yanked crib image courtesy lawrence r ricci model femoral neck fracture yanked crib image courtesy lawrence r ricci md femoral neck fracture yanked crib previous image image courtesy lawrence femoral neck fracture yanked crib previous image image courtesy lawrence r ricci md inflicted pinch mark shaft image courtesy lawrence r ricci md inflicted pinch mark shaft image courtesy lawrence r ricci md burn held hot cement image courtesy lawrence r ricci md burn held hot cement image courtesy lawrence r ricci md old new radius fracture image courtesy lawrence r ricci md old new radius fracture image courtesy lawrence r ricci md child slap mark image courtesy lawrence r ricci md child slap mark image courtesy lawrence r ricci md radiograph old radius ulna fracture child slap mark image courtesy lawrence r radiograph old radius ulna fracture child slap mark image courtesy lawrence r ricci md radiograph multiple rib fractures radiographs also revealed old radius ulna fracture radiograph multiple rib fractures radiographs also revealed old radius ulna fracture child presented slap mark image courtesy lawrence r ricci md sunburn image courtesy lawrence r ricci md sunburn image courtesy lawrence r ricci md burn inflicted lighter image courtesy lawrence r ricci md burn inflicted lighter image courtesy lawrence r ricci md acute subdural shift image courtesy lawrence r ricci md acute subdural shift image courtesy lawrence r ricci md fingernail scratch child acute subdural shift image courtesy lawrence r ricci fingernail scratch child acute subdural shift image courtesy lawrence r ricci md ecological model understanding violence ecological model understanding violence us maltreatment trends 19902010 us maltreatment trends 19902010 adverse child experiences pyramid adverse child experiences pyramid national pediatric trauma group registry findings national pediatric trauma group registry findings buckle fracture distal femur without healing acute buckle fracture distal femur without healing acute distal femur buckle fracture 2week followup film sclerotic fracture line periosteal distal femur buckle fracture 2week followup film sclerotic fracture line periosteal new bone healing guidelines assessment suspected physical abuse guidelines assessment suspected physical abuse linear inflicted bruising extending arm back inflicted belt child shown linear inflicted bruising extending arm back inflicted belt child shown back bruising overlying linear inflicted marks child disclosed came belt child overlying linear inflicted marks child disclosed came belt child shown image arm back ct scan showing liver laceration child severe abdominal bruising see next image ct scan showing liver laceration child severe abdominal bruising see next image caregiver admitted repeatedly punching child abdomen abdominal bruising toddler also liver laceration also see previous ct scan abdominal bruising toddler also liver laceration also see previous ct scan example ear bruising ear bruising rare accidental injury 10monthold child example ear bruising ear bruising rare accidental injury 10monthold child intubated abusive head trauma aht spiral femur fracture ear bruising addition facial bruising mongolian spots darkskinned child mongolian spots darkskinned child mongolian spots lightskinned child mongolian spots greenish cast depending mongolian spots lightskinned child mongolian spots greenish cast depending skin color child faint abdominal bruising toddler elevated liver function test results liver faint abdominal bruising toddler elevated liver function test results liver laceration found abdominal ct scan upper lip frenulum tear note abdominal injury may present little bruising abdomen pattern bruising extensive back bruising 4yearold child found dead home pattern bruising extensive back bruising 4yearold child found dead home reported history autopsy revealed duodenal hematoma perforation cause death pattern contact burn buttocks diapered child burn likely came metal grate pattern contact burn buttocks diapered child burn likely came metal grate surrounding heater series 3 photos likely accidental hot water scald burn leg infant sparing series 3 photos likely accidental hot water scald burn leg infant sparing skintoskin contact areas indicates child flexed knee ankle time injury consistent seated kitchen sink burn injuries require detailed scene investigation case investigators confirmed ease turning faucet high temperature water example strangulationligature marks neck toddler strangulationligature marks example strangulationligature marks neck toddler strangulationligature marks often linear petechiae may fingernail scratches victim struggling free airway author angelo p giardino md phd mph associate professor baylor college medicine chief medical officer texas children’s health plan chief quality officer medicine texas children’s hospital angelo p giardino md phd mph member following medical societies american professional society abuse children harris county medical society international society prevention child abuse neglect ray e helfer society academic pediatric association american academy pediatrics disclosure received grantresearch funds health resources services administration hrsa integrated community systems cshcn grant received advisory board baxter healthcare corporation board membership coauthors eileen r giardino rn msn phd fnpbc anpbc associate professor nursing department family nursing university texas health sciences center houston school nursing eileen r giardino rn msn phd member following medical societies american college health association american professional society abuse children american association nurse practitioners american nurses association international society prevention child abuse neglect disclosure nothing disclose rebecca l moles md assistant professor department pediatrics section general pediatrics yale university school medicine child abuse pediatrician associate medical director yale child abuse programs department pediatrics yalenew hospital rebecca l moles md member following medical societies american academy pediatrics american college physicians american professional society abuse children ray helfer society disclosure nothing disclose pharmacy editor mary l windle pharmd adjunct associate professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure nothing disclose chief editor caroly pataki md health sciences clinical professor psychiatry biobehavioral sciences university california los angeles david geffen school medicine caroly pataki md member following medical societies american academy child adolescent psychiatry new york academy sciences physicians social responsibility disclosure received consulting fee otsuka pharmaceutical board membership additional contributors chet johnson md professor pediatrics associate director developmentalbehavioral pediatrician ku center child health development shiefelbusch institute life span studies assistant dean faculty affairs development university kansas school medicine chet johnson md member following medical societies american academy pediatrics disclosure nothing disclose acknowledgements authors gratefully acknowledge assistance dr lawrence r ricci providing photographs illustrate various injuries may seen evaluating children suspected physical abuse despite busy clinician educator academic leader dr ricci made time select cases article large archive guideline kellogg nd evaluation suspected child physical abuse pediatrics medline farst k reading meyer ja mac bird james l robbins jm hair drug testing children suspected exposure manufacture methamphetamine j forensic leg med medline lane wg dubowitz h langenberg p screening occult abdominal trauma children suspected physical abuse pediatrics medline lindberg makoroff k harper n laskey bechtel k deye k utility hepatic transaminases recognize abuse children pediatrics medline sedlak aj mettenburg j basena et al fourth national incidence study child abuse neglect nis–4 report congress executive summary 2010 sedlak aj mettenburg j basena et al fourth national incidence study child abuse neglect us dept health human services full text national center child abuse neglect national child abuse neglect data system 1991 summary data component washington dc government printing office 1993 working paper 2 helfer developmental basis child abuse neglect epidemiological approach battered child straus kantor gk corporal punishment adolescents parents risk factor epidemiology depression suicide alcohol abuse child abuse wife beating adolescence medline american academy pediatrics web site periodic survey fellows 38 attitudes counseling corporal punishment home july 1998 available wwwaaporgresearchps38exs1htm halliday ke broderick nj somers jm hawkes r dating fractures infants clin radiol medline pilling ml vanezis p perrett johnston visual assessment timing bruising forensic experts j forensic leg med medline christian cw block r abusive head trauma infants children pediatrics medline us department health human services administration children families youth families children’s bureau child maltreatment 2010 us department health human services available httpwwwacfhhsgovprogramscbpubscm10cm10pdf finkelhor jones l shattuck updated trends child maltreatment 2010 httpwwwunheduccrcpdfcv203updated20trends20201020final121911pdf available httpcyberlawharvardedusitescyberlawharvardedufilestrends20in20child20maltreatmentpdf prevent child abuse america 2006 national child maltreatment statistics national center child abuse prevention research us department health human services administration children youth ad families available httpmemberpreventchildabuseorgsitedocserverchildmaltreatmentfactsheet2005pdfdocid221 discala c sege r li g reece rm child abuse unintentional injuries pediatr adolesc med felitti vj anda rf nordenberg williamson df spitz edwards v relationship childhood abuse household dysfunction many leading causes death adults adverse childhood experiences ace study j prev med medline bentley widom cs 30year followup effects child abuse neglect obesity adulthood obesity silver spring medline fox sentinel injuries may precede severe abuse infants medscape medical news march 11 2013 available httpwwwmedscapecomviewarticle780552 sheets lk leach koszewski ij lessmeier nugent simpson p sentinel injuries infants evaluated child physical abuse pediatrics medline hand l skeletal survey guidelines toddler fractures issued medscape medical news available httpwwwmedscapecomviewarticle826776 wood jn fakeye feudtner c mondestin v localio r rubin dm development guidelines skeletal survey young children fractures pediatrics medline christian cw evaluation suspected child physical abuse pediatrics medline brown aap updates guideline child physical abuse medscape medical news available httpwwwmedscapecomviewarticle843827 duffy squires j fromkin jb berger rp use skeletal surveys evaluate physical abuse analysis 703 consecutive skeletal surveys pediatrics medline guideline policy statementchild abuse confidentiality health insurance portability accountability act pediatrics medline guideline policy statementexpert witness participation civil criminal proceedings pediatrics medline child court subject review pediatrics administration children families us department health human services nis4 description full text adverse childhood experiences ace study center disease control available httpwwwcdcgovnccdphpacepyramidhtm american humane association aha fact sheet 12 use physical discipline englewood co 1994 bays j reece rm ludwig eds child abuse medical diagnosis management bays j jenny c genital anal conditions confused child sexual abuse trauma j dis child medline belsky j child maltreatment ecological integration psychol medline berkowitz cd pediatric abuse new patterns injury emerg med clin north medline bronfenbrenner u toward experimental ecology human development psychol brooks physical abuse childhood linked adhd adults medscape medical news full text child maltreatment 2003 us department health human services available httpwwwacfhhsgovprogramscbpubscm03cm2003pdf giardino ap alexander r eds child maltreatment clinical guide reference clark kd tepper jenny c effect screening profile diagnosis nonaccidental burns children pediatr emerg care medline coant pn kornberg ae brody edwardsholmes k markers occult liver injury cases physical abuse children pediatrics medline dubowitz h prevention child maltreatment clinical guide reference duhaime ac christian cw rorke lb zimmerman ra nonaccidental head injury infantsthe shakenbaby syndrome n engl j med medline feldman kw evaluation physical abuse helfer kempe rs krugman rd eds battered child fullerthomson e mehta r valeo establishing link attention deficit disorderattention deficit hyperactivity disorder childhood physical abuse journal aggression maltreatment trauma full text garbarino j human ecology child maltreatment conceptual model research journal marriage family garbarino j brookhouser pe authier kj special children special risks maltreatment children disabilities garbarino j eckenrode j understanding abusive families ecological approach theory practice giardino ap alexander r child maltreatment clinical guide reference giardino ap christian cw giardino er practical guide evaluation child physical abuse neglect giardino ap giardino er recognition child abuse mandated reporter grahambermann sa edleson jl domestic violence lives children future research intervention grossman dc rauh mj rivara fp prevalence corporal punishment among students washington state schools arch pediatr adolesc med medline gushurst ca child abuse behavioral aspects associated problems pediatr clin north medline hansbrough jf hansbrough w pediatric burns pediatr rev medline harding b ridson ra krous hf shaken baby syndrome bmj helfer etiology child abuse pediatrics medline hyman ia case spanking discipline child without hitting harm’s way domestic violence child maltreatment us department health human services children’s bureau administration children youth families administration children families national clearing house child abuse neglect information httpwwwcalibcomdvcpsfactsharmwaydoc jenny c cutaneous manifestations abuse child abuse medical diagnosis management johnson cf inflicted injury versus accidental injury pediatr clin north medline knapp jf dowd md family violence implications pediatrician pediatr rev medline lazoritz baldwin kini n whiplash shaken infant syndrome caffeys syndrome changed changed syndrome child abuse negl medline levin av ocular manifestations child abuse child abuse medical diagnosis management ludwig child abuse textbook pediatric emergency medicine mccormick kf attitudes primary care physicians toward corporal punishment jama medline myers jeb expert testimony apsac handbook child maltreatment reece rm nicholson ce inflicted childhood neurotrauma reece rm sege r childhood head injuries accidental inflicted arch pediatr adolesc med medline robson mc heggers jp pathophysiology burn wound carvajal hf parks dh eds burns children pediatric burn management schene pa past present future roles child protective services future child medline schwartz aj ricci lr accurately bruises aged abused children literature review synthesis pediatrics medline sirotnak ap krugman rd physical abuse children update pediatr rev medline spivak bs biomechanics nonaccidental trauma ludwig kornberg ae eds child abuse medical reference stein mt perrin el guidance effective discipline american academy pediatrics committee psychosocial aspects child family health pediatrics medline straus violence toward children increasing comparison 1975 1985 national survey rates family violence torrey sb ludwig emergency physician courtroom serving expert witness cases child abuse pediatr emerg care medline weston wl lane morelli jg color textbook pediatric dermatology wolraich ml aceves j feldman hm et al american academy pediatrics committee psychosocial aspects child family health child court subject review pediatrics medline world report violence health world health organization available httpwwwwhointviolenceinjurypreventionviolenceworldreportenfullenpdf

Article 30:
gaucher disease gaucher disease practice essentials background pathophysiology gaucher disease clinical presentation history physical causes gaucher disease differential diagnoses gaucher disease workup laboratory studies imaging studies tests gaucher disease treatment management medical care surgical care consultations gaucher disease medication enzyme replacement therapy glucosylceramide synthase inhibitors gaucher disease followup outpatient care inpatient care deterrenceprevention gaucher disease practice essentials background pathophysiology gaucher disease clinical presentation history physical causes gaucher disease differential diagnoses gaucher disease workup laboratory studies imaging studies tests gaucher disease treatment management medical care surgical care consultations gaucher disease medication enzyme replacement therapy glucosylceramide synthase inhibitors gaucher disease followup outpatient care inpatient care deterrenceprevention overview practice essentials background pathophysiology epidemiology presentation history physical causes differential diagnoses workup laboratory studies imaging studies tests procedures histologic findings treatment medical care surgical care consultations diet activity medication followup outpatient care inpatient care deterrenceprevention complications prognosis patient education gaucher disease overview gaucher disease clinical presentation gaucher disease differential diagnoses gaucher disease workup gaucher disease treatment gaucher disease medication gaucher disease followup 944157overview nov 24 2014 201507091748 0 pediatrics genetics metabolic disease 2002 diseases conditions condition 1 2 content 944157 502 5003061 9 age1 jun 05 2015 condition diseases conditions pediatricsgenetics pediatrics genetics metabolic disease pediatricsgeneticsmetabolic metabolic disease gaucher disease gaucher’s disease glucocerebrosidase deficiency cerebroside lipidosis acid betaglucosidase deficiency splenomegaly anemia lipid storage disease lysosomal storage disease glucocerebrosidase pancytopenia massive hepatosplenomegaly treatment symptoms glucocerebrosidase 1 parkinsonism gaucher disease lipid storage disease characterized deposition glucocerebroside cells macrophagemonocyte system disorder results deficiency specific lysosomal hydrolase glucocerebrosidase also termed acid betaglucosidase glucosylceramidase 1 gaucher disease overview practice essentials gaucher disease rare genetic disorder characterized deposition glucocerebroside cells macrophagemonocyte system disorder results deficiency enzyme glucocerebrosidase essential update new drug eliglustat proving work gaucher disease oral glucosylceramide glucocerebroside synthase inhibitor eliglustat approved fda treatment gaucher disease type 1 gd1 august 2014 proven effective intravenous enzyme replacement therapy imiglucerase study 159 patients gaucher’s disease researchers found fewer patients treated eliglustat 85 imiglucerase 94 met criteria hemoglobin level platelet count spleen volume liver volume indicating stable disease 12 months adverse events common eliglustat mild three studies eliglustat superior placebo nine months treatment outcomes similar patients treated eliglustat imiglucerase 4 years outcomes eliglustat treatment similar dosing regimens determined based cyp2d6genotypepredicted phenotype plasma eliglustat concentrations signs symptoms gaucher disease traditionally divided following three clinical subtypes delineated absence presence neurologic involvement progression type 1 nonneuronopathic form type 2 acute neuronopathic form type 3 chronic neuronopathic form patients type 1 disease commonly present painless splenomegaly anemia thrombocytopenia may also chronic fatigue hepatomegaly without abnormal liver function test findings bone pain pathologic fractures may bruise easily thrombocytopenia bleeding secondary thrombocytopenia may manifest nosebleeds bruising patients type 2 disease may present birth infancy increased tone seizures strabismus organomegaly failure thrive swallowing abnormalities oculomotor apraxia hepatosplenomegaly stridor due laryngospasm typical infants type 2 disease addition organomegaly bony involvement individuals type 3 disease neurologic involvement see clinical presentation diagnosis diagnosis confirmed measurement glucocerebrosidase activity peripheral blood leukocytes finding less 15 mean normal activity diagnostic minor elevations liver angiotensinconverting enzyme levels common see workup management enzyme replacement therapy ert indicated patients type 1 gaucher disease exhibit clinical signs symptoms disease including anemia thrombocytopenia skeletal disease visceromegaly oral glucosylceramide inhibitor alternate efficacious therapy see treatment medication background gaucher disease lipid storage disease gaucher disease traditionally divided following 3 clinical subtypes delineated absence presence neurologic involvement progression type 1 nonneuronopathic form type 2 acute neuronopathic form type 3 chronic neuronopathic form however cases fit precisely one categories forms gaucher disease autosomal recessively inherited autosomal recessive inheritance pattern autosomal recessive inheritance pattern type 1 gaucher disease common among individuals ashkenazi jewish descent although 3 types panethnic distribution pathophysiology glucosylceramide accumulated glycolipid primarily derived phagocytosis degradation senescent leukocytes lesser extent erythrocyte membranes glycolipid storage gives rise characteristic gaucher cells macrophages engorged lipid crumpled–tissuepaper appearance displaced nuclei factors contribute neurologic involvement patients types 2 3 disease still unknown may related accumulation cytotoxic glycolipid glucosylsphingosine brain due severe deficiency glucocerebrosidase activity neuroinflammation glucosylceramide accumulation bone marrow liver spleen lungs organs contributes pancytopenia massive hepatosplenomegaly times diffuse infiltrative pulmonary disease progressive infiltration gaucher cells bone marrow may lead thinning cortex pathologic fractures bone pain bony infarcts osteopenia bony features may also related macrophageproduced cytokines disruption ceramidetoglucosylceramide ratio affect barrier formation epidermal layer skin leading ichthyosis collodion skin presentation individuals severely affected type 2 epidemiology frequency united states type 1 gaucher disease common among jewish people eastern european origin carrier frequency individuals approximately 1 per 15 population whereas disease frequency 1 per 855 population gaucher disease rare nonjewish population estimated frequency 1 per 40000 population international international disease frequency similar united states except areas world large ashkenazi jewish populations patients worldwide nonjewish many 60 patients ashkenazi origin estimated homozygous mild n370s mutation accounts 75 disease alleles population many individuals genotype never seek medical attention contributing underestimation disease frequency type 3 disease common norrbottnian region sweden 1 per 50000 population traced common founder 17th century mortalitymorbidity mortality morbidity varies different types type 1 gaucher disease often presents childhood hepatosplenomegaly pancytopenia skeletal disease although striking clinical variability occurs disease severity type 2 gaucher disease causes rapidly progressive neurovisceral storage disease death infancy first years life subset type associated congenital ichthyosis hydrops fetalis type 3 gaucher disease often less rapidly progressive neurovisceral storage disease various associated clinical courses reported cause death childhood early adulthood race forms gaucher disease panethnic type 1 gaucher disease common lysosomal storage disease prevalent genetic disorder individuals ashkenazi jewish descent type 3 disease common norrbottnian region sweden sex 3 types gaucher disease inherited autosomal recessive traits equal sex distribution age patients type 1 gaucher disease may present childhood hepatosplenomegaly pancytopenia crippling skeletal disease patients diagnosed adulthood present low blood counts bone involvement whereas others diagnosed seventh ninth decades life incidental finding thrombocytopenia splenomegaly many affected individuals never develop signs symptoms seek medical attention types 2 3 gaucher disease typically present early childhood subjects parkinsonism found gaucher disease later age clinical presentation history gaucher disease inherited autosomal recessive trait proband commonly first affected individual family type 1 gaucher disease onset patients type 1 gaucher disease commonly present painless splenomegaly anemia thrombocytopenia may also chronic fatigue hepatomegaly without abnormal liver function test findings bone pain pathologic fractures may bruise easily thrombocytopenia bleeding secondary thrombocytopenia may manifest nosebleeds bruising symptomatic patients splenomegaly progressive become massive children massive splenomegaly may short stature energy expenditure required enlarged organ patients type 1 gaucher disease radiologic evidence skeletal involvement including erlenmeyer flask deformity distal femur early skeletal change clinically apparent bony involvement occurs 20 patients gaucher disease present bone pain pathologic fractures patients symptomatic bone disease lytic lesions develop long bones ribs pelvis osteosclerosis osteopenia may evident early age bone crises severe pain swelling occur individuals type 1 gaucher disease frequently mistaken synovitis osteomyelitis symptoms become apparent occasional patients type 1 gaucher disease develop pulmonary involvement parkinsonism multiple myeloma portal hypertension patients milder presentations gaucher disease diagnosed later life evaluations hematologic skeletal problems found splenomegaly routine examinations patients overtly asymptomatic diagnosis made incidentally evaluation medical problems type 2 gaucher disease type 2 disease rare characterized rapid neurodegenerative course extensive visceral involvement death within first 2 years life patients type may present birth infancy increased tone seizures strabismus organomegaly disruption epidermal layers skin observed skin biopsy findings may manifest onset neurological symptoms may always clinically apparent failure thrive swallowing abnormalities oculomotor apraxia hepatosplenomegaly stridor due laryngospasm typical infants type 2 disease progressive psychomotor degeneration brain stem involvement leads death usually caused aspiration respiratory compromise severe neonatal form present utero perinatally hydrops fetalis congenital ichthyosis type 3 gaucher disease form gaucher disease widely varies present infancy childhood addition organomegaly bony involvement individuals type 3 disease neurologic involvement slowing horizontal saccades oculomotor finding often sole neurologic manifestation patients develop myoclonic epilepsy exhibit learning disabilities develop dementia one rare subgroup patients type 3 gaucher disease present oculomotor findings calcifications mitral aortic valves corneal opacities phenotype associated homozygosity d409h mutant allele another rare subgroup patients type 3 gaucher disease genetic isolate norrbottnian region sweden homozygous l444p mutation individuals present early childhood visceral skeletal involvement oculomotor abnormalities may develop seizures cognitive disabilities dementia specific learning disabilities common children type 3 gaucher disease type 23 intermediate gaucher disease patients present severe neurovisceral manifestations infancy early childhood survive past second year life death occurring mid childhood age 37 patients considered fall within phenotypic continuum types 2 3 physical physical examination findings type 1 disease usually include hepatosplenomegaly splenomegaly may dramatic splenic tip extending pelvis bruising along anterior aspect shins petechiae may evident patients thrombocytopenia short stature wasting occasionally found patients massive organomegaly addition findings patients types 2 3 disease may developmental delay oculomotor abnormalities abnormal neurologic examinations splenomegaly patients present highly variable degrees splenomegaly size increase ranges 5fold 80fold adjusted body weight average spleen approximately 02 body weight absolute size spleen known vary 300 g 10 kg accounting 25 body weight enlargement spleen appears rapid children gaucher disease rapid enlargement spleen adult disease prompt suspicion associated disorder may increase glycolipid turnover hematologic malignancy immune thrombocytopenia autoimmune hemolytic anemia nodules surface spleen may represent regions extramedullary hematopoiesis collections gaucher cells resolving infarcts evidence old infarcts common spleens enlarged 20fold splenic infarcts asymptomatic subcapsular infarcts present localized abdominal pain intracapsular bleeding may also occur hepatomegaly hepatomegaly occurs 50 patients type 1 gaucher disease series 88 patients liver volumes ranged within reference range 87fold predicted normal weight normal 25 body weight median 175 hepatic glucocerebroside levels elevated 23fold 389fold reference range massively enlarged liver usually firm palpation irregular surface cirrhosis portal hypertension uncommon occur small number patients gaucher disease compression sinusoids gaucher cells accentuate portal hypertension death variceal bleeding reported especially prior enzyme replacement therapy minor elevations liver enzyme levels common even patients mildly affected presence jaundice impaired hepatocellular synthetic function poor prognostic indicator jaundice patient gaucher disease usually result infection development chronic hepatitis rarely hepatic decompensation late stages presence unconjugated hyperbilirubinemia suggestive hemolysis elevated levels serum ferritin occasionally found individuals gaucher disease however transferrin saturation usually normal glycolipidladen gaucher cells evident sinusoids liver biopsy findings hepatocytes manifest overt glycolipid storage presumably biliary excretion glucocerebroside fact exogenous glycolipid turnover handled mononuclear phagocytes sparing hepatocytes consistent low incidence liver failure individuals gaucher disease skeletal manifestations skeletal manifestations gaucher disease vary ranging asymptomatic erlenmeyer flask deformity distal femora pathologic fractures vertebral collapse acute bone crises confused acute osteomyelitis painful bone crises result episodes bone infarction leading osteosclerosis analogous occurring sickle cell disease children gaucher disease acute hip lesions misinterpreted leggcalvéperthes disease avascular necrosis hips common complication individuals ages hematologic complications hematologic manifestations gaucher disease include cytopenia acquired coagulopathy due factor xi deficiency however genetic factor xi deficiency common individuals ashkenazi descent may present patients gaucher disease cytopenia develops patients undergone splenectomy reflects advanced marrow infiltration gaucher cells bone marrow failure myelofibrosis occur small number patients numerous immunologic abnormalities common individuals gaucher disease including hypergammaglobulinemia tlymphocyte deficiency spleen impaired neutrophil chemotaxis causes 3 forms gaucher disease caused glucocerebrosidase activity deficiency due mutations gba1 300 different mutant gba1 alleles identified patients gaucher disease screening 6 common gba1 mutations derive recombination glucocerebrosidase pseudogene sequence 15 kb downstream shares 96 sequence homology glucocerebrosidase complex alleles regions pseudogene sequence simple polymerase chain reaction pcr–based mutation detection screening inadequate identified patients genotype phenotype correlations noted specific gaucher presentations example patients type 1 gaucher disease homozygous n370s mutation tend later onset relatively mild course patients type 3 gaucher disease homozygous d409h mutation exhibit rare phenotype involves cardiac calcifications oculomotor abnormalities corneal opacities however clinical presentation patients gaucher disease widely varies frequently cannot fully explained underlying mutations severity vary even among siblings identical genotypes similarly amount residual enzymatic activity accurately predict disease subtype severity exception many mutations identified patients severe type 2 gaucher disease express little enzymatic activity vitro frequently nonsense frameshift recombinant alleles cannot form complete protein essentially null alleles differential diagnoses diagnostic considerations multiple myeloma parkinson disease common patients gaucher disease gba1 lewy body dementia patients lewy body dementia also far likely carry mutation gba1 sphingomyelinase deficiency workup laboratory studies enzyme activity testing diagnosis confirmed measurement glucocerebrosidase activity peripheral blood leukocytes finding less 15 mean normal activity diagnostic heterozygotes generally halfnormal enzyme activity much 20 overlap activity levels healthy controls reported rendering enzymatic testing carrier status unreliable genotype testing molecular diagnosis helpful especially ashkenazi patients 6 gba1 gba1 cbc count obtain cbc count differential assess degree cytopenia liver function enzyme testing minor elevations liver enzyme levels common even patients mildly affected gaucher disease however presence jaundice impaired hepatocellular synthetic function merits full hepatic evaluation coagulations studies monitored associated marker testing angiotensinconverting enzyme levels typically elevated total acid phosphatase ferritin levels monitoring levels another enzyme chitotriosidase also useful monitoring disease except 10 population deficiency protein imaging studies ultrasonography abdomen reveal extent organomegaly mri accurate ultrasonography determining organ size hip mri may useful revealing early avascular necrosis mri may useful delineating degree marrow infiltration evaluating spinal involvement skeletal radiography used detect evaluate skeletal manifestations gaucher disease perform chest radiography evaluate pulmonary manifestations dualenergy xray absorptiometry dexa useful evaluating osteopenia tests echocardiograms helpful evaluating possibility pulmonary hypertension neurononpathic gaucher disease eeg brainstemevoked potential swallow studies neuroophthalmalogic evaluation performed regular intervals procedures bone marrow aspiration past diagnosis confirmed finding classic glycolipidladen macrophages bone marrow aspirate collected hematological abnormalities however aspiration recommended diagnostic tool similar pseudogaucher cells also described individuals disorders including chronic granulocytic leukemia thalassemia hodgkin disease mycobacterium avium– bone marrow aspiration initial diagnostic test blood enzyme test sensitive specific much less invasive liver biopsy liver biopsy occasionally performed assess unexplained hepatomegaly avoided patients diagnosis suspected specific diagnostic test available histologic findings gaucher disease classic glycolipidladen macrophages found bone marrow aspirate liver biopsy samples liver biopsy samples glycolipidladen gaucher cells evident sinusoids hepatocytes manifest overt glycolipid storage presumably biliary excretion glucocerebroside exogenous glycolipid turnover handled mononuclear phagocytes sparing hepatocytes consistent low incidence liver failure individuals gaucher disease pathologic hallmark gaucher disease presence gaucher cells macrophagemonocyte system particularly bone marrow cells 20100 mm diameter characteristic wrinkledpaper appearance resulting intracytoplasmic substrate deposition stain strongly positive periodic acid–schiff histologic evaluation biopsy specimens used firstline diagnostic tool treatment management medical care enzyme replacement enzyme replacement therapy ert type 1 gaucher disease includes imiglucerase cerezyme velaglucerase alfa vpriv taliglucerase alfa elelyso historically patients received recombinant enzyme imiglucerase ert indicated patients type 1 gaucher disease exhibit clinical signs symptoms disease including anemia thrombocytopenia skeletal disease visceromegaly severity rate disease progression widely varies especially adults makes treatment decisions extremely difficult patients generally children present symptomatically rather family history may severe disease manifestations require early treatment presymptomatic treatment ert remains controversial lack prognostic correlation genotype disease severity high cost therapy patients gaucher disease united states treatment ert typically guided geneticist hematologist patients receive periodic followup center familiar gaucher disease possible ert remarkable effect hepatosplenomegaly average overall decrease 25 liver spleen volume 6 months therapy patients anemia hemoglobin levels rise 15 gdl first 46 months therapy additional increase 1 gdl observed subsequent 918 months patients persistent anemia platelet count responds slowly doubling average 1 year hematologic status patients splenomegaly must closely monitored splenectomy still occasionally necessary skeletal disease slowest respond symptomatic improvement described within first year treatment although much longer period ert required achieve radiologic response patients bone crises require pain relief hydration close monitoring bone scan sometimes needed differentiate bone crisis infection effects ert children gaucher disease include increased growth velocity weight gain increased energy levels correction delayed puberty hypermetabolic state response patients ert widely varies correlate genotype disease severity splenectomy age however number factors including cirrhosis portal hypertension extensive infarction fibrosis spleen lung involvement portend poor response therapy symptoms patients gaucher disease associated hematologic malignancies respond relatively poorly ert overcome difficulties increased dosage frequency enzyme infusions attempted symptoms patients decompensated liver disease appear respond well ert patients remain risk lifethreatening hemorrhage due variceal bleeding evidence shows ert results neurologic improvement although enzyme affects visceral involvement types 2 3 disease associated brain involvement may persist progress glucosylceramide synthase inhibitors glucosylceramide synthase inhibitors include miglustat zavesca eliglustat cerdelga miglustat approved 2003 monotherapy treatment adults mildtomoderate type 1 gaucher disease enzyme replacement therapy therapeutic option eliglustat approved august 2014 firstline treatment longterm treatment adults gaucher disease type 1 dose eliglustat determined establishing patient’s cyp2d6 phenotype ie extensive metabolizers em intermediate metabolizers im poor metabolizers pm approval based efficacy data 2 positive phase 3 studies involving 199 patients one study involved patients new therapy trial 1 involved patients switching approved enzyme replacement therapies trial 2 efficacy data 4 years cerdelga phase 2 study also contributed approval improvements study participants observed spleen size platelet levels hemoglobin levels liver volume noninferiority enzyme replacement therapy imiglucerase established trial 2 surgical care partial total splenectomy advocated treatment patients gaucher disease however availability ert procedure longer necessary patients addition patients gaucher disease may require hip replacements orthopedic procedures treat skeletal disease best undertaken patient undergone several months ert consultations consultations following specialists indicated medical geneticist hematologist orthopedist neurologist neuroophthalmologist diet dietary manipulation found affect disease progression activity patients massive splenomegaly severe thrombocytopenia avoid contact sports activities place risk splenic rupture bleeding medication medication summary several therapies approved us food drug administration fda treatment type 1 gaucher disease enzyme replacement therapy ert glucocerebrosidase purified human placenta fda approved 1991 followed approval 1994 recombinant form enzyme produced cultured chinese hamster ovary cho cells marketed imiglucerase cerezyme worldwide 4000 patients gaucher disease received ert safe well tolerated 2010 alternate form ert approved form recombinant enzyme produced cultured human cells marketed velaglucerase alfa vpriv glucosylceramide synthase inhibitors miglustat eliglustat approved adults type 1 gaucher disease 2003 2014 respectively approximately 1015 patients gaucher disease treated imiglucerase develop antibodies enzyme protein develop significant allergic reactions controlled premedication hydrocortisone antihistamines antibodies immunoglobulin g igg mostly igg1 subclass patients gaucher disease developed antibodies impair enzyme activity enzyme replacement therapy class summary cases ert highly effective reversing visceral hematologic manifestations type 1 gaucher disease recombinant betaglucocerebrosidase imiglucerase cerezyme replaced original tissuederived product alglucerase ceredase alglucerase orphan drug still manufactured genzyme corporation extremely limited basis patients unable tolerate newer recombinant product presymptomatic use controversial high cost extremely variable clinical course imiglucerase approved children aged 2 years older velaglucerase taliglucerase approved children aged 4 years older imiglucerase cerezyme recombinantderived analog betaglucocerebrosidase produced mammalian cell culture chemically modified mannose termination glycosylated amino acids catalyzes hydrolytic cleavage glucocerebroside glycoprotein glucose ceramide within lysosomes phagocytic cells reticuloendothelial system treatment recombinant enzyme improves anemia thrombocytopenia reduces spleen liver size decreases cachexia velaglucerase alfa vpriv hydrolytic lysosomal glucocerebrosidespecific enzyme indicated longterm enzyme replacement therapy type 1 gaucher disease improves symptoms associated disease including anemia thrombocytopenia increased spleen liver size cachexia taliglucerase alfa elelyso taliglucerase plantbased recombinant enzyme catalyzes hydrolysis glucocerebroside glucose ceramide results reduced spleen liver enlargement increased rbcs platelets glucosylceramide synthase inhibitors class summary agents inhibit enzyme glucosylceramide synthase initial enzyme series reactions result synthesis glycosphingolipids including glucocerebroside goal treatment reduce rate glucocerebroside biosynthesis amount reduced level allows residual activity deficient glucocerebrosidase enzyme effective substrate reduction therapy miglustat zavesca indicated type 1 gaucher disease patients ert therapeutic option reduces gsl production inhibiting glucosylceramide synthase reduces spleen liver volume increases hemoglobin platelet counts eliglustat cerdelga eliglustat specific inhibitor glucosylceramide synthase thereby reducing production glucosylceramide indicated longterm treatment adults gaucher disease type 1 cyp2d6 extensive metabolizers em intermediate metabolizers im poor metabolizers pm detected fdacleared test phenotype dosage based establishing patients cyp2d6 metabolizer status followup outpatient care symptomatic patients gaucher disease receive enzyme replacement therapy ert provided outpatient basis monitoring patients receive miglustat zavesca every 6 months possible development peripheral neuropathy recommended patients osteoporosis responded favorably bisphosphonates inpatient care patients gaucher disease bone crises may require admission pain relief patients severe hematologic manifestations may episodes bleeding require inpatient treatment deterrenceprevention gaucher disease inherited autosomal recessive trait although panethnic gaucher disease common individuals ashkenazi jewish although carrierscreening programs population established centers identify couples risk child affected gaucher disease testing must offered conjunction genetic counseling provide couples risk even asymptomatic individuals description range associated phenotypes options include prenatal diagnosis newborn screening performed gaucher disease complications bone crises may occur secondarily infarcts avascular necrosis hip uncommon splenic rupture result trauma cirrhosis rare complication rarely pulmonary infiltration gaucher cells may manifest overt lung disease may present pulmonary infiltrates lung consolidation pattern especially common patients type 2 disease parenchymal infiltration fibrosis described children type 3 disease intrapulmonary vascular dilatation presence absence portal hypertension also described patients gaucher disease resulting hypoxic lung disease adult patients pulmonary hypertension absence infiltrative disease described patients may follow inexorable progressive course despite therapy hematologic abnormalities including anemia thrombocytopenia leukopenia common individuals gaucher disease immunologic abnormalities including hypergammaglobulinemia tlymphocyte deficiency spleen impaired neutrophil chemotaxis also common malignancy multiple myeloma common individuals gaucher disease new evidence suggests mutations gene glucocerebrosidase risk factor development parkinson disease prognosis many individuals gaucher disease manifestations normal life expectancy without intervention prognosis symptomatic patients type 1 type 3 gaucher disease receive treatment good decrease organomegaly eventual rise hemoglobin levels platelet counts recent study estimated life expectancy birth patients type 1 gaucher disease 68 years compared 77 years reference population skeletal disease slow respond ert widely varies patients describe symptomatic improvement within first year treatment although much longer period ert required achieve radiologic response patient education patients gaucher disease families require education regarding disease manifestations variability symptoms disease progression potential complications addition counseled regarding genetic risks start media autosomal recessive inheritance pattern autosomal recessive inheritance pattern author ellen sidransky md senior investigator chief section molecular neurogenetics medical genetics branch national human genome research institute nih ellen sidransky md member following medical societies american society human genetics international parkinson movement disorder society society pediatric research society inherited metabolic disorders disclosure nothing disclose pharmacy editor mary l windle pharmd adjunct associate professor university nebraska medical center college pharmacy editorinchief medscape drug reference disclosure nothing disclose chief editor maria descartes md professor department human genetics department pediatrics university alabama birmingham school medicine maria descartes md member following medical societies american academy pediatrics american college medical genetics genomics american medical association american society human genetics society inherited metabolic disorders international skeletal dysplasia society southeastern regional genetics group disclosure nothing disclose additional contributors robert steiner md executive director marshfield clinic research foundation chief science officer marshfield clinic clinical professor university wisconsin school medicine public health robert steiner md member following medical societies american academy pediatrics american association advancement science society pediatric research western society pediatric research society inherited metabolic disorders society study inborn errors metabolism american college medical genetics genomics american society human genetics disclosure nothing disclose acknowledgements author acknosledges assistance mary e lamarca coauthored initial version chapter prior death 2010 harrison l evidence mounting eliglustat gauchers disease medscape medical news available httpwwwmedscapecomviewarticle834451 vitner eb farfelbecker eilam r biton futerman ah contribution brain inflammation neuronal cell death neuronopathic forms gauchers disease brain medline grabowski ga phenotype diagnosis treatment gauchers disease lancet medline sidransky e nalls aasly jo aharonperetz j annesi g barbosa er multicenter analysis glucocerebrosidase mutations parkinsons disease n engl j med medline full text siebert sidransky e westbroek w glucocerebrosidase shaking synucleinopathies brain medline full text nalls duran r lopez g kurzawaakanbi mckeith ig chinnery pf et al multicenter study glucocerebrosidase mutations dementia lewy bodies jama neurol medline full text sidransky e pastores gm mori dosing enzyme replacement therapy gaucher disease older wiser genet med medline full text cerdelga eliglustat prescribing information package insert ida industrial park old kilmeaden road waterford ireland genzyme ireland ltd august 2014 lowes r medscape medical news fda clears eliglustat cerdelga gaucher disease available httpwwwmedscapecomviewarticle830172 zimran altarescu g phillips attias jmoudiak deeb phase iii extension study velaglucerase alfa geneactivatedtm human glucocerebrosidase replacement therapy adults type 1 gaucher disease 48month experience blood medline sidransky e pastores gm mori dosing enzyme replacement therapy gaucher disease older wiser genet med medline full text hollak ce evidencebased review potential benefits taliglucerase alfa treatment patients gaucher disease core evid medline full text andersson h kaplan p kacena k yee j eightyear clinical outcomes longterm enzyme replacement therapy 884 children gaucher disease type 1 pediatrics medline westbroek w gustafson sidransky e exploring link glucocerebrosidase mutations parkinsonism trends mol med medline full text hruska ks lamarca scott cr sidransky e gaucher disease mutation polymorphism spectrum glucocerebrosidase gene gba hum mutat medline weinreb nj deegan p kacena ka mistry p pastores gm velentgas p et al life expectancy gaucher disease type 1 j hematol medline mamopoulos hughes da tuck sm mehta ab gaucher disease pregnancy j obstet gynaecol medline ah futerman zimran gaucher disease amato stachiw clarke jt rivard ge gaucher disease variability phenotype among siblings j inherit metab dis medline andersson hc charrow j kaplan p et al individualization longterm enzyme replacement therapy gaucher disease genet med medline barton nw brady ro dambrosia jm et al replacement therapy inherited enzyme deficiencymacrophagetargeted glucocerebrosidase gauchers disease n engl j med medline beutler e lysosomal storage diseases natural history ethical economic aspects mol genet metab medline beutler e gelbart scott cr hematologically important mutations gaucher disease blood cells mol dis medline beutler e grabowski ga cr scriver et al eds metabolic molecular bases inherited disease mcgrawhill new york bohlega kambouris shahid et al gaucher disease oculomotor apraxia cardiovascular calcification gaucher type iiic neurology medline charrow j andersson hc kaplan p et al enzyme replacement therapy monitoring children type 1 gaucher disease consensus recommendations j pediatr medline cox tm aerts jm andria g et al role iminosugar nbutyldeoxynojirimycin miglustat management type nonneuronopathic gaucher disease position statement j inherit metab dis medline depaolo j gokeralpan samaddar lopez g sidransky e association mutations lysosomal protein glucocerebrosidase parkinsonism mov disord medline full text futerman ah zimran gaucher disease crc press boca raton fl gokeralpan schiffmann r park jk et al phenotypic continuum neuronopathic gaucher disease intermediate phenotype type 2 type 3 j pediatr medline grabowski ga kacena k cole ja et al doseresponse relationships enzyme replacement therapy imiglucerasealglucerase patients gaucher disease type 1 genet med medline grabowski ga leslie n wenstrup r enzyme therapy gaucher disease first 5 years blood rev medline itzchaki lebel e dweck et al orthopedic considerations gaucher disease since advent enzyme replacement therapy acta orthop scand medline jmoudiak futerman ah gaucher disease pathological mechanisms modern management br j haematol medline koprivica v stone dl park jk et al analysis classification 304 mutant alleles patients type 1 type 3 gaucher disease j hum genet medline full text guideline langlois wilson rd carrier screening genetic disorders individuals ashkenazi jewish descent j obstet gynaecol medline lwin orvisky e gokeralpan et al glucocerebrosidase mutations subjects parkinsonism mol genet metab medline mistry pk abrahamov practical approach diagnosis management gauchers disease baillieres clin haematol medline mitsui j mizuta toyoda ashida r et al mutations gaucher disease confer high susceptibility parkinson disease arch neurol medline nih technology assessment panel gaucher disease gaucher disease current issues diagnosis treatment jama medline park jk orvisky e tayebi n et al myoclonic epilepsy gaucher disease genotypephenotype insights rare patient subgroup pediatr res medline sibille eng cm kim sj et al phenotypegenotype correlations gaucher disease type clinical therapeutic implications j hum genet medline full text sidransky e gaucher disease complexity simple disorder mol genet metab medline svennerholm l erikson groth cg et al norrbottnian type gaucher diseaseclinical biochemical molecular biology aspects successful treatment bone marrow transplantation dev neurosci medline tayebi n stone dl sidransky e type 2 gaucher disease expanding phenotype mol genet metab medline tayebi n stubblefield bk park jk et al reciprocal nonreciprocal recombination glucocerebrosidase gene region implications complexity gaucher disease j hum genet medline weinreb nj aggio mc andersson hc et al gaucher disease type 1 revised recommendations evaluations monitoring adult patients semin hematol medline wenstrup rj rocaespiau weinreb nj bembi b skeletal aspects gaucher disease review br j radiol medline full text zimran treat gaucher disease blood medline zimran altarescu g rudensky b et al survey hematological aspects gaucher disease hematology medline

